Sentence,class,file
Planta 2013; 237:481- 95; PMID:22968911 ; http://dx.doi.org/10.1007/ s00425-012-1754-3 18.,Non-OADS,/arxiv_data1/oa_pdf/5e/a9/psb-8-e25389.PMC4002602.pdf
Plant Cell 2006; 18:3106-20; PMID:17114352 ;  http://dx.doi.org/10.1105/tpc.106.045641 19.,OADS,/arxiv_data1/oa_pdf/5e/a9/psb-8-e25389.PMC4002602.pdf
BMC Genomics 2007; 8:12; PMID:17212830 ;  http://dx.doi.org/10.1186/1471-2164-8-12 20.,OADS,/arxiv_data1/oa_pdf/5e/a9/psb-8-e25389.PMC4002602.pdf
Science 2011; 331:1436-9; PMID :21415351 ;  http://dx.doi.org/10.1126/science.1201248,Non-OADS,/arxiv_data1/oa_pdf/5e/a9/psb-8-e25389.PMC4002602.pdf
Plant J 2010; 61:122-33;  PMID:19807880 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5e/a9/psb-8-e25389.PMC4002602.pdf
Plant J  2012; 69:47-56;  PMID:21883556 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5e/a9/psb-8-e25389.PMC4002602.pdf
Plant Cell 2010; 22:2537-44; PMID:20693355 ; http://dx.doi.org/10.1105/ tpc.110.075309 25.,OADS,/arxiv_data1/oa_pdf/5e/a9/psb-8-e25389.PMC4002602.pdf
Ann Bot  2008; 103:127-36;  PMID:18974099 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5e/a9/psb-8-e25389.PMC4002602.pdf
Plant Physiol 2009; 149:111-6;  PMID:19005087 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5e/a9/psb-8-e25389.PMC4002602.pdf
"Plant Signal Behav 2013; 8: e25388; http://dx.doi.org/10.4161/psb.25388Introduction The genus Lepidium  is one of the largest genera of the mono - phyletic Brassicaceae family with more than 150 species dis - tributed worldwide.1 Lepidium latifolium  (commonly called as  Pepperweed, Pepperwort or Peppergrass) is an invasive plant2 of  western Asia and southeastern Europe and currently distributed  from Norway in the west to up to western Himalayas in the east.3  In high-altitude cold-arid Ladakh area of Western Himalayas,  leaves of Lepidium latifolium  are consumed as vegetable and salad  by the natives.4 In addition to its agronomic, economic and eco - logical importance, Lepidium  is also known for its high medici - nal value and used in treatment of stomach related disorders.5 Each mature plant of Lepidium  produces thousands of seeds  each year,6 however only a small percentage of seeds survive.7 The  inherent dormancy in the Lepidium  seeds further delays the onset  of advanced generation by a few months.",Non-OADS,/arxiv_data1/oa_pdf/0e/66/psb-8-e25388.PMC4002603.pdf
Am J Bot 2001; 88:2051-63;  PMID:21669637; http://dx.doi.org/10.2307/3558431 2.,Non-OADS,/arxiv_data1/oa_pdf/0e/66/psb-8-e25388.PMC4002603.pdf
Crop Prot 2007; 26:189-97;  http://dx.doi.org/10.1016/j.cropro.2005.07.014 8.,OADS,/arxiv_data1/oa_pdf/0e/66/psb-8-e25388.PMC4002603.pdf
Physiol Mol Biol Plants 2011; 17:403- 6; PMID:23573034; http://dx.doi.org/10.1007/ s12298-011-0082-6 9.,Non-OADS,/arxiv_data1/oa_pdf/0e/66/psb-8-e25388.PMC4002603.pdf
J Agron Crop Sci 2009; 195:237-46; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/66/psb-8-e25388.PMC4002603.pdf
Curr Genomics 2009; 10:269-80; PMID:19949548;  http://dx.doi.org/10.2174/138920209788488535 26.,OADS,/arxiv_data1/oa_pdf/0e/66/psb-8-e25388.PMC4002603.pdf
Nature 1965; 207:216-7; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/66/psb-8-e25388.PMC4002603.pdf
Plant Sci 2005; 168:823-9;  http://dx.doi.org/10.1016/j.plantsci.2004.10.015 20.,OADS,/arxiv_data1/oa_pdf/0e/66/psb-8-e25388.PMC4002603.pdf
J Plant Physiol  2008; 165:623-30; PMID:17723253; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/66/psb-8-e25388.PMC4002603.pdf
Plant Physiol  2009; 149:88-95; PMID:19126699; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/66/psb-8-e25388.PMC4002603.pdf
Acta Physiol Plant 2010; 32:205-10;  http://dx.doi.org/10.1007/s11738-009-0382-4 14.,Non-OADS,/arxiv_data1/oa_pdf/0e/66/psb-8-e25388.PMC4002603.pdf
DRE-binding transcription fac - tor gene ( LlaDREB1b ) is regulated by various abi - otic stresses in Lepidium latifolium  L. Mol Biol Rep  2013; 40:2573-80; PMID:23242653; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/66/psb-8-e25388.PMC4002603.pdf
Seed  Sci Res 2004; 14:345-53; http://dx.doi.org/10.1079/ SSR2004188 17.,OADS,/arxiv_data1/oa_pdf/0e/66/psb-8-e25388.PMC4002603.pdf
"PLoS O ne2013; 8:e66160;  Pmid :23750279; http://dx.doi.org/10.1371/jour - nal.pone.0066160Keywords:  annexin, AnxGb6, F-actin,  fiber elongation, CDPK (calcium   dependentprotein kinase) Submitted: 06/27/13Accepted: 06/30/13 Citation: Huang Y, Deng T, Zuo K. Cotton annexin  proteins participate in the establishment of fiber cell elongation scaffold.",OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Plant Signal Behav 2013; 8:e25601; http://dx.doi.org/10.4161/psb.25601*Correspondence to: Kaijing Zuo;  Email: kjzuo@sjtu.edu.cnCotton plant is one of the most impor - tant economic crops in the world  which supplies natural fiber for textile  industry.,Non-OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Int Rev Cytol 1984; 89:65-113; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Plant Physiol 2001; 127:1361- 6; PMID:11743074; http://dx.doi.org/10.1104/ pp.010724 3.,Non-OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Dev Biol 2000; 227:618-32; PMID:11071779; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Plant J 2008; 54:863-75; PMID:18298672; http://dx.doi.org/10.1111/j.1365-313X.2008.03451.x 6.,OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
PLoS ONE  2009; 4:e5744; PMID:19478943; http://dx.doi.org/10.1371/journal.pone.0005744 7.,Non-OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
In Vitro Cell Dev Biol Plant 1998; 34:173-80; http://dx.doi.org/10.1007/ BF02822704 8.,Non-OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Protoplasma 1990; 159:44-59; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Plant Cell 2005; 17:859-75; PMID:15722467; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Plant Biotechnol J 2009; 7:13-23; PMID:18761653; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
22 AnxGb6 is predicted  to have several phosphorylation sites like Ser 113 and Ser169 by searching phosphoryla - tion site on ExPASy (http://www.expasy.org/).,Non-OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
FASEB J 2009; 23:4000-10;  PMID:19625660; http://dx.doi.org/10.1096/fj.09- 131391 20.,Non-OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Plant J 1993; 3:763-72; PMID:8401609;  http://dx.doi.org/10.1111/j.1365-313X.1993.00763.x 22.,OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Planta 2007;  225:783-99; PMID:16947054; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Mol  Cell Proteomics 2010; 9:2019-33; PMID:20525998;  http://dx.doi.org/10.1074/mcp.M110.000349 16.,Non-OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Plant Physiol  2013; 162:675-88; PMID:23606596; http://dx.doi.org/10.1104/pp.113.215277 17.,Non-OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Plant J 2013; PMID:23647215; http://dx.doi.org/10.1111/ tpj.12227 18.,OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
New Phytol 2012; 196:695-712;  PMID:22994944; http://dx.doi.org/10.1111/j.1469- 8137.2012.04308.x11.,Non-OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Plant Cell Physiol 2010; 51:1276-90; PMID:20558432; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
PLoS ONE  2013; 8:e66160; PMID:23750279; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
J  Proteome Res 2010; 9:1076-87; PMID:19954254;  http://dx.doi.org/10.1021/pr900975t 14.,Non-OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
J Biol Chem 1999; 274:35191- 5; PMID:10575003; http://dx.doi.org/10.1074/ jbc.274.49.35191,OADS,/arxiv_data1/oa_pdf/de/49/psb-8-e25601.PMC4002604.pdf
Plant Signal Behav 2013; 8: e25565; http://dx.doi.org/10.4161/psb.25565AtALMT1  (Arabidopsis thaliana ALuminum activated Malate Transporter 1 ) encodes an Arabidopsis thaliana  malate  transporter that has a pleiotropic role in Arabidopsis  stress tolerance.,Non-OADS,/arxiv_data1/oa_pdf/bf/82/psb-8-e25565.PMC4002621.pdf
Planta 1999; 208:373-82; http://dx.doi.org/10.1007/ s0042500505723.,OADS,/arxiv_data1/oa_pdf/bf/82/psb-8-e25565.PMC4002621.pdf
Planta 1995; 196:788-95;  http://dx.doi.org/10.1007/BF01106775 4.,Non-OADS,/arxiv_data1/oa_pdf/bf/82/psb-8-e25565.PMC4002621.pdf
Plant Physiol 2008; 148:1547-56;  PMID:18820082 ;  http://dx.doi.org/10.1104/pp.108.1276135.,Non-OADS,/arxiv_data1/oa_pdf/bf/82/psb-8-e25565.PMC4002621.pdf
Proc Natl Acad Sci USA 2006;  103:9738-43;  PMID:16740662 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/82/psb-8-e25565.PMC4002621.pdf
Plant Physiol 2007; 145:843-52;  PMID:17885092 ;  http://dx.doi.org/10.1104/pp.107.102335 Â©2013 Landes Bioscience.,Non-OADS,/arxiv_data1/oa_pdf/bf/82/psb-8-e25565.PMC4002621.pdf
Plant Physiol 2012; 160:1642-61;  PMID:22972705 ;  http://dx.doi.org/10.1104/pp.112.2003869.,Non-OADS,/arxiv_data1/oa_pdf/bf/82/psb-8-e25565.PMC4002621.pdf
Proc Natl Acad Sci USA 2004; 101:15249- 54; PMID :15471989 ; http://dx.doi.org/10.1073/ pnas.0406258101 10.,OADS,/arxiv_data1/oa_pdf/bf/82/psb-8-e25565.PMC4002621.pdf
Plant Physiol 2009; 150:281- 94; PMID:19321711 ; http://dx.doi.org/10.1104/ pp.108.134700 12.,Non-OADS,/arxiv_data1/oa_pdf/bf/82/psb-8-e25565.PMC4002621.pdf
Plant Signal Behav 2013; 8:e25478http://dx.doi.org/10.4161/ psb.25478Plant cell wall synthesis requires a number of different nucleotide sugars which provide the building blocks of the  different polymers.,Non-OADS,/arxiv_data1/oa_pdf/10/36/psb-8-e25478.PMC4002622.pdf
Annu Rev Plant Biol 2011; 62:127-55;  PMID:21370975 ; http://dx.doi.org/10.1146/ annurev-arplant-042110-103918 2.,OADS,/arxiv_data1/oa_pdf/10/36/psb-8-e25478.PMC4002622.pdf
Plant Cell 2003; 15:523-31;  PMID:12566589 ; http://dx.doi.org/10.1105/ tpc.0084253.,OADS,/arxiv_data1/oa_pdf/10/36/psb-8-e25478.PMC4002622.pdf
Science  1996; 272:1808-10;  PMID:8650583 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/36/psb-8-e25478.PMC4002622.pdf
Plant Physiol  2010 ; 153:915-24 ;  PMID:20442274 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/36/psb-8-e25478.PMC4002622.pdf
J  Biol Chem 2004; 279:45728-36; PMID :15326166 ;  http://dx.doi.org/10.1074/jbc.M408716200dissect this observation we analyzed the activity of glucurono - kinase12 as a representative enzyme of the sugar-1-kinase group  and of USP in transgenic lines showing a downregulation of  USP by expression of a miRNA targeted against the USP  gene.,OADS,/arxiv_data1/oa_pdf/10/36/psb-8-e25478.PMC4002622.pdf
a mi rna 319 targeting USP  was designed according to  (http://wmd3.weigelworld.org/cgi-bin/webapp.cgi).,Non-OADS,/arxiv_data1/oa_pdf/10/36/psb-8-e25478.PMC4002622.pdf
Plant Physiol Biochem 2006; 44:171-80; PMID:16757173 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/10/36/psb-8-e25478.PMC4002622.pdf
Biosci Biotechnol Biochem 2007; 71:761-71;  PMID:17341835 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/36/psb-8-e25478.PMC4002622.pdf
Anal Biochem 2006; 352:182-7;   PMID:16581011 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/10/36/psb-8-e25478.PMC4002622.pdf
Plant J 2013; 74:239-47; PMID:23373795 ; http://dx.doi.org/10.1111/ tpj.12116 12.,OADS,/arxiv_data1/oa_pdf/10/36/psb-8-e25478.PMC4002622.pdf
J Biol Chem  2010; 285:2902-10;  PMID:19951951 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/36/psb-8-e25478.PMC4002622.pdf
Anal Biochem 2009; 388:254- 9; PMID:19272347 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/10/36/psb-8-e25478.PMC4002622.pdf
"OncoImmunology 2014; 3:e27680; http://dx.doi.org/10.4161/onci.27680Eomesodermin is required for antitumor immunity  mediated by 4-1BB-agonist immunotherapy changÂ  song1, KavithaÂ  sadashivaiah1, akiÂ Furusawa1, eduardoÂ Davila2, KojiÂ Tamada3, andÂ a rnobÂ Banerjee1,* 1Program in Oncology; g reenebaum c ancer c enter; c enter for s tem c ell r esearch and r egenerative Medicine; Department of Medicine; University of Maryland s chool of  Medicine; Baltimore, MD U sa; 2Department of Otolaryngology; University of Maryland s chool of Medicine; Baltimore, MD U sa; 3Department of i mmunology and c ellular  signal a nalysis; Yamaguchi University s chool of Medicine; Ube, Japan Keywords:  T cells, tumor immunotherapy, 4-1BB, eomesodermin, PD-1, Lag3 Abbreviations:  4-1BB/TNFRSF9, tumor necrosis factor receptor superfamily member 9; Î± 4-1BB, agonistic anti-4-1BB antibody;  Eomes, eomesodermin; Lag3, lymphocyte-activation gene 3; LCMV, lymphocytic choriomeningitis virus; PD-1, programmed cell  death-1; Tbet, T-bet/Tbx21, T-box 21; TNFRS, tumor necrosis family receptor superfamily cD8+ T cells in progressing tumors frequently fail to mount an effective antitumor response often in association with  the expression of inhibitory receptors, including programmed cell death-1 (PD-1) and lymphocyte-activation gene 3  (lag3).",Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Clin Cancer Res 2013; 19:1044-53;  PMID:23460535 ; http://dx.doi.org/10.1158/1078- 0432.CCR-12-2065 2.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Curr Opin Immunol  2013; 25:230-7;  PMID:23414607 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Mol Cancer Ther 2012; 11:1062-70;  PMID:22532596 ; http://dx.doi.org/10.1158/1535- 7163.MCT-11-0677 4.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Clin Exp Immunol  2009; 157:9-19;  PMID:19659765 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Semin Oncol 2010; 37:508- 16; PMID:21074066 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
PLoS One  2010; 5:e11003;  PMID:20543982 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Immunol Rev 2009; 229:192-215;  PMID:19426223 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
J Immunol 2010; 185:4988-92; PMID:20935204 ; http://dx.doi.org/10.4049/ jimmunol.1002042 14.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Science 2008; 321:408- 11; PMID:18635804 ; http://dx.doi.org/10.1126/ science.115980615.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Science 2012; 338:1220- 5; PMID:23197535 ; http://dx.doi.org/10.1126/ science.1229620 17.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Cell 1988; 54:777- 85; PMID:3261634 ; http://dx.doi.org/10.1016/ S0092-8674(88)91043-4 18.,OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
J Clin Invest  2002; 109:651-9;  PMID:11877473 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Cell 1994; 76:17-27;  PMID:8287475 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
PLoS One 2011; 6:e19499; PMID :21559358 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
J Immunol 2011; 187:3555-64;  PMID:21880986 ;  http://dx.doi.org/10.4049/jimmunol.1101244 25.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Age (Dordr) 2009; 31:285- 91; PMID:19479342 ; http://dx.doi.org/10.1007/ s11357-009-9100-9 26.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Int Immunol 2007; 19:391-400; PMID:17307799 ;  http://dx.doi.org/10.1093/intimm/dxm004 27.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Nat Med 1997; 3:682-5; PMID:9176498 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Immunol Rev 2011; 244:197-217; PMID:22017440 ;  http://dx.doi.org/10.1111/j.1600-065X.2011.01063.x 30.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Immunol Rev 2008;  222:277-86;  PMID:18364008 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Cancer Res 2004; 64:8411-9;  PMID :15548712 ; http://dx.doi.org/10.1158/0008- 5472.CAN-04-0590 32.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Cancer Res 2007; 67:8891-9;  PMID:17875731 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Cancer Res 2007; 67:7875-84;  PMID:17699794 ; http://dx.doi.org/10.1158/0008- 5472.CAN-06-1744 34.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Mol Cancer Ther 2009; 8:469-78;  PMID:19190115 ; http://dx.doi.org/10.1158/1535- 7163.MCT-08-0993 35.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Cell Immunol 1998; 190:167-72; PMID:9878117 ;  http://dx.doi.org/10.1006/cimm.1998.1396 36.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
J  Natl Cancer Inst 2000; 92:931-6; PMID:10841829 ;  http://dx.doi.org/10.1093/jnci/92.11.931 37.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Blood 2009; 114:3431-8; PMID:19641184 ; http://dx.doi.org/10.1182/ blood-2009-05-223958 38.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Eur  J Immunol 2009; 39:2424-36; PMID:19662633 ;  http://dx.doi.org/10.1002/eji.200838958 39.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Int J Biol Sci 2007; 3:455- 62; PMID :18071585 ; http://dx.doi.org/10.7150/ ijbs.3.455 40.,OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
J  Immunol 2010; 185:3174-83;  PMID:20713880 ;  http://dx.doi.org/10.4049/jimmunol.1000749 41.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Eur J Immunol 2009; 39:883-93; PMID:19224637 ; http://dx.doi.org/10.1002/ eji.200838770,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Ann N Y Acad Sci  2013; 1291:1-13;  PMID:23772560 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Clin Cancer Res 2013; 19:997-1008;  PMID:23460531 ; http://dx.doi.org/10.1158/1078- 0432.CCR-12-2214 45.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
J Immunol  2011; 187:1634-42;  PMID:21742975 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Clin  Cancer Res 2007; 13:1823-30; PMID:17325342 ;  http://dx.doi.org/10.1158/1078-0432.CCR-06-2154 47.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Nat Immunol  2011; 12:663-71;  PMID:21623380 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
J  Immunol 2013; 190:4899-909; PMID:23536636 ;  http://dx.doi.org/10.4049/jimmunol.1300271 49.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Oncoimmunology 2013; 2:e23849; PMID:23734331 ; http://dx.doi.org/10.4161/ onci.2384950.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Curr Top Microbiol Immunol  2011; 344:269-78;  PMID:21086108 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Oncoimmunology 2012; 1:369-71; PMID:22737618 ; http://dx.doi.org/10.4161/ onci.18342 52.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
J Immunother  2011; 34:236-50;  PMID:21389874 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/21/onci-3-e27680.PMC4002624.pdf
Plant Signal Behav 2013; 8:e25422; http://dx.doi.org/10.4161/psb.25422,OADS,/arxiv_data1/oa_pdf/fb/28/psb-8-e25422.PMC4002625.pdf
Science 2005; 309:86; PMID:15994532;  http://dx.doi.org/10.1126/science.309.5731.86 2.,OADS,/arxiv_data1/oa_pdf/fb/28/psb-8-e25422.PMC4002625.pdf
Plant Physiol 2003; 133:653- 63; PMID:14512519; http://dx.doi.org/10.1104/pp.103.023499 3.,Non-OADS,/arxiv_data1/oa_pdf/fb/28/psb-8-e25422.PMC4002625.pdf
Plant Physiol 2008; 146:1663-72; PMID:18305206; http://dx.doi.org/10.1104/ pp.108.1158324.,Non-OADS,/arxiv_data1/oa_pdf/fb/28/psb-8-e25422.PMC4002625.pdf
In Vitro Cell Dev  Biol Plant 2001; 37:62-7; http://dx.doi.org/10.1007/ s11627-001-0012-3 5.,OADS,/arxiv_data1/oa_pdf/fb/28/psb-8-e25422.PMC4002625.pdf
Plant Physiol 2013; 161:2113-27; PMID:23457229; http://dx.doi.org/10.1104/ pp.113.2162757.,OADS,/arxiv_data1/oa_pdf/fb/28/psb-8-e25422.PMC4002625.pdf
Plant Physiol 2008; 146:1622-36; PMID:18235037; http://dx.doi.org/10.1104/ pp.107.110379 8.,Non-OADS,/arxiv_data1/oa_pdf/fb/28/psb-8-e25422.PMC4002625.pdf
"BMC Plant Biol 2012; 12:244; PMID:22269060;  http://dx.doi.org/10.1186/1471-2229-12-244Figure 4.  acc , a precursor to ethylene, affects Arabidopsis  Sam S e.  means and standard error of the mean are shown for two biological  replicates of the experiment (n = 3â4 flasks scored per replicate).",OADS,/arxiv_data1/oa_pdf/fb/28/psb-8-e25422.PMC4002625.pdf
Funct Integr Genomics 2006; 6:60-70;  PMID:16317577; http://dx.doi.org/10.1007/s10142- 005-0012-1 10.,OADS,/arxiv_data1/oa_pdf/fb/28/psb-8-e25422.PMC4002625.pdf
Plant Cell  2004; 16:1206-19; PMID:15084721; http://dx.doi.org/10.1105/tpc.021261 12.,OADS,/arxiv_data1/oa_pdf/fb/28/psb-8-e25422.PMC4002625.pdf
Plant Sci 2008; 175:71-86; http://dx.doi.org/10.1016/j.plantsci.2008.02.001,OADS,/arxiv_data1/oa_pdf/fb/28/psb-8-e25422.PMC4002625.pdf
"http://informahealthcare.com/dre ISSN 0963-8288 print/ISSN 1464-5165 online Disabil Rehabil, 2014; 36(7): 600â607 !2014 Informa UK Ltd. DOI: 10.3109/09638288.2013.805257 RESEARCH PAPER The experience of living with knee osteoarthritis: exploring illness and treatment beliefs through thematic analysis Nektaria Pouli, Roshan Das Nair, Nadina Berrice Lincoln, and David Walsh Arthritis Research UK Pain Centre, University of Nottingham, Nottingham, UK Abstract Purpose : Knee osteoarthritis (OA) is a major cause of disability in older adults.",Non-OADS,/arxiv_data1/oa_pdf/c9/8b/DRE-36-600.PMC4002631.pdf
Available from: http://www.nhs.uk/Conditions/ Osteoarthritis/Pages/treatment.aspx [last assessed 1 Nov 2011].,Non-OADS,/arxiv_data1/oa_pdf/c9/8b/DRE-36-600.PMC4002631.pdf
"http://informahealthcare.com/iht ISSN: 0895-8378 (print), 1091-7691 (electronic) Inhal Toxicol, 2014; 26(5): 259â270 !2014 Informa Healthcare USA, Inc. DOI: 10.3109/08958378.2014.881940 REVIEW ARTICLE Perlite toxicology and epidemiology â a review L. Daniel Maxim1, Ron Niebo1, and Ernest E. McConnell2 1Everest Consulting Associates, Cranbury, NJ, USA and2ToxPath Inc., Raleigh, NC, USA Abstract Perlite is a generic name for an amorphous volcanic aluminaâsilicate rock that expands by a factor of 4â20 when rapidly heated to 1400â1800/C14F (760â980/C14C).",Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"Origin US Greece Turkey Hungary Yemen Korea Bulgaria Slovakia SiO 2 65â77.5 71â75 71â75 68â75 65â75 68â69 70â80 68â73 Al2O3 11â18 12â16 12.5â18 10â15 9.4â12.8 11.95â15.8 10â15 7.5â15 Na2O 2.4â4.6 3.0â4.0 2.9â4.0 2.8â4.5 3.37â4.25 3.2â4.4 510 2.5â5.0 K2O 1.4â5.7 4.0â5.0 4.0â5.0 3.2â4.5 3.6â4.1 2â3.94 510 2â5.5 Fe2O3 0.5â2.2 0.5â2.0 0.1â1.5 1.0â2.5 2.68â3.66 0.7â1.63 51.5 1.0â2.0 MgO 0.1â0.7 0.2â0.7 0.03â0.5 0.2â1.5 0.5â0.93 0.35â0.48 51.0 51.0 CaO 0.5â3.6 0.5â1.5 0.5â2.0 1.5â2.0 0.87â1.84 1.57â1.89 51.5 0.5â2.0 Loss on ignition 2â5 2â5 4.1 2.0â5.0 0.35â3.94 NR 55 3.0â4.1 Source Diverse Sampatakakis et al., 2013DogËan & Alkan, 2004; Kabra et al., 2013Mineralholding Ltd. Saâad et al., 2010Noh & Boles, 1989Yaneva et al., 2012LB Minerals Mineralholding Ltd. Data available at http://www.mineralholding.hu/ipariasvanyok/en/raw_perlite.html.",Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"WHMIS Does not meet criteriaFDA GRAS SCOGS Report #61, 1979 (http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/SCOGS/ ucm260952.htm) EFSA EFSA approved in subcategory of binders, anticaking agents, and coagulants E 599 Panel on Additives and Products (http://www.efsa.europa.eu/en/search/doc/68e.pdf).",Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"OELs for selected countries OSHA PNOR: 15 mg/m 3(total dust), 5 mg/m3(respirable fraction) 8-h TWA NIOSH REL: 10 mg/m3(total dust), 5 mg/m3(respirable fraction) 8-h TWA ACGIH TLV: PNOS 10 mg/m3(inhalable particles), 3 mg/m3(respirable fraction) 8-h TWA Australia: 10 mg/m3, 8-h TWA Belgium: 10 mg/m3(inhalable particles), 2 mg/m3(respirable fraction) 8-h TWA Canada (Ontario, British Columbia): 10 mg/m3, 8-h TWA, http://www.e-laws.gov.on.ca/html/ regs/english/elaws_regs_900833_e.htm and http://www2.worksafebc.com/publications/ohsregulation/GuidelinePart5.asp?ReportID Â¼32895.",Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"China: 8 mg/m3(total dust), 4 mg/m3(respirable fraction) 8-h TWA (Liang et al., 2003) Denmark: 10 mg/m3(inhalable particles), 5 mg/m3(respirable fraction) 8-h TWA Greece: 10 mg/m3 (inhalable particles), 5 mg/m3(respirable fraction) 8-h TWA Ireland: 10 mg/m3(inhalable particles), 5 mg/m3 (respirable fraction) 8-h TWAaNetherlands: 10 mg/m3, 8-h TWA, as inhalable dust Spain: 10 mg/m3(inhalable particles), 3 mg/m3(respirable fraction) 8-h TWAbUK: 10 mg/m3(inhalable particles), 4 mg/m3(respirable fraction) 8-h TWA Potentially exposed cohort in the USTotal from NOES survey 215,854 persons in 1981â1983, see http://www.cdc.gov/noes/noes1/b0105sic.html.",Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
aSee http://consultation.hsa.ie/general-applications/Chemical-Agents-Regulations-2011/public%20consultation%20draft%202011chemica l%20agents% 20COP%20January%202011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
bSee http://www.insht.es/InshtWeb/Contenidos/Documentacion/TextosOnline/Valores_Limite/GT-LEPN024-07%20VLA%202008%20negro_2.pdf.DOI: 10.3109/08958378.2014.881940 Perlite toxicology and epidemiology 261,Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"The estimated population exposed toperlite in the United States was 215 854 persons, which ranked 385th among the agents included in the NOES database (http://www.cdc.gov/noes/noes3/empl0001.html).This survey has not been updated.",OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"The results of the tests showed that the acute oral LD 50of perlites for rats is greater than the largest dose administered in the test (10 g/kg body weight).Schundler Company, 2002, http://www.schundle- r.com/perlitehealth.htm.",Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
")Schundler Company, 2002, http://www.schundle- r.com/perlitehealth.htm.",Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"Although environ-mental exposure occurs 24 h per day for 7 d per week whereas 8We could not find data specific to Milos, but according to the UNCTAD Handbook of Statistics, the average length of stay of tourists in Greece in2007 was 5.37 d (see http://www.nationsencyclopedia.com/WorldStats/UNCTAD-average-length-stay-visitors.html).DOI: 10.3109/08958378.2014.881940 Perlite toxicology and epidemiology 267",Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
Available from: http://www.minsocam.org/ammin/am37/am37_197.pdf.,OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"Online document published by the Milos Mining Museum, Milos, Greece, 4 p. Available from: http://www.milosminingmuseum.com/ wp-content/uploads/2011/11/mining_history_en1.pdf.",Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
Available from: http://www.gezondheidsraad.nl/en/publications/ healthy-working-conditions/health-based-reassessment-administrative-occupational-exp-13.,Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"IARC Monograph 100 C. Lyon, France: IARC, 355â406.Available from: http://monographs.iarc.fr/ENG/Monographs/vol100C/ mono100C.pdf.",Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
Available from: http://www.cdc.gov/niosh/pdfs/90-1082s.pdf.,OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
See also Sustainability fact sheet http://www.perlite.com/ Sustainability_Fact_Sheet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
Available from: http://www.empr.gov.bc.ca/Mining/Geoscience/PublicationsCatalogue/Fieldwork/Documents/2002/13_GSp165-174.,Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
Available from:http://www.schundler.com/perlitehealth.htm.,Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
1 p. Available from: http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/SCOGS/ucm261095.htm.,Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
Available from: http://www.empr.gov.bc.ca/Mining/Geoscience/IndustrialMinerals/Documents/223-226-simandl.pdf.,OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
Presentation Availablefrom: http://www.sdimi.org/papers_2013/SDIMI_A1/2nd%20day/Milos%20island_A%20sustainable%20case%20of%20mining%20&%20tourism.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"68-02-3064, Emission Standards and Engineering Division, USEPA, Washington, D.C. 76 p. Available from: http://www.nepis.epa.gov.",OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"Washington, DC: USEPA, 5 p. Available from: http://www.epa.gov/ttn/chief/ap42/ch11/final/c11s30.pdf.",OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"Washington, DC: USEPA, 22 p. Available from: http://www.epa.gov/ttnchie1/ap42/ch11/bgdocs/b11s30.pdf.",OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"June 2003, Washington,DC: USEPA, 74 p. Available from: http://www.epa.gov/iris/toxre- views/0061tr.pdf.",OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
Select committee on GRAS substances (SCOGS) opinion: perlite (filter aid).Available from: http://www.fda.gov/Food/IngredientsPackaging Labeling/GRAS/SCOGS/ucm260952.htm.,Non-OADS,/arxiv_data1/oa_pdf/98/6c/IHT-26-259.PMC4002636.pdf
"http://informahealthcare.com/jas ISSN: 0277-0903 (print), 1532-4303 (electronic) J Asthma, 2014; 51(4): 380â390 !2014 Informa Healthcare USA, Inc. DOI: 10.3109/02770903.2013.876430 ASTHMA IN THE PRIMARY CARE SETTING Adapting community based participatory research (CBPR) methods to the implementation of an asthma shared decision making intervention in ambulatory practices Hazel Tapp, PhD1, Lindsay Kuhn, PA-C1, Thamara Alkhazraji, MS1, Mark Steuerwald, MS1, Tom Ludden, MS1, Sandra Wilson, PhD2, Lauren Mowrer, BA1, Sveta Mohanan, MD1, and Michael F. Dulin, MD, PhD1 1Department of Family Medicine, Carolinas Healthcare System, Charlotte, NC, USA and2Department of Health Services Research, Palo Alto Medical Foundation Research Institute, Palo Alto, CA, USA Abstract Objective : Translating research findings into clinical practice is a major challenge to improve the quality of healthcare delivery.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/JAS-51-380.PMC4002642.pdf
Providers issued electronic or paper generated asthma action plans as a part of the SDM toolkit (https://asthma.carolinashealthcare.org).,Non-OADS,/arxiv_data1/oa_pdf/1f/2c/JAS-51-380.PMC4002642.pdf
For example A training video was made and can befound at https://asthma.carolinashealthcare.org/ The advisory board and practice champions were regularly exposed to the qualitative assessments that were collected.,Non-OADS,/arxiv_data1/oa_pdf/1f/2c/JAS-51-380.PMC4002642.pdf
"http://informahealthcare.com/imt ISSN: 1547-691X (print), 1547-6901 (electronic) J Immunotoxicol, 2014; 11(2): 99â109 !2014 Informa Healthcare USA, Inc. DOI: 10.3109/1547691X.2013.821564 REVIEW ARTICLE Immunogenicity of therapeutic proteins: Influence of aggregation Kirsty D. Ratanji, Jeremy P. Derrick, Rebecca J. Dearman, and Ian Kimber Faculty of Life Sciences, University of Manchester, Manchester, UK Abstract The elicitation of anti-drug antibodies (ADA) against biotherapeutics can have detrimental effects on drug safety, efficacy, and pharmacokinetics.",Non-OADS,/arxiv_data1/oa_pdf/08/f5/IMT-11-099.PMC4002659.pdf
Available at: http://www.genengnews.com/gen- articles/improving-stability-while-adding-value/1259/.,Non-OADS,/arxiv_data1/oa_pdf/08/f5/IMT-11-099.PMC4002659.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/bc/btt-8-193.PMC4003144.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2014:8 193â198Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  193Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BTT .S5957 4anti-TnF therapy in Jordan: a focus on severe  infections and tuberculosis Khaldoon M alawneh1 Mahmoud h ayesh1 Basheer Y Khassawneh1 salwa shihadeh saadeh1 Mahmoud smadi2 Khaldoun Bashaireh3 1Department of Medicine, college of  Medicine, King abdullah University  hospital, 2college of science,   3Department of special surgery,   college of Medicine, King abdullah  University hospital, Jordan University  of science and T echnology, irbid,   Jordan correspondence: Khaldoon M alawneh   Department of Medicine, college of   Medicine, King abdullah University  hospital, Jordan University of science   and Technology, PO box 3030,   irbid 22110, Jordan   email kma1234@msn.co mBackground:  A high rate of infection has been reported in patients receiving treatment with  anti-tumor necrosis factor (anti-TNF).",Non-OADS,/arxiv_data1/oa_pdf/b3/bc/btt-8-193.PMC4003144.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/b3/bc/btt-8-193.PMC4003144.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b3/bc/btt-8-193.PMC4003144.pdf
"Available from: http://www.phac-aspc.gc.ca/tbpc-latb/ itir-eng.ph p. Accessed February 25, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b3/bc/btt-8-193.PMC4003144.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fb/1a/dddt-8-391.PMC4003145.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 391â396Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  391Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6270 9effects of switching from prandial premixed   insulin therapy to basal plus two times bolus   insulin therapy on glycemic control and quality   of life in patients with type  2 diabetes mellitus hiroyuki ito Mariko abe shinichi antoku Takashi Omoto Masahiro shinozaki shinya nishio Mizuo Mifune Michiko T ogane Department of Diabetes,    Metabolism and Kidney Disease,    edogawa hospital, T okyo, Japan correspondence: hiroyuki ito   Department of Diabetes, Metabolism   and Kidney Disease, edogawa hospital,   2-24-18, higashikoiwa, edogawa-ku,   Tokyo,  133-0052, Japan   Tel +81 3 3673 1221  Fax +81 3 3673 1229  email ito@edogawa.or.j pBackground:  The effects of switching from prandial premixed insulin therapy (PPT) injected  three times a day to basal plus two times bolus insulin therapy (B2B) on glycemic control and  quality of life were investigated in patients with type  2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/fb/1a/dddt-8-391.PMC4003145.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/fb/1a/dddt-8-391.PMC4003145.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/1a/dddt-8-391.PMC4003145.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/76/cia-9-719.PMC4003146.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 719â726Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  719OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5944 8Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Padubidri et al Running head recto: Falls, cognitive decline, and older Mexican Americans DOI: http://dx.doi.org/10.2147/CIA.S59448 Anokha Padubidri1,2 soham Al snih2,3 rafael samper-T ernent2,4 Kyriakos s Markides2,5 Kenneth J Ottenbacher2,3 Mukaila A raji2,6 1College of Medicine, northeast  Ohio Medical University, rootstown,   Oh, UsA; 2sealy Center on Aging,   3Division of rehabilitation sciences,   school of health Professions, the  University of T exas Medical Branch,   galveston, TX, UsA; 4Department  of Internal Medicine, hospital  Universitario san Ignacio, Pontificia  Universidad Javeriana, Bogota,   Columbia; 5Department of Preventive  Medicine and Community health,   6Department of Internal Medicine,    the University of Texas Medical  Branch, galveston, TX, UsA Correspondence: Mukaila A raji Division of geriatrics, sealy Center   on Aging, University of T exas Medical  Branch, 301 University Blvd, galveston,   TX 77555-0177, UsA T el +1 409 772 1987 Fax +1 409 747 3585 email muraji@utmb.ed uBackground:  Little is known about long-term emotional and cognitive consequences of falls.",Non-OADS,/arxiv_data1/oa_pdf/6c/76/cia-9-719.PMC4003146.pdf
Available from: http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5709a1.htm.,OADS,/arxiv_data1/oa_pdf/6c/76/cia-9-719.PMC4003146.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/6c/76/cia-9-719.PMC4003146.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6c/76/cia-9-719.PMC4003146.pdf
Available from: http://www.alz.co.uk/research/ WorldAlzheimerReport2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6c/76/cia-9-719.PMC4003146.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/1f/ce-9-061.PMC4003147.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCore Evidence 2014:9 61â67Core Evidence Dove press submit your manuscript | www.dovepress.co m Dove press  61REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S4849 8Development of cabozantinib for the treatment   of prostate cancer Ulka N vaishampayan Department of Oncology, wayne State  University/Karmanos Cancer institute,    Detroit, M i, USA Correspondence: Ulka N vaishampayan   wayne State University, 4100 John R,  Detroit Mi 48201, USA   Tel +1 313 576 8715   Fax +1 313 576 8487   Email vaishamu@karmanos.or gAbstract:  Cabozantinib (XL184) is a multitargeted receptor tyrosine kinase with predominantly  MET  and vascular endothelial growth factor inhibition properties.",Non-OADS,/arxiv_data1/oa_pdf/50/1f/ce-9-061.PMC4003147.pdf
"Core Evidence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/core-evidence-journa lCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of  drugs throughout their development lifecycle from preclinical to post - launch.",Non-OADS,/arxiv_data1/oa_pdf/50/1f/ce-9-061.PMC4003147.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/1f/ce-9-061.PMC4003147.pdf
Available  from: http://clinicaltrials.gov/show/NCT01605227.,Non-OADS,/arxiv_data1/oa_pdf/50/1f/ce-9-061.PMC4003147.pdf
Available from: http://clinicaltrials.gov/show/NCT01812668.,Non-OADS,/arxiv_data1/oa_pdf/50/1f/ce-9-061.PMC4003147.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/77/76/hiv-6-061.PMC4003148.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpHIV/AIDS â Research and Palliative Care 2014:6 61â67HIV/AIDS â Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  61ORIg InAl RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S5906 1Relationship between socioeconomic status   and HIV infection in a rural tertiary health center Olarinde Jeffrey Ogunmola1 Yusuf Olatunji Oladosu2 Michael Adeyemi  Olamoyegun3 1Cardiac Care Centre, Department  of Internal Medicine, Federal Medical  Centre, Ido-Ekiti, Ekiti State, nigeria,   2Department of Internal Medicine,   Federal Medical Centre, Ido-Ekiti,   Ekiti State, nigeria, 3Endocrinology,   Diabetes and Metabolism Unit,   Department of Internal Medicine,   ladoke-Akintola University of  T echnology T eaching Hospital,   Ogbomoso, Oyo State, nigeria Correspondence: Olarinde Jeffrey  Ogunmola   Consultant Physician and Cardiologist,  Cardiac Care Center, Department of  Internal Medicine, Federal Medical Center,  Ido Ekiti, Ekiti State, nigeria   T el +23 4 803 388 0875;   +23 4 807 551 6385   Email joogunmola@yahoo.co mBackground:  There is a scarcity of data in rural health centers in Nigeria regarding the  relationship between socioeconomic status (SES) and HIV infection.",Non-OADS,/arxiv_data1/oa_pdf/77/76/hiv-6-061.PMC4003148.pdf
Available from:  http://www.h-net.org/reviews/showrev.php?id =1386 5.,Non-OADS,/arxiv_data1/oa_pdf/77/76/hiv-6-061.PMC4003148.pdf
"Available from: http://www.apa.org/pi/ses/resources/publications/ task-force-2006.pd f. Accessed December 3, 2013.",OADS,/arxiv_data1/oa_pdf/77/76/hiv-6-061.PMC4003148.pdf
Available from: http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/77/76/hiv-6-061.PMC4003148.pdf
"Available from: http://www.zero-hiv.org/wp-content/ uploads/2013/09/PCRP-2013-2015-real-2-Aug-2013.pd f. Accessed  December 7, 2013.",Non-OADS,/arxiv_data1/oa_pdf/77/76/hiv-6-061.PMC4003148.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/77/76/hiv-6-061.PMC4003148.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/76/hiv-6-061.PMC4003148.pdf
"Available from: http://data.unaids.org/Pub/report/2010/ nigeria_2010_country_progress_report_en.pd f. Accessed December 7,  2013.",OADS,/arxiv_data1/oa_pdf/77/76/hiv-6-061.PMC4003148.pdf
Available  from: http://www.nbs.go.tz/tnada/index.php/catalog/6/download/2 3.,Non-OADS,/arxiv_data1/oa_pdf/77/76/hiv-6-061.PMC4003148.pdf
Available from: http://www.undp.org/content/dam/aplaws/publication/ en/publications/hiv-aids/poverty-and-hiv-aids-in-sub-saharan-africa/87.,Non-OADS,/arxiv_data1/oa_pdf/77/76/hiv-6-061.PMC4003148.pdf
Available from: http://www.wfwp.,Non-OADS,/arxiv_data1/oa_pdf/77/76/hiv-6-061.PMC4003148.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/dd/btt-8-183.PMC4003149.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2014:8 183â192Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  183Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S4056 7Clinical and comparative utility of afatinib   in non-small cell lung cancer Manolo DâArcangelo Fred R Hirsch University of Colorado Denver,   Department of Medical Oncology,   Aurora, CO, USA Correspondence: Fred R Hirsch   University of Colorado Cancer Center,  12801 e 17th Avenue, Mail Stop 8117,  Aurora, CO, USA   Tel +1 303 724 3858   email f red.hirsch@ucdenver.ed uAbstract:  The first targeted agents approved for non-small cell lung cancer (NSCLC) treat - ment, the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) gefitinib  and erlotinib, have an impressive activity in the presence of activating mutations of the EGFR   gene.",Non-OADS,/arxiv_data1/oa_pdf/e5/dd/btt-8-183.PMC4003149.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/e5/dd/btt-8-183.PMC4003149.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/e5/dd/btt-8-183.PMC4003149.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/0d/ceor-6-209.PMC4003150.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2014:6 209â216ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  209ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S5524 5Drug adherence to olmesartan/amlodipine fixed  combination in an italian clinical practice setting luca Degli Esposti stefania saragoni stefano Buda Ezio Degli Esposti Clicon srl health, Economics and  Outcomes Research, Ravenna, italy Correspondence: luca Degli Esposti   Clicon srl, Via salara, 36, 48121   Ravenna, italy   Tel +39 054 438 393   Fax +39 054 421 2699   Email luca.degliesposti@clicon.i tObjective:  To investigate the criteria for prescribing a combination pill for hypertensive  patients, and whether the combination pill improves medication adherence.",Non-OADS,/arxiv_data1/oa_pdf/e7/0d/ceor-6-209.PMC4003150.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/e7/0d/ceor-6-209.PMC4003150.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/0d/ceor-6-209.PMC4003150.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/64/cia-9-727.PMC4003151.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 727â736Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  727OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5998 5A Chinese Chan-based mindâbody intervention  improves psychological well-being and physical  health of community-dwelling elderly: a pilot study ruby Yu1 Jean Woo1 Agnes s Chan2â4 sophia l sze2,3 1Department of Medicine and  Therapeutics, 2Department of  Psychology, 3Chanwuyi research  Center for neuropsychological   Well-Being, The Chinese University  of hong Kong, new Territories,   hong Kong; 4henan songshan  research Institute for Chanwuyi,  henan, Peopleâs republic of China Correspondence: ruby Yu   Department of Medicine and  Therapeutics, The Chinese University  of hong Kong, 10/F, Clinical sciences  Building, Prince of Wales hospital,   shatin, new Territories, hong Kong   Tel +852 2632 2190   Fax +852 2637 9215   email rubyyu@cuhk.edu.h kBackground:  The aim of this study was to explore the potential benefits of the Dejian mindâbody  intervention (DMBI) for psychological and physical health in older Chinese adults.",Non-OADS,/arxiv_data1/oa_pdf/80/64/cia-9-727.PMC4003151.pdf
Available from: http://www.un.org/esa/population/ publications/worldageing19502050 /.,Non-OADS,/arxiv_data1/oa_pdf/80/64/cia-9-727.PMC4003151.pdf
"Available from: http://www.heart.org/HEARTORG/Conditions/ HighBloodPressure/AboutHighBloodPressure/Understanding-Blood- Pressure-Readings_UCM_301764_Article.js p. Assessed January 31,  2014.",Non-OADS,/arxiv_data1/oa_pdf/80/64/cia-9-727.PMC4003151.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/80/64/cia-9-727.PMC4003151.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/64/cia-9-727.PMC4003151.pdf
This article is distributed under the terms of an Attributionâ  NoncommercialâShare AlikeâNo Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"After six months it is available under a  Creative Commons License (AttributionâNoncommercialâShare Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
Online supple-mental material is available at http://www.jgp.org/cgi/content/full/jgp.201311050/DC1.,Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi .org/10.1161/01.RES.0000147311.54833.03 Earley, S., T.J. Heppner, M.T.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi .org/10.1161/01.RES.0000194321.60300.d6 Earley, S., T. Pauyo, R. Drapp, M.J. Tavares, W. Liedtke, and J.E.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1152/ajpheart.00241.2009 Essin, K., A. Welling, F. Hofmann, F.C.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi .org/10.1113/jphysiol.2007.138982 Fan, H.C., X. Zhang, and P.A.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1074/jbc.M109.028803 Fecto, F., Y. Shi, R. Huda, M. Martina, T. Siddique, and H.X.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"286:17281â 17291. http://dx.doi.org/10.1074/jbc.M111.237685 Fleischmann, B.K., R.K. Murray, and M.I.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi .org/10.1073/pnas.91.25.11914 FÃ¶lling, J., M. Bossi, H. Bock, R. Medda, C.A.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1038/nmeth.1257 Guerrero, A., J.J. Singer, and F.S.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1085/jgp.104.2.395 Harder, D.R., R. Gilbert, and J.H.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10 .1016/j.molcel.2010.01.014 Idevall-Hagren, O., E.J.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi .org/10.1073/pnas.1211305109 Jaggar, J.H., G.C.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1046/j.1365-201X .1998.00462.x Lachmanovich, E., D.E.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10 .1046/j.1365-2818.2003.01239.x Liedtke, W., Y. Choe, M.A.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1038/ nature07926 Amberg, G.C., and L.F. Santana.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"93:965â 971. http://dx.doi.org/10.1161/01.RES.0000100068.43006.36 Amberg, G.C., M.F.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"579:187â 201. http://dx.doi.org/10.1113/jphysiol.2006.124420 Bayliss, W.M.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"224:213â 232. http://dx.doi.org/10.1111/j.1365-2818.2006.01706.x Cao, D.S., S.Q.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"5:5.  http://dx.doi.org/10.1186/1744-8069-5-5 Cheng, H., W.J.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1126/ science.8235594 Digman, M.A., P.W.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi .org/10.1073/pnas.0806036106 Digman, M.A., P.W.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/ 10.1016/j.bpj.2008.09.051 Dixon, R.E., C. Yuan, E.P.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi .org/10.1016/S0092-8674(00)00143-4 Narayanan, D., S. Bulley, M.D.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1113/jphysiol.2013.258319 Navedo, M.F., G.C.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1085/jgp.200609519 Navedo, M.F., M. Nieves-CintrÃ³n, G.C.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi .org/10.1161/CIRCRESAHA.107.167809 Navedo, M.F., E.P .",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.109.213363 Nelson, M.T., H. Cheng, M. Rubart, L.F. Santana, A.D. Bonev,  H.J.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi .org/10.1126/science.270.5236.633 Rossow, M.J., J.M.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1038/nprot.2010.122 Rubart, M., J.B. Patlak, and M.T.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/ 10.1085/jgp.107.4.459 Schermelleh, L., R. Heintzmann, and H. Leonhardt.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1083/jcb.201002018 Sonkusare, S.K., A.D. Bonev, J. Ledoux, W. Liedtke, M.I.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1126/ science.1216283 Spassova, M.A., T. Hewavitharana, W. Xu, J. Soboloff, and D.L.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"2:695â 702. http://dx.doi.org/10.1038/35036318 Takeda, Y., M.A.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1152/ajpheart.00488.2011 Thorneloe, K.S., A.C. Sulpizio, Z. Lin, D.J.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1038/nature01807 Welsh, D.G., A.D. Morielli, M.T.",Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1161/ hh0302.105662 Zenisek, D., V. Davila, L. Wan, and W. Almers.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
"http://dx.doi.org/10.1085/ jgp.116.6.845 Zou, H., L.M.",OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
http://dx.doi .org/10.1073/pnas.092654999,Non-OADS,/arxiv_data1/oa_pdf/b1/6f/JGP_201311050.PMC4003184.pdf
This article is distributed under the terms of an Attributionâ NoncommercialâShare AlikeâNo Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"After six months it is available under a  Creative Commons License (AttributionâNoncommercialâShare Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
Online supplemen-tal material is available at http://www.jgp.org/cgi/content/full/jgp.201411171/DC1.,Non-OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1085/jgp.201311030 Bootman, M.D., P. Lipp, and M.J. Berridge.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1038/ncb0609-669 DeHaven, W.I., J.T.",Non-OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1073/ pnas.1114814108 Derler, I., M. Fahrner, O. Carugo, M. Muik, J. Bergsmann, R.  Schindl, I. Frischauf, S. Eshaghi, and C. Romanin.",Non-OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi .org/10.1074/jbc.M808312200 Feske, S., Y. Gwack, M. Prakriya, S. Srikanth, S.H.",Non-OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1038/ nature04702 Hou, X., L. Pedi, M.M.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1126/science.1228757 Liou, J., M.L.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1016/j.cub .2007.03.065 McNally, B.A., M. Yamashita, A. Engh, and M. Prakriya.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10 .1073/pnas.0909574106 McNally, B.A., A. Somasundaram, M. Yamashita, and M. Prakriya.",Non-OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1152/ physrev.00057.2003 Peinelt, C., A. Lis, A. Beck, A. Fleig, and R. Penner.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1113/jphysiol.2008 .151365 Prakriya, M., S. Feske, Y. Gwack, S. Srikanth, A. Rao, and P.G.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1038/nature05122 Putney, J.W., Jr. 1986.",Non-OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1016/0143- 4160(86)90026-6 Roos, J., P.J.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1083/jcb.200502019Schindl, R., J. Bergsmann, I. Frischauf, I. Derler, M. Fahrner, M.  Muik, R. Fritsch, K. Groschner, and C. Romanin.",Non-OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1038/nrm3414 Srikanth, S., M.K.",Non-OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1074/jbc.M111.265884 Vig, M., A. Beck, J.M.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1016/j.cub.2006 .08.085 Vig, M., C. Peinelt, A. Beck, D.L.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi .org/10.1126/science.1127883 Yamashita, M., L. Navarro-Borelly, B.A.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi .org/10.1085/jgp.200709872 Yamashita, M., A. Somasundaram, and M. Prakriya.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1074/jbc.M110.189035 Yeromin, A.V., J. Roos, K.A.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1085/jgp.200308982 Yeromin, A.V., S.L.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1038/nature05108 Zhang, S.L., Y. Yu, J. Roos, J.A.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/ 10.1038/nature04147 Zhang, S.L., J.A.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1074/jbc.M801536200 Zhang, S.L., A.V.",OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
"http://dx.doi.org/10.1073/ pnas.1114821108 Zhou, Y., S. Ramachandran, M. Oh-Hora, A. Rao, and P.G.",Non-OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
http://dx.doi .org/10.1073/pnas.1001169107,Non-OADS,/arxiv_data1/oa_pdf/84/33/JGP_201411171.PMC4003185.pdf
This article is distributed under the terms of an AttributionâNoncom- mercialâShare AlikeâNo Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"After six months it is available under a Creative  Commons License (AttributionâNoncommercialâShare Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
The online supplemental   ma terial is available at http://www.jgp.org/cgi/content/full/ jgp.201311036/DC1.,Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"4:1350. http://dx.doi.org/10.1038/ncomms2356 Groenewegen, W.A., M. Firouzi, C.R.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1161/ 01.RES.0000050585.07097.D7 Groome, J.R., and V. Winston.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/ 10.1085/jgp.201210935 Hille, B.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10 .1085/jgp.201110642 Long, S.B., E.B.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1126/science .1116269 Lu, Z., A.M. Klem, and Y. Ramu.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"3:1102. http://dx.doi.org/10.1038/ ncomms2077 McNair, W.P., L. Ku, M.R.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"110:2163â 2167. http://dx.doi.org/10.1161/01.CIR.0000144458.58660.BB McPhee, J.C., D.S.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi .org/10.1073/pnas.91.25.12346 McPhee, J.C., D.S.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1074/jbc.273.2.1121 Muroi, Y., M. Arcisio-Miranda, S. Chowdhury, and B. Chanda.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1038/nsmb.1749 Nowak, M.W., J.P. Gallivan, S.K.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"141:389â 395. http://dx.doi.org/10.1085/jgp.201210940 Bezanilla, F. 2008.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1038/nrm2376 Bosmans, F., M.F.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1038/ nature07473 Burley, S.K., and G.A.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1016/ 0014-5793(86)80730-X Capes, D.L., M. Arcisio-Miranda, B.W.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10 .1073/pnas.1115575109 Cashin, A.L., M.M.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1021/bi061638b Catterall, W.A.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/ 10.1016/j.neuron.2010.08.021 Cha, A., P.C.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80680-7 Chanda, B., and F. Bezanilla.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10 .1085/jgp.20028679 Cheng, Y.M., C.M.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1085/jgp.201310992 DeCaen, P .G., V. Yarov-Yarovoy, Y. Zhao, T. Scheuer, and W.A.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"271:163â 168. http://dx.doi.org/10.1126/science.271.5246.163 Gallivan, J.P., and D.A.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1016/ S0076-6879(98)93031-2 Paldi, T., and M. Gurevitz.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1016/j.bpj.2010 .04.053 Papazian, D.M., X.M.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10 .1016/0896-6273(95)90276-7 Payandeh, J., T. Scheuer, N. Zheng, and W.A.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1038/nature10238 Payandeh, J., T.M.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi .org/10.1146/annurev-pharmtox-011112-140343 Pless, S.A., J.D.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"2:351. http://dx.doi.org/10.1038/ncomms1351 Pless, S.A., J.D.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10 .1038/nchembio.622 Pless, S.A., A.W.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi .org/10.1074/jbc.M111.269027 Santarelli, V.P., A.L.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1074/ jbc.M611334200 Sato, Y., M. Sakaguchi, S. Goshima, T. Nakamura, and N. Uozumi.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1074/jbc.M300431200 Schwaiger, C.S., P. Bjelkmar, B. Hess, and E. Lindahl.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1016/j.bpj.2012.11.3827 Seoh, S.A., D. Sigg, D.M.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80142-7 Sheets, M.F., J.W.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1016/S0006-3495(99)76929-8 Tao, X., A. Lee, W. Limapichat, D.A.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1126/science.1185954 Tiwari-Woodruff, S.K., C.T.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"72:1489â 1500. http://dx.doi.org/10.1016/S0006-3495(97)78797-6 Tiwari-Woodruff, S.K., M.A.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1085/ jgp.115.2.123 Ulbricht, W. 2005.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi .org/10.1152/physrev.00024.2004 Watanabe, H., T. Yang, D.M.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1161/CIRCULATIONAHA.110.987248 West, J.W., D.E.",Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi.org/10.1085/jgp.201010408 Yang, N., and R. Horn.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi .org/10.1016/0896-6273(95)90078-0 Yarov-Yarovoy, V., P.G.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
"http://dx.doi .org/10.1073/pnas.1118434109 Zhang, L., Y. Sato, T. Hessa, G. von Heijne, J.K. Lee, I. Kodama, M.  Sakaguchi, and N. Uozumi.",OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
http://dx.doi.org/ 10.1073/pnas.95.21.12088,Non-OADS,/arxiv_data1/oa_pdf/87/8a/JGP_201311036.PMC4003186.pdf
This article is distributed under the terms of an AttributionâNon - commercialâShare AlikeâNo Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"After six months it is available under a Creative  Commons License (AttributionâNoncommercialâShare Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.3322/caac.20114 Anderson, W.D., E.J.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"462:895â 912. http://dx.doi.org/10.1007/s00424-011-1025-3 Anthony, J.R., K.L.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/ 10.1073/pnas.0502225102 Baier, J., T. Maisch, M. Maier, E. Engel, M. Landthaler, and W.  BÃ¤umler.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1039/c1pp05142c Biel, M., C. Wahl-Schott, S. Michalakis, and X. Zong.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1152/physrev .00029.2008 Bruening-Wright, A., F. Elinder, and H.P.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1099/mic.0.054700-0 MistrÃ­k, P., A. Pfeifer, and M. Biel.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1007/s00424-006-0095-0 Morais Cabral, J.H., A. Lee, S.L.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1016/S0092- 8674(00)81635-9 Nam, T.W., E.C.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi .org/10.1128/mBio.00541-12 Nolan, M.F., G. Malleret, K.H.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi .org/10.1016/S0092-8674(03)00884-5 Ogilby, P.R.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10 .1039/b926014p Ohara, K., K. Kikuchi, T. Origuchi, and S. Nagaoka.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1016/ j.jphotobiol.2009.08.010 Pedersen, B.W., L.E.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10 .1111/j.1751-1097.2011.00951.x Proenza, C., and G. Yellen.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi .org/10.1085/jgp.200509389 Proenza, C., D. Angoli, E. Agranovich, V. Macri, and E.A.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1074/jbc .M106974200 Prole, D.L., and G. Yellen.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1085/jgp.200609590 Qi, Y.B., E.J.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1073/ pnas.1204096109 Robinson, R.B., and S.A. Siegelbaum.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1146/ annurev.physiol.65.092101.142734 Rothberg, B.S., K.S.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1085/jgp.200308928 Ryu, S., and G. Yellen.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/ 10.1085/jgp.200709769 del Camino, D., M. Holmgren, Y. Liu, and G. Yellen.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1038/ 35002099 DeRosa, M.C., and R.J. Crutchley.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1016/S0010-8545(02)00034-6 Eisenman, L.N., H.J.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1016/j .freeradbiomed.2009.04.015 Graf, E.M., J.F.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1007/s002100100431 Guo, H.C., H.S.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"6:486â 495. http://dx.doi.org/10.1016/j.nano.2009.11.004 Hagiwara, N., H. Irisawa, H. Kasanuki, and S. Hosoda.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1529/ biophysj.107.107128 Kochevar, I.E.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1085/jgp .201210838 Latch, D.E., and K. McNeill.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1126/science.1121636 Liao, J.C., J. Roider, and D.G.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/ 10.1073/pnas.91.7.2659 Long, S.B., X. Tao, E.B.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10 .1038/nature06265 Maccaferri, G., and C.J.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1085/ jgp.201210850 Sassone-Corsi, P. 1998.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1038/31821 Schneider, C.A., W.S.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1038/nmeth.2089 Schweitzer, C., and R. Schmidt.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"103:1685â 1758. http://dx.doi.org/10.1021/cr010371d Shin, K.S., C. Maertens, C. Proenza, B.S.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1016/S0896-6273(04)00083-2 Shu, X., V. Lev-Ram, T.J. Deerinck, Y. Qi, E.B.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1021/jp051163i Steinbeck, M.J., A.U.",Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1038/ nbt914 TriantaphylidÃ¨s, C., and M. Havaux.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"14:219â 228. http://dx.doi.org/10.1016/j.tplants.2009.01.008 Valenzeno, D.P ., and M. Tarr.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1111/j.1751-1097.1991 .tb03923.x Wang, M., B.P.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1016/j.cell.2007.03.015 Wu, S., Z.V.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
"http://dx.doi.org/10.1016/j.bpj.2011.01.034 Wu, S., W. Gao, C. Xie, X. Xu, C. Vorvis, F. Marni, A.R.",OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
http://dx.doi.org/10.1085/ jgp.201110749,Non-OADS,/arxiv_data1/oa_pdf/dd/63/JGP_201311112.PMC4003188.pdf
This article is distributed under the terms of an Attributionâ  NoncommercialâShare AlikeâNo Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"After six months it is available under a  Creative Commons License (AttributionâNoncommercialâShare Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"97:1506â 1518. http://dx.doi.org/10.1111/j.1471-4159.2006.03859.x Abaffy, T., A. Malhotra, and C.W.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1074/jbc.M609355200 Adipietro, K.A., J.D.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1371/journal.pgen.1002821 Anselmi, C., A. Buonocore, M. Centini, R.M.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1038/81774 Araneda, R.C., Z. Peterlin, X. Zhang, A. Chesler, and S. Firestein.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1021/bi1017396 Bavan, S., B. Sherman, C.W.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1371/journal.pone.0092064 Belluscio, L., C. Lodovichi, P. Feinstein, P. Mombaerts, and L.C.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/ 10.1038/nature01001 Bieri, S., K. Monastyrskaia, and B. Schilling.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1093/chemse/bjh050 Bockaert, J., and J.P. Pin.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"18:1723â 1729. http://dx.doi.org/10.1093/emboj/18.7.1723 Boyle, S.M., S. McInally, and A. Ray.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.7554/eLife.01120 Bozza, T., P. Feinstein, C. Zheng, and P. Mombaerts.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1038/nmeth.1197 Hall, S.E., W.B.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1093/ chemse/bjh063 Hamana, H., L. Shou-xin, L. Breuils, J. Hirono, and T. Sato.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1016/ j.jneumeth.2009.09.024 Hummel, P., N. Vaidehi, W.B.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1110/ps.041119705 Igarashi, K.M., and K. Mori.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1152/jn .00873.2004 Inglese, J., R.L.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"3:466â 479. http://dx.doi.org/10.1038/nchembio.2007.17 Jacquier, V., H. Pick, and H. Vogel.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1111/j.1471-4159 .2006.03771.x Jaeger, S.R., J.F.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/ 10.1016/j.cub.2013.07.030 Kajiya, K., K. Inaki, M. Tanaka, T. Haga, H. Kataoka, and K. Touhara.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1016/S0006-291X(03)00863-5 Katada, S., T. Hirokawa, Y. Oka, M. Suwa, and K. Touhara.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4723-04 .2005 Kato, A., S. Katada, and K. Touhara.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1111/j.1471-4159.2008 .05693.x Keller, A., H. Zhuang, Q. Chi, L.B.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1038/ nature06162 Kerr, D.S., L.E.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/ 10.1016/j.mcn.2008.03.006Bunzow, J.R., H.H.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1038/336783a0 Bush, C.F., and R.A. Hall.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10 .1007/s00018-012-1116-0 Civelli, O., R.K. Reinscheid, Y. Zhang, Z. Wang, R. Fredriksson, and  H.B.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10 .1146/annurev-pharmtox-010611-134548 Corcelli, A., S. Lobasso, P. Lopalco, M. Dibattista, R. Araneda, Z.  Peterlin, and S. Firestein.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1038/ nchembio.1206 Ellgaard, L., and A. Helenius.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi .org/10.1038/nrm1052 Emkey, R., and N.B.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1007/978-1-60327-258-2_7 Fargin, A., J.R. Raymond, M.J. Lohse, B.K.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1038/335358a0 Feinstein, P., T. Bozza, I. Rodriguez, A. Vassalli, and P. Mombaerts.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"117:833â 846. http://dx.doi.org/10.1016/j.cell.2004.05.013 Firestein, S. 2001.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1038/35093026 Gelis, L., S. Wolf, H. Hatt, E.M. Neuhaus, and K. Gerwert.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1002/anie.201103980 Gether, U.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1210/edrv.21.1.0390 Ghosh, S., S.D.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1038/nature09945 Grabenhorst, F., E.T.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"27:13532â 13540. http://dx.doi.org/10.1523/JNEUROSCI.3337-07.2007 Grosmaitre, X., A. Vassalli, P. Mombaerts, G.M.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
http://dx.doi.org/10.1016/0006-8993(77)90978-7,OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1034/ j.1600-0854.2003.00097.x Lu, M., L. Staszewski, F. Echeverri, H. Xu, and B.D.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/ 10.1371/journal.pone.0035259 Mainland, J.D., A. Keller, Y.R.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/ 10.1038/nn.3598 Malnic, B.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1007/s12035-007-0013-2 Malnic, B., J. Hirono, T. Sato, and L.B.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10 .1016/S0092-8674(00)80581-4 Man, O., Y. Gilad, and D. Lancet.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1110/ps .03296404 Matarazzo, V., O. Clot-Faybesse, B. Marcet, G. Guiraudie-Capraz,  B. Atanasova, G. Devauchelle, M. Cerutti, P. EtiÃ©vant, and C. Ronin.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1093/chemse/ bji015 McClintock, T.S., and N. Sammeta.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi .org/10.1097/00001756-200308260-00001 McRae, J.F., J.D.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi .org/10.1093/chemse/bjs049 Menashe, I., T. Abaffy, Y. Hasin, S. Goshen, V. Yahalom, C.W.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1371/ journal.pbio.0050284 Minic, J., M.A.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1111/j.1742-4658.2004 .04494.x Mitsui, K., T. Sakihama, K. Takahashi, K. Masuda, R. Fukuda, H.  Hamana, T. Sato, and T. Hamakubo.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1093/chemse/bjs067 Mombaerts, P. 2004.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi .org/10.1038/nrn1365 Mombaerts, P., F. Wang, C. Dulac, S.K.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10 .1016/S0092-8674(00)81387-2 Nagashima, A., and K. Touhara.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1016/j.cell.2011.09.049 Kim, P.S., and P. Arvan.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1002/ cbdv.200890099 Krautwurst, D., K.W.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1016/S0092- 8674(00)81716-X Kurland, M.D., M.B.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/ 10.1021/bi100976w Lai, P.C., M.S.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1093/chemse/ bji070 Lai, P.C., G. Bahl, M. Gremigni, V. Matarazzo, O. Clot-Faybesse, C.  Ronin, and C.J.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1007/s10969-008-9043-x Lai, P.C., B. Guida, J. Shi, and C.J.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1093/ chemse/bjt060 Launay, G., S. TÃ©letchÃ©a, F. Wade, E. Pajot-Augy, J.F.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1093/protein/gzs037 Lettvin, J.Y., H.R.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1109/JRPROC.1959.287207 Levasseur, G., M.A.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"270:2905â 2912. http://dx.doi.org/10.1046/j.1432-1033.2003.03672.x Li, J., R. Haddad, S. Chen, V. Santos, and C.W.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1111/j.1471-4159 .2012.07740.x Li, Y.R., and H. Matsunami.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1038/nature03414 Liu, A.H., X. Zhang, G.A.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/ 10.1016/S0888-7543(03)00022-3 Liu, X., X. Su, F. Wang, Z. Huang, Q. Wang, Z. Li, R. Zhang, L. Wu,  Y. Pan, Y. Chen, et al.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi .org/10.1093/bioinformatics/btr385 Lu, M., F. Echeverri, and B.D.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1371/journal.pone .0068758 Shepherd, G.M.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1038/ nature05405 Shirasu, M., K. Yoshikawa, Y. Takai, A. Nakashima, H. Takeuchi,   H. Sakano, and K. Touhara.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1016/j.neuron.2013.10.021 Shirokova, E., K. Schmiedeberg, P. Bedner, H. Niessen, K. Willecke,  J.D.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1074/jbc.M411508200 Singer, M.S.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1093/chemse/25.2.155 Singer, M.S., and G.M.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1097/00001756-199406020-00036 Sivertsen, B., N. Holliday, A.N.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1111/bph .12361 Soucy, E.R., D.F.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1038/ nn.2262 Spehr, M., G. Gisselmann, A. Poplawski, J.A.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1126/science.1080376 Touhara, K. 2007.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1016/j.neuint.2007.05.020 Touhara, K., S. Sengoku, K. Inaki, A. Tsuboi, J. Hirono, T. Sato, H.  Sakano, and T. Haga.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1073/ pnas.96.7.4040 Tsuboi, A., T. Imai, H.K.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1111/ j.1460-9568.2010.07495.x Uchida, N., Y.K.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1080/10409230591008161 Vassar, R., S.K.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/ 10.1016/0092-8674(94)90029-9 Von Dannecker, L.E., A.F.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1523/JNEUROSCI .4595-04.2005Nara, K., L.R.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"31:9179â 9191. http://dx.doi.org/10.1523/JNEUROSCI.1282-11.2011 Oka, Y., A. Nakamura, H. Watanabe, and K. Touhara.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1093/chemse/bjh247 Oka, Y., M. Omura, H. Kataoka, and K. Touhara.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1016/j.neuron.2006.10.019 Palczewski, K., T. Kumasaka, T. Hori, C.A.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1126/science .289.5480.739 Peterlin, Z., Y. Li, G. Sun, R. Shah, S. Firestein, and K. Ryan.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"15:1317â 1327. http://dx.doi.org/10.1016/j.chembiol.2008.10.014 Potter, S.M., C. Zheng, D.S.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1093/chemse/bjp028 Repicky, S.E., and C.W.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1111/j .1471-4159.2009.05925.x Ressler, K.J., S.L.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1016/0092-8674(94)90015-9 Rubin, B.D., and L.C.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80803-X Saito, H., M. Kubota, R.W.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/ 10.1016/j.cell.2004.11.021 Saito, H., Q. Chi, H. Zhuang, H. Matsunami, and J.D.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1126/scisignal.2000016 Sanz, G., C. Schlegel, J.C. Pernollet, and L. Briand.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1093/chemse/bji002 Sanz, G., T. Thomas-Danguin, H. Hamdani, C. Le Poupon, L. Briand,  J.C. Pernollet, E. Guichard, and A. Tromelin.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1016/ j.jsb.2007.04.013 Shepard, B.D., N. Natarajan, R.J. Protzko, O.W.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi .org/10.1073/pnas.0913392107 Wetzel, C.H., M. Oles, C. Wellerdieck, M. Kuczkowiak, G.  Gisselmann, and H. Hatt.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi .org/10.1074/jbc.M112.345884Zhang, J., G. Huang, A. Dewan, P. Feinstein, and T. Bozza.",Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.4299-12.2013 Zhang, X., X. Zhang, and S. Firestein.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1016/j.ygeno.2007.01.002 Zhao, H., L. Ivic, J.M.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
"http://dx.doi.org/10.1126/ science.279.5348.237 Zhuang, H., and H. Matsunami.",OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
http://dx.doi.org/10.1074/jbc.M700386200,Non-OADS,/arxiv_data1/oa_pdf/f0/d1/JGP_201311151.PMC4003190.pdf
This article is distributed under the terms of an Attributionâ  NoncommercialâShare AlikeâNo Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"After six months it is available under a  Creative Commons License (AttributionâNoncommercialâShare Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1007/BF01738442 Barclay, C.J.",Non-OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1113/jphysiol.2012.242073 Baylor, S.M., and S. Hollingworth.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi .org/10.1085/jgp.200709827by either a single AP or one high-frequency train of APs,  the results indicate that it takes tens of seconds for the SR to resequester a large fraction of the released Ca 2+  (16Â°C; Figs.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"141:567â 583. http://dx.doi.org/10.1085/jgp.201310961 Hollingworth, S., C. Soeller, S.M.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1111/j.1469-7793.2000 .t01-1-00551.x Hollingworth, S., J. Peet, W.K.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1085/jgp.118.6.653 Hollingworth, S., M.M.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/ 10.1113/jphysiol.2011.220780 Hou, T.-T., J.D.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1016/S0006-3495(02)75384-8 Rome, L.C.",Non-OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1146/annurev.physiol.68.040104.105418 Rome, L.C., D.A.",Non-OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.2170/jjphysiol.41.277 Tanokura, M. 1990.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10 .1111/j.1432-1033.1990.tb15366.x Woodruff, M.L., A.P.",Non-OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1113/ jphysiol.2001.013987 Young, I.S., C.L.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1152/ajpcell.00025 .2003Baylor, S.M., and S. Hollingworth.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi .org/10.1085/jgp.20028620 Briggs, N. 1975.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi .org/10.1038/ncb734 Ecob-Prince, M.S., and E. Leberer.",Non-OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi .org/10.1111/j.1432-0436.1989.tb00808.x Elemans, C.P .H., A.F.",Non-OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1242/jeb.097444 Feher, J.J., T.D.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1023/A:1005333215172 Felder, E., and C. Franzini-Armstrong.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1073/ pnas.032657599 Ferguson, D.G., and C. Franzini-Armstrong.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1002/mus.880110607 Gerday, C., and J.M.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1007/ BF00712090 Harkins, A.B., N. Kurebayashi, and S.M.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
"http://dx.doi.org/10.1016/S0006-3495 (93)81112-3 Harwood, C.L., I.S.",OADS,/arxiv_data1/oa_pdf/95/29/JGP_201411160.PMC4003191.pdf
This article is distributed under the terms of an AttributionâNoncommercialâ  Share AlikeâNo Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"After six months it is available under a Creative Commons  License (AttributionâNoncommercialâShare Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
Online supplemental material is available at http://www.jgp.org/cgi/content/full/jgp.201311114/DC1.,Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"4:2137. http://dx.doi.org/10.1038/ncomms3137 Csonka, L.N., and A.D. Hanson.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1146/annurev.mi.45.100191.003033 Edwards, M.D., S. Black, T. Rasmussen, A. Rasmussen, N.R.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.4161/chan.20998 Ellis, R.J. 2001.",Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1016/S0959-440X(00)00172-X Grajkowski, W., A. Kubalski, and P. Koprowski.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10 .1016/0263-7855(96)00018-5 Kamaraju, K., V. Belyy, I. Rowe, A. Anishkin, and S. Sukharev.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1085/jgp.201110606 Koch, A.L., and S. Woeste.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi .org/10.1074/jbc.M110.176131 Lai, J.Y., Y.S.",Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"22:502â 509. http://dx.doi.org/10.1002/pro.2222 Levina, N., S. TÃ¶temeyer, N.R.",Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1093/emboj/18.7.1730 Li, Y., P.C.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10 .1093/emboj/cdf537 Liedtke, W. 2005.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1007/s00424-005-1449-8 Machiyama, H., H. Tatsumi, and M. Sokabe.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1016/S0076-6879(98)95038-8 Naismith, J.H., and I.R.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
http://dx.doi.org/10 .1146/annurev-biophys-101211-113227This work was supported by National Institutes of Health grants  GM075225 and GM107652 to S. Sukharev.,OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1085/jgp.200409198 Akitake, B., A. Anishkin, N. Liu, and S. Sukharev.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1085/jgp.200810000 Anishkin, A., A.L.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10 .1002/prot.22618 Balleza, D., and F. GÃ³mez-Lagunas.",Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"38:1013â 1027. http://dx.doi.org/10.1007/s00249-009-0460-y Bass, R.B., P. Strop, M. Barclay, and D.C. Rees.",Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1126/ science.1077945 Belyy, V., A. Anishkin, K. Kamaraju, N. Liu, and S. Sukharev.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10 .1038/nsmb.1775 Belyy, V., K. Kamaraju, B. Akitake, A. Anishkin, and S. Sukharev.",Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1085/jgp.200910371 Boer, M., A. Anishkin, and S. Sukharev.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1021/ bi1019435 Cayley, S., and M.T.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1021/ bi0347297 Cayley, S., B.A.",Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10 .1016/0022-2836(91)90212-O Cayley, D.S., H.J.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10 .1016/S0006-3495(00)76726-9 Cox, C.D., T. Nomura, C.S.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi .org/10.1016/j.bpj.2013.06.054 Nomura, T., M. Sokabe, and K. Yoshimura.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi .org/10.1529/biophysj.107.114785 Petrov, E., D. Palanivelu, M. Constantine, P.R.",Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10 .1016/j.bpj.2013.01.055 Pivetti, C.D., M.R.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/ 10.1128/MMBR.67.1.66-85.2003 Record, M.T.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1016/ S0968-0004(98)01207-9 Reiser, V., D.C. Raitt, and H. Saito.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1083/ jcb.200301099 Schumann, U., M.D.",Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/ 10.1038/368265a0 Sukharev, S.I., W.J.",Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1085/jgp.113.4.525 Sukharev, S., B. Akitake, and A. Anishkin.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1093/emboj/18.24 .6927 Vasquez, V., and E. Perozo.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1016/j.jmb.2007.10.086 Vollmer, W., and J.V.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1016/ S1369-5274(01)00261-2 Wang, L.C., L.K.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1038/emboj.2012.99 Wang, W., S.S. Black, M.D.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1126/ science.1159262 Wood, J.M.",Non-OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1016/S0076-6879(07) 28005-X Wood, J.M., E. Bremer, L.N.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/ 10.1016/S1095-6433(01)00442-1 Yao, X., M. Jericho, D. Pink, and T. Beveridge.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
"http://dx.doi.org/10.1016/S0006-3495 (01)76192-9 Zhang, X., J. Wang, Y. Feng, J. Ge, W. Li, W. Sun, I. Iscla, J. Yu, P.  Blount, Y. Li, and M. Yang.",OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
http://dx.doi .org/10.1016/0022-2836(91)90499-V,OADS,/arxiv_data1/oa_pdf/4e/da/JGP_201311114.PMC4003192.pdf
This article is distributed under the terms of an AttributionâNoncommercialâ Share AlikeâNo Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"After six months it is available under a Creative Commons  License (AttributionâNoncommercialâShare Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201309092/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi   .org/10.1006/bbrc.2000.363 6 Borghi, N., M. Sorokina, O.G.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1091/mbc.E06-02-013 2 Brazzelli, V., V. Grasso, and G. Borroni.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi   .org/10.1111/jdv.1217 2 Burton, E.A., R. Plattner, and A.M. Pendergast.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1093/emboj/cdg51 2 Calautti, E., S. Cabodi, P.L.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
http://dx.doi   .org/10.1083/jcb.141.6.144 9at Y822 was recognized with a rabbit polyclonal antibody (Abcam).,Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"Upon pulses of force, bead displacements were  captured with a high-speed video camera (Jai Pulnix) and tracked using  Video Spot Tracker software developed by the Center for Computer Inte - grated Systems for Microscopy and Manipulation at the University of North  Carolina at Chapel Hill (http://cismm.cs.unc.edu).",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/   10.1529/biophysj.107.10847 2 Niessen, C.M.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1038/   sj.jid.570086 5 Owens, D.W., G.W.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1091/mbc.11.1.5 1 Pasapera, A.M., I.C.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"188:877â 890. http://dx.doi.org/10.1083/jcb.20090601 2 Peng, X., L.E.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1242/jcs.05643 2 Place, T.L., J.T.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1371/journal.pone.008302 1 Plotnikov, S.V ., and C.M.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1016/j.ceb.2013.06.00 3 Riveline, D., E. Zamir, N.Q.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1083/jcb.153.6.117 5 Ruoslahti, E., E.G.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1016/0076-6879(82)82103- 4 Saunders, R.M., M.R.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1016/j.ejcb.2006.01.01 4 Sefton, B.M., T. Hunter, E.H. Ball, and S.J.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1016/0092-8674(81)90512- 2 Shen, K., C.E.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10   .1074/jbc.M111.24429 3 Subauste, M.C., O. Pertz, E.D.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"12:48. http://dx.doi.org/   10.1186/1471-2121-12-4 8 Tsai, J., and L. Kam.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1016/   j.bpj.2009.01.00 5 Volberg, T., B. Geiger, J. Kartenbeck, and W.W. Franke.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1083/jcb.102.5.183 2 Xu, W., H. Baribault, and E.D.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1038/ncb205 5 Zandy, N.L., and A.M. Pendergast.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.4161/cc.7.4.545 2 Zandy, N.L., M. Playford, and A.M. Pendergast.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1016/j.cub.2004.07.02 1Chen, C.S., J. Tan, and J. Tien.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/   10.1146/annurev.bioeng.6.040803.14004 0 Chen, Z., E. Lessey, M.E.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1371/journal.pone.005223 3 Chrzanowska-Wodnicka, M., and K. Burridge.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1083/jcb.133.6.140 3 DeMali, K.A., C.A.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1083/jcb.20020604 3 Fisher, J.K., J. Cribb, K.V.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1063/1.216650 9 Galbraith, C.G., K.M.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1083/jcb.20020415 3 Geiger, B.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"18:193â 205. http://dx.doi.org/10.1016/0092-8674(79)90368- 4 Geiger, B., K.T.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1006/excr.1997.391 5 Goldyn, A.M., B.A.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/   10.1038/nature0919 8 Guilluy, C., V. Swaminathan, R. Garcia-Mata, E.T.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"272:32448â 32453. http://dx.doi.org/10.1074/jbc.272.51.3244 8 Huveneers, S., and J. de Rooij.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1242/jcs.10944 7 Huveneers, S., J. Oldenburg, E. Spanjaard, G. van der Krogt, I. Grigoriev, A.  Akhmanova, H. Rehmann, and J. de Rooij.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1083/jcb.20110812 0 Irvine, E., and C. Williams.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1002/phar.126 6 Kain, K.H., and R.L.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1074/jbc.M10009520 0 le Duc, Q., Q. Shi, I. Blonk, A. Sonnenberg, N. Wang, D. Leckband, and J.  de Rooij.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/   10.1083/jcb.20100114 9 Lessey, E.C., C. Guilluy, and K. Burridge.",OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1021/   bi300758 e Maddugoda, M.P., M.S.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
"http://dx.doi.org/10.1091/mbc.E06-12-115 4 Mierke, C.T., P. Kollmannsberger, D.P.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/JCB_201309092.PMC4003237.pdf
This article is distributed under the terms of an Attributionâ NoncommercialâShare AlikeâNo Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"After six months it is available under a  Creative Commons License (AttributionâNoncommercialâShare Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201309029/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10.1016/j   .biomaterials.2011.07.00 3 Maskarinec, S.A., C. Franck, D.A.",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10.1016/j.cell.2011   .01.01 6 Morin, X., and Y .",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.06.01 2 Pampaloni, F., E.G.",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10.1038/nrm223 6 Paszek, M.J., N. Zahir, K.R.",Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10.1016/j.ccr.2005.08.01 0 Saito, K., A. Kawaguchi, S. Kashiwagi, S. Yasugi, M. Ogawa, and T. Miyata.",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
http://dx.doi.org/10.1046/j.1524-4725.2003.690.,Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10.1038/   nature0964 2 Straight, A.F., A. Cheung, J. Limouze, I. Chen, N.J. Westwood, J.R.",Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi   .org/10.1126/science.108141 2 ThÃ©ry, M., and M. Bornens.",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10.1016/j.ceb.2006.10.00 1 ThÃ©ry, M., V. Racine, A. PÃ©pin, M. Piel, Y. Chen, J.B. Sibarita, and M. Bornens.",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
http://dx.doi.org/10.1038/ncb130 7This research was supported by grants from the National Science  Foundation (Division of Materials Research No.,OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10   .1038/nn.254 7 Burton, K., and D.L.",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi   .org/10.1038/385450a 0 Cramer, L., and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"122:833â 843. http://dx.doi.org/10.1083/jcb.122.4.83 3 Cukierman, E., R. Pankov, and K.M.",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi   .org/10.1016/S0955-0674(02)00364- 2 Discher, D.E., P. Janmey, and Y.L.",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/   10.1126/science.111699 5 Effler, J.C., Y.S.",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10   .1016/j.cub.2006.08.02 7 Fink, J., N. Carpi, T. Betz, A. BÃ©tard, M. Chebah, A. Azioune, M. Bornens, C.  Sykes, L. Fetler, D. Cuvelier, and M. Piel.",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/   10.1038/ncb226 9 Fraley, S.I., Y .F.",Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/   10.1038/ncb206 2 Franck, C., S. Hong, S.A. Maskarinec, D.A.",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10.1007/s11340-007-9037- 9 Franck, C., S.A. Maskarinec, D.A.",Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10.1371/ journal.pone.001783 3 Gillies, T.E., and C. Cabernard.",Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10.1016/j.cub.2011.06.05 5 Hakkinen, K.M., J.S.",OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10.1089/ten   .tea.2010.027 3 Hirschi, K.K., S.A. Rohovsky, L.H.",Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10.1161/01.RES.84.3.29 8 Hur, S.S., Y .H.",Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"http://dx.doi.org/10.1007/s12195-009-0082- 6 Koch, T.M., S. MÃ¼nster, N. Bonakdar, J.P. Butler, and B. Fabry.",Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/53/JCB_201309029.PMC4003238.pdf
"Although the mechanisms  underlying these NE restructuring events are currently  being defined, one common theme is activation of protein  kinase C family members in the interphase nucleus to dis - rupt the nuclear lamina, demonstrating the importance of  the lamina in maintaining nuclear integrity.Breaching the nuclear envelope in development   and disease Emily Hatch and Martin Hetzer Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037 Â© 2014 Hatch and Hetzer  This article is distributed under the terms of an Attributionâ NoncommercialâShare AlikeâNo Mirror Sites license for the first six months after the pub Â­ lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"After six months it is available under a  Creative Commons License (AttributionâNoncommercialâShare Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by Â­ncÂ­sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"482:53â 58. http://dx.doi.org/10.1038/nature1080 2 Cross, T., G. Griffiths, E. Deacon, R. Sallis, M. Gough, D. Watters, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"19:2331â 2337. http://dx.doi.org/10.1038/sj.onc.120355 5 DâAngelo, M.A., D.J.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1126/science.112419 6 Daigle, N., J. Beaudouin, L. Hartnell, G. Imreh, E. Hallberg, J. Lippincott- Schwartz, and J. Ellenberg.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1083/jcb.20010108 9 Dawson, T.R., M.D.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1083/jcb.20080617 4 de Noronha, C.M., M.P.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"294:1105â 1108. http://dx.doi.org/10.1126/science.106395 7 De V os, W.H., F. Houben, M. Kamps, A. Malhas, F. Verheyen, J. Cox, E.M.  Manders, V .L.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1093/hmg/ddr34 4 Dechat, T., S.A. Adam, P. Taimen, T. Shimi, and R.D.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/   10.1101/cshperspect.a00054 7 Devos, D., S. Dokudovskaya, F. Alber, R. Williams, B.T.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi   .org/10.1371/journal.pbio.002038 0 Devos, D., S. Dokudovskaya, R. Williams, F. Alber, N. Eswar, B.T.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"141:1030â 1041. http://dx.doi.org/10.1016/j.cell.2010.04.03 6 Ellenberg, J., E.D.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/   10.1083/jcb.138.6.119 3 FidziaÅska, A., Z.T.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j.jns.2008.03   .017 Freund, A., R.-M. Laberge, M. Demaria, and J. Campisi.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1091/mbc.E11-10-088 4 Fuchs, T.A., U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, V. Wahn, Y.  Weinrauch, V. Brinkmann, and A. Zychlinsky.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"176:231â 241. http://dx.doi.org/10.1083/jcb.20060602 7 Funkhouser, C.M., R. Sknepnek, T. Shimi, A.E.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1101/SQB.1956   .021.01.02 1 Gerace, L. 2004.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j.neuron.2005.11.01 0 Goss, V .L., B.A.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j   .cell.2012.05.04 8 Andersen, J.L., E. Le Rouzic, and V .",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10   .1016/j.yexmp.2008.03.01 5 Anderson, D.J., and M.W.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1038/ncb163 6 Anderson, D.J., J.D.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10   .1083/jcb.20090110 6 Bakheet, S.A., S.M.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1093/mutage/ger01 3 Beaudouin, J., D. Gerlich, N. Daigle, R. Eils, and J. Ellenberg.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/S0092-8674(01)00627- 4 Brandes, D., B.H.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1126/science.149.3690.137 3 Brinkmann, V., and A. Zychlinsky.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1083/jcb.20120317 0 Brinkmann, V ., U. Reichard, C. Goosmann, B. Fauler, Y .",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1126/   science.109238 5 Brohawn, S.G., J.R. Partridge, J.R. Whittle, and T.U.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j.str.2009.07.01 4 Burke, B., and C.L.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1038/nrm348 8 Casey, A.K., T.R.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10   .1534/genetics.112.14146 5 Chavez, S.L., K.E.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"3:1251. http://dx.doi   .org/10.1038/ncomms224 9 Chen, C.-Y ., Y .-H. Chi, R.A. Mutalif, M.F.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j.cell.2012.01.05 9 Coffinier, C., H.-J.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1074/jbc.M110.12883 5 Cohen, S., and N. PantÃ©.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1099/vir.0.80967- 0 Cohen, S., A.R.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1099/vir.0.82232- 0 Cohen, S., A.K.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1128/JVI.01999-1 0 Collas, P. 1999.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1083/jcb.137.5.100 1 Longo, F.J., and E. Anderson.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1083/jcb.39.2.33 9 Lu, L., M.S.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1083/jcb.20101206 3 Maric, M., J. Shao, R.J. Ryan, C.-S. Wong, P. Gonzalez-Alegre, and R.J. Roller.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1128/JVI.05314-1 1 Marschall, M., S. Feichtinger, and J. Milbradt.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi   .org/10.1016/0092-8674(92)90224- Z Melloy, P., S. Shen, E. White, J.R. McIntosh, and M.D.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1083/jcb.20070615 1 Melloy, P., S. Shen, E. White, and M.D.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"20:3773â 3782. http://dx.doi.org/10.1091/mbc.E09-02-016 3 Mettenleiter, T.C., B.G.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j.virusres   .2009.03.01 8 Milbradt, J., R. Webel, S. Auerochs, H. Sticht, and M. Marschall.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1074/jbc.M109.06362 8 Moir, R.D., M. Yoon, S. Khuon, and R.D.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10   .1083/jcb.151.6.115 5 Mor, A., S. Suliman, R. Ben-Yishay, S. Yunger, Y. Brody, and Y. Shav-Tal.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1038/ncb205 6 Mou, F., E. Wills, and J.D.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1128/JVI.00090-0 9 Muranyi, W., J. Haas, M. Wagner, G. Krohne, and U.H.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1126/science.107150 6 Newport, J.W., K.L.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1083/jcb.111.6.224 7 Oliva, H., A. Valle, L.D.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/   10.1371/journal.ppat.100367 1 Prokocimer, M., A. Margalit, and Y. Gruenbaum.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j.jsb.2006.02.01 6 Puckelwartz, M.J., E. Kessler, Y. Zhang, D. Hodzic, K.N.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi   .org/10.1093/hmg/ddn38 6GrÃ¼nwald, D., R.H. Singer, and M. Rout.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1038/   nature1031 8 Gupta, P., Z.T.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10   .1007/s00395-010-0085- 4 GÃ¼ttinger, S., E. Laurell, and U. Kutay.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1038/nrm264 1 Hadek, R., and H. Swift.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10   .1083/jcb.13.3.44 5 Hanson, P.I., and S.W.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1038/nrm168 4 Haraguchi, T., T. Kojidani, T. Koujin, T. Shimi, H. Osakada, C. Mori, A.  Yamamoto, and Y .",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1242/jcs.03359 7 Hatch, E.M., A.H. Fischer, T.J. Deerinck, and M.W.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j.cell.2013.06.00 7 Hocevar, B.A., D.J.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi   .org/10.1083/jcb.104.6.147 1 Ivanov, A., J. Pawlikowski, I. Manoharan, J. van Tuyn, D.M.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"202:129â 143. http://dx.doi.org/10.1083/jcb.20121211 0 Johnson, D.C., and J.D.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi   .org/10.1038/nrmicro255 9 Jokhi, V., J. Ashley, J. Nunnari, A. Noma, N. Ito, N. Wakabayashi-Ito, M.J.  Moore, and V. Budnik.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j.celrep.2013.03.01 5 Kandert, S., Y. LÃ¼ke, T. Kleinhenz, S. Neumann, W. Lu, V.M.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1093/hmg/ddm25 5 Kim, Y ., A.A. Sharov, K. McDole, M. Cheng, H. Hao, C.-M.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"334:1706â 1710. http://dx.doi.org/10.1126/science.121122 2 Kim, Y., X. Zheng, and Y. Zheng.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1038/cr.2013.11 8 Kiseleva, E., M.W.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1097/CCO.000000000000003 8 Klupp, B.G., H. Granzow, W. Fuchs, G.M.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10   .1016/j.virol.2010.07.00 2 Lemaitre, J.-M., G. GÃ©raud, and M. MÃ©chali.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1083/   jcb.142.5.115 9 LÃ©nÃ¡rt, P., and J. Ellenberg.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/S0955-0674(02)00011- X Lenz-BÃ¶hme, B., J. Wismar, S. Fuchs, R. Reifegerste, E. Buchner, H. Betz, and  B. Schmitt.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10   .1101/cshperspect.a00056 2 Wilson, K.L., and R. Foisner.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1101/cshperspect   .a00055 4 Worman, H.J., C. Ostlund, and Y. Wang.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1101/ cshperspect.a00076 0 Ydenberg, C.A., and M.D.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/   10.1007/978-1-59745-250-2_ 1 Yipp, B.G., B. Petri, D. Salina, C.N.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10   .1038/nm.284 7 Zhang, C.-Z., M.L.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1101/gad.229559.11 3 Zhang, Q., C. Bethmann, N.F.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1093/hmg/ddm23 8 Zink, D., A.H. Fischer, and J.A.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1038/nrc143 0 Zufferey, R., D. Nagy, R.J. Mandel, L. Naldini, and D. Trono.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1038/nbt0997-87 1Puckelwartz, M.J., E.J.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j.yjmcc.2009.11.00 6 Roshal, M., B. Kim, Y. Zhu, P. Nghiem, and V. Planelles.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1074/jbc.M30394820 0 Rothballer, A., and U. Kutay.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j.tibs.2013.04.00 1 Rothballer, A., and U. Kutay.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1007/s00412-013-0417- x Salina, D., K. Bodoor, D.M.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/S0092-8674(01)00628- 6 Schermelleh, L., P.M. Carlton, S. Haase, L. Shao, L. Winoto, P. Kner, B.  Burke, M.C.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi   .org/10.1126/science.115694 7 Shimi, T., K. Pfleghaar, S. Kojima, C.G.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1101/gad.173520 8 Shimi, T., V. Butin-Israeli, S.A. Adam, R.B.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1101/gad.179515.11 1 Smoyer, C.J., and S.L.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/   10.1016/j.ceb.2013.08.00 2 Speese, S.D., J. Ashley, V. Jokhi, J. Nunnari, R. Barria, Y. Li, B. Ataman, A.  Koon, Y.-T. Chang, Q. Li, et al.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j.cell.2012.03.03 2 Stackpole, C.W.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j.cell.2010.11.05 5 Stewart, C.L., K.J.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi   .org/10.1126/science.114203 4 Strambio-De-Castilla, C. 2013.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.4161/nucl.2423 7 Sullivan, T., D. Escalante-Alcalde, H. Bhatt, M. Anver, N. Bhat, K. Nagashima,  C.L.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1083/jcb.147.5.91 3 SzÃ¶llÃ¶si, M.S., and D. SzÃ¶llÃ¶si.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.4161/nucl.2338 8 Tapley, E.C., and D.A.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1016/j.ceb.2012.10.01 4 Thompson, L.J., and A.P.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.1074/jbc.271.25.1504 5 Vargas, J.D., E.M. Hatch, D.J.",OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
"http://dx.doi.org/10.4161/nucl.1895 4 Vergnes, L., M. PÃ©terfy, M.O.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/JCB_201402003.PMC4003239.pdf
This article is distributed under the terms of an Attributionâ NoncommercialâShare AlikeâNo Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"After six months it is available under a  Creative Commons License (AttributionâNoncommercialâShare Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
Online  supplemental material is available at http://www.jcb.org/cgi/content/full/ jcb.201311003/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"Additional data are available in the JCB DataViewer  at http://dx.doi.org/10.1083/jcb.201311003.d v. We thank Richard Weinberg, Patrick Brennwald, and the Gupton laboratory  for thoughtful critique of the manuscript.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/   10.1016/j.devcel.2010.05.01 6 Arlotta, P., B.J.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi   .org/10.1016/j.neuron.2004.12.03 6 Balastik, M., F. Ferraguti, A. Pires-da Silva, T.H.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/   S0092-8674(00)80804- 1 Horn, K.E., S.D.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/j.celrep.2012.12.00 5 Hung, A.Y ., C.C.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1371/journal.pone.000984 2 Joazeiro, C.A.P., and A.M. Weissman.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10   .1016/S0092-8674(00)00077- 5 Jordan, B.A., B.D.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/0959-4388(95)80091- 3 Kubbutat, M.H., and K.H.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/j.neuron.2007.09.00 8 Lebrand, C., E.W.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/S0896-6273(04)00108- 4 Lerman-Sagie, T., L. Ben-Sira, R. Achiron, L. Schreiber, G. Hermann, D. Lev, D.  Kidron, and G. Malinger.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1002/   uog.635 6 Leyva-DÃ­az, E., and G. LÃ³pez-Bendito.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"276:40824â 40833. http://dx.doi.org/10.1074/jbc.M10614120 0 Martinez-Arca, S., P. Alberts, A. Zahraoui, D. Louvard, and T. Galli.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1083/jcb.149.4.88 9 Meroni, G., and G. Diez-Roux.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/   10.1016/j.cub.2010.03.04 8 MiesenbÃ¶ck, G., D.A.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1038/2819 0 Molyneaux, B.J., P. Arlotta, J.R.L.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"8:427â 437. http://dx.doi.org/10.1038/nrn215 1 Moore, S.W., M. Tessier-Lavigne, and T.E.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1007/   978-0-387-76715-4_ 2 Morikawa, R.K., T. Kanamori, K.-I.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/   10.1073/pnas.110984310 8 Pfenninger, K.H.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1038/nrn259 3 Proux-Gillardeaux, V ., R. Rudge, and T. Galli.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
http://dx.doi.org/10.1111/j.1600- 0854.2005.00288. xcauses accumulation of neurofilament light chain and neurodegenera - tion.,OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10   .1073/pnas.080226110 5 Berti, C., S. Messali, A. Ballabio, A. Reymond, and G. Meroni.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/S0925-4773(02)00013- 8 Bouchard, J.-F., S.W.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4934-03.200 4 Bouchard, J.-F., K.E.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
107:398â 417. http://dx.doi.org/10.1111/j.1471-4159.2008.05609.,Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1126/science.119522 7 Cotrufo, T., F. PÃ©rez-BrangulÃ­, A. Muhaisen, O. Ros, R. AndrÃ©s, T. Baeriswyl,  G. Fuschini, T. Tarrago, M. Pascual, J. UreÃ±a, et al.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3018-11.201 1 Cotrufo, T., R.M.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
http://dx.doi.org/10.1111/j.1460-9568.2012.08259.,Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/   10.1523/JNEUROSCI.4963-03.200 4 Drachman, D.A.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1212/01.WNL.0000166914.38327.B B Fazeli, A., S.L.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1038/386796a 0 Feng, G., R.H. Mellor, M. Bernstein, C. Keller-Peck, Q.T.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)00084- 2 Gaudenz, K., E. Roessler, N. Quaderi, B. Franco, G. Feldman, D.L.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10   .1086/30201 0 GÃ¶Ã§men, R., and K.K.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/j.schres.2012.02.02 3 Gupton, S.L., and F.B.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"18:725â 736. http://dx.doi.org/10.1016/j.devcel.2010.02.01 7 Gupton, S.L., D. Riquelme, S.K.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"355:101â 114. http://dx.doi.org/10.1016/j.ydbio.2011.04.01 6 HÃ¤mÃ¤lÃ¤inen, R.H., K. Avela, J.A.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"23:522. http://dx.doi.org/10.1002/humu.923 3 Hao, J.C., C.E.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.02.01 9 Hatakeyama, S. 2011.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
http://dx.doi.org/10.1038/nrc313 9,Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi   .org/10.1074/jbc.M111.30767 8 Yang, Y., S. Fang, J.P. Jensen, A.M. Weissman, and J.D.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1177/   107385841037151 3 Zhu, X.-J., C.-Z.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"7:609.  http://dx.doi.org/10.3389/fnhum.2013.0060 9 Zylbersztejn, K., M. Petkovic, A. Burgo, M. Deck, S. Garel, S. Marcos, E. Bloch- Gallego, F. Nothias, G. Serini, D. Bagnard, et al.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1083/jcb.20110611 3Quaderi, N.A., S. Schweiger, K. Gaudenz, B. Franco, E.I.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi   .org/10.1038/ng1197-28 5 Quinn, C.C., D.S.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/j.cub.2008.04.05 0 Reuss, B., and O. von Bohlen und Halbach.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"313:139â 157. http://dx.doi.org/10.1007/s00441-003-0756- 7 Round, J., and E. Stein.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/j.conb   .2007.01.00 3 Saccone, V., M. Palmieri, L. Passamano, G. Piluso, G. Meroni, L. Politano, and  V. Nigro.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"29:240â 247. http://dx.doi.org/10.1002/humu.2063 3 Schiavo, G., F. Benfenati, B. Poulain, O. Rossetto, P. Polverino de Laureto, B.R.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1038/359832a 0 Schiavo, G., O. Rossetto, S. Catsicas, P. Polverino de Laureto, B.R.",Non-OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/0092-8674(94)90420- 0 Serafini, T., S.A. Colamarino, E.D.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81795- X Shi, M., C. Guo, J.-X.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/j.mcn   .2008.07.02 3 Short, K.M., and T.C.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1074/jbc.M51275520 0 SÃ¶llner, T., M.K.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/0092-8674(93)   90376- 2 Srour, M., J.-B.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"328:592. http://dx.doi.org/10.1126/   science.118646 3 Strasser, G.A., N.A.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/j.neuron.2004.05.01 5 SÃ¼dhof, T.C.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi   .org/10.1016/j.neuron.2012.06.01 2 Suzuki, M., Y .",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1002/1098- 2779(2000) 6:4<258::AID-MRDD5>3.0.CO;2- H Tanji, K., T. Kamitani, F. Mori, A. Kakita, H. Takahashi, and K. Wakabayashi.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1016/j.nbd.2010.01.00 7 Tojima, T., H. Akiyama, R. Itofusa, Y .",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1038/nn181 4 Tursun, B., A. SchlÃ¼ter, M.A.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
"http://dx.doi.org/10.1101/gad   .134060 5 Wei, Z., J. Yan, Q. Lu, L. Pan, and M. Zhang.",OADS,/arxiv_data1/oa_pdf/52/9e/JCB_201311003.PMC4003241.pdf
This article is distributed under the terms of an AttributionâNoncommercialâ   Share AlikeâNo Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"After six months it is available under a Creative Commons  License (AttributionâNoncommercialâShare Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1074/jbc.M109.05734 9 Buxboim, A., K. Rajagopal, A.E.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"22:194116.  http://dx.doi.org/10.1088/0953-8984/22/19/19411 6 Chen, Y.P., T.E.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1083/jcb.20130213 1 Choi, C.K., J. Zareno, M.A.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1016/j.bpj.2010.12.371 9 Cluzel, C., F. Saltel, J. Lussi, F. Paulhe, B.A.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1083/jcb   .20050301 7 Deakin, N.O., and C.E.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1242/jcs.01804 4 Deakin, N.O., and C.E.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1091/mbc.E10-09-079 0 del Rio, A., R. Perez-Jimenez, R. Liu, P. Roca-Cusachs, J.M.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1126/   science.116291 2 de Pereda, J.M., K.L.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10   .1074/ jbc.M41318020 0 Engler, A.J., S. Sen, H.L.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi   .org/10.1016/j.cell.2006.06.04 4 Friedland, J.C., M.H.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1074/jbc.M50806020 0 Goksoy, E., Y.Q.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1016/j   .molcel.2008.06.01 1 Green, J.A., A.L.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1074/jbc.M80593420 0 Guillou, H., A. Depraz-Depland, E. Planus, B. Vianay, J. Chaussy, A. Grichine, C.  AlbigÃ¨s-Rizo, and M.R.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1016/j.yexcr.2007.10.02 6 Hagel, M., E.L. George, A. Kim, R. Tamimi, S.L.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/   10.1128/MCB.22.3.901-915.200 2 Harburger, D.S., M. Bouaouina, and D.A.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"284:11485â 11497. http://dx.doi.org/10.1074/jbc.M80923320 0 Hynes, R.O.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1016/S0092-8674(02)00971- 6 HytÃ¶nen, V.P., and V. Vogel.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1371/journal.pcbi.004002 4 Kieffer, N., C. Melchior, J.M.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201308136/DC1.,Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
Additional  data are available in the JCB DataViewer at http://dx.doi.org/10.1083/ jcb.201308136.d v. The authors thank Drs.,OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/   10.1038/emboj.2009.28 7 Anthis, N.J., K.L.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi   .org/10.1083/jcb.20010710 7 Barsukov, I.L., A. Prescot, N. Bate, B. Patel, D.N.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1074/jbc.M30385020 0 Berrier, A.L., A.M. Mastrangelo, J.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1083/jcb.151.7.154 9 Berrier, A.L., R. Martinez, G.M.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1242/jcs.0010 9 Bledzka, K., J. Liu, Z. Xu, H.D.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1074/jbc.M111.33674 3 Boettiger, D. 2012.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1016/   j.ceb.2012.07.00 2 Brown, M.C., J.A.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
http://dx.doi.org/   10.1083/jcb.135.4.110 9,Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10   .1083/jcb.20090813 4 Schaffner-Reckinger, E., V. Gouon, C. Melchior, S. PlanÃ§on, and N. Kieffer.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1038/nmeth.201 9 Schmidt, S., I. Nakchbandi, R. Ruppert, N. Kawelke, M.W.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1083/ jcb  .20100714 1 Shi, Q., and D. Boettiger.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1091/mbc.E03-01-004 6 Sin, S., F. Bonin, V. Petit, D. Meseure, F. Lallemand, I. BiÃ¨che, A. BellahcÃ¨ne,  V. Castronovo, O. de Wever, C. Gespach, et al.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1093/jnci/djr29 0 Song, X., J. Yang, J. Hirbawi, S. Ye, H.D.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1038/cr.2012.9 7 Taddei, M.L., E. Giannoni, T. Fiaschi, and P. Chiarugi.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi   .org/10.1002/path.300 0 Tadokoro, S., S.J.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1126/science.108665 2 Tanentzapf, G., and N.H. Brown.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1038/ncb141 1 Tse, J.R., and A.J.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1038/sj .onc  .120501 3 Wang, P., C. Ballestrem, and C.H.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi   .org/10.1083/jcb.20110412 8 Wegener, K.L., A.W.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1016/j.cell   .2006.10.04 8 Wegener, K.L., J. Basran, C.R.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi   .org/10.1016/j.jmb.2008.06.08 7 Wehrle-Haller, B.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1016/j.ceb.2011.11.00 1 Yates, L.A., A.K.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1074/jbc   .M112.41520 8 Yeung, T., P.C.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1002/cm.2004 1 YlÃ¤nne, J., J. Huuskonen, T.E.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.3109/1541906960901076 1 Kong, F., A.J.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1083/jcb.20081000 2 Kong, X., X. Wang, S. Misra, and J. Qin.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1016/j.jmb.2006.02.04 8 LaFlamme, S.E., L.A. Thomas, S.S. Yamada, and K.M.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi   .org/10.1083/jcb.126.5.128 7 Lawson, C., S.T.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/   10.1083/jcb.20110807 8 Lehnert, D., B. Wehrle-Haller, C. David, U. Weiland, C. Ballestrem, B.A.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1242/jcs.0083 6 Ma, Y.Q., J. Qin, C. Wu, and E.F.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1083/jcb   .20071019 6 Miyamoto, S., S.K.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1126/science.784653 1 Miyamoto, S., H. Teramoto, J.S.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi   .org/10.1083/jcb.135.6.163 3 Monkley, S.J., X.-H. Zhou, S.J.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1002/   1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2- Y Monkley, S.J., V. Kostourou, L. Spence, B. Petrich, S. Coleman, M.H.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi   .org/10.1016/j.ydbio.2010.11.01 0 Montanez, E., S. Ussar, M. Schifferer, M. BÃ¶sl, R. Zent, M. Moser, and R.  FÃ¤ssler.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1101/gad.46940 8 Moser, M., B. Nieswandt, S. Ussar, M. Pozgajova, and R. FÃ¤ssler.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1038/nm172 2 Moser, M., M. Bauer, S. Schmid, R. Ruppert, S. Schmidt, M. Sixt, H.V.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1038/nm.192 1 Partridge, M.A., and E.E.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/   10.1091/mbc.E06-06-049 6 Paszek, M.J., N. Zahir, K.R.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1016/j.ccr.2005.08.01 0 Petrich, B.G., P. Fogelstrand, A.W.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/   10.1172/JCI3102 4 Petrich, B.G., P. Marchese, Z.M.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/   10.1084/jem.2007180 0 Pluskota, E., J.J. Dowling, N. Gordon, J.A.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10.1182/blood-2010-11-32118 2 Rajagopalan, P., W.A.",Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi   .org/10.1038/ncb176 5 Zhu, J., J. Zhu, and T.A.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
"http://dx.doi.org/10   .1083/jcb.20121203 7 Zouq, N.K., J.A.",OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
http://dx.doi   .org/10.1242/jcs.03047 8,Non-OADS,/arxiv_data1/oa_pdf/76/19/JCB_201308136.PMC4003243.pdf
This article is distributed under the terms of an Attributionâ NoncommercialâShare AlikeâNo Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"After six months it is available under a  Creative Commons License (AttributionâNoncommercialâShare Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201304101/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3111-05.200 5 Chen, Y .H., M.H.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"429:675â 680. http://dx.doi.org/10.1038/nature0264 1 Chen, Y ., B. Stevens, J. Chang, J. Milbrandt, B.A.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1016/j.jneumeth   .2008.03.01 3 Chien, A.J., X. Zhao, R.E.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1074/jbc.270.50.3003 6 Christopherson, K.S., E.M. Ullian, C.C.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1016/j.cell.2004   .12.02 0 Colecraft, H.M., B. Alseikhan, S.X.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"541:435â 452. http://dx.doi.org/10.1113/jphysiol.2002.01851 5 De Waard, M., D.R.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1074/jbc.270   .20.1205 6 Dieni, S., T. Matsumoto, M. Dekkers, S. Rauskolb, M.S.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10   .1083/jcb.20120103 8 Dolphin, A.C. 2003.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1023/B:JOBB.0000008026   .37790.5 a Evans, R.M., and G.W.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1016/j.tins.2006.08.00 6 Fan, M., Z. Buraei, H.R.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1074/jbc.M41426120 0 Fletcher, R., and M.D.J.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1093/comjnl/   6.2.16 3 Flynn, R., and G.W.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.4161/chan   .4.6.1286 5 Fujita, Y., M. Mynlieff, R.T. Dirksen, M.S.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi   .org/10.1016/0896-6273(93)90162- K Gandini, M.A., A. Sandoval, R. GonzÃ¡lez-RamÃ­rez, Y. Mori, M. de Waard, and  R. Felix.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"286:15757â 15765. http://dx.doi.org/10.1074/jbc.M110.18775 7 Geib, S., G. Sandoz, K. Mabrouk, A. Matavel, P. Marchot, T. Hoshi, M. Villaz,  M. Ronjat, R. Miquelis, C. LÃ©vÃªque, and M. de Waard.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1101/gr.259650 4 Gonoi, T., N. Mizuno, N. Inagaki, H. Kuromi, Y .",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1016/   S0896-6273(03)00820- 1References Adler, J., and I. Parmryd.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1002/cyto.a.2089 6 Altier, C., S.J.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1074/ jbc.M20247620 0 Altier, C., A. Garcia-Caballero, B. Simms, H. You, L. Chen, J. Walcher, H.W.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1038/   nn.271 2 Arikkath, J., and K.P.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1016/S0959-4388(03)00066- 7 Atiya-Nasagi, Y ., H. Cohen, O. Medalia, M. Fukudan, and R. Sagi-Eisenberg.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1242/jcs.0171 0 Atwood, H.L.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"312:1008â 1009. http://dx.doi.org/10.1126/science.112844 5 Beedle, A.M., J.E.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1038/nn118 0 BÃ©guin, P., K. Nagashima, T. Gonoi, T. Shibasaki, K. Takahashi, Y .",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1038/3507962 1 BÃ©guin, P., R.N.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1042/BJ2005041 4 BÃ©guin, P., R.N.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10   .1242/jcs.0232 1 BÃ©guin, P., R.N.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1016/j.jmb.2005.10.01 3 BÃ©guin, P., Y .J.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/   10.1074/jbc.M60642320 0 Bell, D.C., A.J.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1038/378623a 0 Bidaud, I., A. Mezghrani, L.A. Swayne, A. Monteil, and P .",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"1763:1169â 1174. http://dx.doi.org/10.1016/j.bbamcr.2006.08.04 9 Brice, N.L., N.S.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
9:749â 759. http://dx.doi.org/10.1111/j.1460-9568.1997.tb01423.,Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1152/physrev.00057.200 9 CantÃ­, C., A. Davies, N.S.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1016/S0006-3495(01)75799- 2 Catterall, W.A.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1146/   annurev.cellbio.16.1.52 1 Chen, H., H.L.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1016/S0896-6273(04)00250- 8 Pragnell, M., M. De Waard, Y .",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1101/gr.080531.10 8 Richards, M.W., A.J.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1016/j.tips.2004.10.00 8 Schneider, C.A., W.S.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10   .1038/nmeth.208 9 Sheng, Z.H., J. Rettig, M. Takahashi, and W.A.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"13:1303â 1313. http://dx.doi.org/10.1016/0896-6273(94)90417- 0 Spafford, J.D., and G.W.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1016/S0959-   4388(03)00061- 8 Ullian, E.M., K.S.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1002/glia.2008 2 Van Petegem, F., K.A.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1038/   nature0258 8 Vega, I.E., and S.C. Hsu.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1007/s00424-011-0926- 5 Yang, S.N., and P.O.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1210/er.2005-088 8 Yang, T., X. Xu, T. Kernan, V. Wu, and H.M. Colecraft.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1113/jphysiol.2010.18720 3 Zhai, R.G., and H.J.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1038/1472 1Herlitze, S., D.E.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1038/380258a 0 Hidalgo, P., G. Gonzalez-Gutierrez, J. Garcia-Olivares, and A. Neely.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1074/jbc.M60593020 0 Ikeda, S.R.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi   .org/10.1038/380255a 0 Jarvis, S.E., and G.W.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1016/j.ceb.2007.04.02 0 Jones, L.P., S.K.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1085/jgp.112.2.12 5 Josephson, I.R., and G. Varadi.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1016/S0006-3495(96)79685- 6 Kameyama, K., K. Aono, and K. Kitamura.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1093/bja/82.3.40 2 Kamp, T.J., M.T.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
http://dx.doi   .org/10.1038/nprot.2009.,Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1038/nn190 4 Launey, T., S. Endo, R. Sakai, J. Harano, and M. Ito.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1038/2019 4 Mahalakshmi, R.N., K. Nagashima, M.Y.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1111/j.1600-   0854.2007.00598. x Mahalakshmi, R.N., M.Y.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
http://dx.doi.org/10.1111/j.1600-0854.2007.00599.,Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1038/350398a 0 Neher, E. 1998.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80983- 6 Niidome, T., T. Teramoto, Y. Murata, I. Tanaka, T. Seto, K. Sawada, Y. Mori,  and K. Katayama.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1006/bbrc.1994.239 9 Nishimune, H., J.R. Sanes, and S.S. Carlson.",OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1038/nature0311 2 Obermair, G.J., B. Schlick, V. Di Biase, P. Subramanyam, M. Gebhart, S.  Baumgartner, and B.E.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"http://dx.doi.org/10.1074/jbc.M109.04427 1 Opatowsky, Y ., O. Chomsky-Hecht, M.G.",Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
http://dx.doi   .org/10.1074/jbc.M30356420 0,Non-OADS,/arxiv_data1/oa_pdf/13/83/JCB_201304101.PMC4003244.pdf
"These results explain a feed- forward mechanism of PINK1-mediated initiation of Par - kin E3 ligase activity.PINK1 phosphorylates ubiquitin to activate Parkin  E3 ubiquitin ligase activity Lesley A. Kane,1 Michael Lazarou,1 Adam I. Fogel,1 Yan Li,2 Koji Yamano,1 Shireen A. Sarraf,1 Soojay Banerjee,1   and Richard J. Youle1 1Biochemistry Section, Surgical Neurology Branch, and 2Protein/Peptide Sequencing Facility, National Institute of Neurological Disorders and Stroke, National Institutes   of Health, Bethesda, MD 20824 This article is distributed under the terms of an AttributionâNoncommercialâShare AlikeâNo  Mirror Sites license for the first six months after the publication date (see http://www.rupress   .org/terms).",Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"392:605â 608. http://dx.doi.org/10.1038/3341 6 Kondapalli, C., A. Kazlauskaite, N. Zhang, H.I.",Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"2:120080. http://dx.doi.org/10.1098/rsob.12008 0 Lazarou, M., S.M.",Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
http://dx.doi   .org/10.1111/j.1471-4159.2008.05398.,Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1021/   pr900377 3 Matsuda, N., S. Sato, K. Shiba, K. Okatsu, K. Saisho, C.A.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10   .1083/jcb.20091014 0 Moritz, A., Y. Li, A. Guo, J. VillÃ©n, Y. Wang, J. MacNeill, J. Kornhauser, K.  Sprott, J. Zhou, A. Possemato, et al.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1126/scisignal.200099 8 Narendra, D., A. Tanaka, D.F.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1083/jcb.20080912 5 Narendra, D.P., S.M.",Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1101/cshperspect   .a01133 8 Okatsu, K., T. Oka, M. Iguchi, K. Imamura, H. Kosako, N. Tani, M. Kimura, E.  Go, F. Koyano, M. Funayama, et al.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"3:1016. http://dx.doi.org/10.1038/   ncomms201 6 Olsen, J.V ., B. Blagoev, F. Gnad, B. Macek, C. Kumar, P. Mortensen, and M.  Mann.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1016/j.cell   .2006.09.02 6 Phanstiel, D.H., J. Brumbaugh, C.D.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1038/nmeth.169 9 Rikova, K., A. Guo, Q. Zeng, A. Possemato, J. Yu, H. Haack, J. Nardone, K. Lee,  C. Reeves, Y .",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1038/nature1204 3 Shiba-Fukushima, K., Y .",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"2:1002. http://dx.doi.org/10.1038/srep0100 2 Shiromizu, T., J. Adachi, S. Watanabe, T. Murakami, T. Kuga, S. Muraoka, and  T. Tomonaga.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1021/pr300825 v Tanaka, A., M.M.",Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201402104/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1038/cdd.2012.8 1 Bennetzen, M.V ., D.H. Larsen, J. Bunkenborg, J. Bartek, J. Lukas, and J.S.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1074/mcp.M900616-MCP20 0 Bodenmiller, B., D. Campbell, B. Gerrits, H. Lam, M. Jovanovic, P. Picotti, R.  Schlapbach, and R. Aebersold.",Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"26:1339â 1340. http://dx.doi.org/10.1038/nbt1208-133 9 Chan, N.C., A.M. Salazar, A.H. Pham, M.J. Sweredoski, N.J. Kolawa, R.L.",Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1093/hmg/ddr04 8 Deas, E., H. Plun-Favreau, S. Gandhi, H. Desmond, S. Kjaer, S.H.",Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1093/hmg/ddq52 6 Geisler, S., K.M.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi   .org/10.1038/ncb201 2 Gu, T.L., X. Deng, F. Huang, M. Tucker, K. Crosby, V. Rimkunas, Y. Wang, G.  Deng, L. Zhu, Z. Tan, et al.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1371/journal.pone.001564 0 Hasson, S.A., L.A. Kane, K. Yamano, C.H.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1038/   nature1274 8 Iguchi, M., Y .",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1074/jbc.M113.46753 0 Jin, S.M., M. Lazarou, C. Wang, L.A. Kane, D.P.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi   .org/10.1083/jcb.20100808 4 Kinoshita, E., and E. Kinoshita-Kikuta.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1002/pmic.20100047 2 Kinoshita, E., E. Kinoshita-Kikuta, K. Takiyama, and T. Koike.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1074/mcp.T500024-MCP20 0 Kitada, T., S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, S. Minoshima,  M. Yokochi, Y. Mizuno, and N. Shimizu.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"191:1367â 1380. http://dx.doi.org/10.1083/jcb.20100701 3 Trempe, J.F., V .",Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"340:1451â 1455. http://dx.doi.org/10.1126/science.123790 8 Valente, E.M., P.M. Abou-Sleiman, V .",Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.1126/science.109628 4 VillÃ©n, J., S.A. Beausoleil, S.A. Gerber, and S.P.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10   .1038/emboj.2013.12 5 Winklhofer, K.F.",Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"1:110012. http://dx.doi.org/10.1098/rsob.11001 2 Yamano, K., and R.J. Youle.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/10.4161/auto.2463 3 Yoshii, S.R., C. Kishi, N. Ishihara, and N. Mizushima.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
"http://dx.doi.org/   10.1074/jbc.M110.20933 8 Zheng, X., and T. Hunter.",OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
23:886â 897. http://dx.doi.org/10.1038/cr.2013.6 6,Non-OADS,/arxiv_data1/oa_pdf/e0/fa/JCB_201402104.PMC4003245.pdf
This article is distributed under the terms of an Attributionâ NoncommercialâShare AlikeâNo Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"After six months it is available under a  Creative Commons License (AttributionâNoncommercialâShare Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"Additional data  are available in the JCB DataViewer at http://dx.doi.org/10.1083/ jcb.201307088.d v. We thank M. Korte, T.M.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi   .org/10.1016/j.cell.2007.08.03 0 Andersson, F., J. Jakobsson, P. LÃ¶w, O. Shupliakov, and L. Brodin.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.1754-07.200 8 Anggono, V., K.J.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1093/hmg/ddr47 0 Boeckers, T.M., M.R.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1006/bbrc.1999.148 9 Braun, A., R. Pinyol, R. Dahlhaus, D. Koch, P. Fonarev, B.D.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1091/mbc.E05-01-007 6 Carlson, B.R., K.E.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4433-10.201 1antiâsyndapin I antibodies (1:50; 4Â°C overnight) and 10 nm gold-conjugated  secondary antibodies (2 h, RT).",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/   10.1091/mbc.10.2.50 1 Qualmann, B., T.M.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.5479-   03.200 4 Qualmann, B., D. Koch, and M.M.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/   10.1038/emboj.2011.26 6 Ryan, K.P., W.B.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
http://dx.doi.org/10.1111/j.1365-2818.1990.tb03008.,Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1074/jbc.M113.46129 3 Schmeisser, M.J., E. Ey, S. Wegener, J. Bockmann, A.V.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1242/jcs.11167 4 Schwintzer, L., N. Koch, R. Ahuja, J. Grimm, M.M.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi   .org/10.1038/emboj.2011.20 7 Severs, N.J., and H. Robenek.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1016/S0091-   679X(08)00411- 1 Sinning, A., L. Liebmann, A. Kougioumtzes, M. Westermann, C. Bruehl,   and C.A.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1016/   j.conb.2005.12.00 1 tom Dieck, S., L. SanmartÃ­-Vila, K. Langnaese, K. Richter, S. Kindler, A. Soyke,  H. Wex, K.-H. Smalla, U. KÃ¤mpf, J.T.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1083/jcb.142.2.49 9 Wang, Q., M.V .",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/   10.1073/pnas.090297410 6 Won, H., H.R.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1038/nature1120 8Dharmalingam, E., A. Haeckel, R. Pinyol, L. Schwintzer, D. Koch, M.M.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3973-09.200 9 Fujimoto, K. 1995.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1038/   emboj.2010.33 6 Haag, N., L. Schwintzer, R. Ahuja, N. Koch, J. Grimm, H. Heuer, B. Qualmann,  and M.M.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10   .1523/JNEUROSCI.0843-12.201 2 Haeckel, A., R. Ahuja, E.D.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0336-08.200 8 Hering, H., and M. Sheng.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.3032-07.200 8 Itoh, T., K.S.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"9:791â 804. http://dx.doi.org/10.1016/j.devcel.2005.11.00 5 Kessels, M.M., and B. Qualmann.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1093/   emboj/cdf60 4 Kessels, M.M., and B. Qualmann.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1074/jbc.M51022620 0 Kessels, M.M., A.E.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1091/   mbc.11.1.39 3 Kessels, M.M., A.E.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1083/jcb.153.2.35 1 Koch, D., I. Spiwoks-Becker, V. Sabanov, A. Sinning, T. Dugladze, A.  Stellmacher, R. Ahuja, J. Grimm, S. SchÃ¼ler, A. MÃ¼ller, et al.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1038/   emboj.2011.33 9 Koch, D., M. Westermann, M.M.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10.1007/s00418-012-0945- 0 Koch, N., E. Dharmalingam, M. Westermann, B. Qualmann, U. Thomas, and  M.M.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi   .org/10.1242/jcs.10145 1 Korobova, F., and T. Svitkina.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi.org/10   .1091/mbc.E09-07-059 6 PeÃ§a, J., C. Feliciano, J.T.",Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
"http://dx.doi   .org/10.1038/nn168 0 Qualmann, B., and R.B.",OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
http://dx.doi.org/10.1083/jcb.148.5.104 7,Non-OADS,/arxiv_data1/oa_pdf/d0/b7/JCB_201307088.PMC4003247.pdf
This article is distributed under the terms of an Attributionâ NoncommercialâShare AlikeâNo Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"After six months it is available under a  Creative Commons License (AttributionâNoncommercialâShare Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
Online supplemental material is available at http://www.jcb .org/cgi/   content/full/jcb.201307116/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi   .org/10.1074/jbc.M01162820 0 Akhmanova, A., and J.A.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10   .1016/j.ceb.2010.04.00 8 Ally, S., A.G. Larson, K. Barlan, S.E.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1083/jcb.20090807 5 Andrews, N.W.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1016/   S0962-8924(00)88965- 5 Barbar, E. 2012.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1042/   BST2012018 0 Bremner, K.H., J. Scherer, J. Yi, M. Vershinin, S.P.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi   .org/10.1016/j.chom.2009.11.00 6 Cantalupo, G., P. Alifano, V .",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1093/   emboj/20.4.68 3 Carette, J.E., M. Raaben, A.C. Wong, A.S. Herbert, G. Obernosterer, N.  Mulherkar, A.I.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
http://dx.doi.org/10.1038/nature1034 8objective.,Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi   .org/10.1038/3509600 9 Matanis, T., A. Akhmanova, P .",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1038/ncb89 1 McEwan, W.A., J.C. Tam, R.E.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1038/ni.254 8 McKenney, R.J., M. Vershinin, A. Kunwar, R.B.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1016/j.cell.2010.02.03 5 McKenney, R.J., S.J.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1074/jbc.M111.28901 7 Mikami, A., B.M.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1016/0896-6273(93)90195- W Miyazawa, N., R.G.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10   .1128/JVI.75.3.1387-1400.200 1 Niclas, J., V.J.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1083/jcb.133.3.58 5 Palmer, K.J., H. Hughes, and D.J.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1091/mbc.E08-12-116 0 Paschal, B.M., H.S.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1083/   jcb.105.3.127 3 Progida, C., L. MalerÃ¸d, S. Stuffers, A. Brech, C. Bucci, and H. Stenmark.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1242/jcs.01730 1 Radtke, K., K. DÃ¶hner, and B. Sodeik.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1083/jcb.142.3.80 3 Rocha, N., C. Kuijl, R. van der Kant, L. Janssen, D. Houben, H. Janssen, W. Zwart,  and J. Neefjes.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1083/jcb.20081100 5 Rodionov, V ., J. Yi, A. Kashina, A. Oladipo, and S.P.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi   .org/10.1016/j.cub.2003.10.02 7 Scherer, J., and R.B.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.3390/v308141 7 Soppina, V ., A.K.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1091/mbc   .E12-03-021 0 Suomalainen, M., M.Y .",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1083/jcb.144.4.65 7 Suomalainen, M., M.Y .",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1091/mbc.E10-02-012 9Carey, B., M.K.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi   .org/10.1016/j.tcb.2006.08.00 2 Caviston, J.P., A.L.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1091/mbc   .E10-03-023 3 Chardonnet, Y ., and S. Dales.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10   .1016/0042-6822(70)90189- 3 CÃ´tÃ©, M., J. Misasi, T. Ren, A. Bruchez, K. Lee, C.M.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1038/nature1038 0 Dell, K.R., C.W.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
http://dx.doi.org/10.1034/j.1600-0854.2000.010107.,Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1038/emboj.2011.28 3 Engelke, M.F., C.J.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.3390/v303023 3 Enquist, L.W.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1371/journal.ppat.100247 2 Greber, U.F., and M. Way.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1016/j.cell.2006.02.01 8 Greber, U.F., M. Willetts, P. Webster, and A. Helenius.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1038/304738a 0 Holleran, E.A., M.K.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1242/jcs.05267 0 Hunt, S.D., A.K.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi   .org/10.1242/jcs.12231 7 Jordens, I., M. Fernandez-Borja, M. Marsman, S. Dusseljee, L. Janssen, J.  Calafat, H. Janssen, R. Wubbolts, and J. Neefjes.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi   .org/10.1016/S0960-9822(01)00531- 0 Kardon, J.R., and R.D.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1038/   nrm280 4 Kim, H., S.C. Ling, G.C.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1083/jcb.20060812 8 King, S.J., and T.A.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10   .1038/7133 8 Korolchuk, V.I., S. Saiki, M. Lichtenberg, F.H.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1038/ncb220 4 Kramer, T., and L.W.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1089/1043034005001623 8 Mallery, D.L., W.A.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"71:1117â 1130. http://dx.doi.org/10.1016/S0092-8674(05)80061- 3 Tynan, S.H., M.A.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1074/jbc.M00153720 0 Tynan, S.H., A. Purohit, S.J.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1074/ jbc.M00153620 0 Vallee, R.B., R.J. McKenney, and K.M.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi   .org/10.1038/ncb242 0 van der Kant, R., A.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/   10.1242/jcs.12927 0 Wickham, T.J., P. Mathias, D.A.",Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
"http://dx.doi.org/10.1016/0092-8674   (93)90231- E Yi, J.Y ., K.M.",OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
http://dx.doi.org/10.1083/jcb.20110407 6,Non-OADS,/arxiv_data1/oa_pdf/f3/8a/JCB_201307116.PMC4003248.pdf
This article is distributed under the terms of an Attributionâ NoncommercialâShare AlikeâNo Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"After six months it is available under a  Creative Commons License (AttributionâNoncommercialâShare Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1091/mbc.8.1.12 9 Caputo, C., and P. BolaÃ±os.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"455:733â 743. http://dx.doi.org/10.1007/s00424-007-0317- 0 Casas, M., R. Figueroa, G. Jorquera, M. Escobar, J. MolgÃ³, and E. Jaimovich.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"136:455â 467. http://dx.doi.org/10.1085/jgp.20091039 7 Cereghetti, G.M., A. Stangherlin, O. Martins de Brito, C.R.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1111/j.1749- 6632.2010.05615. x Chen, H., S.A. Detmer, A.J.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1083/jcb.20021104 6 Chen, H., A. Chomyn, and D.C. Chan.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"280:26185â 26192. http://dx.doi.org/10.1074/jbc.M50306220 0 Chen, H., M. Vermulst, Y.E.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"141:280â 289. http://dx.doi.org/10.1016/j.cell.2010.02.02 6 Chen, Y., Y. Liu, and G.W.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.111.25872 3 Chen, Y ., G. CsordÃ¡s, C. Jowdy, T.G.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.112.26658 5 Das, S., N. HajnÃ³czky, A.N.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1007/s00424-012-1100- 4 de Brito, O.M., and L. Scorrano.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1038/   nature0753 4 De Palma, C., S. Falcone, S. Pisoni, S. Cipolat, C. Panzeri, S. Pambianco, A.  Pisconti, R. Allevi, M.T.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10   .1038/cdd.2010.4 8 Detmer, S.A., and D.C. Chan.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10   .1038/nrm227 5 DiFranco, M., M. Quinonez, J. Capote, and J. Vergara.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi   .org/10.1016/j.ceca.2010.11.00 1 Eisner, V ., G. CsordÃ¡s, and G. HajnÃ³czky.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1242/jcs.09360 9 Estruch, R., E. Sacanella, J. FernÃ¡ndez-SolÃ¡, J.M.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi   .org/10.1212/WNL.0b013e31821a441 e FernÃ¡ndez-SolÃ , J., J.M.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
2011:830573. http://dx.doi.org/10.1155/   2011/83057 32% osmium tetroxide in 0.1 M sodium cacodylate buffer for 2 h. Then the  samples were washed with water and stained with 5% uranyl acetate for  2 h. Stained samples were dehydrated on an acetone dilution series and em - bedded in Spurrâs resin according to the manufacturerâs instructions (Elecron  Microscopy Sciences).,Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201312066/DC1.,Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"6:2. http://dx.doi   .org/10.3389/fnmol.2013.0000 2 Amchenkova, A.A., L.E.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1083/jcb.107.2.48 1 Bhat, M.B., J. Zhao, W. Zang, C.W.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1085/jgp.110.6.74 9 Boncompagni, S., A.E.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
http://dx.doi.org/10.1091/mbc   .E08-07-078 3,Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1038/   9011 6 Pacher, P., A.P.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1128/MCB.00911-1 0 Partikian, A., B. Olveczky, R. Swaminathan, Y. Li, and A.S. Verkman.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1083/jcb.140.4.82 1 Picard, M., K. White, and D.M.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"114:161â 171. http://dx.doi.org/10.1152/japplphysiol.01096.201 2 Pouvreau, S. 2010.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1371/journal.pone.001303 5 Rizzuto, R., C. Bastianutto, M. Brini, M. Murgia, and T. Pozzan.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10   .1093/emboj/17.17.498 7 Rogers, K.L., S. Picaud, E. Roncali, R. Boisgard, C. Colasante, J. Stinnakre, B.  Tavitian, and P. BrÃ»let.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1371/journal   .pone.000097 4 Rossi, A.E., S. Boncompagni, L. Wei, F. Protasi, and R.T. Dirksen.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1152/ajpcell.00194.201 1 Rudolf, R., M. Mongillo, P.J.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1083/   jcb.20040310 2 Santel, A., S. Frank, B. Gaume, M. Herrler, R.J. Youle, and M.T.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/   10.1242/jcs.0047 9 Shkryl, V .M., and N. Shirokova.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1074/jbc.M50502420 0 Song, S.K., and E. Rubin.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1126/science.175   .4019.32 7 Szabadkai, G., A.M. Simoni, M. Chami, M.R.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1016/j.molcel.2004   .09.02 6 Tatsuta, T., and T. Langer.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi   .org/10.1038/sj.emboj.760197 2 Twig, G., A. Elorza, A.J.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1038/sj.emboj.760196 3 Twig, G., X. Liu, M. Liesa, J.D.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1152/ajpcell.00427.200 9 Vendelin, M., N. BÃ©raud, K. Guerrero, T. Andrienko, A.V .",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1152/ajpcell.00281.200 4Frezza, C., S. Cipolat, O. Martins de Brito, M. Micaroni, G.V .",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/   10.1016/j.cell.2006.06.02 5 Frezza, C., S. Cipolat, and L. Scorrano.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1038/nprot.2006.47 8 Frieden, M., D. James, C. Castelbou, A. Danckaert, J.C. Martinou, and N.  Demaurex.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"279:22704â 22714. http://dx.doi.org/10.1074/jbc.M31236620 0 FÃ¼lÃ¶p, L., G. Szanda, B. Enyedi, P. VÃ¡rnai, and A. SpÃ¤t.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1016/0092-8674(95)90430- 1 Hom, J.R., J.S.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1002/jcp.2105 1 Hoppins, S., and J. Nunnari.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1016/   j.bbamcr.2008.07.00 5 Huang, X., L. Sun, S. Ji, T. Zhao, W. Zhang, J. Xu, J. Zhang, Y. Wang, X. Wang,  C. Franzini-Armstrong, et al.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1038/   377438a 0 Jouaville, L.S., P. Pinton, C. Bastianutto, G.A.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1016/j.ceb.2011.05.00 7 Karbowski, M., D. Arnoult, H. Chen, D.C. Chan, C.L.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1038/cdd.2012.12 8 Lackner, L.L., and J.M.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"1792:1138â 1144. http://dx.doi.org/10.1016/j.bbadis.2008.11.01 1 Lemasters, J.J. 2005.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
http://dx.doi.org/10.1089/rej.2005.8.,OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1038/emboj   .2009.25 5 Lodi, R., C. Tonon, M.L.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1001/archneurol.2010.22 8 Mitchell, T., B. Chacko, S.W.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1042/   BST2012023 1 NicolÃ¡s, J.M., E. AntÃºnez, A.P.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
http://dx.doi.org/10.1111/j.1530-0277.1998.tb03705.,Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1097/   NEN.0b013e3182764d4 7 Wei, L., G. Salahura, S. Boncompagni, K.A.",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1096/fj.11-18725 2 Weiss, N., T. Andrianjafiniony, S. DuprÃ©-Aucouturier, S. Pouvreau, D.  Desplanches, and V .",Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1007/s00424-009-0764- x Westerblad, H., J.A.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/10.1038/nrm301 3 Yi, M., D. Weaver, V .",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"52:355â 365. http://dx.doi.org/10.1016/j.ceca.2012.05.01 2 Yu-Wai-Man, P., P.G.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
"http://dx.doi.org/   10.1093/brain/awq00 7 Zhou, J., J. Yi, R. Fu, E. Liu, T. Siddique, E. RÃ­os, and H.X.",OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
http://dx.doi.org/10.1074/ jbc.M109.04131 9,Non-OADS,/arxiv_data1/oa_pdf/cd/84/JCB_201312066.PMC4003250.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/92/ppa-8-503.PMC4003261.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 503â511Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  503Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S3898 9Factors involved in treatment preference   in patients with renal cancer: pazopanib   versus sunitinib Catherine C Mitchell Omi A Parikh Lancashire Teaching Hospitals   NHS Foundation Trust, Preston,    Lancashire, UK Correspondence: Omi A Parikh   Royal Preston Hospital, Sharoe   Green Lane North, Fulwood,   Preston, Lancashire, PR2 9HT, UK   Tel +4417 7252 2089   email o mi.parikh@lthtr.nhs.u kAbstract:  The last decade has seen a surge in the treatment options for metastatic renal cell  carcinoma and life expectancies are now approaching 3 years from diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/c5/92/ppa-8-503.PMC4003261.pdf
"Available  at: http://www.dailymail.co.uk/health/article-398444/Magic-bullet- cancer.htm l. Accessed September 30, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c5/92/ppa-8-503.PMC4003261.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/c5/92/ppa-8-503.PMC4003261.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/92/ppa-8-503.PMC4003261.pdf
Available from: http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/c5/92/ppa-8-503.PMC4003261.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/23/d2/ppa-8-493.PMC4003262.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 493â502Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  493open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5916 9Review Patient considerations in the management of   type 2 diabetes â critical appraisal of dapagliflozin Marissa C Salvo1 Amie D Brooks2 Stacey M Thacker3 1Department of Pharmacy Practice,   University of Connecticut School of  Pharmacy, Storrs, CT, 2Department of  Pharmacy Practice, St Louis College of  Pharmacy, St Louis, MO, 3Department  of Pharmacy Practice, Southern  illinois University edwardsville,   edwardsville, iL, USA Correspondence: Amie D Brooks   Department of Pharmacy Practice,  St Louis College of Pharmacy, 4588  Parkview Place, St Louis, MO 63110, USA   Tel +1 314 446 8503   Fax +1 314 466 8500   email  amie.brooks@stlcop.ed uAbstract:  Type 2 diabetes affects more than 350 million people worldwide, and its prevalence  is increasing.",Non-OADS,/arxiv_data1/oa_pdf/23/d2/ppa-8-493.PMC4003262.pdf
Available from: http://www.idf.org/worlddiabetesday/ toolkit/gp/facts- figures.,OADS,/arxiv_data1/oa_pdf/23/d2/ppa-8-493.PMC4003262.pdf
Available from: http://www.marketwatch.,Non-OADS,/arxiv_data1/oa_pdf/23/d2/ppa-8-493.PMC4003262.pdf
Available from: http://www.forxiga.,Non-OADS,/arxiv_data1/oa_pdf/23/d2/ppa-8-493.PMC4003262.pdf
Available from: http://news.bms.,Non-OADS,/arxiv_data1/oa_pdf/23/d2/ppa-8-493.PMC4003262.pdf
"Available from:  http://www.fda.gov/downloads/ AdvisoryCommittees/Committees- MeetingMaterials/Drugs/ EndocrinologicandMetabolicDrugsAdvisor yCommittee/UCM262994.pd f. Accessed November 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/23/d2/ppa-8-493.PMC4003262.pdf
"Available from: http://www.fda.gov/downloads/ advisorycommittees/committeesmeetingmaterials/drugs/endocrino - logicandmetabolicdrugsadvisorycommittee/ucm378079.pd f. Accessed  November 12, 2013.",OADS,/arxiv_data1/oa_pdf/23/d2/ppa-8-493.PMC4003262.pdf
Available from: http://www.renalandurol - ogynews.com/urinary-tract-infections-more-common-in-diabetics/ article/30205 6.,Non-OADS,/arxiv_data1/oa_pdf/23/d2/ppa-8-493.PMC4003262.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/23/d2/ppa-8-493.PMC4003262.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/23/d2/ppa-8-493.PMC4003262.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/77/tcrm-10-295.PMC4003263.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 295â303Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  295Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5972 3Acute-on-chronic liver failure: a review Luis eduardo Zamora Nava1 Jonathan Aguirre valadez2 Norberto C ChÃ¡vez-Tapia3 Aldo T orre2 1Department of endoscopy,   2Department of Gastroenterology,    National institute of Medical   Sciences and Nutrition Salvador   ZubirÃ¡n, 3Obesity and Digestive  Diseases Unit, Medica Sur Clinic and  Foundation, Mexico City, Mexico Correspondence: Aldo Torre   vasco de Quiroga 15, Colonia   SecciÃ³n Xvi, Tlalpan CP14000,   Mexico DF, Mexico   Tel +52 55 5487 0900   email detoal@yahoo.co mAbstract:  There is no universally accepted definition of acute-on-chronic liver failure; however,  it is recognized as an entity characterized by decompensation from an underlying chronic liver  disease associated with organ failure that conveys high short-term mortality, with alcohol - ism and infection being the most frequent precipitating events.",Non-OADS,/arxiv_data1/oa_pdf/ea/77/tcrm-10-295.PMC4003263.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ea/77/tcrm-10-295.PMC4003263.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/77/tcrm-10-295.PMC4003263.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/e7/ijnrd-7-153.PMC4003264.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2014:7 153â156International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  153Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJNRD.S5710 9Granulomatosis with polyangiitis: rapidly  progressive necrotizing glomerulonephritis   in a pediatric patient Mariana Luna1 Victoria Bocanegra3 patricia G VallÃ©s1,2 1Nephrology Division, pediatric  Department, Dr Humberto Notti  pediatric Hospital, Mendoza,   argentina; 2pathophysiology area,   pathology Department, school of  Medicine, National Cuyo University,   Mendoza, argentina; 3National Council  of scientific and technical Research of  argentina (CoNICet), Buenos aires,   argentina Correspondence: patricia G VallÃ©s   pathiophysiology area, pathology  Department, school of Medicine,  National Cuyo University, Centro  Universitario Cp 5500, Mendoza,  argentina   tel +54 261 413 262 4   Fax +54 261 428 737 0   email pvalles@fcm.uncu.edu.a rAbstract:  Granulomatosis with polyangiitis (GPA) is associated with a broad range of clinical  manifestations including renal disease.",Non-OADS,/arxiv_data1/oa_pdf/36/e7/ijnrd-7-153.PMC4003264.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/36/e7/ijnrd-7-153.PMC4003264.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/e7/ijnrd-7-153.PMC4003264.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/48/8b/ott-7-627.PMC4003265.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 627â632OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  627Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5873 4health behaviors and quality of life in chinese  survivors of cervical cancer: a retrospective study shu-xia nie chuan-qiang gao Department of gynecology and  Obstetrics, Peopleâs hospital of Xintai  city, shandong Province, affiliated to  Taishan Medical University, Xintai,   Peopleâs republic of china correspondence: chuan-qiang gao   Department of Thoracic surgery,  Peopleâs hospital of Xintai city,  Shandong Province, Affiliated to Taishan  Medical University, Xintai 271200,  Peopleâs republic of china   email zlflk_2012@163.co mBackground:  The aim of this study was to evaluate health behaviors and quality of life (QoL)  in cervical cancer survivors, and to identify factors that may compromise or enhance their  health-related QoL.",Non-OADS,/arxiv_data1/oa_pdf/48/8b/ott-7-627.PMC4003265.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/48/8b/ott-7-627.PMC4003265.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/8b/ott-7-627.PMC4003265.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/be/ppa-8-513.PMC4003266.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 513â517Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  513CAse seriesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5623 8Clinical outcomes of transfusion-associated   iron overload in patients with refractory   chronic anemia Chong Gao Li Li Baoan Chen Huihui song Jian Cheng Xiaoping Zhang Yunyu sun Department of Hematology   and Oncology, Key Department of  Jiangsu Medicine, Zhongda Hospital,  Medical school, southeast University,  Nanjing, Jiangsu Province, Peopleâs  republic of China Correspondence: Baoan Chen   Department of Hematology, Zhongda  Hospital, Medical school, southeast  University, Nanjing 210009, Jiangsu  Province, Peopleâs republic of China   Tel +86 25 8327 2006   Fax +86 25 8327 2011   email cba8888@hotmail.co mBackground:  The purpose of this study was to evaluate the clinical outcomes of transfusion- associated iron overload in patients with chronic refractory anemia.",Non-OADS,/arxiv_data1/oa_pdf/cf/be/ppa-8-513.PMC4003266.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/cf/be/ppa-8-513.PMC4003266.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/be/ppa-8-513.PMC4003266.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/a0/ott-7-587.PMC4003267.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 587â597OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  587Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6028 9Mir-519d represses ovarian cancer cell   proliferation and enhances cisplatin-mediated   cytotoxicity in vitro by targeting XiaP Yingxin Pang1 hongluan Mao1 liang shen2 Zhe Zhao1 ruihan liu1 Peishu liu1 1Department of Obstetrics and  gynecology, Qilu hospital of  shandong University, Jinan, Peopleâs   republic of china;  2Department of  Obstetrics and gynecology,    Provincial hospital affiliated   with shandong University, Jinan,    Peopleâs republic of china correspondence: Peishu liu   Department of Obstetrics and   gynecology, Qilu hospital of   shandong University, no  107 Wen   hua Xi road, Jinan, shandong  250012,   Peopleâs republic of china   Tel +86 531 8216 9571  Fax +86 531 9692 7544  email peishuliu@126.co mBackground:  MicroRNAs (miRNAs) are small, noncoding RNAs that are believed to play  fundamental roles in tumorigenesis and tumor development at the posttranscriptional level, as  negative regulators of gene expression.",Non-OADS,/arxiv_data1/oa_pdf/88/a0/ott-7-587.PMC4003267.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/88/a0/ott-7-587.PMC4003267.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/a0/ott-7-587.PMC4003267.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/87/0d/ijn-9-1909.PMC4003268.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1909â1917International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1909OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6027 4Preparation and properties of poly(vinyl  alcohol)/chitosan blend bionanocomposites  reinforced with cellulose nanocrystals/ZnO-ag  multifunctional nanosized filler susan azizi1 Mansor Bin ahmad1 Mohd Zobir hussein1 Nor azowa Ibrahim1 Farideh Namvar2,3 1Department of chemistry, Faculty of  science, 2Institute of Tropical Forestry  and Forest Products, University Putra  Malaysia, selangor, Malaysia; 3Mashhad  Branch, Islamic azad University,   Mashhad, Iran correspondence: susan azizi   Department of chemistry, Faculty   of science, Universiti Putra Malaysia,  43400 UPM serdang, selangor, Malaysia   email azisusan@gmail.co mAbstract:  A series of novel bionanocomposites were cast using different contents of zinc  oxide-silver nanoparticles (ZnO-AgNPs) stabilized by cellulose nanocrystals (CNC) as mul - tifunctional nanosized fillers in poly(vinyl alcohol)/chitosan (PV A/Cs) matrices.",Non-OADS,/arxiv_data1/oa_pdf/87/0d/ijn-9-1909.PMC4003268.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/87/0d/ijn-9-1909.PMC4003268.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/0d/ijn-9-1909.PMC4003268.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/e1/opth-8-789.PMC4003269.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 789â792Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  789Case RepOR topen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5866 9presumed toxoplasmic central retinal   artery occlusion and multifocal retinitis   with perivascular sheathing Haruka arai1 tsutomu sakai1 Kiichiro Okano1 Ranko aoyagi1 ayano Imai2 Hiroshi takase2 Manabu Mochizuki2 Hiroshi tsuneoka1 1Department of Ophthalmology, Jikei  University school of Medicine, tokyo,   Japan; 2Department of Ophthalmology  and Visual science, tokyo Medical and  Dental University, tokyo, Japan Correspondence: tsutomu sakai   Department of Ophthalmology,   Jikei University school of Medicine,   3-25-8 Nishishimbashi, Minato-ku,   tokyo 105-8461, Japan   tel +81 3 3433 1111 ext 3581   Fax +81 3 3433 1936   email tstmski@jikei.ac.j pAbstract:  Central retinal artery occlusion (CRAO) and multifocal retinitis with perivascular  sheathing are rare in ocular toxoplasmosis.",Non-OADS,/arxiv_data1/oa_pdf/70/e1/opth-8-789.PMC4003269.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/70/e1/opth-8-789.PMC4003269.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/e1/opth-8-789.PMC4003269.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/19/ijn-9-2031.PMC4003270.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2031â2041International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2031OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5645 9Tissue-specific direct microtransfer   of nanomaterials into Drosophila  embryos   as a versatile in vivo test bed for nanomaterial  toxicity assessment sasha Vega-alvarez1 adriana herrera2 carlos rinaldi2â4 Franklin a carrero- MartÃ­nez1,5 1Department of Biology, 2Department  of chemical engineering, University  of Puerto rico-MayagÃ¼ez, MayagÃ¼ez,   Puerto rico; 3J crayton Pruitt  Family Department of Biomedical  engineering, 4Department of chemical  engineering, University of Florida,   gainesville, Fl, Usa; 5Department  of anatomy and Neuroscience,   University of Puerto rico, Medical  sciences campus, san Juan, Puerto  rico correspondence : Franklin a   carrero-MartÃ­nez   University of Puerto rico-MayagÃ¼ez,   PO Box 9000, MayagÃ¼ez,   Puerto rico 00680-9000   Tel +787 832 4040 ext 3923   email franklin.carrero@upr.ed uAbstract:  Nanomaterials are the subject of intense research, focused on their synthesis,   modification, and biomedical applications.",Non-OADS,/arxiv_data1/oa_pdf/fa/19/ijn-9-2031.PMC4003270.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fa/19/ijn-9-2031.PMC4003270.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/19/ijn-9-2031.PMC4003270.pdf
"2005; http://www.fda.gov/downloads/Drugs/GuidanceCompliance  RegulatoryInformation/Guidances/UCM078932.pd f. Accessed   August 21 , 2011 .",OADS,/arxiv_data1/oa_pdf/fa/19/ijn-9-2031.PMC4003270.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/0e/ijn-9-2019.PMC4003271.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2019â2030International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2019OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5774 4Folate-targeted paclitaxel-conjugated polymeric  micelles inhibits pulmonary metastatic hepatoma  in experimental murine h22 metastasis models Yan Zhang1 hui Zhang2 Wenbin Wu2 Fuhong Zhang3,4 shi liu3 rui Wang3 Yingchun sun1 Ti T ong1 Xiabin Jing3 1Department of Thoracic surgery, The  second hospital of Jilin University,   changchun, Jilin, Peopleâs republic  of china; 2Department of Thoracic  surgery, Xuzhou central hospital,   Xuzhou, Jiangsu, Peopleâs republic  of china; 3state Key laboratory  of Polymer Physics and chemistry,   changchun Institute of applied  chemistry, chinese academy of  sciences, changchun, Jilin, Peopleâs  republic of china; 4Department of  Otolaryngology, The First hospital of  lanzhou University, lanzhou, gansu,   Peopleâs republic of china correspondence: Ti Tong   Department of Thoracic surgery, second  hospital of Jilin University, No.",Non-OADS,/arxiv_data1/oa_pdf/99/0e/ijn-9-2019.PMC4003271.pdf
Available from: http://blog.china.com.cn/ home.php?mod=space&uid=1235808&do=blog&id=19811 7.,Non-OADS,/arxiv_data1/oa_pdf/99/0e/ijn-9-2019.PMC4003271.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/99/0e/ijn-9-2019.PMC4003271.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/0e/ijn-9-2019.PMC4003271.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/7b/ijn-9-2043.PMC4003272.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2043â2050International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2043OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6045 7apoptosis selectively induced in Bel-7402 cells  by folic acid-modified magnetic nanoparticles  combined with 100 Hz magnetic field Jian Wen1 Shulian Jiang1 Zhiqiang Chen1 Wei Zhao1 Y ongxiang Yi1 Ruili Yang1 Baoan chen2 1second affiliated hospital of  southeast University, 2Department  of Hematology, Zhongda Hospital,   Medical school, southeast University,   Nanjing, Peopleâs Republic of China correspondence: Baoan chen   Department of Hematology,   Zhongda Hospital, Medical School,   Southeast University, 87 Dingjia Qiao,   Nanjing Hunan Road, Nanjing 210029,   Peopleâs Republic of China   Tel +86 25 8327 2006   Fax +86 25 8327 2011   email cba8888@hotmail.co mObjective:  To explore the effect of folic acid-modified magnetic nanoparticles (FA-MNPs)  combined with a 100 Hz extremely low-frequency electromagnetic field (ELF-EMF) on the  apoptosis of liver cancer BEL-7402 cells.",Non-OADS,/arxiv_data1/oa_pdf/13/7b/ijn-9-2043.PMC4003272.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/13/7b/ijn-9-2043.PMC4003272.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/7b/ijn-9-2043.PMC4003272.pdf
"Furthermore, it was shown that FAPs harvested from TSA-treated young mdx mice behave differentlyfrom their wild-type counterparts harvested from un-perturbed muscles in that they could form myosin heavy /C2112014 Faralli and Dilworth This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/69/60/809.PMC4003273.pdf
[Keywords : SWI/SNF chromatin remodeling; BAF60; microRNA; HDAC; FAPs; muscular dystrophy] 3Corresponding author E-mail jdilworth@ohri.ca Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.241182.114.,Non-OADS,/arxiv_data1/oa_pdf/69/60/809.PMC4003273.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/b6/82/812.PMC4003274.pdf
[Keywords : DNA methylation; development; epigenetics; reprogramming] 4Corresponding author E-mail danielm@imcb.a-star.edu.sg Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.234294.113.,Non-OADS,/arxiv_data1/oa_pdf/b6/82/812.PMC4003274.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/88/ea/829.PMC4003275.pdf
[Keywords : diabetes; transcription factors; somatostatin; pancreatic islet; dcell] 3Corresponding author E-mail kaestner@mail.med.upenn.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.235499.113.,Non-OADS,/arxiv_data1/oa_pdf/88/ea/829.PMC4003275.pdf
"Depletion of eIF3c reduced eIF3d levels, which had little effect on eIF4E /C2112014 Walsh and Mohr This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/d1/b6/835.PMC4003276.pdf
[Keywords : eIF4E phosphorylation; Mnk1; eIF3; ribosome recruitment; translation initiation] 1Corresponding author E-mail derek.walsh@nyumc.org Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.236752.113.,Non-OADS,/arxiv_data1/oa_pdf/d1/b6/835.PMC4003276.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.234468.113.,Non-OADS,/arxiv_data1/oa_pdf/04/02/841.PMC4003277.pdf
The complete list of up-regulated and down- regulated genes is accessible through Gene ExpressionOmnibus (GEO) series accession number GSE34843 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc =GSE34843).,Non-OADS,/arxiv_data1/oa_pdf/04/02/841.PMC4003277.pdf
The complete list of NASs in FAPs from young and old mdx mice with or without TSA treatment is accessible through GEO series accession number GSE52062(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE52062).,Non-OADS,/arxiv_data1/oa_pdf/04/02/841.PMC4003277.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/858.PMC4003278.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.5Corresponding author E-mail klusmann.jan-henning@mh-hannover.de Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.233791.113.",Non-OADS,/arxiv_data1/oa_pdf/c6/7e/858.PMC4003278.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/4b/0c/875.PMC4003279.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.239194.114.,Non-OADS,/arxiv_data1/oa_pdf/4b/0c/875.PMC4003279.pdf
2011).Substrate residues flanking scissile peptide bonds bind to /C2112014 Kim and Sauer This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/5b/96/902.PMC4003281.pdf
2Corresponding author E-mail bobsauer@mit.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.238394.114.,Non-OADS,/arxiv_data1/oa_pdf/5b/96/902.PMC4003281.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/24/55/912.PMC4003282.pdf
org/licenses/by-nc/4.0/.3Corresponding author E-mail sigal@technion.ac.il Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.239335.114.,Non-OADS,/arxiv_data1/oa_pdf/24/55/912.PMC4003282.pdf
The analysis was performed with Fiji software (http://fiji.sc/fiji).Images were stitched using the Stitching plugin.,OADS,/arxiv_data1/oa_pdf/24/55/912.PMC4003282.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/8d/ndt-10-671.PMC4003284.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 671â674Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  671LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6141 2Letter to the editor regarding âStudy design of  âFriends for Lifeâ: a process and effect evaluation  of an indicated school-based prevention  programâ: response to Lima et al Mia P KÃ¶sters1 Mai JM Chinapaw2 Marieke Zwaanswijk3 Marcel F van der Wal1 Hans M Koot4,5 1Department of epidemiology and  Health Promotion, Public Health  Service of Amsterdam (GGD),   Amsterdam, 2Department of  Public and Occupational Health,   eMGO Institute for Health and  Care research, VU University  Medical Centre, Amsterdam,   3NIVeL, Netherlands Institute for  Health Services research, Utrecht,   4Department of Developmental  Psychology, Faculty of Psychology and  education, VU University, Amsterdam,   5eMGO Institute for Health and Care  research, VU University Medical  Centre, Amsterdam, The Netherlands Correspondence: Mia P KÃ¶sters   Department of epidemiology and Health  Promotion, Public Health Service of  Amsterdam, PO Box 2200, 1000 Ce,  Amsterdam, The Netherlands   Tel +31 6 2255 5431   email mkosters@ggd.amsterdam.n lDear editor We would like to respond to the paper âChildhood depression: a systematic reviewâ,  recently published in Neuropsychiatric Disease and Treatment  by Lima et al.1 The  aforementioned paper presents a systematic review of childhood depression and refers  several times to our paper, âStudy design of âFRIENDS for Lifeâ: a process and effect  evaluation of an indicated school-based prevention programme for childhood anxiety  and depressionâ, published in BMC Public Health  by KÃ¶sters et al.2 Unfortunately  we noted a number of erroneous statements about our paper.",Non-OADS,/arxiv_data1/oa_pdf/c7/8d/ndt-10-671.PMC4003284.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c7/8d/ndt-10-671.PMC4003284.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/8d/ndt-10-671.PMC4003284.pdf
Available from: http://www.who.int/whr/2001/en /.,OADS,/arxiv_data1/oa_pdf/c7/8d/ndt-10-671.PMC4003284.pdf
http://www.pmda.go.jp/390 Adv Ther (2014) 31:375â391,Non-OADS,/arxiv_data1/oa_pdf/a0/67/12325_2014_Article_112.PMC4003341.pdf
http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Public_asse ssment_report/human/002154/WC500103073.pdf(last accessed Feb 2014).Adv Ther (2014) 31:375â391 391,Non-OADS,/arxiv_data1/oa_pdf/a0/67/12325_2014_Article_112.PMC4003341.pdf
"The CochraneCollaboration; 2011. http://www.cochrane- handbook.org (last accessed April 3, 2014).",OADS,/arxiv_data1/oa_pdf/5a/fc/12325_2014_Article_116.PMC4003343.pdf
http://ohg.cochrane.org/sites/ohg.,OADS,/arxiv_data1/oa_pdf/5a/fc/12325_2014_Article_116.PMC4003343.pdf
http://www.ncbi.nlm.nih.gov/pubmed/22357831 .,Non-OADS,/arxiv_data1/oa_pdf/68/71/12325_2014_Article_115.PMC4003344.pdf
"ArchivedCDC vaccine price list as of September 10, 2012. http://www.cdc.gov/vaccine s/programs/vfc/awardees/ vaccine-management/price-list/2012/2012-09-10.html .",Non-OADS,/arxiv_data1/oa_pdf/68/71/12325_2014_Article_115.PMC4003344.pdf
December 2012. http://www.bls.gov/cpi/cpid1212.,Non-OADS,/arxiv_data1/oa_pdf/68/71/12325_2014_Article_115.PMC4003344.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Correspondence should be addressed to J.W.",Non-OADS,/arxiv_data1/oa_pdf/19/be/emss-58073.PMC4003391.pdf
"Cumulative number of confirmed human cases of avian influenza A (H5N1) infection reported to the World Health Organization, http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/index.html ; influenza activity in the United States and worldwide, 2004â2005 season, http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5425a3.htm ; Narcisse, http://narcisse.toulouse.inra.fr/multi/cgi-bin/narcisse.cgi ; InnateDB, http://www.innatedb.com/index.jsp ; Ingenuity Systems Pathway Analysis (IPA), http://www.ingenuity.com/ .",Non-OADS,/arxiv_data1/oa_pdf/19/be/emss-58073.PMC4003391.pdf
Reprints and permissions information is available online at http://www.nature.com/reprints/index.html .Europe PMC Funders Group Author Manuscript Nat Genet .,Non-OADS,/arxiv_data1/oa_pdf/19/be/emss-58073.PMC4003391.pdf
Retrived from http://www.psychiatriapolska.pl .,Non-OADS,/arxiv_data1/oa_pdf/8b/3f/10862_2013_Article_9392.PMC4003404.pdf
"The current COG trial, AALL0631 (http://clinicaltrials.gov/ct2/ show/NCT00557193), opened in 2008 and incorporates risk-directed therapy according to signiï¬cant prognostic factorsidentiï¬ed from combined analysis of the three 9407 cohorts.Infants are classiï¬ed as standard risk ( MLL- nonrearranged), intermediate risk ( MLL-rearranged, X90 days at diagnosis) or high risk ( MLL-rearranged, o90 days at diagnosis).",Non-OADS,/arxiv_data1/oa_pdf/34/3d/bcj201417a.PMC4003413.pdf
"45 The current study, Interfant-06 (http://clinicaltrials.gov/show/ NCT00550992) commenced enrollment in 2006 and, based on results of Interfant-99, stratiï¬es infants into low risk ( MLL germ- line), high risk ( MLL-rearranged and age o6 months and WBC X300/C2109/l at diagnosis and/or poor day 8 prednisone response) and medium risk (all other cases).",Non-OADS,/arxiv_data1/oa_pdf/34/3d/bcj201417a.PMC4003413.pdf
"National Cancer Institute: Bethesda, MD, 2013. http://seer.cancer.gov/csr/1975_2010/based on November 2012 SEER data submission, posted to the SEER web site.",OADS,/arxiv_data1/oa_pdf/34/3d/bcj201417a.PMC4003413.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Evolution of clinical trials for infant ALL RS Kotecha et al 13 &2014 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/34/3d/bcj201417a.PMC4003413.pdf
"Propidium iodide ï¬uorescencewas analyzed using a FACS Calibur, and the cell-cycle phase was determined on the basis of DNA content using the ModFit LTsoftware (Verity Software House, http://www.vsh.com/).",OADS,/arxiv_data1/oa_pdf/0f/01/bcj201425a.PMC4003419.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)H3K4me2 in RARaand sensitivity to ATRA in AML K Sakamoto et al 8 Blood Cancer Journal &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/0f/01/bcj201425a.PMC4003419.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Letter to the Editor 3 &2014 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/a1/00/bcj201426a.PMC4003420.pdf
"The image manipulations are performed with the ImageMagick software package  (http://www.imagemagick.org), and the differential im- ages with the actual threshold levels are visualized with  the ImageJ program http://www.rsbweb.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/bd/80/JCB-6-22279.PMC4003421.pdf
http://www.rtog.org/ClinicalTrials/ProtocolTable/Study Details.aspx?study=0413.,Non-OADS,/arxiv_data1/oa_pdf/93/6e/JCB-6-22299.PMC4003423.pdf
16. http://www.rtog.org/CoreLab/ContouringAtlases/Breast-CancerAtlas.aspx.,Non-OADS,/arxiv_data1/oa_pdf/93/6e/JCB-6-22299.PMC4003423.pdf
Med Phys 2014; 41; http://dx.doi.org/10.1118/1.4862505.,Non-OADS,/arxiv_data1/oa_pdf/75/4b/JCB-6-22302.PMC4003426.pdf
Med  Phys 2014; 41; http://dx.doi.org/10.1118/1.4862506.,Non-OADS,/arxiv_data1/oa_pdf/75/4b/JCB-6-22302.PMC4003426.pdf
Available from http://www.nea.fr  21.,Non-OADS,/arxiv_data1/oa_pdf/75/4b/JCB-6-22302.PMC4003426.pdf
Available from http://www-pub.iaea.org/books/   22.,Non-OADS,/arxiv_data1/oa_pdf/75/4b/JCB-6-22302.PMC4003426.pdf
Clinical Practice Guidelines in Oncology â v.1.2003 â Cervical Cancer; available at: http://www.nccn.org/physician_gls/index.html.,Non-OADS,/arxiv_data1/oa_pdf/e1/0a/JCB-6-22581.PMC4003429.pdf
"References  1. http://www.cancerresearchuk.org/cancer-info/cancerstats/  world; accessed: January 26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b2/a5/JCB-6-22583.PMC4003431.pdf
"22. http://www.physics.carleton.ca/clrp/seed_database/Pd103/ Prospera_Med3633_ideal; accessed: January 26, 2014, Carle-ton University.",OADS,/arxiv_data1/oa_pdf/b2/a5/JCB-6-22583.PMC4003431.pdf
"23. http://www.physics.carleton.ca/clrp/seed_database/I125/ OncoSeed_6702; accessed: January 26, 2014, Carleton Univer-sity.",OADS,/arxiv_data1/oa_pdf/b2/a5/JCB-6-22583.PMC4003431.pdf
"24. http://www.physics.carleton.ca/clrp/seed_database/Yb169_ HDR/HDR_4140; accessed: January 26, 2014, Carleton Uni-versity.",OADS,/arxiv_data1/oa_pdf/b2/a5/JCB-6-22583.PMC4003431.pdf
"25. http://www.physics.carleton.ca/clrp/seed_database/Ir192_HDR/GammaMed_12i; accessed: January 26, 2014, Carleton University.",OADS,/arxiv_data1/oa_pdf/b2/a5/JCB-6-22583.PMC4003431.pdf
"30. http://physics.nist.gov/PhysRefData/XrayMassCoef/tab4.html; accessed: January 26, 2014, National Institute of Stan-dards and Technology.",OADS,/arxiv_data1/oa_pdf/b2/a5/JCB-6-22583.PMC4003431.pdf
"2013. http://www.nccn.org/professionals/physician_gls/pdf/  prostate.pdf; accessed: Nov. 20, 2013.",Non-OADS,/arxiv_data1/oa_pdf/7f/68/JCB-6-22585.PMC4003433.pdf
References 1. http://www.cancerresearchuk.org/cancer-help/type/womb ;  accessed March 2014.,Non-OADS,/arxiv_data1/oa_pdf/d8/59/JCB-6-22587.PMC4003435.pdf
3. http://www.cijfersoverkanker.nl/; accessed May 2014.,Non-OADS,/arxiv_data1/oa_pdf/d8/59/JCB-6-22587.PMC4003435.pdf
15. http://www.oncoline.nl/endometriumcarcinoom;  accessed  March 2014.,Non-OADS,/arxiv_data1/oa_pdf/d8/59/JCB-6-22587.PMC4003435.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4833 | DOI: 10.1038/srep04833 9",Non-OADS,/arxiv_data1/oa_pdf/71/e7/srep04833.PMC4003474.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b0/4b/srep04834.PMC4003476.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4834 | DOI: 10.1038/srep04834 7",Non-OADS,/arxiv_data1/oa_pdf/b0/4b/srep04834.PMC4003476.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4831 | DOI: 10.1038/srep04831 5",Non-OADS,/arxiv_data1/oa_pdf/ff/0f/srep04831.PMC4003477.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/65/2a/srep04837.PMC4003479.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4837 | DOI: 10.1038/srep04837 6",Non-OADS,/arxiv_data1/oa_pdf/65/2a/srep04837.PMC4003479.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fe/a9/srep04842.PMC4003480.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4842 | DOI: 10.1038/srep04842 7",Non-OADS,/arxiv_data1/oa_pdf/fe/a9/srep04842.PMC4003480.pdf
"1 1      http://www.medsci.org  538  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  538-544.  doi: 10.7150/ ijms.7896   Short Research Communication   Senescence Affects Endothelial Cells Susceptibility to  Dengue Virus Infection   Sazaly AbuBakar1ïª, Meng -Hooi Shu1, Jefree Johari1 and Pooi -Fong Wong2 ïª  1.",Non-OADS,/arxiv_data1/oa_pdf/fd/60/ijmsv11p0538.PMC4003538.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/fd/60/ijmsv11p0538.PMC4003538.pdf
"11     http://www.medsci.org  539  changes is seen in the endothelium of autopsy mat e- rials of patients who succumbed to DHF/DSS [11, 12,  21].",Non-OADS,/arxiv_data1/oa_pdf/fd/60/ijmsv11p0538.PMC4003538.pdf
"11     http://www.medsci.org  540  added to 96 -well E -plate (ACEA Biosciences, USA)  and used as the background reading.",Non-OADS,/arxiv_data1/oa_pdf/fd/60/ijmsv11p0538.PMC4003538.pdf
"11     http://www.medsci.org  541  of late senescent HUVECs, suggesting that late s e- nescent cells did not support productive DENV infe c- tion.",Non-OADS,/arxiv_data1/oa_pdf/fd/60/ijmsv11p0538.PMC4003538.pdf
11     http://www.medsci.org  542  stimulation or infection.,Non-OADS,/arxiv_data1/oa_pdf/fd/60/ijmsv11p0538.PMC4003538.pdf
11     http://www.medsci.org  543    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/fd/60/ijmsv11p0538.PMC4003538.pdf
http://www.who.int/mediacentre/factsheets/fs117/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/fd/60/ijmsv11p0538.PMC4003538.pdf
Global strategy for dengue prevention  and control 2012-2020.   http://apps.who.int/iris/bitstream/10665/75303/1/9789241504034_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fd/60/ijmsv11p0538.PMC4003538.pdf
11     http://www.medsci.org  544  9.,Non-OADS,/arxiv_data1/oa_pdf/fd/60/ijmsv11p0538.PMC4003538.pdf
"1 1      http://www.medsci.org  545  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  545-553.  doi: 10.7150/ ijms.6994   Research Paper   The Use of  a Whole Animal Biophotonic  Model as  a  Screen for the  Angiogenic Potential of  Estrogenic  Compounds   Ramey C Youngblood1,2ïª, Marcus McGee5, Jean M Feugang1,2, Scott T Willard1,4, Peter L Ryan1,2,3  1.",Non-OADS,/arxiv_data1/oa_pdf/90/e7/ijmsv11p0545.PMC4003539.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   license s/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/e7/ijmsv11p0545.PMC4003539.pdf
"11     http://www.medsci.org  546  endothelial cells [2]  VEGF elicits physiological responses by binding  to one of several membrane bound tyrosine kinase  receptors including VEGF receptor -1 (VEGFR -1),  VEGF receptor- 2 (VEGFR -2), and VEGF rec eptor -3  (VEGFR -3).",Non-OADS,/arxiv_data1/oa_pdf/90/e7/ijmsv11p0545.PMC4003539.pdf
11     http://www.medsci.org  547  cleaning with Betadine surgical scrub [28] .,Non-OADS,/arxiv_data1/oa_pdf/90/e7/ijmsv11p0545.PMC4003539.pdf
"11     http://www.medsci.org  548  Histology    Sections (5ÂµM) of fixed, paraffin wax -embedded  dermal wound samples were mounted on glass slides.",Non-OADS,/arxiv_data1/oa_pdf/90/e7/ijmsv11p0545.PMC4003539.pdf
1 1      http://www.medsci.org  549    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/90/e7/ijmsv11p0545.PMC4003539.pdf
11     http://www.medsci.org  550    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/90/e7/ijmsv11p0545.PMC4003539.pdf
1 1      http://www.medsci.org  551    Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/90/e7/ijmsv11p0545.PMC4003539.pdf
11     http://www.medsci.org  552  alter wound h ealing mediated VEGFR -2-Luc gene  expression patterns compared to controls.,Non-OADS,/arxiv_data1/oa_pdf/90/e7/ijmsv11p0545.PMC4003539.pdf
http://purl.fdlp.gov/GPO/gpo31609.,Non-OADS,/arxiv_data1/oa_pdf/90/e7/ijmsv11p0545.PMC4003539.pdf
"11     http://www.medsci.org  553  immune, and reproductive system function.",Non-OADS,/arxiv_data1/oa_pdf/90/e7/ijmsv11p0545.PMC4003539.pdf
"11       http://www.medsci.org  554  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  554-563.  doi: 10.7150/ ijms.8407   Research Paper   Mutational S pectrum of the NKX2 -5 Gene in Patients  with Lone Atrial Fibrillation   Hong Yu1#, Jia-Hong Xu1#, Hao -Ming Song1#, Lan Zhao2#, Wen -Jun Xu1, Juan Wang1, Ruo -Gu Li3, Lei Xu3,  Wei- Feng Jiang3, Xing -Biao Qiu3, Jin-Qi Jiang4, Xin -Kai Qu3, Xu Liu3, Wei -Yi Fang3, Jin-Fa Jiang1ïª, Yi-Qing  Yang3,5,6ïª  1.",Non-OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
"11     http://www.medsci.org  555  The prevalence of AF is estimated to be approx i- mately  1% in  the general population , and increases   markedly with advancing age, ris ing from less than  1% in individuals  under 60  years of age  to nearly 10%  in subjects aged 80 years and above [1] .",Non-OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
"The referential genomic DNA sequence  of NKX2 -5 was derived from GenBank  (GenBank ID:  NG_013340.1) , a gene sequence database at the N a- tional Center for Biotechnical Information (NCBI ;  http://www.ncbi.nlm.nih.gov/) .",OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
"With the aid of the  online Primer 3 program  (http://frodo.wi.mit.edu/),",Non-OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
11     http://www.medsci.org  556  the primer pairs used to amplify the coding exons  (exon 1â2) and intronâ exon boundaries of NKX2 -5 by  polymerase chain reaction (PCR)  were designed as  previously described [35].,Non-OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
"For identified  sequence va r- iants , several standard datab ases including t he H u- man Gene Mutation Database (HGMD ;  http://www.hgmd.cf.ac.uk/)  and the NCBIâ² s Single  Nucleotide Polymorphism (SNP;  http:// www.ncbi.nlm.nih.gov/ snp) and PubMed  Databases  (http:// www.ncbi.nlm.nih.gov /pubmed )  were queried  to confirm their  novelty.",OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
"Alignment of multiple NKX2 -5 protein  sequences   The c onservation of the amino acids  of NKX2 -5  was evaluat ed by aligning human NKX2 -5 to chi m- panzee, monkey, dog, cow, mouse, rat, chicken, and  zebrafish NKX2 -5 using the  HomoloGene and Show  Multiple Alignment links on the NCBI âs web site   (http://www.ncbi.nlm.nih.gov/homologene ).",OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
"Prediction of the disease-causing potential of  NKX2 -5 sequence variations  The disease- causing potential of NKX2 -5 se- quence vari ation s was predicted by MutationTaster  (an online program at website  http://www.mutationtaster.org)  and PolyPhen -2  (http://genetics.bwh.harvard.edu/pph2/) , automa t- ically giving a probability score for each  alteration to  be either pathogenic or benign .",OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
"11     http://www.medsci.org  557  NKX2-5-pEFSA  and 0.1 Î¼g of each mutant  NKX2-5-pEFSA  were used,  in the presence of 0.",OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
11       http://www.medsci.org  558  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
11     http://www.medsci.org  559    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
"11     http://www.medsci.org  560  specificity: 0.95) for c .61G>C and 1 .00 (sensitivity:  0.14; specificity: 0.99) for c.538A>G, implying that  mutated NKX2 -5 might contribute to the development  of AF  in these families.",Non-OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
"11     http://www.medsci.org  561  NKX2 -5 protein ha s a highly conser ved structure  composed of the N -terminal  TN domain, the home o- domain  (HD) , and the C -terminal NK2 -specific d o- main (NK).",Non-OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
"11     http://www.medsci.org  562  carriers had atrioventricular block,  of which three  mutation carriers  had also  AF and cardiac structural  anomalies [60].",Non-OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
11     http://www.medsci.org  563  12.,Non-OADS,/arxiv_data1/oa_pdf/b2/77/ijmsv11p0554.PMC4003540.pdf
"1 1      http://www.medsci.org  564  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  564-577.  doi: 10.7150/ ijms.7704   Research Paper   Inhibition of MAPKs, Myc/Max, NF ÎºB, and Hypoxia  Pathways  by Phyllanthus Prevents Proliferation,  Metastasis and Angiogenesis in Human Melanoma   (MeWo) Cancer Cell Line   Yin-Quan Tang1, Indu Bala Jaganath2, Rishya Manikam3 and Shamala Devi Sekaran1 ïª  1.",Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
"11     http://www.medsci.org  565  underlying cause of melanoma progression and m e- tastasis is poorly understood, hence limiting the e f- fectiveness of current treatments and contributing to  increased cases of recurrence or refractory melanoma.",Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
"11     http://www.medsci.org  566  factor -responsive reporter of each pathway into the  cells, was performed to ensure highly transfection  efficiency and inh ibit transformation.",Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
11     http://www.medsci.org  567  (100 mM NH 4HCO 3 containing 10 mM DTT) for 30  min at 60Â°C.,Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
11     http://www.medsci.org  568    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
"11     http://www.medsci.org  569  than 52 are significant, p<0.05) and 2) reoccurrence in  the three repeated experiments (Figure 6).",Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
11     http://www.medsci.org  570    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
11     http://www.medsci.org  571    Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
11     http://www.medsci.org  572  Table 2:  Fold changes of differential expressed proteins in aqueous - and methanolic -treated MeWo cells.,Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
"11     http://www.medsci.org  573  No UniProtKB/Swiss -Prot  (Accession number)  Protein  Phyllanthus   PA(H)  PN(H)  PU(H)  PW(H)  PA(M)  PN(M)  PU(M)  PW(M)   1-alpha -like 3   44 Q5TGZ0  Mitochondrial inner membrane  organizing system protein 1  -1.53 -1.63 -1.74 -1.56 -1.67 -1.68 -1.64 -1.75  45 P07339  Cathepsin D  -1.54 -1.54 -1.65 -1.46 -1.68 -1.68 -1.47 -1.58  46 Q9Y587  AP-4 complex subunit sigma -1 -1.33 -1.57 -1.56 -1.36 -1.68 -1.74 -1.58 -1.67  47 P00568  Adenylate kinase  -1.58 -1.39 -1.53 -1.57 -1.56 -1.63 -1.68 -1.58  48 P80294  Metallothionein -1H -1.29 -1.74 -1.73 -1.45 -1.59 -1.58 -1.76 -1.68  49 Q76KX8  Zinc finger protein 534  -1.59 -1.46 -1.57 -1.64 -1.54 -1.63 -1.58 -1.58  50 Q9Y6H3  Mitochondrial inner membrane  protease ATP23 homolog  -1.59 -1.56 -1.57 -1.67 -1.68 -1.67 -1.68 -1.63  51 Q8WVM8  Sec1 family domain -containing pr o- tein 1  -1.44 -1.56 -1.64 -1.54 -1.76 -1.65 -1.75 -1.64  52 Q9NVH6  Trimethyllysine dioxygenase, mit o- chondrial  -1.58 -1.48 -1.58 -1.54 -1.79 -1.68 -1.53 -1.66      Discussion   Understanding cell signalling  in cancer is of  paramount importance and may provide potential  targets for anticancer agents to induce apoptosis and/or inhibitions tumour metastasis and angioge n- esis.",Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
11     http://www.medsci.org  574  [43-45].,Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
11     http://www.medsci.org  575  signalling pathways and protein -protein interaction  in melanoma MeWo cells.,Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
"1 1      http://www.medsci.org  576  Acknowledgments   This study was supported by Postgraduate R e- search Grant, University of Malaya (PV053/2011B) ,  University of Malaya Research Grant (UMRG)  (RG391- 11HTM) and Malaysian Agricultural and Re- search Development Institute (MARDI) (53-02-03-1002).",Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
11     http://www.medsci.org  577  52.,Non-OADS,/arxiv_data1/oa_pdf/91/86/ijmsv11p0564.PMC4003541.pdf
"1 1      http://www.medsci.org  578  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  578-586.  doi: 10.7150/ ijms.8365   Research Paper   Tanshinone II A Attenuates Bleomycin -Induced  Pulmonary Fibrosis via Modulating Angiotensin -  Converting Enzyme  2/ Angiotensin -(1-7) Axis in Rats  Huajie Wu1,3*, Yan Li4*, Yanxia Wang2,3*, Dunquan Xu2, Congcong Li5, Manling Liu2, Xin Sun1ïª, Zhichao  Li2,3ïª  1.",Non-OADS,/arxiv_data1/oa_pdf/78/f9/ijmsv11p0578.PMC4003542.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/78/f9/ijmsv11p0578.PMC4003542.pdf
11     http://www.medsci.org  579  tions.,Non-OADS,/arxiv_data1/oa_pdf/78/f9/ijmsv11p0578.PMC4003542.pdf
"11     http://www.medsci.org  580  Immunohistochemical staining analyses   Lung sections of 4 -Î¼m were prepared and de- paraffinized, rehydrated, and blocked by incubating  in 0.3% H 2O2 for 30 min.",Non-OADS,/arxiv_data1/oa_pdf/78/f9/ijmsv11p0578.PMC4003542.pdf
11     http://www.medsci.org  581  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/78/f9/ijmsv11p0578.PMC4003542.pdf
11     http://www.medsci.org  582    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/78/f9/ijmsv11p0578.PMC4003542.pdf
"1 1      http://www.medsci.org  583  TIIA treatment up -regulated ACE-2  expression in rat lungs after BLM  administration  As the immunohistochemical staining showed  that BLM resulted in significant decrease expression  of ACE -2 in rat lungs  compared to those of control  group at the endpoint of 28 days ( P<0.01, Fig.",Non-OADS,/arxiv_data1/oa_pdf/78/f9/ijmsv11p0578.PMC4003542.pdf
11     http://www.medsci.org  584    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/78/f9/ijmsv11p0578.PMC4003542.pdf
1 1      http://www.medsci.org  585  Discussion   In the present study we examined the protective  effects of T IIA on a BLM induced PF model of rats.,Non-OADS,/arxiv_data1/oa_pdf/78/f9/ijmsv11p0578.PMC4003542.pdf
"11     http://www.medsci.org  586  No81200036), and  the Open Project of the Key Labo r- atory of High Altitude Medicine  (No.",Non-OADS,/arxiv_data1/oa_pdf/78/f9/ijmsv11p0578.PMC4003542.pdf
"1 1      http://www.medsci.org  587  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  587-592.  doi: 10.7150/ ijms.8025   Research Paper   Late-onset Depression in the Absence of Stroke:  Associated with Silent Brain Infarctions, Microbleeds  and Lesion Locations   Ri-Han Wu1*, Chao Feng1, 2*, Yu Xu3, Ting Hua3, Xue-Yuan Liu1ïª, Min Fang1ïª  1.",Non-OADS,/arxiv_data1/oa_pdf/d7/2a/ijmsv11p0587.PMC4003543.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/2a/ijmsv11p0587.PMC4003543.pdf
11     http://www.medsci.org  588  stroke patients are aged.,Non-OADS,/arxiv_data1/oa_pdf/d7/2a/ijmsv11p0587.PMC4003543.pdf
11     http://www.medsci.org  589  = 27/20) on the axial plane with a thickness of 1.5 mm.,Non-OADS,/arxiv_data1/oa_pdf/d7/2a/ijmsv11p0587.PMC4003543.pdf
"11     http://www.medsci.org  590  Logistic regression models were constructed to  analyze the significance of the presence  (yes/no) , ac- cumulation  (numbers)  and locations of SBIs and MBs  for the presence of  LOD respectively with step -wise  method.",OADS,/arxiv_data1/oa_pdf/d7/2a/ijmsv11p0587.PMC4003543.pdf
"11     http://www.medsci.org  591  sociation between SBIs and LOD again, and also  suggested that MBs might be associated with LOD just like WML  and SBIs .",OADS,/arxiv_data1/oa_pdf/d7/2a/ijmsv11p0587.PMC4003543.pdf
11     http://www.medsci.org  592  13.,Non-OADS,/arxiv_data1/oa_pdf/d7/2a/ijmsv11p0587.PMC4003543.pdf
"1 1      http://www.medsci.org  593  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  593-601.  doi: 10.7150/ ijms.8096   Research Paper   King Cobra ( Ophiophagus hannah ) Venom L -Amino Acid  Oxidase Induces Apoptosis in PC -3 Cells  and Suppresses PC -3 Solid Tumor Growth in a Tumor  Xenograft Mouse Model   Mui Li Lee1, Shin Yee Fung1, Ivy Chung2, Jayal akshmi Pailoor3, Swee Hung Cheah4, Nget Hong Tan1 ïª  1.",Non-OADS,/arxiv_data1/oa_pdf/4c/55/ijmsv11p0593.PMC4003544.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/4c/55/ijmsv11p0593.PMC4003544.pdf
"11     http://www.medsci.org  594  L-amino acid: O 2 oxidoreductase, EC 1.4.3.2) has bee n  reported to exhibit a wide range of pharmacological  activities including anti- proliferative [3] and a n- ti-bacterial activities [4].",Non-OADS,/arxiv_data1/oa_pdf/4c/55/ijmsv11p0593.PMC4003544.pdf
11     http://www.medsci.org  595  washed twice with PBS followed by centrifugation.,Non-OADS,/arxiv_data1/oa_pdf/4c/55/ijmsv11p0593.PMC4003544.pdf
1 1      http://www.medsci.org  596      Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/4c/55/ijmsv11p0593.PMC4003544.pdf
11     http://www.medsci.org  597    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/4c/55/ijmsv11p0593.PMC4003544.pdf
1 1      http://www.medsci.org  598      Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/4c/55/ijmsv11p0593.PMC4003544.pdf
11     http://www.medsci.org  599    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/4c/55/ijmsv11p0593.PMC4003544.pdf
"11     http://www.medsci.org  600  studies (1 Âµg/g body weight) was estimated to give a  theoretical level of LAAO of about 5 Âµg/mL in the extracellular fluid (ECF) of the mice, assuming that ECF was 20% of body weight [24], if all the injected LAAO were absorbed and distributed throughout t he  entire ECF compartment instantaneously.",Non-OADS,/arxiv_data1/oa_pdf/4c/55/ijmsv11p0593.PMC4003544.pdf
11     http://www.medsci.org  601  15.,Non-OADS,/arxiv_data1/oa_pdf/4c/55/ijmsv11p0593.PMC4003544.pdf
"1 1      http://www.medsci.org  602  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  602-607.  doi: 10.7150/ ijms.8341   Research Paper   Energy and Nutritional Composition of Tiger Milk  Mushroom (Lignosus tigris  Chon S. Tan) Sclerotia and the  Antioxidant Activity of Its Extracts  Hui-Yeng Yeannie Yap1ïª, Azlina Abdul Aziz1, Shin- Yee Fung1, Szu -Ting Ng2, Chon -Seng Tan2, Nget -Hong  Tan1  1.",Non-OADS,/arxiv_data1/oa_pdf/a9/44/ijmsv11p0602.PMC4003545.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/44/ijmsv11p0602.PMC4003545.pdf
11     http://www.medsci.org  603  tritional composition; to evaluate whether this new  species of mushroom can also be used as functional foods with beneficial biopharmacological properties.,Non-OADS,/arxiv_data1/oa_pdf/a9/44/ijmsv11p0602.PMC4003545.pdf
11     http://www.medsci.org  604  action mixtures were then aspirated and cells were  cultured in  fresh growth medium for an additional 72  h prior to cell viability assessment by MTT assay.,Non-OADS,/arxiv_data1/oa_pdf/a9/44/ijmsv11p0602.PMC4003545.pdf
11     http://www.medsci.org  605  the cold water extracts indicating that the efficiency of  extraction of phenolic compounds was not dependent on temperature of the extraction medium.,Non-OADS,/arxiv_data1/oa_pdf/a9/44/ijmsv11p0602.PMC4003545.pdf
1 1      http://www.medsci.org  606    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/a9/44/ijmsv11p0602.PMC4003545.pdf
11     http://www.medsci.org  607  Competing  Interest s  The authors have declared that no competing  interest exists.,Non-OADS,/arxiv_data1/oa_pdf/a9/44/ijmsv11p0602.PMC4003545.pdf
http://methods.aaccnet.org/toc.aspx   11.,OADS,/arxiv_data1/oa_pdf/a9/44/ijmsv11p0602.PMC4003545.pdf
"1 1      http://www.medsci.org  608  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  608-613.  doi: 10.7150/ ijms.8428   Research Paper   The Expression  of Toll- like Receptor  8 and Its  Relationship with VEGF and Bcl -2 in Cervical Cancer   Yun Zhang1, Heng Yang1, Prince Amoah Barnie1, Peifang Yang2, Zhaoliang Su1, Jianguo Chen2, Zhijun  Jiao2, Liwei Lu3, Shengjun Wang1ïª, Huaxi Xu1ïª  1.",Non-OADS,/arxiv_data1/oa_pdf/59/96/ijmsv11p0608.PMC4003546.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/59/96/ijmsv11p0608.PMC4003546.pdf
11     http://www.medsci.org  609  sions and squamous cell carcinomas.,Non-OADS,/arxiv_data1/oa_pdf/59/96/ijmsv11p0608.PMC4003546.pdf
"11     http://www.medsci.org  610  CL075 at 37â for 48h, and stained by PI for f low c y- tometry  analysis.",Non-OADS,/arxiv_data1/oa_pdf/59/96/ijmsv11p0608.PMC4003546.pdf
11     http://www.medsci.org  611    Fig.2  Intracellular localization of TLR8 and the  effect of CL075 stimulation in Hela cells .,Non-OADS,/arxiv_data1/oa_pdf/59/96/ijmsv11p0608.PMC4003546.pdf
1 1      http://www.medsci.org  612    Fig.3 .,Non-OADS,/arxiv_data1/oa_pdf/59/96/ijmsv11p0608.PMC4003546.pdf
11     http://www.medsci.org  613  tumor development.,Non-OADS,/arxiv_data1/oa_pdf/59/96/ijmsv11p0608.PMC4003546.pdf
"1 1      http://www.medsci.org  614  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  614-619.  doi: 10.7150/ ijms.8582   Research Paper   TMPRSS6 rs855791 Polymorphism Influences the  Susceptibility to Iron Deficiency Anemia in Women at  Reproductive Age   Sung -Nan Pei1,2,3, Ming -Chun Ma1, Huey -Ling You2,4, Hung -Chun Fu2,5, Ching -Yuan Kuo1, Kun -Ming  Rau1,2, Ming -Chung Wang1,2, Chien -Te Lee2,6ïª  1.",Non-OADS,/arxiv_data1/oa_pdf/74/29/ijmsv11p0614.PMC4003547.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/29/ijmsv11p0614.PMC4003547.pdf
11     http://www.medsci.org  615  moglobin (Hb)  levels and adequate iron store s [2].,Non-OADS,/arxiv_data1/oa_pdf/74/29/ijmsv11p0614.PMC4003547.pdf
1 1      http://www.medsci.org  616    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/74/29/ijmsv11p0614.PMC4003547.pdf
"11     http://www.medsci.org  617  menorrhagia,  no difference between IDA and healthy  women was observed in the frequency distribution of  TT, TC, and CC genotypes  (p = 0.91; Table 3 ) or of the  CC and TX genotypes  (OR = 0.78, 95% CI , 0.14â4.34, p  = 0.78;  Figure 3b) .",OADS,/arxiv_data1/oa_pdf/74/29/ijmsv11p0614.PMC4003547.pdf
11     http://www.medsci.org  618    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/74/29/ijmsv11p0614.PMC4003547.pdf
11     http://www.medsci.org  619  have PBAC scores and these data allowed us to pe r- form additional analysis according to menstrual  amount.,Non-OADS,/arxiv_data1/oa_pdf/74/29/ijmsv11p0614.PMC4003547.pdf
http://www.who.int/nutrition/publications/   en/ida_assessment_prevention_control.pdf  2.,Non-OADS,/arxiv_data1/oa_pdf/74/29/ijmsv11p0614.PMC4003547.pdf
"1 1      http://www.medsci.org  620  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  620-625.  doi: 10.7150/ ijms.8251   Research Paper   PIK3CA  Gene Amplification  and PI3K p110Î±  Protein  Expression in Breast Carcinom a  Mohammad Firoozinia1, Mohammad Zareian Jahromi2, Soheil Zorofchian Moghadamtousi1, Sonia  Nikzad1, and Habsah Abdul Kadir1ïª  1.",Non-OADS,/arxiv_data1/oa_pdf/d2/36/ijmsv11p0620.PMC4003548.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d2/36/ijmsv11p0620.PMC4003548.pdf
"11     http://www.medsci.org  621  fellow malignancies [1,2].",Non-OADS,/arxiv_data1/oa_pdf/d2/36/ijmsv11p0620.PMC4003548.pdf
"11     http://www.medsci.org  622  tissue sections were wash ed in Tris -buffered saline  with 0.1% Tween -20 (TBS -T), pH7.6.",Non-OADS,/arxiv_data1/oa_pdf/d2/36/ijmsv11p0620.PMC4003548.pdf
"1 1      http://www.medsci.org  623  Relationship between PIK3CA  gene copy  number, PI3K p110Î±  protein expression, age,  race and histological types   In the present study, the relationship between  PIK3CA  gene amplification, age, race and histological  type was analysed in breast carcinoma.",OADS,/arxiv_data1/oa_pdf/d2/36/ijmsv11p0620.PMC4003548.pdf
11     http://www.medsci.org  624  The PI3K pathway deviations are existing in a  significant quantity of breast carcinoma patients.,Non-OADS,/arxiv_data1/oa_pdf/d2/36/ijmsv11p0620.PMC4003548.pdf
11     http://www.medsci.org  625  16.,Non-OADS,/arxiv_data1/oa_pdf/d2/36/ijmsv11p0620.PMC4003548.pdf
"1 1      http://www.medsci.org  626  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  626-633.  doi: 10.7150/ ijms.8228   Research Paper   HGF/c -Met Signaling Mediated M esenchymal Stem  Cell-induced Liver Recovery in Intestinal Ischemia  Reperfusion Model   Jianpei Liu1, Guozheng Pan2, Tangzhao Liang3, Pinjie Huang4ïª  1.",Non-OADS,/arxiv_data1/oa_pdf/30/54/ijmsv11p0626.PMC4003549.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/30/54/ijmsv11p0626.PMC4003549.pdf
11     http://www.medsci.org  627  modify the  course of this condition.,Non-OADS,/arxiv_data1/oa_pdf/30/54/ijmsv11p0626.PMC4003549.pdf
11     http://www.medsci.org  628  4ÂºC overnight.,Non-OADS,/arxiv_data1/oa_pdf/30/54/ijmsv11p0626.PMC4003549.pdf
11     http://www.medsci.org  629  Results   Characterization of  rat MSCs   Rat MSCs were identified by western blot anal y- sis and the mesenchymal lineage differentiation.,Non-OADS,/arxiv_data1/oa_pdf/30/54/ijmsv11p0626.PMC4003549.pdf
11     http://www.medsci.org  630      Figure 2 Rat MSC improved the histopathologic  changes of the liver and  reduced the release of serum enzymes in rats with IIR.,Non-OADS,/arxiv_data1/oa_pdf/30/54/ijmsv11p0626.PMC4003549.pdf
"11     http://www.medsci.org  631  Effect of HGF and c -Met inhibitor on migration  of MSCs   As the conce ntration of HGF increased, MSC  migration increased consequently.",Non-OADS,/arxiv_data1/oa_pdf/30/54/ijmsv11p0626.PMC4003549.pdf
11     http://www.medsci.org  632  cated that MSCs were viable to function shortl y after  transplantation.,Non-OADS,/arxiv_data1/oa_pdf/30/54/ijmsv11p0626.PMC4003549.pdf
11     http://www.medsci.org  633  8.,Non-OADS,/arxiv_data1/oa_pdf/30/54/ijmsv11p0626.PMC4003549.pdf
"1 1      http://www.medsci.org  634  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  634-640.  doi: 10.7150/ ijms.8686   Research Paper   Organ Donation Knowledge and Attitudes among  Health Science Students in Greece : Emerging  Interprofessional Needs   Emmanouil K. Symvoulakis1, George Rachiotis2, Dimitrios Papagiannis2*, Adelais Markaki3*ïª, Yiannis  Dimitroglou2, Myfanwy Morgan4, Christos Hadjichris todoulou2, Roger Jones5  1.",Non-OADS,/arxiv_data1/oa_pdf/41/e0/ijmsv11p0634.PMC4003550.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/41/e0/ijmsv11p0634.PMC4003550.pdf
1 1      http://www.medsci.org  635  Introduction  The debate over the optimum ways to reform  organ donation and transplantation legislation has  been underscored by individual countriesâ successes and failures.,Non-OADS,/arxiv_data1/oa_pdf/41/e0/ijmsv11p0634.PMC4003550.pdf
"11     http://www.medsci.org  636  The questionnaire comprised of 21 it ems, grouped in  three main domains: knowledge, general attitudes to  kidney donation, and specific concerns.",Non-OADS,/arxiv_data1/oa_pdf/41/e0/ijmsv11p0634.PMC4003550.pdf
"11     http://www.medsci.org  637  Table 2: Kidney organ donation knowledge, attitudes and concerns by health science student category (* P<0.05, ** P<0.001)    Questionnaire domains / items   Nursing studentsâ   positive responses   n (%)   Medical studentsâ   positive responses   n (%) Medical Laboratory  studentsâ   positive responses   n (%)   Knowledge      1.",Non-OADS,/arxiv_data1/oa_pdf/41/e0/ijmsv11p0634.PMC4003550.pdf
11     http://www.medsci.org  638  Table 3: Organ/tiss ue donation awareness and stand by health science student category   Supplementary Questionnaire items  Nursing studentsâ   positive responses  Medical studentsâ   positive responses  Medical Lab studentsâ   positive  responses  P value   1.,Non-OADS,/arxiv_data1/oa_pdf/41/e0/ijmsv11p0634.PMC4003550.pdf
"11     http://www.medsci.org  639  form of a 3- item tool  to pre -assess the likelihood for  opt-out among individuals or groups, while avoiding  asking a direct question that may lead to socially e x- pected responses, could be promising .",Non-OADS,/arxiv_data1/oa_pdf/41/e0/ijmsv11p0634.PMC4003550.pdf
11     http://www.medsci.org  640  facilitating t he conduct of this study as well as all  participating students for taking the time to complete  this survey.,Non-OADS,/arxiv_data1/oa_pdf/41/e0/ijmsv11p0634.PMC4003550.pdf
http://ec.europa.eu/   health/blood_tissues_organs/docs/ev_20121009_facts_figures.pdf  4.,Non-OADS,/arxiv_data1/oa_pdf/41/e0/ijmsv11p0634.PMC4003550.pdf
Human Transplantation (Wales) Act  2013. http://www.senedd.assemblywales.org/mgIssueHistoryHome.aspx?,Non-OADS,/arxiv_data1/oa_pdf/41/e0/ijmsv11p0634.PMC4003550.pdf
"1 1      http://www.medsci.org  641  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  641-645.  doi: 10.7150/ ijms.7643   Research Paper   Serum Lactate Dehydrogenase  Levels as a Predictive  Marker o f Oxaliplatin -Induced Hypersensitivity  Reactions i n Japanese Patients w ith Advanced  Colorectal Cancer  Kyoko Seki 1, Yasuo Tsuduki 2, Takeshi Ioroi 3, Michiko Yamane 4, Hiroko Yamauchi 5, Yukinari Shiraishi 1,  Tadaaki Ogawa 1, Izumi Nakata 2, Kohshi Nishiguchi 3, Teruhisa Matsubayashi 4, Yoshihide Takakubo 5,  Motohiro Yamamori 6, Akiko Kuwahara 6, Noboru Okamura 6, and Toshiyuki Sakaeda 3,7,8 ïª  1.",Non-OADS,/arxiv_data1/oa_pdf/af/18/ijmsv11p0641.PMC4003551.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/af/18/ijmsv11p0641.PMC4003551.pdf
"1 1      http://www.medsci.org  642  Introduction  Oxaliplatin (L -OHP) is a third- generation plat i- num anticancer drug, and L- OHP -containing reg i- mens, including FOLFOX4 and mFOLFOX6, are cu r- rently standard treatments for colorectal cancer [1 -5].",Non-OADS,/arxiv_data1/oa_pdf/af/18/ijmsv11p0641.PMC4003551.pdf
"11     http://www.medsci.org  643  roni correction, P values of less than 0.05 were co n- sidered significant.",OADS,/arxiv_data1/oa_pdf/af/18/ijmsv11p0641.PMC4003551.pdf
11     http://www.medsci.org  644  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/af/18/ijmsv11p0641.PMC4003551.pdf
11     http://www.medsci.org  645  than in those without reactions.,Non-OADS,/arxiv_data1/oa_pdf/af/18/ijmsv11p0641.PMC4003551.pdf
118 Journal of Traditional and Complementary Medicine Journal homepage http://www.jtcm.orgï INTRODUCTION Multidrug resistance (MDR) is the main cause of failure in  chemotherapy of cancer patients.,Non-OADS,/arxiv_data1/oa_pdf/a1/b0/JTCM-4-118.PMC4003701.pdf
126 Journal of Traditional and Complementary Medicine Journal homepage http://www.jtcm.orgï INTRODUCTION Nicotine is an alkaloid found in the nightshade family of  plants (Solanaceae) and has been found to be a potent parasympa - thomimetic and a stimulant drug.,Non-OADS,/arxiv_data1/oa_pdf/b5/de/JTCM-4-126.PMC4003702.pdf
Available  from: http://cancercontrol.cancer.gov/brp/tcrb/monographs/9/m9_3.,Non-OADS,/arxiv_data1/oa_pdf/b5/de/JTCM-4-126.PMC4003702.pdf
132 Journal of Traditional and Complementary Medicine Journal homepage http://www.jtcm.orgï INTRODUCTION The activation and clonal growth of T cells is the central  incident in the generation of immune responses.,Non-OADS,/arxiv_data1/oa_pdf/07/d7/JTCM-4-132.PMC4003703.pdf
75 Journal of Traditional and Complementary Medicine Journal homepage http://www.jtcm.orgï Prostate cancer typically develops later in life.,Non-OADS,/arxiv_data1/oa_pdf/62/ec/JTCM-4-75.PMC4003704.pdf
77 Journal of Traditional and Complementary Medicine Journal homepage http://www.jtcm.orgï INTRODUCTION Adult neurogenesis is a continuous bioactivity in certain brain  regions.,Non-OADS,/arxiv_data1/oa_pdf/b8/ce/JTCM-4-77.PMC4003705.pdf
"82 Journal of Traditional and Complementary Medicine Journal homepage http://www.jtcm.orgï INTRODUCTION The genus Salvia , commonly known as sage, is the largest  member of Lamiacea or mint family containing over 900 species  throughout the world.",Non-OADS,/arxiv_data1/oa_pdf/d8/9a/JTCM-4-82.PMC4003706.pdf
89 Journal of Traditional and Complementary Medicine Journal homepage http://www.jtcm.orgï INTRODUCTION Traumatic brain injury (TBI) is an acquired brain trauma that  occurs when any sudden trauma/injury causes damage to the brain.,Non-OADS,/arxiv_data1/oa_pdf/09/99/JTCM-4-89.PMC4003707.pdf
"Available from: http://www.cdc.gov/traumaticbraininjury/Page last  reviewed: March 6, 2014.",Non-OADS,/arxiv_data1/oa_pdf/09/99/JTCM-4-89.PMC4003707.pdf
93 Journal of Traditional and Complementary Medicine Journal homepage http://www.jtcm.orgï INTRODUCTION Inflamm ation is a part of the immune response that can prevent  infection through production of proâinflammatory cytokines and  generation of inflammatory mediators in response to microbial  products.,Non-OADS,/arxiv_data1/oa_pdf/1c/aa/JTCM-4-93.PMC4003708.pdf
99 Journal of Traditional and Complementary Medicine Journal homepage http://www.jtcm.orgï INTRODUCTION Arthritis is a disease that affects both the physical  (e.g.,Non-OADS,/arxiv_data1/oa_pdf/e5/15/JTCM-4-99.PMC4003709.pdf
Available from: http://www.tobaccoctrl.ng10.,Non-OADS,/arxiv_data1/oa_pdf/0d/71/NMJ-55-121.PMC4003713.pdf
Mancunian Matters.Obtainable from http://en.wikipedia.org/wiki/Atrial_septal_defect.,Non-OADS,/arxiv_data1/oa_pdf/8c/6e/NMJ-55-126.PMC4003714.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/8c/6e/NMJ-55-126.PMC4003714.pdf
2008; 13 (1) :71-5URL http://pajoohande.sbmu.ac.ir/browse.php?a_code=A-10-2-103&slc_lang=en&sid=1 2.,Non-OADS,/arxiv_data1/oa_pdf/78/4e/NMJ-55-134.PMC4003716.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/78/4e/NMJ-55-134.PMC4003716.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/68/5a/NMJ-55-148.PMC4003719.pdf
Available from: http://www.searo.who.int/en/Section1174/Section1199/Section1567/Section1826.htm.,Non-OADS,/arxiv_data1/oa_pdf/8b/33/NMJ-55-156.PMC4003720.pdf
URL: Available from: http://www.usatoday.com/news/health/mental/2002-05-22-college-depression.htm [Last accessed on 2010 Jul 2].,Non-OADS,/arxiv_data1/oa_pdf/8b/33/NMJ-55-156.PMC4003720.pdf
Available from: http://wwwapps.nimh.nih.gov/ecb/ archives/nimhblueprint.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8b/33/NMJ-55-156.PMC4003720.pdf
Available from: http://www.roche.com; 2007 [Last accessed  on 2013 November 16].,Non-OADS,/arxiv_data1/oa_pdf/00/59/NMJ-55-99.PMC4003728.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4827 | DOI: 10.1038/srep04827 4",Non-OADS,/arxiv_data1/oa_pdf/12/e0/srep04827.PMC4003729.pdf
Copyright Â© 2014 The Korean Audiological Society  41CASE REPORT Korean J Audiol 2014 ;18(1):41-44 pISSN 2092-9862 / eISSN 2093-3797 http://dx.doi.org/10.7874/kja.2014.18.1.41 Introduction Post-traumatic Meniereâs disease (PTMD ) is Meniereâs syn - drome that develops after acoustic or physical trauma.,Non-OADS,/arxiv_data1/oa_pdf/65/3b/kja-18-41.PMC4003730.pdf
Copyright Â© 2014 The Korean Audiological Society  13ORIGINAL ARTICLE Korean J Audiol 2014 ;18(1):13-18 pISSN 2092-9862 / eISSN 2093-3797 http://dx.doi.org/10.7874/kja.2014.18.1.13 Introduction One type of hearing loss is conductive hearing loss (CHL )  that shows an air-bone gap in the standard audiometry.1) The  sound is affected before entering the inner ear in CHL2) and  leads to some undesirable consequences.,Non-OADS,/arxiv_data1/oa_pdf/83/14/kja-18-13.PMC4003731.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.online Â© ML Comm",Non-OADS,/arxiv_data1/oa_pdf/83/14/kja-18-13.PMC4003731.pdf
"34 Copyright Â© 2014 The Korean Audiological SocietyCASE REPORT Korean J Audiol 2014 ;18(1):34-37 pISSN 2092-9862 / eISSN 2093-3797 http://dx.doi.org/10.7874/kja.2014.18.1.34 Introduction Metastatic temporal tumor is an uncommon disease, and it  is difficult to be diagnosed because it is mostly shown with no  clinical symptoms.1-5) The most common origin of the metas - tasis is breast cancer, followed by lung, kidney, gastrointesti - nal tract, prostate, larynx and thyroid gland cancers.",Non-OADS,/arxiv_data1/oa_pdf/ad/ea/kja-18-34.PMC4003732.pdf
"Even  This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Unusual Presentation of a Metastatic Tumor to the Temporal   Bone : Severe Otalgia and Facial Paralysis Sung Ho Choi, Il-Seok Park, Young Bok Kim, and Seok Min Hong Department of Otorhinolaryngology-Head and Neck Surgery, Hallym University, Dongtan Sacred Heart Hospital,   Hwaseong, Korea Received   M ay 22, 2013 Revised   D ecember 17, 2013 Accepted   J anuary 5, 2014 Address for correspondence Seok Min Hong, MD Department of Otorhinolaryngology- Head and Neck Surgery,  Dongtan Sacred Heart Hospital,  7 Keunjaebong-gil, Hwaseong 445-907, KoreaTel  + 82-31-8086-2670 Fax + 82-31-8086-2681 E-mail  t hecell@medimail.co.krMetastatic temporal bone tumors are rare diseases and they are usually clinically asymptom - atic, so it is difficult to diagnose them.",Non-OADS,/arxiv_data1/oa_pdf/ad/ea/kja-18-34.PMC4003732.pdf
Copyright Â© 2014 The Korean Audiological Society  19ORIGINAL ARTICLE Korean J Audiol 2014 ;18(1):19-27 pISSN 2092-9862 / eISSN 2093-3797 http://dx.doi.org/10.7874/kja.2014.18.1.19 Introduction Tinnitus is the experience of hearing a sound without any  relevant external stimulation.,Non-OADS,/arxiv_data1/oa_pdf/75/d7/kja-18-19.PMC4003733.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.online Â© ML Comm",Non-OADS,/arxiv_data1/oa_pdf/75/d7/kja-18-19.PMC4003733.pdf
Copyright Â© 2014 The Korean Audiological Society  1REVIEW Korean J Audiol 2014 ;18(1):1-7 pISSN 2092-9862 / eISSN 2093-3797 http://dx.doi.org/10.7874/kja.2014.18.1.1 Introduction Multiple acoustic cues are usually used to interpret and un - derstand speech in the human auditory system.,Non-OADS,/arxiv_data1/oa_pdf/df/c6/kja-18-1.PMC4003734.pdf
38 Copyright Â© 2014 The Korean Audiological SocietyCASE REPORT Korean J Audiol 2014 ;18(1):38-40 pISSN 2092-9862 / eISSN 2093-3797 http://dx.doi.org/10.7874/kja.2014.18.1.38 Introduction Osteoma of the temporal bone is benign pedunculated tu - mors of the lamellar bone that are most commonly found in  the external auditory canal.,Non-OADS,/arxiv_data1/oa_pdf/41/7a/kja-18-38.PMC4003735.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.online Â© ML Comm",Non-OADS,/arxiv_data1/oa_pdf/41/7a/kja-18-38.PMC4003735.pdf
"28 Copyright Â© 2014 The Korean Audiological SocietyORIGINAL ARTICLE Korean J Audiol 2014 ;18(1):28-33 pISSN 2092-9862 / eISSN 2093-3797 http://dx.doi.org/10.7874/kja.2014.18.1.28 Introduction The degradation of speech comprehension is one of the  characteristics of older listeners (i.e., adults 65 years of age or  older ), indicating poor temporal and frequency resolutions,  especially for complex speech sounds.1) In a noisy environ - ment,2) reverberation listening condition,3) or fast speaking  rates,4) speech perception ability among those who are older is  much worse than for younger listeners.",Non-OADS,/arxiv_data1/oa_pdf/3f/a2/kja-18-28.PMC4003736.pdf
8 Copyright Â© 2014 The Korean Audiological SocietyORIGINAL ARTICLE Korean J Audiol 2014 ;18(1):8-12 pISSN 2092-9862 / eISSN 2093-3797 http://dx.doi.org/10.7874/kja.2014.18.1.8 Introduction Hearing disturbance is defined by difficulties and/or abnor - malities in hearing sounds and understanding language.,Non-OADS,/arxiv_data1/oa_pdf/b9/91/kja-18-8.PMC4003737.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.online Â© ML Comm",Non-OADS,/arxiv_data1/oa_pdf/b9/91/kja-18-8.PMC4003737.pdf
Available  from : http://www.krila.re.kr/common/filedown.asp?ix=7221.,OADS,/arxiv_data1/oa_pdf/b9/91/kja-18-8.PMC4003737.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/38/8e/srep04690.PMC4003820.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4690 | DOI: 10.1038/srep04690 7",Non-OADS,/arxiv_data1/oa_pdf/38/8e/srep04690.PMC4003820.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/56/53/S0021859613000117a.PMC4003854.pdf
"Published by Oxford University Press.Carcinogenesis  vol.35 no.5 pp.992â1002, 2014 doi:10.1093/carcin/bgt396 Advance Access publication December 4, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/64/bgt396.PMC4004199.pdf
"J.Kminkova etÂ al.miRNAsâ SNP frequency in CLL patients versus control population To find out whether allelic SNP frequencies detected in miRNAs in our cohorts  of CLL patients differ from the control population, the data from the 1000  genomes project ( http://1000genomes.org ) were applied since it provides the  most comprehensive resource of naturally occurring human variation.",OADS,/arxiv_data1/oa_pdf/6b/64/bgt396.PMC4004199.pdf
miRNAs secondary structures prediction The RNAfold web tool ( http://rna.tbi.univie.ac.at ) (42) was used to predict  the most stable secondary structures of wild-type (wt) miRNAs and variant  sequences.,OADS,/arxiv_data1/oa_pdf/6b/64/bgt396.PMC4004199.pdf
"In 96 CLL patients, 18 SNPs were detected in 15 miRNAs in total  (http://1000genomes.org ; dbSNP Build 134).",OADS,/arxiv_data1/oa_pdf/6b/64/bgt396.PMC4004199.pdf
"Published by Oxford University Press.Carcinogenesis  vol.35 no.5 pp.1055â1066, 2014 doi:10.1093/carcin/bgu001 Advance Access publication January 13, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/e3/bgu001.PMC4004203.pdf
AÂ list of angiogenesis-related genes was created using 2635 genes annotated  under the term âangiogenesisâ by Gene Ontology ( http://www.geneontology.,OADS,/arxiv_data1/oa_pdf/52/e3/bgu001.PMC4004203.pdf
"Statistically significant expression changes were determined using per - mutation tests (SAM, http://www-stat.stanford.edu/~tibs/SAM/ ).",OADS,/arxiv_data1/oa_pdf/52/e3/bgu001.PMC4004203.pdf
Annotations were  obtained through the DA VID database ( http://david.abcc.ncifcrf.gov/ ).,OADS,/arxiv_data1/oa_pdf/52/e3/bgu001.PMC4004203.pdf
"This kit uses an  array of 55 antibodies directed to proteins involved in angiogenesis and inva - siveness (the complete list of the antibodies spotted in the antibody array can  be found at http://www.rndsystems.com/index.aspx ), spotted onto a nitrocellu - lose membrane in a duplicate way.",Non-OADS,/arxiv_data1/oa_pdf/52/e3/bgu001.PMC4004203.pdf
"ImageJ News,   5 October 2012. http://image.bio.methods.free.fr/ImageJ/?Angiogenesis- Analyzer-for-ImageJ  (21 October 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/52/e3/bgu001.PMC4004203.pdf
"Graphi-cal analyses were done in GraphPad Prism version 5.03 forWindows, GraphPad Software, San Diego, California, USA,http://www.graphpad.com.",OADS,/arxiv_data1/oa_pdf/25/d7/bcp0077-0880.PMC4004408.pdf
Competing Interests Both authors have completed the Uniï¬ed CompetingInterest form at http://www.icmje.org/coi_disclosure.pdf L. Calver & G. K. Isbister 884 / 77:5 / Br J Clin Pharmacol,Non-OADS,/arxiv_data1/oa_pdf/25/d7/bcp0077-0880.PMC4004408.pdf
Two months after publication it is avail - able to the public under an AttributionâNoncommercialâShare Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d6/66/1411.PMC4004591.pdf
Two months after publication it is avail - able to the public under an AttributionâNoncommercialâShare Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b9/92/1421.PMC4004592.pdf
The  probability that a certain region adopts a coiled-coil conformation  was predicted by the COILS/PCOILS tool (http://toolkit.tuebingen   .mpg.de/pcoils/) using either a single sequence or the protein  alignment as query.,OADS,/arxiv_data1/oa_pdf/b9/92/1421.PMC4004592.pdf
"The presence of Nup92 and Nup110 ortho - logues in the genomes of other kinetoplastids was determined  by blast searches in various protein and nucleotide databases  (http://tritrypdb.org/tritrypdb/, www.genedb.org, NCBI GenBank,  and our in-house database of kinetoplastid genomes).",OADS,/arxiv_data1/oa_pdf/b9/92/1421.PMC4004592.pdf
Two months after publica - tion it is available to the public under an AttributionâNoncommercialâShare Alike  3.0 Unported Creative Commons License (http://creativecommons.org/licenses   /by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b0/dd/1437.PMC4004593.pdf
Two months after publication it is available  to the public under an AttributionâNoncommercialâShare Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/96/e8/1446.PMC4004594.pdf
Two months after publication it is avail - able to the public under an AttributionâNoncommercialâShare Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1a/1a/1458.PMC4004595.pdf
"Secondary structure analyses were carried out using  CDSSTR (Sreerama and Woody, 2003) with the reference database  available in DICHROWEB (http://dichroweb.cryst.bbk.ac.uk/html/ home.shtml).",OADS,/arxiv_data1/oa_pdf/1a/1a/1458.PMC4004595.pdf
Two months after publication it is avail - able to the public under an AttributionâNoncommercialâShare Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/cd/a2/1472.PMC4004596.pdf
"FAP20 homologues are annotated as members of the domain  of unknown function (DUF667) family in protein family databases  (e.g., http://pfam.sanger.ac.uk/).",Non-OADS,/arxiv_data1/oa_pdf/cd/a2/1472.PMC4004596.pdf
Two months after publication it is available  to the public under an AttributionâNoncommercialâShare Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0f/24/1484.PMC4004597.pdf
Two months after publication it is avail - able to the public under an AttributionâNoncommercialâShare Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1d/2f/1493.PMC4004598.pdf
"RESULTS Systematic identification of lamin Aâinteracting proteins To identify lamin Aâinteracting proteins in an unbiased manner, we  performed a yeast two-hybrid (Y2H) screen using the human OR - Feome V5.1 library, which contains 15,483 cloned open reading  frames (ORFs), corresponding to 12,794 nonredundant human genes  (a complete list of ORFs is available at http://horfdb.dfci   .harvard.edu/hv5/).",OADS,/arxiv_data1/oa_pdf/1d/2f/1493.PMC4004598.pdf
"GO analysis GO analysis of interactors was performed for GO categories cellular  components, biological process, and molecular function using  ORFeome v5.1 (http://horfdb.dfci.harvard.edu/hv5/) as background  (Huang da et al., 2009).",OADS,/arxiv_data1/oa_pdf/1d/2f/1493.PMC4004598.pdf
T wo months after publication it is  available to the public under an AttributionâNoncommercialâShare Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9c/39/1511.PMC4004599.pdf
Two months after publication it is available  to the public under an AttributionâNoncommercialâShare Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/10/cc/1523.PMC4004600.pdf
Two months after publication it is avail - able to the public under an AttributionâNoncommercialâShare Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f2/d3/1532.PMC4004601.pdf
"OncoImmunology 2013; 2:e27357;  http://dx.doi.org/10.4161/onci.27357Sustained CD4+ T cell-driven lymphopenia   without a compensatory IL-7/IL-15 response  among high-grade glioma patients treated   with radiation and temozolomide susannahÂ  ellsworth1,*, aniÂ Balmanoukian1, FerdynandÂ Kos2, christopherÂ J nirschl3, ThomasÂ r nirschl3,   stuartÂ a g rossman3, leoÂ l uznik3, andÂ c harlesÂ g Drake3,4 1Department of r adiation Oncology and Molecular r adiation s ciences; Johns h opkins University s chool of Medicine and s idney Kimmel c omprehensive c ancer c enter;  Baltimore, MD U sa; 2Mayo c linic a rizona; Phoenix, a Z Usa; 3Department of Medical Oncology; Johns h opkins University s chool of Medicine and s idney Kimmel  comprehensive c ancer c enter; Baltimore, MD U sa; 4James Buchanan Brady Urological i nstitute; Johns h opkins University s chool of Medicine   and s idney Kimmel c omprehensive c ancer c enter; Baltimore, MD U sa Keywords : CD4+ lymphopenia, glioblastoma, IL-7, immunotherapy, lymphocytes, radiation therapy, radiotherapy Abbreviations:  GBM, glioblastoma multiforme; NK, natural killer; RT, radiation therapy; PBL, peripheral blood lymphocyte;  TGFÎ²1, transforming growth factor Î² 1; TLC, total lymphocyte counts; TMZ, temozolomide; Treg, regulatory T cell Prolonged lymphopenia correlating with decreased survival commonly occurs among glioma patients undergoing  radiation therapy ( rT) and temozolomide (TMZ) treatment.",Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Supplemental Materials Supplemental materials may be found here:   http://www.landesbioscience.com/journals/oncoimmunology/article/27357/  References 1.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
J Clin Oncol 2006; 24:1253-65; PMID:16525180 ; http://dx.doi.org/10.1200/ JCO.2005.04.5302 2.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Lancet Oncol 2009; 10:459-66;  PMID:19269895 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Clin  Cancer Res 2011; 17:5473-80; PMID:21737504 ;  http://dx.doi.org/10.1158/1078-0432.CCR-11-0774 4.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Arch Surg 1970; 101:114-21; PMID:5451189 ; http://dx.doi.org/10.1001/ archsurg.1970.01340260018003 5.,OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Int J Radiat Oncol Biol Phys 2005; 62:1423-6; PMID:16029802 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Nature 2011; 480:480- 9; PMID:22193102 ; http://dx.doi.org/10.1038/ nature10673 7.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Blood 2002; 99:3892-904; PMID:12010786 ;  http://dx.doi.org/10.1182/blood.V99.11.38928.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Clin Cancer Res  2010; 16:727-35;  PMID:20068111 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
J Immunother 2006; 29:313-9;  PMID:16699374 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Blood 2001; 97:14- 32; PMID:11133738 ; http://dx.doi.org/10.1182/ blood.V97.1.14 11.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Curr Opin Immunol 2008; 20:241-6;  PMID:18508251 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
J Clin Invest 2008; 118:1991-2001;  PMID:18523649 ;  http://dx.doi.org/10.1172/JCI35180 14.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Clin  Exp Immunol 2001; 126:287-94; PMID:11703373 ;  http://dx.doi.org/10.1046/j.1365-2249.2001.01670.x16.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
J Clin Oncol 2008; 26:5233-9; PMID:18809613 ;  http://dx.doi.org/10.1200/JCO.2008.16.5449 17.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Bone Marrow Transplant 1999; 23:783-8; PMID:10231140 ; http://dx.doi.org/10.1038/ sj.bmt.1701655 18.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
CNS Oncol 2012; 1:149-54; PMID:23828734 ;  http://dx.doi.org/10.2217/cns.12.14 19.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Eur J Cancer  1992; 28A:1729-34;  PMID:1389495 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
J Neurol Sci 1997; 152:182-92;  PMID:9415540 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Arthritis Rheum  1987; 30:1-10;  PMID:2949753 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
http://aidsinfo.nih.gov/guidelines/html/1/ adult-and-adolescent-arv-guidelines/0 .,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Semin Hematol 2010; 47:187-98;  PMID:20350666 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Pneumocystis carinii pneumonia in HIV negative patients  with primary brain tumor s. J Neurooncol 2003;  63:263-70;  PMID:12892232 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Schiff D. Pneumocystis pneumonia in brain  tumor patients: risk factors and clinical feature s.  J Neurooncol 1996; 27:235-40; PMID:8847557 ;  http://dx.doi.org/10.1007/BF00165480 28.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
The association between treatment-related lymphopenia and survival in newly diag - nosed patients with resected adenocarcinoma of the pancrea s. Cancer Invest 2012; 30:571-6;  PMID:22812722 ; http://dx.doi.org/10.3109/07357 907.2012.700987 29.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Am J Clin Oncol 2013; Forthcoming;  PMID:23648440 ; http://dx.doi.org/10.1097/ COC.0b013e3182940ff9 30.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Cancer Invest 2013;  31:183-8;  PMID:23432821 ; http://dx.doi.org/10.31 09/07357907.2013.76734231.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Mutations in the gene for the IL-7 receptor result in T(-)B(+)NK(+) severe  combined immunodeficiency diseas e. Curr Opin  Immunol 2000; 12:468-73;  PMID:10899029 ;  http://dx.doi.org/10.1016/S0952-7915(00)00122-9 32.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Reconstitution of the lym - phocyte compartment after lymphocyte depletion: a key issue in clinical immunolog y. Eur J Immunol  2005; 35:3099-102;  PMID:16231288 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Increased circulat - ing interleukin-7 levels in HIV-1-infected wome n.  J Acquir Immune Defic Syndr 2005; 40:581-4; PMID:16284535 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Blood 2009; 113:6304-14; PMID:19380868 ; http://dx.doi.org/10.1182/ blood-2008-10-186601 36.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
"Budagian V, Bulanova E, Paus R, Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through  an expanding univers e. Cytokine Growth Factor Rev  2006; 17:259-80;  PMID :16815076 ; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Blood 2011; 118:3003- 12; PMID:21768296 ; http://dx.doi.org/10.1182/ blood-2011-02-33456538.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Int Immunol  2013; 25:471-83;  PMID:23657000 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
New rationales for using TGFbeta  inhibitors in radiotherap y. Int J Radiat Biol 2007;  83:803-11;  PMID:18058368 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Effects of  radiotherapy with concomitant and adjuvant temo - zolomide versus radiotherapy alone on survival in  glioblastoma in a randomised phase III study: 5-year  analysis of the EORTC-NCIC tria l. Lancet Oncol  2009; 10:459-66;  PMID:19269895 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
Blood 2007; 110:1689-97; PMID:17478639 ; http://dx.doi.org/10.1182/ blood-2007-03-079160,Non-OADS,/arxiv_data1/oa_pdf/42/9a/onci-3-e27357.PMC4004618.pdf
"OncoImmunology 2014; 3:e27763; http://dx.doi.org/10.4161/onci.27763Toll-like receptor genetic variants   and colorectal cancer alexander Nr  weber1,* and a sta FÃ¶rsti2,3,* 1Interfaculty Institute for Cell Biology; Department of Immunology; u niversity of TÃ¼bingen; TÃ¼bingen, Germany;   2Division of Molecular Genetic e pidemiology; German Cancer r esearch Center (DKFZ); h eidelberg, Germany;   3Center for Primary h ealth Care r esearch; Clinical r esearch Center; Lund u niversity; MalmÃ¶, s weden Keywords:  biomarker, colorectal cancer, flagellin, single-nucleotide polymorphism, Toll-like receptors single-nucleotide polymorphisms in Toll-like receptor 5 ( TLR5 ), encoding a sensor for flagellin, have been shown to  influence cytokine responses to intestinal bacteria and to be associated with significant alterations in the survival of  colorectal carcinoma (C rC) patients.",Non-OADS,/arxiv_data1/oa_pdf/04/25/onci-3-e27763.PMC4004619.pdf
CA Cancer J Clin  2011; 61:69-90;  PMID:21296855 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/25/onci-3-e27763.PMC4004619.pdf
Nat Rev Immunol  2010 ; 10:131-44; PMID:20098461 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/25/onci-3-e27763.PMC4004619.pdf
J Leukoc Biol 2008 ; 84:981- 7; PMID:18559950 ; http://dx.doi.org/10.1189/ jlb.1107773 4.,Non-OADS,/arxiv_data1/oa_pdf/04/25/onci-3-e27763.PMC4004619.pdf
Immunity  2011 ; 34:637-50;  PMID:21616434 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/04/25/onci-3-e27763.PMC4004619.pdf
Cancer Res  2013 ; 73:7232 -42; PMID :24154872 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/25/onci-3-e27763.PMC4004619.pdf
Eur J Cancer 2011 ; 47:1203 - 10; PMID:21239167 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/04/25/onci-3-e27763.PMC4004619.pdf
Int J Biol Sci 2012 ; 8:1248 -53; PMID:23136553 ;  http://dx.doi.org/10.7150/ijbs.46148.,OADS,/arxiv_data1/oa_pdf/04/25/onci-3-e27763.PMC4004619.pdf
Cell 2013 ; 152:703-13; PMID :23415221 ;  http://dx.doi.org/10.1016/j.cell.2013.01.035 9.,OADS,/arxiv_data1/oa_pdf/04/25/onci-3-e27763.PMC4004619.pdf
"OncoImmunology 2013; 2:e27615; http://dx.doi.org/10.4161/onci.27615Understanding the influence of the tumor  microenvironment on macrophage responses   to CD40 agonists Nadia Luheshi, Gareth Davies, and James Legg* MedImmune Ltd.; Cambridge u K Keywords:  CD40, macrophage, microenvironment, polarization, pancreatic cancer Both Th1 and Th2 cytokines influence the antitumor functions of macrophages.",Non-OADS,/arxiv_data1/oa_pdf/c7/8a/onci-3-e27615.PMC4004620.pdf
Nat Rev Cancer 2012;  12:298-306; http://dx.doi.org/10.1038/nrc3245 ;  PMID:224192532.,Non-OADS,/arxiv_data1/oa_pdf/c7/8a/onci-3-e27615.PMC4004620.pdf
Nat Immunol 2010; 11:889-96; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c7/8a/onci-3-e27615.PMC4004620.pdf
Nature  1998; 393:480-3; http://dx.doi.org/10.1038/31002 ;  PMID:9624005 5.,Non-OADS,/arxiv_data1/oa_pdf/c7/8a/onci-3-e27615.PMC4004620.pdf
Science 2011; 331:1612-6; http://dx.doi.org/10.1126/science.1198443 ;  PMID:21436454 6.,Non-OADS,/arxiv_data1/oa_pdf/c7/8a/onci-3-e27615.PMC4004620.pdf
Cancer Immunol Immunother 2008; 57:1151-60 ; http://dx.doi.org/10.1007/s00262-007- 0447-4 ; PMID:182144767.,Non-OADS,/arxiv_data1/oa_pdf/c7/8a/onci-3-e27615.PMC4004620.pdf
J Exp Med 2012; 209:1869- 82; http://dx.doi.org/10.1084/jem.20112738 ;  PMID:22927549 8.,OADS,/arxiv_data1/oa_pdf/c7/8a/onci-3-e27615.PMC4004620.pdf
Eur J Immunol 2013; http://dx.doi.org/10.1002/ eji.201343351 ; PMID:24114634 9.,Non-OADS,/arxiv_data1/oa_pdf/c7/8a/onci-3-e27615.PMC4004620.pdf
J Immunol 2011; 187:1157- 65; http://dx.doi.org/10.4049/jimmunol.1100889 ;  PMID :2170915810.,Non-OADS,/arxiv_data1/oa_pdf/c7/8a/onci-3-e27615.PMC4004620.pdf
Proc Natl Acad Sci U S  A 2009; 106:19455-60; http://dx.doi.org/10.1073/ pnas.0909474106 ; PMID:19892741,OADS,/arxiv_data1/oa_pdf/c7/8a/onci-3-e27615.PMC4004620.pdf
"OncoImmunology 2014; 3:e27884; http://dx.doi.org/10.4161/onci.27884Immune-related gene signatures predict the  outcome of neoadjuvant chemotherapy gautierÂ s toll1,2, DavidÂ e not3, BernhardÂ Mlecnik1,5,6, JÃ©rÃ´meÂ g alon1,5,6, laurenceÂ Zitvogel7, 8,9, andÂ g uidoÂ Kroemer1,2,3,9,10,* 1UniversitÃ© Paris Descartes/Paris V, s orbonne Paris c itÃ©; Paris, France; 2equipe 11 labellisÃ©e l igue n ationale contre le c ancer ; c ordeliers r esearch c enter; inser M U1138;  Paris, France; 3Metabolomics and c ell Biology Platforms; g ustave r oussy c ancer c ampus; Villejuif, France; 4laboratory of i ntegrative cancer i mmunology; inser M U1138;  Paris, France; 5cordeliers r esearch c enter; UniversitÃ© Pierre et Marie c urie Paris 6; Paris, France; 6inser M U1015; Villejuif, France; 7FacultÃ© de MÃ©decine; UniversitÃ© Paris s ud;  le Kremlin BicÃªtre, France; 8center of c linical i nvestigations in Biotherapies of c ancer ( cicBT) 507; Villejuif, France; 9inser M, U848; Villejuif, France; 10PÃ´le de Biologie; h Ã´pital  europÃ©en g eorges Pompidou, a P-hP; Paris, France Keywords:  autophagy, breast cancer, colorectal cancer, endoplasmic stress, immunogenic cell death,   tumor-infiltrating lymphocytes Abbreviations:  ALOX5AP, arachidonate 5-lipoxygenase-activating protein; ATF4, activating transcription factor 4;   ATF6, activating transcription factor 6; CXCL13, chemokine (C-X-C motif) ligand 13; ER, endoplasmic reticulum;   FAC, fluorouracil plus doxorubicin plus cyclophosphamide; FEC, fluorouracil plus epirubicin plus cyclophosphamide;   HIF1Î±, hypoxia-inducible factor 1 Î±; LAMP3, lysosomal-associated membrane protein; pCR, pathological complete response;  TCGA, The Cancer Genome Atlas; TH1, Type 1 T helper; Treg, regulatory T cell; XBP1, x-box binding protein 1 There is ample evidence that neoadjuvant chemotherapy of breast carcinoma is particularly efficient if the tumor  presents signs of either a pre-existent or therapy-induced anticancer immune response.",Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Supplemental Materials Supplemental materials may be found here:http://www.landesbioscience.com/journals/ oncoimmunology/article/27884/  References 1.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Nat Rev Clin Oncol 2011; 8:151-60;  PMID:21364688 ; http://dx.doi.org/10.1038/ nrclinonc.2010.223 2.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Immunity 2013; 39:74-88; PMID:23890065 ;  http://dx.doi.org/10.1016/j.immuni.2013.06.014 3.,OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Curr Opin Immunol  2013; 25:261-7;  PMID:23579076 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Nat Rev Cancer 2012; 12:298- 306; PMID:22419253 ; http://dx.doi.org/10.1038/ nrc3245 5.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Science 2006; 313:1960- 4; PMID:17008531 ; http://dx.doi.org/10.1126/ science.1129139 7.,OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Cancer Res 2007; 67:1883-6;  PMID:17332313 ; http://dx.doi.org/10.1158/0008- 5472.CAN-06-48068.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Cancer Discov  2011; 1:54-67;  PMID:22039576 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
J Clin Oncol  2011; 29:1949-55;  PMID:21483002 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology 2012; 1:364- 5; PMID:22737616 ; http://dx.doi.org/10.4161/ onci.18614 11.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Cancer Res 2009; 69:2000-9;  PMID:19244125 ; http://dx.doi.org/10.1158/0008- 5472.CAN-08-2360 13.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
J Clin Oncol 2010; 28:105-13;  PMID:19917869 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology 2013; 2:e24720;  PMID:24073365 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Breast Cancer Res 2011; 13:R126; PMID :22151962 ;  http://dx.doi.org/10.1186/bcr3072 17.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
J Pathol 2011; 224:389-400; PMID:21437909 ;  http://dx.doi.org/10.1002/path.2866 18.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Science 2012; 337:1678-84;  PMID:23019653 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Breast Cancer  Res Treat 2012; 131:871-80; PMID:21479927 ;  http://dx.doi.org/10.1007/s10549-011-1470-x,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Clin Cancer Res 2008; 14:5158-65; PMID:18698033 ; http://dx.doi.org/10.1158/1078- 0432.CCR-07-4756 21.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
J Clin Oncol 2012; 30:1996-2004;  PMID:22508827 ; http://dx.doi.org/10.1200/ JCO.2011.39.5624 22.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Breast Cancer Res  2010; 12:R85;  PMID:20946665 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Annu Rev Immunol 2013; 31:51-72; PMID :23157435 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-100008 24.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Science 2011; 334:1573-7; PMID:22174255 ; http://dx.doi.org/10.1126/ science.1208347 25.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
EMBO J 2009; 28:578-90; PMID:19165151 ;  http://dx.doi.org/10.1038/emboj.2009.1 26.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Immunity 2013;  39:211-27;  PMID:23973220 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Cell Death Differ 2014; 21:79-91;  PMID:23852373 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology 2013; 2:e25988;  PMID:24244895 ; http://dx.doi.org/10.4161/ onci.25988 29.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Sci Transl Med 2012; 4:143ra99; PMID:22814852 ;  http://dx.doi.org/10.1126/scitranslmed.3003807 31.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Lancet Oncol  2007; 8:1071-8;  PMID:18024211 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
JAMA 2011; 305:1873- 81; PMID :21558518 ; http://dx.doi.org/10.1001/ jama.2011.59333.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Clin Cancer Res  2010; 16:5351-61;  PMID:20829329 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology 2013;  2:e22764;  PMID:23525353 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology 2013; 2:e24677;  PMID:23894722 ; http://dx.doi.org/10.4161/ onci.24677 36.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology 2013; 2:e23127;  PMID:23802063 ; http://dx.doi.org/10.4161/ onci.23127 37.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology  2013; 2:e24185;  PMID:23734337 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology 2013; 2:e23638;   PMID:23734317 ; http://dx.doi.org/10.4161/ onci.23638 39.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology  2013; 2:e24383;  PMID:23762808 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology  2013; 2:e23837;  PMID:23734330 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology 2013; 2:e25854; PMID:24244909 ; http://dx.doi.org/10.4161/ onci.25854 42.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology 2013; 2:e23660;   PMID:23734321 ; http://dx.doi.org/10.4161/ onci.23660 43.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology 2013; 2:e25474;  PMID:24073384 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology  2013; 2:e26245;  PMID:24228233 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncoimmunology 2013; 2:e25752;   PMID:24083082 ; http://dx.doi.org/10.4161/ onci.2575246.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
J Biol Chem 2006;  281:34457-64;  PMID:16966319 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Am J Pathol 2012; 181:733-42; PMID:22796439 ;  http://dx.doi.org/10.1016/j.ajpath.2012.05.012 49.,OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Apoptosis  2006; 11:5-13;  PMID:16374548 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Science 2011; 331:1565- 70; PMID:21436444 ; http://dx.doi.org/10.1126/ science.1203486 52.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Annu Rev Immunol 2011; 29:235-71;  PMID:21219185 ; http://dx.doi.org/10.1146/ annurev-immunol-031210-101324 53.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Immunity 2013; 39:782- 95; PMID:24138885 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Gastroenterology  2010; 138:1429-40;  PMID:19909745 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Mol Cell 2010; 40:280- 93; PMID:20965422 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Autophagy  2012; 8:1175-84;  PMID:22647537 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Gastroenterology 2010; 138:958- 68; PMID:19914252 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
"Gastroenterology 2012; 142:562,  e2; PMID:22115830 ; http://dx.doi.org/10.1053/j.",Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Int  J Colorectal Dis 2011; 26:847-58; PMID:21465190 ;  http://dx.doi.org/10.1007/s00384-011-1176-x 62.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Oncogene 2008; 27:6607- 22; PMID:18679425 ; http://dx.doi.org/10.1038/ onc.2008.25163.,OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
BMC Bioinformatics  2011; 12:474;  PMID:22172014 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Am J Hum Genet  2010; 86:719-29;  PMID:20398888 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Semin Cancer Biol 2013; 23:310-22; PMID:23726895 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Hum Mol Genet  2011; 20:3852-66;  PMID:21752829 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
Lancet 2003; 361:1590- 6; PMID:12747878 ; http://dx.doi.org/10.1016/ S0140-6736(03)13308-9,Non-OADS,/arxiv_data1/oa_pdf/2e/5c/onci-3-e27884.PMC4004621.pdf
"Median CD4Ã¾cell count increased with duration of ART and was higher in those with viral suppression (Supplementary ï¬gure 1, http://links.lww.com/QAD/ A495).",Non-OADS,/arxiv_data1/oa_pdf/27/b1/aids-28-1193.PMC4004637.pdf
"The proportion of patients with CD4Ã¾cell count at least 350 cells/ ml increased markedly in the ï¬rst year of ART, and continued to increase up to 5 years on ART (Supplementary ï¬gure 2, http://links.lww.com/QAD/ A495).",Non-OADS,/arxiv_data1/oa_pdf/27/b1/aids-28-1193.PMC4004637.pdf
"Secondary analyses show the contributions of viral suppression unadjusted for CD4Ã¾cell count (supple- mentary table 6, http://links.lww.com/QAD/A495) and CD4Ã¾cell count unadjusted for viral suppression (supplementary table 7, http://links.lww.com/QAD/ A495) to decrease in life expectancy of men.",Non-OADS,/arxiv_data1/oa_pdf/27/b1/aids-28-1193.PMC4004637.pdf
"After 5 years on ART , expected age at death was 50 (38â63), 72 (64â79) and 75 (70â81) years depending on whether their attained CD4Ã¾cell count was less than 200, 200â349 or at least 350 cells/ ml, respectively (supplementary table 7, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/27/b1/aids-28-1193.PMC4004637.pdf
World Health Organization; 2013. http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/27/b1/aids-28-1193.PMC4004637.pdf
BHIVA guidelines for the treatment of HIV-1 positive adults with antiretroviral therapy 2012. http://www.bhiva.org/documents/Guidelines/Treatment/2012/ 120430TreatmentGuidelines.pdf [Accessed 17December2013].,Non-OADS,/arxiv_data1/oa_pdf/27/b1/aids-28-1193.PMC4004637.pdf
"Causes of deaths are reported in supplemental page Table 1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/5e/61/aids-28-1143.PMC4004638.pdf
Geneva: World Health Organization; 2012. http://apps.who.int/iris/bit stream/10665/75183/1/9789241503938_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5e/61/aids-28-1143.PMC4004638.pdf
Available at: http://www.unos.org/ .,Non-OADS,/arxiv_data1/oa_pdf/09/b5/meg-26-668.PMC4004640.pdf
"As shown in a supplemental table, http://links.lww.com/ QAD/A510, MSM were signiï¬cantly more likely than MSW or WSM to engage in unprotected sex, and WSM were signiï¬cantly more likely than MSW to engage in unprotected sex (available at www.AIDSonline.com).",Non-OADS,/arxiv_data1/oa_pdf/3d/20/aids-28-1203.PMC4004641.pdf
They also thank the 2009 MMP staff: http://www.cdc.gov/hiv/ pdf/research_mmp_studygroupmembers_2009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3d/20/aids-28-1203.PMC4004641.pdf
http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/3d/20/aids-28-1203.PMC4004641.pdf
http://www.cdc.gov/hiv/topics/surveillance/resources/ reports/.,Non-OADS,/arxiv_data1/oa_pdf/3d/20/aids-28-1203.PMC4004641.pdf
http://www.aapor.org/ AM/Template.cfm?Section=Standard_Deï¬nitions2&Template=/ CM/ContentDisplay.cfm&ContentID=3156.,OADS,/arxiv_data1/oa_pdf/3d/20/aids-28-1203.PMC4004641.pdf
2009. http://www.hhs.gov/ohrp/humansubjects/guidance/ 45cfr46.html.,Non-OADS,/arxiv_data1/oa_pdf/3d/20/aids-28-1203.PMC4004641.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 1-2 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.729  Journal of Microbiology & Biology Education   1 Volume 15, Number 1Editorial Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/e7/8f/jmbe-15-1.PMC4004732.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/8f/jmbe-15-1.PMC4004732.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 13-17 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.678 Journal of Microbiology & Biology Education   13 Volume 15, Number 1Perspectives Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/08/3c/jmbe-15-13.PMC4004733.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/3c/jmbe-15-13.PMC4004733.pdf
"While programs like âThe Naked Scientists,â in England (see http://www.thenakedscientists.com/ ), and NPR  Science Friday, Myth busters, and Radio Lab (see http://www.radiolab.org), in the United States, use various media formats to demystify science and make it accessible to the general public, to the best of our knowledge, in academia, at the undergraduate and graduate levels, little emphasis has been placed on developing curricula that train scientists to communicate with the public.",Non-OADS,/arxiv_data1/oa_pdf/08/3c/jmbe-15-13.PMC4004733.pdf
"We developed a Science CafÃ© course based on the international Science CafÃ© grassroots movement ( http://www.cafescientifique.org/ , http://www.",Non-OADS,/arxiv_data1/oa_pdf/08/3c/jmbe-15-13.PMC4004733.pdf
to engage in lively debates on specific topics (5; http://www.informallearning.com/archive/Desai-75.htm ).,Non-OADS,/arxiv_data1/oa_pdf/08/3c/jmbe-15-13.PMC4004733.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 18-25 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.692 Curriculum Journal of Microbiology & Biology Education  Volume 15, Number 1 18*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/6d/70/jmbe-15-18.PMC4004734.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/70/jmbe-15-18.PMC4004734.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 26-27 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.598 Tips & Tools Journal of Microbiology & Biology Education  Volume 15, Number 1 26Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/6c/b9/jmbe-15-26.PMC4004735.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/b9/jmbe-15-26.PMC4004735.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 28-29 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.634 Tips & Tools Journal of Microbiology & Biology Education  Volume 15, Number 1 28*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/93/5a/jmbe-15-28.PMC4004736.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/5a/jmbe-15-28.PMC4004736.pdf
The paper copy of  their gene includes upstream and downstream sequences in addition to the coding sequence downloaded from the xBASE site ( http://www.xbase.ac.uk/ ).,OADS,/arxiv_data1/oa_pdf/93/5a/jmbe-15-28.PMC4004736.pdf
"The students work in pairs and open EcoCyc ( http:// ecocyc.org/ ), New England Biolabs (NEB) Cutter ( http:// tools.neb.com/NEBcutter2/index.php),  and Integrated  DNA Technologies OligoAnalyzer 3.1 ( http://www.idtdna.",Non-OADS,/arxiv_data1/oa_pdf/93/5a/jmbe-15-28.PMC4004736.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 3-4 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.725 Journal of Microbiology & Biology Education   3 Volume 15, Number 1Letter to the Editor Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/04/92/jmbe-15-3.PMC4004737.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/92/jmbe-15-3.PMC4004737.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 30-32 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.639 Tips & Tools Journal of Microbiology & Biology Education  Volume 15, Number 1 30Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/58/d5/jmbe-15-30.PMC4004738.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/d5/jmbe-15-30.PMC4004738.pdf
http://www.pogil.org .,Non-OADS,/arxiv_data1/oa_pdf/58/d5/jmbe-15-30.PMC4004738.pdf
"Retrieved June 20, 2013. http://www.pogil.org/uploads/media_items/descriptions-of- roles-expanded.original.pdf .",Non-OADS,/arxiv_data1/oa_pdf/58/d5/jmbe-15-30.PMC4004738.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 33-35 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.640 Journal of Microbiology & Biology Education   33 Volume 15, Number 1Tips & Tools Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/d6/d3/jmbe-15-33.PMC4004739.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/d3/jmbe-15-33.PMC4004739.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 36-37 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.643 Tips & Tools Journal of Microbiology & Biology Education  Volume 15, Number 1 36*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/04/fe/jmbe-15-36.PMC4004740.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/fe/jmbe-15-36.PMC4004740.pdf
"Our solution was to choose one example to serve as an overarching âumbrellaâ incor - porating the genetics and biotechnology topics and linking them in ways that provide opportunities for students to integrate information and concepts.PROCEDURE As case studies are well-established pedagogical tools  for engaging students (see http://sciencecasenet.org/), we developed one to convey concepts in genetics.",Non-OADS,/arxiv_data1/oa_pdf/04/fe/jmbe-15-36.PMC4004740.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 38-40 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.645 Tips & Tools Journal of Microbiology & Biology Education  Volume 15, Number 1 38*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/7e/69/jmbe-15-38.PMC4004741.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/69/jmbe-15-38.PMC4004741.pdf
"The detailed protocol, as well as a list of materials and reagents, are available at the CUNY Undergraduate Research Site ( http://www.cuny.edu/ research/sr/undergrad-research/for-faculty/AREM.html ).",Non-OADS,/arxiv_data1/oa_pdf/7e/69/jmbe-15-38.PMC4004741.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 41-42 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.650 Journal of Microbiology & Biology Education   41 Volume 15, Number 1Tips & Tools Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/90/88/jmbe-15-41.PMC4004742.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/88/jmbe-15-41.PMC4004742.pdf
The technique activates prior biology knowledge and incorporates scientific practices and modeling which are emphasized by the Next Generation Science Standards (NGSS) ( http://www.nextgenscience.org ).,Non-OADS,/arxiv_data1/oa_pdf/90/88/jmbe-15-41.PMC4004742.pdf
http://espn.go.com/nfl/story/_/id/8335923/ pittsburgh-steelers-ryan-clark-play-denver.,Non-OADS,/arxiv_data1/oa_pdf/90/88/jmbe-15-41.PMC4004742.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 43-44 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.652 Journal of Microbiology & Biology Education   43 Volume 15, Number 1Tips & Tools Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/1b/5e/jmbe-15-43.PMC4004743.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/5e/jmbe-15-43.PMC4004743.pdf
"A video demonstrating this game can be found at  http://www.jht.com/icuf/Science-Math%20Master/Science-Math_Master_Molecules.html , with the simulation starting  at time 8:16.",Non-OADS,/arxiv_data1/oa_pdf/1b/5e/jmbe-15-43.PMC4004743.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 45-46 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.656 Journal of Microbiology & Biology Education   45 Volume 15, Number 1Tips & Tools Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/d1/6a/jmbe-15-45.PMC4004744.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/6a/jmbe-15-45.PMC4004744.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 47-48 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.661 Journal of Microbiology & Biology Education   47 Volume 15, Number 1Tips & Tools Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/46/29/jmbe-15-47.PMC4004745.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/29/jmbe-15-47.PMC4004745.pdf
http://visionandchange.org/finalreport.,Non-OADS,/arxiv_data1/oa_pdf/46/29/jmbe-15-47.PMC4004745.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 49-50 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.663 Journal of Microbiology & Biology Education   49 Volume 15, Number 1Tips & Tools Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/41/31/jmbe-15-49.PMC4004746.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/31/jmbe-15-49.PMC4004746.pdf
http://www.aacu.org/value/rubrics/ .,Non-OADS,/arxiv_data1/oa_pdf/41/31/jmbe-15-49.PMC4004746.pdf
http://www.p21.org/overview/skills-framework/260 .,Non-OADS,/arxiv_data1/oa_pdf/41/31/jmbe-15-49.PMC4004746.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 5-12 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.629 Journal of Microbiology & Biology Education   5 Volume 15, Number 1Research Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/bb/48/jmbe-15-5.PMC4004747.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/48/jmbe-15-5.PMC4004747.pdf
"In 2012, 52% of high school graduates took the American  College Testing (ACT), and of these students 52% met the reading benchmark of 21 and 31% met the science benchmark of 24 ( http://www.act.org/research-policy/college-career- readiness-report-2012/ ).",Non-OADS,/arxiv_data1/oa_pdf/bb/48/jmbe-15-5.PMC4004747.pdf
"The ACT is a national college entrance exam that has four sections: English, Reading, Math and Science ( http://www.actstudent.",Non-OADS,/arxiv_data1/oa_pdf/bb/48/jmbe-15-5.PMC4004747.pdf
http://chronicle.com/free/v52/i27/27b00901.htm.,Non-OADS,/arxiv_data1/oa_pdf/bb/48/jmbe-15-5.PMC4004747.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 51-52 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.665 Journal of Microbiology & Biology Education   51 Volume 15, Number 1Tips & Tools Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/c8/a4/jmbe-15-51.PMC4004748.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/a4/jmbe-15-51.PMC4004748.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 53-54 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.679 Journal of Microbiology & Biology Education   53 Volume 15, Number 1Tips & Tools Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/93/21/jmbe-15-53.PMC4004749.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/21/jmbe-15-53.PMC4004749.pdf
http://www.bioassess.edu.au/ .,Non-OADS,/arxiv_data1/oa_pdf/93/21/jmbe-15-53.PMC4004749.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 55-58 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.682 Journal of Microbiology & Biology Education   55 Volume 15, Number 1Tips & Tools Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/e4/7f/jmbe-15-55.PMC4004750.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/7f/jmbe-15-55.PMC4004750.pdf
Google Scholar (http://scholar.google.com) was recommended for finding journal articles.,Non-OADS,/arxiv_data1/oa_pdf/e4/7f/jmbe-15-55.PMC4004750.pdf
"More examples of monologues, drawings, poems, music and models can be found at the following url: http://stjohns.campusguides.com/bacterial_monologue.",Non-OADS,/arxiv_data1/oa_pdf/e4/7f/jmbe-15-55.PMC4004750.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 59-64 Copyright Â© 2014 American Society for Microbiology   Journal of Microbiology & Biology Education   59 Volume 15, Number 1Reviews JOURNAL WATCH  DOI: http://dx.doi.org/10.1128/jmbe.v15i1.715 In this section, I provide articles on recent develop - ments and new technology used in microbiology and related  fields.",Non-OADS,/arxiv_data1/oa_pdf/f7/28/jmbe-15-59-a.PMC4004751.pdf
Full article can be found at: http://www.ascp.org/PDF/Advocacy/ASCP-Task-Force-on-Lab-Pros.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/28/jmbe-15-59-a.PMC4004751.pdf
"BOOKS  The Ups and Downs of Emerging Infectious Diseases at Your FingertipsDOI: http://dx.doi.org/10.1128/jmbe.v15i1.707  Review of: Emerging Infectious Diseases: A Guide to Diseases,  Causative Agents, and Surveillance; Lisa A Beltz; (2011).",Non-OADS,/arxiv_data1/oa_pdf/f7/28/jmbe-15-59-a.PMC4004751.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 59-64 Copyright Â© 2014 American Society for Microbiology   Journal of Microbiology & Biology Education   59 Volume 15, Number 1Reviews JOURNAL WATCH  DOI: http://dx.doi.org/10.1128/jmbe.v15i1.715 In this section, I provide articles on recent develop - ments and new technology used in microbiology and related  fields.",Non-OADS,/arxiv_data1/oa_pdf/da/13/jmbe-15-59-b.PMC4004752.pdf
Full article can be found at: http://www.ascp.org/PDF/Advocacy/ASCP-Task-Force-on-Lab-Pros.pdf.,Non-OADS,/arxiv_data1/oa_pdf/da/13/jmbe-15-59-b.PMC4004752.pdf
"BOOKS  The Ups and Downs of Emerging Infectious Diseases at Your FingertipsDOI: http://dx.doi.org/10.1128/jmbe.v15i1.707  Review of: Emerging Infectious Diseases: A Guide to Diseases,  Causative Agents, and Surveillance; Lisa A Beltz; (2011).",Non-OADS,/arxiv_data1/oa_pdf/da/13/jmbe-15-59-b.PMC4004752.pdf
"Narveen Jandu Ashland University, Ashland, OH E-mail: njandu@ashland.edu  A Textbook that Gets Students Excited about  MicrobiologyDOI: http://dx.doi.org/10.1128/jmbe.v15i1.711  Review of:  Microbiology: An Evolving Science, 3rd ed.",Non-OADS,/arxiv_data1/oa_pdf/da/13/jmbe-15-59-b.PMC4004752.pdf
"Narveen Jandu Ashland University, Ashland, OH E-mail: njandu@ashland.edu  A Textbook that Gets Students Excited about  MicrobiologyDOI: http://dx.doi.org/10.1128/jmbe.v15i1.711  Review of:  Microbiology: An Evolving Science, 3rd ed.",Non-OADS,/arxiv_data1/oa_pdf/41/ae/jmbe-15-60.PMC4004753.pdf
"Overall, this updated, captivating textbook is a great choice for teaching general microbiolog y. Ann AumanPacific Lutheran University, Tacoma, WAE-mail: aumanaj@plu.edu Pandemics During the Rise of Virology DOI: http://dx.doi.org/10.1128/jmbe.v15i1.718 Review of: To Catch a Virus; J ohn Booss and Marilyn J.  August; (2013).",Non-OADS,/arxiv_data1/oa_pdf/41/ae/jmbe-15-60.PMC4004753.pdf
"Susan Kring Sullivan Louisiana State University at Alexandria, Alexandria, LA E-mail: ssullivan@lsua.edu A Guide to Understanding the Science behind Useful  Approaches to LearningDOI: http://dx.doi.org/10.1128/jmbe.v15i1.712  Review of: The New Science of Learning: How to Learn in  Harmony With Your Brain; Terry Doyle and Todd Zakrajsek;  (2013).",Non-OADS,/arxiv_data1/oa_pdf/41/ae/jmbe-15-60.PMC4004753.pdf
"Overall, this updated, captivating textbook is a great choice for teaching general microbiolog y. Ann AumanPacific Lutheran University, Tacoma, WAE-mail: aumanaj@plu.edu Pandemics During the Rise of Virology DOI: http://dx.doi.org/10.1128/jmbe.v15i1.718 Review of: To Catch a Virus; J ohn Booss and Marilyn J.  August; (2013).",Non-OADS,/arxiv_data1/oa_pdf/d3/ed/jmbe-15-61-a.PMC4004754.pdf
"Susan Kring Sullivan Louisiana State University at Alexandria, Alexandria, LA E-mail: ssullivan@lsua.edu A Guide to Understanding the Science behind Useful  Approaches to LearningDOI: http://dx.doi.org/10.1128/jmbe.v15i1.712  Review of: The New Science of Learning: How to Learn in  Harmony With Your Brain; Terry Doyle and Todd Zakrajsek;  (2013).",Non-OADS,/arxiv_data1/oa_pdf/d3/ed/jmbe-15-61-a.PMC4004754.pdf
"Overall, this updated, captivating textbook is a great choice for teaching general microbiolog y. Ann AumanPacific Lutheran University, Tacoma, WAE-mail: aumanaj@plu.edu Pandemics During the Rise of Virology DOI: http://dx.doi.org/10.1128/jmbe.v15i1.718 Review of: To Catch a Virus; J ohn Booss and Marilyn J.  August; (2013).",Non-OADS,/arxiv_data1/oa_pdf/a0/5f/jmbe-15-61-b.PMC4004755.pdf
"Susan Kring Sullivan Louisiana State University at Alexandria, Alexandria, LA E-mail: ssullivan@lsua.edu A Guide to Understanding the Science behind Useful  Approaches to LearningDOI: http://dx.doi.org/10.1128/jmbe.v15i1.712  Review of: The New Science of Learning: How to Learn in  Harmony With Your Brain; Terry Doyle and Todd Zakrajsek;  (2013).",Non-OADS,/arxiv_data1/oa_pdf/a0/5f/jmbe-15-61-b.PMC4004755.pdf
"Bryan M. Dewsbury Florida International University, Miami, FL E-mail: bdews001@fiu.edu Creative Teaching Models for the Innovative Faint  of HeartDOI: http://dx.doi.org/10.1128/jmbe.v15i1.705 Review of:  Exemplary College Science Teaching; Robert E.  Yager (ed); (2013).",Non-OADS,/arxiv_data1/oa_pdf/a0/5f/jmbe-15-61-b.PMC4004755.pdf
"Bryan M. Dewsbury Florida International University, Miami, FL E-mail: bdews001@fiu.edu Creative Teaching Models for the Innovative Faint  of HeartDOI: http://dx.doi.org/10.1128/jmbe.v15i1.705 Review of:  Exemplary College Science Teaching; Robert E.  Yager (ed); (2013).",Non-OADS,/arxiv_data1/oa_pdf/07/76/jmbe-15-62.PMC4004756.pdf
"Deborah K. Anderson  St. Norbert College, De Pere, WI E-mail: deborah.anderson@snc.edu  WEBSITES/ONLINE RESOURCES A Weekly Spark for Progressive Educators: Annie Murphy Paulâs Brilliant Blog and NewsletterDOI: http://dx.doi.org/10.1128/jmbe.v15i1.716  Review of: Annie Murphy Paul: Brilliant: The Science of  Smart.",Non-OADS,/arxiv_data1/oa_pdf/07/76/jmbe-15-62.PMC4004756.pdf
"http://anniemurphypaul.com/ If youâre anything like me and my community of prac - tice colleagues, youâre always looking for a fresh idea, a spark that leads to some new insight, or (some weeks) just a short, interesting distraction that reinvigorates.",Non-OADS,/arxiv_data1/oa_pdf/07/76/jmbe-15-62.PMC4004756.pdf
"One of my favorites for all these purposes is Annie Murphy Paulâs Brilliant Blog, http://anniemurphypaul.com/.",Non-OADS,/arxiv_data1/oa_pdf/07/76/jmbe-15-62.PMC4004756.pdf
"Deborah K. Anderson  St. Norbert College, De Pere, WI E-mail: deborah.anderson@snc.edu  WEBSITES/ONLINE RESOURCES A Weekly Spark for Progressive Educators: Annie Murphy Paulâs Brilliant Blog and NewsletterDOI: http://dx.doi.org/10.1128/jmbe.v15i1.716  Review of: Annie Murphy Paul: Brilliant: The Science of  Smart.",Non-OADS,/arxiv_data1/oa_pdf/0c/1f/jmbe-15-63.PMC4004757.pdf
"http://anniemurphypaul.com/ If youâre anything like me and my community of prac - tice colleagues, youâre always looking for a fresh idea, a spark that leads to some new insight, or (some weeks) just a short, interesting distraction that reinvigorates.",Non-OADS,/arxiv_data1/oa_pdf/0c/1f/jmbe-15-63.PMC4004757.pdf
"One of my favorites for all these purposes is Annie Murphy Paulâs Brilliant Blog, http://anniemurphypaul.com/.",Non-OADS,/arxiv_data1/oa_pdf/0c/1f/jmbe-15-63.PMC4004757.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, May 2014, p. 65-80 DOI: http://dx.doi.org/10.1128/jmbe.v15i1.728 Journal of Microbiology & Biology Education   65 Volume 15, Number 1ASMCUE Abstracts Â©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/f3/05/jmbe-15-65.PMC4004758.pdf
"This is an Open Access article distributed under the terms of the a Creative Commons Attribution â Noncommercial â  Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/05/jmbe-15-65.PMC4004758.pdf
Available from http://www.who.int/neglected_diseases/2010report/en/ (2010) (Accessed on 18/02/2014).,Non-OADS,/arxiv_data1/oa_pdf/3d/1b/srep04703.PMC4004771.pdf
"Available from ,http://clinicaltrials.gov/ct2/show/ NCT01377480?term 5A1Study 1of1the1Use1of1Oral1Posaconazole 1 %28POS%29 1in1the1Treatment 1of1Asymptomatic 1Chronic 1Chagas 1 Disease&rank 5 1.Identifier NCT 01377480.",Non-OADS,/arxiv_data1/oa_pdf/3d/1b/srep04703.PMC4004771.pdf
"Available from ,http://clinicaltrials.gov/ct2/show/ NCT01489228?term 5chagas 1disease&rank 59.Identifier NCT 01489228.",OADS,/arxiv_data1/oa_pdf/3d/1b/srep04703.PMC4004771.pdf
"Availablefrom,http://clinicaltrials.gov/ct2/show/study/NCT01162967?term 5 chagasazol&rank 51.Identifier NCT 01162967.",Non-OADS,/arxiv_data1/oa_pdf/3d/1b/srep04703.PMC4004771.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3d/1b/srep04703.PMC4004771.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4703 | DOI: 10.1038/srep04703 11",Non-OADS,/arxiv_data1/oa_pdf/3d/1b/srep04703.PMC4004771.pdf
"Anthropometry revealed a height of 94 cm (97th centile, CDC growth charts, developed by the  National Center for Health Statistics in  collaboration with the National Center for  Chronic Disease Prevention and Health  Promotion; http://www.cdc.gov/growthcharts)  and weight of 14 kg (90th centile, CDC growth  charts).",OADS,/arxiv_data1/oa_pdf/a9/36/cpe-17-061.PMC4004855.pdf
"To date, nearly 200 mutations havebeen found in the PHEX  gene and they are listed at http://www.phexdb.mcgill.ca.",Non-OADS,/arxiv_data1/oa_pdf/1a/16/cpe-15-129.PMC4004864.pdf
19. from AR database:http://www.androgendb.mcgill.ca/ 20.,OADS,/arxiv_data1/oa_pdf/ff/87/cpe-15-151.PMC4004867.pdf
8.Available online from: http://www.ensembl.org   9.Available online from: http://www.ebi.ac.uk/ clustalw/,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/cpe-16-059.PMC4004873.pdf
Matsuda and Yokota 34 Vol.17 / No.2 Single Nucleotide Polymorphisms (JSNP)  database (http://snp.ims.u-tokyo.ac.jp).,OADS,/arxiv_data1/oa_pdf/a8/c7/cpe-17-031.PMC4004921.pdf
"To date, 178 mutations in the AVPR2 gene have been identified in cases with X-linked NDI, according to the Human Gene Mutation Database (http://archive.uwcm.ac.uk/uwcm/mg/hgmd0.html).",Non-OADS,/arxiv_data1/oa_pdf/e0/3d/cpe-14-027.PMC4004929.pdf
"There are 178 putative disease-causing AVPR2 mu tations that have been identified in 250 famili es, so far (Data obtained from the Human Gene Mutation Database and theNephrogenic Diabetes  Insipidus Mutation Database, http://www.medicine.mcgill.ca/ nephros/).",Non-OADS,/arxiv_data1/oa_pdf/e0/3d/cpe-14-027.PMC4004929.pdf
"At higher temperatures, conidia become large spherical cells (20 Âµm, mean diameter), and directly produce conidiophores followingvesicle formation when the temperature drops to 30 oC,Mini-review Mycobiology 2014 March, 42(1): 1-5 http://dx.doi.org/10.5941/MYCO.2014.42.1.1 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: jungle@dau.ac.kr Received  February 15, 2014 Revised  February 27, 2014 Accepted  February 27, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/c8/mb-42-1.PMC4004940.pdf
"In addition,the Alternaria  isolate CNU 3010 (Jinan, Korea; SeptemberResearch Article Mycobiology 2014 March, 42(1): 12-16 http://dx.doi.org/10.5941/MYCO.2014.42.1.12 pISSN 1229-8093  eISSN 2092-9323Â© The Korean Society of Mycology *Corresponding author E-mail: shunyu@cnu.ac.kr â These authors contributed equally to this work Received  October 24, 2013 Revised  October 31, 2013 Accepted  January 20, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/93/mb-42-12.PMC4004941.pdf
"A Nikon SMZ-168Research Article Mycobiology 2014 March, 42(1): 17-21 http://dx.doi.org/10.5941/MYCO.2014.42.1.17 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: jshur1@sunchon.ac.kr Received  November 4, 2013 Revised  January 23, 2014 Accepted  February 3, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/45/mb-42-17.PMC4004942.pdf
"[2] for theResearch Article Mycobiology 2014 March, 42(1): 22-26 http://dx.doi.org/10.5941/MYCO.2014.42.1.22 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: hansk75@forest.go.kr (S.-K. Han),        sung97330@gmail.com (G.-H.",Non-OADS,/arxiv_data1/oa_pdf/1c/6f/mb-42-22.PMC4004943.pdf
Available from: http://www.mushroomexpert.com/megacollybia.html.,Non-OADS,/arxiv_data1/oa_pdf/1c/6f/mb-42-22.PMC4004943.pdf
"1).Research Article Mycobiology 2014 March, 42(1): 27-33 http://dx.doi.org/10.5941/MYCO.2014.42.1.27 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: htaechul@hanmail.net Received  September 12, 2013 Revised  December 19, 2013 Accepted  January 21, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/e1/mb-42-27.PMC4004944.pdf
"Relationship between Climatic Factor s and Distribution of Higher Fungi 29 [13], and the final categorization followed CABIâs Index Fungorum (http://www.indexfungorum.org/).",OADS,/arxiv_data1/oa_pdf/17/e1/mb-42-27.PMC4004944.pdf
"T o  d a t e ,  o n l y  a  f e w  l i c h e n  P K S s ,mostly NR-PKSs, have been analyzed [14-19].Research Article Mycobiology 2014 March, 42(1): 34-40 http://dx.doi.org/10.5941/MYCO.2014.42.1.34 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: jshur1@sunchon.ac.kr Received  September 6, 2013 Revised  October 25, 2013 Accepted  October 30, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/63/mb-42-34.PMC4004945.pdf
The potential openreading frame (ORF) was scanned with FGENESH [22] usingAspergillus as the matrix (http://linux1.softberry.com).,OADS,/arxiv_data1/oa_pdf/81/63/mb-42-34.PMC4004945.pdf
The conserveddomain was confirmed using the CDD-Search/PRS-BLAST(http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi).,OADS,/arxiv_data1/oa_pdf/81/63/mb-42-34.PMC4004945.pdf
The alignment wasanalyzed using ClustalW embedded in the MEGA 4.0.2program (http://www.megasoftware.net/).,OADS,/arxiv_data1/oa_pdf/81/63/mb-42-34.PMC4004945.pdf
"Theeffects of elicitors on the content of Î²-glucan, a key functional metabolite in cauliflower mushroom, were examined todetermine the possibilities of adapting the elicitationconcept for the cultivation of edible/medicinal mushroomsResearch Article Mycobiology 2014 March, 42(1): 41-45 http://dx.doi.org/10.5941/MYCO.2014.42.1.41 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: hyunpark@forest.go.kr Received  October 1, 2013 Revised  December 20, 2013 Accepted  January 6, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/45/mb-42-41.PMC4004946.pdf
"Molecular genetic studies on the mycelial sectorResearch Article Mycobiology 2014 March, 42(1): 46-51 http://dx.doi.org/10.5941/MYCO.2014.42.1.46 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: rohyeon@gnu.ac.kr Received  September 6, 2013 Revised  January 23, 2014 Accepted  January 23, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/d7/mb-42-46.PMC4004947.pdf
ELECTRONIC SUPPLEMENTARY MATERIALS Supplementary data including two figures can be found with this article online at http://www.mycobiology.or.kr/src/sm/mb-42-46-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9e/d7/mb-42-46.PMC4004947.pdf
"Therefore,the deletion of the Nudix hydrolase gene, YSA1 , increases intracellular concentrations of ADPr and OAADPr, whichResearch Article Mycobiology 2014 March, 42(1): 52-58 http://dx.doi.org/10.5941/MYCO.2014.42.1.52 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: ysbahn@yonsei.ac.kr Received  February 15, 2014 Revised  February 20, 2014 Accepted  February 20, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/8c/mb-42-52.PMC4004948.pdf
The phylogenetic tree was generated using Phylodendron Phylogenetic Tree Printer software (http://iubio.bio.indiana.edu/treeapp/treeprint-form.html).,OADS,/arxiv_data1/oa_pdf/75/8c/mb-42-52.PMC4004948.pdf
"However, a BLAST search of an S. cerevisiae Ysa1 ortholog in the C. neoformans genome database (http://www.broadinstitute.org)  generated a single hit: CNAG_ 02986 (score of 130.183 and e-value of 3.36E-31).",OADS,/arxiv_data1/oa_pdf/75/8c/mb-42-52.PMC4004948.pdf
cerevisiae genome database (http://www.yeastgenome.org) also revealed Ysa1 as its closest hit.,OADS,/arxiv_data1/oa_pdf/75/8c/mb-42-52.PMC4004948.pdf
"Furthermore, based onprotein domain analysis conducted using Pfam (http://www.pfam.janelia.org), CNAG_02986 contains a typicalNudix domain (PF00293), which is widely found in aprotein family of phosphohydrolases, with the Nudix motif(GxxxxxExxxxxxxREUxEExGU, where x is any amino acid)(Fig.",Non-OADS,/arxiv_data1/oa_pdf/75/8c/mb-42-52.PMC4004948.pdf
"An important step in developing entomopathogenicResearch Article Mycobiology 2014 March, 42(1): 59-65 http://dx.doi.org/10.5941/MYCO.2014.42.1.59 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: jskim10@jbnu.ac.kr Received  October 1, 2013 Revised  December 20, 2013 Accepted  January 6, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/be/mb-42-59.PMC4004949.pdf
"Then,Ã§s Ã§sResearch Article Mycobiology 2014 March, 42(1): 6-11 http://dx.doi.org/10.5941/MYCO.2014.42.1.6 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: jshur1@sunchon.ac.kr Received  October 15, 2013 Revised  November 5, 2013 Accepted  December 9, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/27/mb-42-6.PMC4004950.pdf
"All examinedlocalities of specimens were mapped using open sourceGIS software Quantum GIS 1.7.0 (http://www.qgis.org).Voucher specimens have been deposited in the herbariumof the Lichen & Allied Bio-resource Centre at the KoLRI,Sunchon National University, South Korea.",OADS,/arxiv_data1/oa_pdf/bf/27/mb-42-6.PMC4004950.pdf
"Theobjectives of the present study are isolation and identificationResearch Article Mycobiology 2014 March, 42(1): 66-72 http://dx.doi.org/10.5941/MYCO.2014.42.1.66 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: hyakumac@gifu-u.ac.jp Received  December 19, 2013 Revised  January 22, 2014 Accepted  February 3, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/2c/mb-42-66.PMC4004951.pdf
"Based ontheir genetic differences, eight distinct molecular typeshave been recognized in two species: VNI and VNII ( C.Research Article Mycobiology 2014 March, 42(1): 73-78 http://dx.doi.org/10.5941/MYCO.2014.42.1.73 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: smhwang@cup.ac.kr Received  February 8, 2014 Revised  February 16, 2014 Accepted  February 23, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/31/mb-42-73.PMC4004952.pdf
Each unique allelicprofile was concatenated and assigned a sequence type (ST)according to the MLST scheme (http://cneoformans.mlst.net).The phylogenetic tree from the combined DNA sequencesof the 7 genes was inferred by neighbor-joining using theMEGA 4 software (http://www.megasoftware.net) [22].,OADS,/arxiv_data1/oa_pdf/41/31/mb-42-73.PMC4004952.pdf
"A portionof the 28S rDNA gene was amplified using the primersNL1 and NL4 (5'-GCA TAT CAA TAA GCG GAG GAAResearch Note Mycobiology 2014 March, 42(1): 79-81 http://dx.doi.org/10.5941/MYCO.2014.42.1.79 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: heeyoung@knu.ac.kr Received  December 1, 2013 Revised  February 11, 2014 Accepted  February 23, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/24/mb-42-79.PMC4004953.pdf
"Morphologicalcharacteristics were observed using a phase-contrast microscopeResearch Note Mycobiology 2014 March, 42(1): 82-85 http://dx.doi.org/10.5941/MYCO.2014.42.1.82 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: piceae@dankook.ac.kr Received  November 19, 2013 Revised  December 15, 2013 Accepted  January 15, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/25/mb-42-82.PMC4004954.pdf
"When we used the DUCC4002 ITS rDNAsequence as a query to search the GenBank DNA databaseof the National Center for Biotechnology Information(NCBI; http://www.ncbi.nlm.nih.gov), we found that its h o w e d  1 0 0 %  s e q u e n c e  s i m i l a r i t y  w i t h  t h a t  o f  M. roridum BBA71015 (AJ302001).",OADS,/arxiv_data1/oa_pdf/11/25/mb-42-82.PMC4004954.pdf
aITS rDNA sequence of a Korean isolate (KACC4892) that was downloaded from the Rural Development Administration Genebank website (http://www.genebank.go.kr).Fig.,OADS,/arxiv_data1/oa_pdf/11/25/mb-42-82.PMC4004954.pdf
"Here, we provide descriptions and illustrationsof two previously unrecorded taxa of the tribe ArachnopezizeaeResearch Note Mycobiology 2014 March, 42(1): 86-91 http://dx.doi.org/10.5941/MYCO.2014.42.1.86 pISSN 1229-8093  eISSN 2092-9323 Â© The Korean Society of Mycology *Corresponding author E-mail: hdshin@korea.ac.kr Received  December 5, 2013 Revised  February 11, 2014 Accepted  February 13, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/98/mb-42-86.PMC4004955.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Yasunaga, M. & Matsumura, Y.",Non-OADS,/arxiv_data1/oa_pdf/6d/28/srep04852.PMC4004982.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4852 | DOI: 10.1038/srep04852 9",Non-OADS,/arxiv_data1/oa_pdf/6d/28/srep04852.PMC4004982.pdf
"Thus, both  Received: July 17, 2013 Accepted: December 12, 2013 Corresponding author: Dr. Atsuko Kawano, Department  of Endocrinology and Metabolism, Fukuoka Childrenâs  Hospital, 2-5-1 Tojin-machi, Chuoku, Fukuoka 810-0063,  Japan E-mail: sasaki.a@fcho.jp This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Clin Pediatr Endocrinol 2014; 23(2), 27â34 CopyrightÂ© 2014 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/e6/56/cpe-23-027.PMC4004995.pdf
"Classic forms include the salt-wasting (SW) form, Received: August 19, 2013 Accepted: December 16, 2013 Correspondence author: Dr. Toshihiro Tajima, Depart- ment of Pediatrics, Hokkaido University School of  Medicine, N15, W7, Kita-Ku, Sapporo 060-8638, Japan E-mail: tajeari@med.hokudai.ac.jp This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Clin Pediatr Endocrinol 2014; 23(2), 35â43 CopyrightÂ© 2014 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/43/08/cpe-23-035.PMC4004996.pdf
"In 2004, chromodomain helicase DNA binding protein 7 (CHD7), located on chromosome 8q12.1, was identified as the Received: May 27, 2013 Accepted: January 8, 2014 Correspondence author: Dr. Yasuko Shoji, Department  of Gastroenterology and Endocrinology, Osaka Medical  Center and Research Institute for Maternal and Child  Health, 840 Murodo, Izumi, Osaka 594-1101, Japan E-mail: yshoji@mch.pref.osaka.jp This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Clin Pediatr Endocrinol 2014; 23(2), 45â51 CopyrightÂ© 2014 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/c3/2d/cpe-23-045.PMC4004997.pdf
"Received: November 7, 2013 Accepted: December 16, 2013 Corresponding author: Dr. Atsuko Yoshizawa-Ogas - awara, Tanaka Growth Clinic, 2-36-7 Yoga, Setagaya-ku, Tokyo 158-0097, Japan E-mail: ayoshizawa-endo@umin.ac.jp This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Clin Pediatr Endocrinol 2014; 23(2), 53â58 CopyrightÂ© 2014 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/bb/4c/cpe-23-053.PMC4004998.pdf
"Received: December 9, 2013 Accepted: January 23, 2014 Corresponding Author: Dr. Kanako Kojima-Ishii, De- partment of Pediatrics, Graduate School of Medical  Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku,  Fukuoka 814-8582, Japan E-mail: k-kanako@momo.so-net.ne.jp This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Clin Pediatr Endocrinol 2014; 23(2), 59â64 CopyrightÂ© 2014 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/c4/50/cpe-23-059.PMC4004999.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: A patent application with Priority date March 31st 2012 has been filled for the control of droplet production in electric fields.,Non-OADS,/arxiv_data1/oa_pdf/af/44/srep04787.PMC4005000.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4787 | DOI: 10.1038/srep04787 8",Non-OADS,/arxiv_data1/oa_pdf/af/44/srep04787.PMC4005000.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/5e/79/ATM-9-104.PMC4005156.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/5e/79/ATM-9-104.PMC4005156.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/73/99/ATM-9-120.PMC4005158.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/17/99/ATM-9-55.PMC4005164.pdf
Available from: http://www.goldcopd.org/uploads/ users/files/GOLD_Report_2013_Feb20.pdf.,OADS,/arxiv_data1/oa_pdf/d4/13/ATM-9-77.PMC4005165.pdf
"U.S. Code Collection, available from: http://www4.law.cornell.",Non-OADS,/arxiv_data1/oa_pdf/1f/e6/ATM-9-92.PMC4005168.pdf
"Ambulatory care sensitive emergency department visits chronic  disease conditions new hampshire, 2001-2005, available from:  http://www.dhhs.state.nh.us/dphs/cdpc/documents/ emergencydeptvisits.pdf; [Last accessed on 15 April 2013].",Non-OADS,/arxiv_data1/oa_pdf/1f/e6/ATM-9-92.PMC4005168.pdf
Medical Council of India Post Graduate Medical Education  Regulations 2000 (Amended up to May 2013) Available  from: http://www.mciindia.org/RulesandRegulations/ PGMedicalEducationRegulations2000.aspx.,Non-OADS,/arxiv_data1/oa_pdf/c1/33/JFMPC-3-1.PMC4005191.pdf
Available  from: http://www.en.wikipedia.org/wiki/prevalence of  mental disorders.,Non-OADS,/arxiv_data1/oa_pdf/9c/82/JFMPC-3-12.PMC4005192.pdf
Available  from: http://www.mciindia.org/RulesandRegulations/ PGMedicalEducationRegulations2000.aspx [Last accessed  on 2012 Dec 24].,Non-OADS,/arxiv_data1/oa_pdf/9c/b0/JFMPC-3-22.PMC4005194.pdf
Available from:  http://www.mciindia.org/rulesâandâregulation/ PostgraduateâMedicalâEducationâRegulationsâ2000.pdf [Last  accessed on 2012 Dec 24].,Non-OADS,/arxiv_data1/oa_pdf/9c/b0/JFMPC-3-22.PMC4005194.pdf
Available from: http://www.idi.org.au/obesityreport.htm.,Non-OADS,/arxiv_data1/oa_pdf/0a/1c/JFMPC-3-25.PMC4005195.pdf
Available from: http://www.scaleupdate.,Non-OADS,/arxiv_data1/oa_pdf/91/e3/JFMPC-3-3.PMC4005197.pdf
Available from:  http://www.ginasthma.com [Last accessed on 2012  Dec 20].,Non-OADS,/arxiv_data1/oa_pdf/92/bd/JFMPC-3-33.PMC4005198.pdf
Available from:  http://dx.doi.org/10.1016/j.ajme.,OADS,/arxiv_data1/oa_pdf/92/bd/JFMPC-3-33.PMC4005198.pdf
Available from: http://www.nigeria.,Non-OADS,/arxiv_data1/oa_pdf/9a/b0/JFMPC-3-39.PMC4005199.pdf
Available  from: http://www.medicine.manchester.ac.uk/primarycare/ npcrdc archive/GPAQ_a_patient_questionnaire_for_ general_practice_.htm.,Non-OADS,/arxiv_data1/oa_pdf/da/29/JFMPC-3-5.PMC4005202.pdf
Available from: http://www.cdc.gov/malaria/ about/disease.html.,Non-OADS,/arxiv_data1/oa_pdf/b3/12/JFMPC-3-54.PMC4005203.pdf
Available from: http://www.who.int/malaria/publications/ atoz/9789241547925/en/index.html?,Non-OADS,/arxiv_data1/oa_pdf/b3/12/JFMPC-3-54.PMC4005203.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/b3/12/JFMPC-3-54.PMC4005203.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/c3/c2/JFMPC-3-58.PMC4005204.pdf
Available from: http://www.unicef.org/nutrition/ training/2.5/9.html.,Non-OADS,/arxiv_data1/oa_pdf/4f/e2/JFMPC-3-63.PMC4005205.pdf
Available from: http://eac.gov.in/ reports/rep_nfsb.pdf.,OADS,/arxiv_data1/oa_pdf/4f/e2/JFMPC-3-63.PMC4005205.pdf
Available from: http://www.fao.,Non-OADS,/arxiv_data1/oa_pdf/4f/e2/JFMPC-3-63.PMC4005205.pdf
Available from: http://wcd.nic.in/ research/nti1947/7.5%20iycn%203.2.2008%20prema.,OADS,/arxiv_data1/oa_pdf/4f/e2/JFMPC-3-63.PMC4005205.pdf
Available from:  http://www.nfhsindia.org/india1.html.,Non-OADS,/arxiv_data1/oa_pdf/4f/e2/JFMPC-3-63.PMC4005205.pdf
Available from: http://www.nnmbindia.,Non-OADS,/arxiv_data1/oa_pdf/4f/e2/JFMPC-3-63.PMC4005205.pdf
Available from: http://www.capgan.,Non-OADS,/arxiv_data1/oa_pdf/4f/e2/JFMPC-3-63.PMC4005205.pdf
Available  from: http://www.nfhsindia.org/NFHS.../NFHS 3%20 Nutritional%20Status%20of%20Children.ppt.,Non-OADS,/arxiv_data1/oa_pdf/4f/e2/JFMPC-3-63.PMC4005205.pdf
Available from: http://www.nfhsindia.,Non-OADS,/arxiv_data1/oa_pdf/4f/e2/JFMPC-3-63.PMC4005205.pdf
Available  from: http://www.cini.org.uk/childmalutrition.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/e2/JFMPC-3-63.PMC4005205.pdf
Available from:  http://www.prb.org/articles/2010/indiapoverty.aspx.,Non-OADS,/arxiv_data1/oa_pdf/4f/e2/JFMPC-3-63.PMC4005205.pdf
Available from: http://www.isid.ac.in/~pu/conference/ dec_08_conf/Papers/PeterSvedberg.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/e2/JFMPC-3-63.PMC4005205.pdf
Available  from: http://www.gdcâuk.org [Last cited on 2013 May 20].,Non-OADS,/arxiv_data1/oa_pdf/8d/22/JFMPC-3-68.PMC4005206.pdf
Available from: http://www.nlm.,Non-OADS,/arxiv_data1/oa_pdf/8d/22/JFMPC-3-68.PMC4005206.pdf
Available from: http://www.ineedce.com/ courses/1451/PDF/InformedConsent.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/22/JFMPC-3-68.PMC4005206.pdf
"Life Extension, Available from: http://www.garynullforum.com/ articles/pdf/foundarticles1/lef/CATARACTS.pdf(Last accessed on  08.09.10).",Non-OADS,/arxiv_data1/oa_pdf/14/d6/IJO-62-103.PMC4005220.pdf
Available from: http://www.searo.who.int/LinkFiles/ Publications_SEAâOphthalâ117.pdf[Last accessed on 27.3.11].,Non-OADS,/arxiv_data1/oa_pdf/14/d6/IJO-62-103.PMC4005220.pdf
Available from: http://health.nytimes.com/health/ guides/disease/cataract/riskâfactors.html.,Non-OADS,/arxiv_data1/oa_pdf/14/d6/IJO-62-103.PMC4005220.pdf
Available from: http://www.who.int/blindness/causes/priority/ cataractâmagnitude/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/14/d6/IJO-62-103.PMC4005220.pdf
Available from: http://www.richmondeye.,Non-OADS,/arxiv_data1/oa_pdf/14/d6/IJO-62-103.PMC4005220.pdf
Available from:  http://www.sciencedaily.comÂ¬/releases/2010/03/100301122326.,Non-OADS,/arxiv_data1/oa_pdf/14/d6/IJO-62-103.PMC4005220.pdf
Available  from: http://findarticles.com/p/articles/mi_m3469/is_n8_v44/ ai_13661584.,Non-OADS,/arxiv_data1/oa_pdf/14/d6/IJO-62-103.PMC4005220.pdf
Available from: http://www.lvpei.org/resources/ eyeâfaq/blindnessdue.html.,Non-OADS,/arxiv_data1/oa_pdf/14/d6/IJO-62-103.PMC4005220.pdf
Available from:  http://www.apa.org.,Non-OADS,/arxiv_data1/oa_pdf/f0/0d/IJO-62-141.PMC4005227.pdf
Available from:  http://www.unescodoc.unesco.org [Last cited on 2012 Jan 2].,Non-OADS,/arxiv_data1/oa_pdf/f0/0d/IJO-62-141.PMC4005227.pdf
Available from: http://www.styopkin.com/perfect screen ruler.,Non-OADS,/arxiv_data1/oa_pdf/bb/2f/IJO-62-145.PMC4005228.pdf
Available from: http://www.government of Maharashtra/ Sindhudurg.,Non-OADS,/arxiv_data1/oa_pdf/c5/ef/IJO-62-240.PMC4005244.pdf
This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons  Attribution License (http://creativecommons.org/licenses/by-nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/7f/bi-4-1.PMC4005277.pdf
"Non-commercial uses of the work are permitted, provided the original work is  properly cited.The challenges of green nanotechnologyEditorialde la Guardia , BioImpacts, 2014, 4(1), 1-2 doi: 10.5681/bi.2014.009 http://bi.tbzmed.ac.ir/  BioImpacts Publishing GroupTUOMS A R T I C L E  I N F O Article History: Received: 13 Oct. 2013 Accepted: 04 Dec. 2013 ePublished: 02 Feb. 2014 Keywords: Nanomaterials green nanotechnologySumarry Nanomaterials have great impacts on life sciences; however,  these advanced materials may induce inadvertant consequences.",Non-OADS,/arxiv_data1/oa_pdf/0e/7f/bi-4-1.PMC4005277.pdf
"Babaei M., Ganjalikhani M., BioImpacts, 2014, 4(1), 15-20 doi: 10.5681/bi.2014.003 http://bi.tbzmed.ac.ir/ The potential effectiveness of nanoparticles as radio sensitizers for  radiotherapy Mohammad Babaei1, Maryam Ganjalikhani2* 1 Department of Radiotherapy Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran  2 Tehran University of Medical Sciences, Tehran, Iran Article info Article History: Received: 17 July 2013 Revised: 19 Sep. 2013 Accepted: 19 Nov. 2013 ePublished: 08 Mar.",Non-OADS,/arxiv_data1/oa_pdf/13/e1/bi-4-15.PMC4005278.pdf
This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons  Attribution License (http://creativecommons.org/licenses/by-nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/13/e1/bi-4-15.PMC4005278.pdf
", BioImpacts, 2014, 4(1), 21-27 doi: 10.5681/bi.2014.001 http://bi.tbzmed.ac.ir/ Marrubium vulgare L. methanolic extract inhibits inflammatory  response and prevents cardiomyocyte fibrosis in isoproterenol- induced acute myocardial infarction in rats Keyvan Y ousefi1, Fatemeh Fathiazad2, Hamid Soraya3, Maryam Rameshrad4, Nasrin Maleki-Dizaji4, Alireza Garjani4* 1 Student Research Committee, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran 2 Department of Pharmacognosy, Tabriz University of Medical Sciences, Tabriz, Iran 3 Department of Pharmacology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia , Iran 4 Department of Pharmacology and Toxicology, Tabriz University of Medical Sciences, Tabriz, Iran Article info Article History: Received: 25 June 2013 Revised: 23 Aug. 2013 Accepted: 8 Sep. 2013 ePublished: 27 Feb. 2014 Keywords: Marrubium vulgare Myocardial infarction  Isoproterenol Anti-inflammatory Myeloperoxidase TNF-Î±Abstract Introduction:  Nowadays, finding new therapeutic compounds from natural products for  treatment and prevention of a variety of diseases including cardiovascular disorders is getting a  great deal of attention.",Non-OADS,/arxiv_data1/oa_pdf/3f/72/bi-4-21.PMC4005279.pdf
This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons  Attribution License (http://creativecommons.org/licenses/by-nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/72/bi-4-21.PMC4005279.pdf
"Jelvegari et al.,  BioImpacts, 2014, 4(1), 29-38 doi: 10.5681/bi.2014.002 http://bi.tbzmed.ac.ir/ Comparative study of in vitro  release and mucoadhesivity of gastric- compacts composed of multiple unit system/bilayered discs using  direct compression of metformin hydrochloride Mitra Jelvehgari1,2*, Parvin Zakeri-Milani2,3, Fatemeh Khonsari4 1 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran 2 Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran 3 Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran 4 Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran Article info Article History: Received: 19 June 2013 Revised: 27 Oct. 2013 Accepted: 07 Nov. 2013 ePublished: 12 March 2014 Keywords: Metformin hydrochloride  Carbomer 934P  Ethylcellulose  Bilayered discs Multiple unit system discsAbstract Introduction:  Metformin is an oral anti-diabetic  drug  in the biguanide  class .",Non-OADS,/arxiv_data1/oa_pdf/8b/05/bi-4-29.PMC4005280.pdf
This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons  Attribution License (http://creativecommons.org/licenses/by-nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8b/05/bi-4-29.PMC4005280.pdf
"Barar J., Omidi Y., BioImpacts, 2014, 4(1), 3-14 doi: 10.5681/bi.2014.011 http://bi.tbzmed.ac.ir/ Surface modified multifunctional nanomedicines for simultaneous  imaging and therapy of cancer Jaleh Barar*, Y adollah Omidi*  Research Center for Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran School of Advanced Biomedical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran Article info Article History: Received: 20 Jan. 2014Revised: 17 Feb. 2014Accepted: 27 Feb. 2014ePublished: 28 Mar.",Non-OADS,/arxiv_data1/oa_pdf/28/3a/bi-4-3.PMC4005281.pdf
This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons  Attribution License (http://creativecommons.org/licenses/by-nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/28/3a/bi-4-3.PMC4005281.pdf
", BioImpacts, 2014, 4(1), 39-42 doi: 10.5681/bi.2014.005 http://bi.tbzmed.ac.ir/ A fast and simple spectrofluorometric method for the determination of  alendronate sodium in pharmaceuticals Jafar Ezzati Nazhad Dolatabadi1,2, Hamed Hamishehkar3, Miguel de la Guardia4, Hadi Valizadeh3,5* 1 Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran 2 Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran 3 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran 4 Department of Analytical Chemistry, University of Valencia, Valencia, Spain 5 Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran Article info Article History: Received: 13 Oct. 2013 Revised: 04 Dec. 2013 Accepted: 27 Jan. 2014 ePublished: 05 Feb. 2014 Keywords: Alendronate O-phthalaldehyde Enthalpy Entropy SpectrofluorimetryAbstract Introduction:  Alendronate sodium enhances bone formation and increases osteoblast  proliferation and maturation and leads to the inhibition of osteoblast apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/9e/00/bi-4-39.PMC4005282.pdf
This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons  Attribution License (http://creativecommons.org/licenses/by-nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9e/00/bi-4-39.PMC4005282.pdf
", BioImpacts, 2014, 4(1), 43-48 doi: 10.5681/bi.2014.013 http://bi.tbzmed.ac.ir/ Analgesic, anti-inflammatory and anti-pyretic activities of  Caesalpinia decapetala Amna Parveen1, Muhammad Sajid Hamid Akash2,3*, Kanwal Rehman3, Qaisar Mahmood3,  Muhammad Imran Qadir2* 1 College of Pharmacy, Chung-Ang University, Seoul, South Korea 2 College of Pharmacy, Government College University Faisalabad, Faisalabad, Pakistan 3 Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University,  Hangzhou, China Introduction Herb- and plant-derived medicines have been used since  ancient times and considered as part of our health remedies.",Non-OADS,/arxiv_data1/oa_pdf/ea/a8/bi-4-43.PMC4005283.pdf
This work is published by BioImpacts as an open access article distributed under the terms of the Creative  Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/a8/bi-4-43.PMC4005283.pdf
"Mojarad Khanghah S., Ganbrov K., BioImpacts, 2014, 4(1), 49-52 doi: 10.5681/bi.2014.014 http://bi.tbzmed.ac.ir/ Lactobacillus with probiotic potential from homemade cheese in  Azerbijan Saeed Mojarad Khanghah, Khudaverdi Ganbarov*  Department of Microbiology, Faculty of biology, State University of Baku, Azarbayjan Introduction   Probiotics are defined as live microorganisms or their  components which when administered in adequate  amounts could confer health benefits such as the  improvement of human immune system, rearrangement   of  intestinal microflora, and establishment of antagonistic  effect on the growth of harmful bacteria.1   Lactic acid bacteria  (LAB) especially Lactobacillus  are the  most common types of microbes defined as probiotics.2  Lactobacilli  are commonly used as starter culture of  dairy product s such as yogurt and traditional cheese.2  Consumption of native foods containing such indigenous  microorganisms possesses many advantages;3 therefore,  the study of probiotics is ubiquitous and many countries  have made a great endeavor to isolate probiotic bacteria  from natural sea salt,4 plants,5 and so from the human  gastrointestinal tract,6 particularly with many endeavors   from traditional fermented foods such as cheese.7   It should be noted that the complex microflora intensity  of traditional cheese is due to so many processing and  fermentation steps such as clarification of raw milk, heating,  cooling, incubation, salting, and usage of homemade  cheese starter.8 Although there are many of commercial  probiotic supplements and dairy products, there is an  emphasis on the isolation of probiotics with respect to the  native microbiome.9,10 Hence, in this research we aimed to study the rural regions of Azarbyjan including Lankaran,  Jalil Abad and Salian  that their homemade cheese could be  a valuable source of probiotic microorganism.",Non-OADS,/arxiv_data1/oa_pdf/0e/17/bi-4-49.PMC4005284.pdf
This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons  Attribution License (http://creativecommons.org/licenses/by-nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/17/bi-4-49.PMC4005284.pdf
"Having used BLAST software  (http://blast.ncbi.nlm.nih.gov/Blast.cgi), the determined  sequences were compared with the sequences deposited  in NCBI GenBank as 16s rDNA gene of different  Lactobacillus  species.",OADS,/arxiv_data1/oa_pdf/0e/17/bi-4-49.PMC4005284.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 Â· eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.2.99 Asia Pac Allergy 2014;4:99-105Association of insulin resistance with bronchial  hyperreactivity Kyung-Mook Kim1,â , Sun-Sin Kim2,3,â , So-Hee Lee2,3, Woo-Jung Song2, Yoon-Seok Chang4, Kyung-Up Min2, and Sang-Heon Cho2,3,* 1Department of Internal Medicine, Gyeonggi Provincial Medical Center Suwon Hospital, Suwon 440-842, Korea  2Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea 3Seoul National University Hospital, Healthcare System Gangnam Center, Seoul 135-984, Korea 4Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-707, Korea Background: Several epidemiologic studies showed the significant association of insulin resistance with asthma.",Non-OADS,/arxiv_data1/oa_pdf/d4/b3/apa-4-99.PMC4005343.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/d4/b3/apa-4-99.PMC4005343.pdf
Asia Pacific allergy100 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.99INTRODUCTION Both obesity and asthma are common chronic diseases in many  westernized countries.,Non-OADS,/arxiv_data1/oa_pdf/d4/b3/apa-4-99.PMC4005343.pdf
Insulin resistance and bronchial hyperreactivity101       apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.99assessment of insulin resistance (HOMA-IR) [22].,Non-OADS,/arxiv_data1/oa_pdf/d4/b3/apa-4-99.PMC4005343.pdf
Asia Pacific allergy102 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.99Table 2.,Non-OADS,/arxiv_data1/oa_pdf/d4/b3/apa-4-99.PMC4005343.pdf
"Insulin resistance and bronchial hyperreactivity103 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.99with those without AHR ( p = 0.001 and p < 0.001, respectively)  (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/d4/b3/apa-4-99.PMC4005343.pdf
Asia Pacific allergy104 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.99[13-15].,Non-OADS,/arxiv_data1/oa_pdf/d4/b3/apa-4-99.PMC4005343.pdf
Insulin resistance and bronchial hyperreactivity105       apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.99index and asthma incidence among USA adults.,Non-OADS,/arxiv_data1/oa_pdf/d4/b3/apa-4-99.PMC4005343.pdf
"Case ReportAsia Pacific allergypISSN 2233-8276 Â· eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2014.4.2.129 Asia Pac Allergy 2014;4:129-130Omalizumab in recurring larynx angioedema: a  case report Ayse Bilge Ozturk1,* and Emek Kocaturk2 1Adult Allergy Unit, GÃ¶ztepe Tainning and Research Hospital, Istanbul Medeniyet University, Istanbul 34469, Turkey 2Department of Dermatology, OkmeydanÄ± Trainning and Research Hospital, Istanbul 34126, Turkey Angioedema with swelling of larynx is a serious  allergic  reaction and can be life-threatening.",Non-OADS,/arxiv_data1/oa_pdf/ec/58/apa-4-129.PMC4005344.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/ec/58/apa-4-129.PMC4005344.pdf
"Ozturk AB and Kocaturk EAsia Pacific allergy130 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.129CASE REPORT A 47-year-old man had symptoms of weekly recurrent angioedema  attacks in lips, tongue, larynx, and scrotum for seven years and  experienced swelling of larynx twice weekly in the last 3 months.",Non-OADS,/arxiv_data1/oa_pdf/ec/58/apa-4-129.PMC4005344.pdf
"Asia Pacific allergypISSN 2233-8276 Â· eISSN 2233-8268 Hypothesis & Experience Original Article  http://dx.doi.org/10.5415/apallergy.2014.4.2.113 Asia Pac Allergy 2014;4:113-118Efficacy of the Precise Climate Controller on the   reduction of indoor microorganisms Greetha Moungthong1, Pana Klamkam1,*, Prasit Mahakit1, Thanit Chalermwatanachai1, Sudaluck Thunyaharn2,   and Veerapol Monyakul3 1Department of Otolaryngology, Phramongkutklao Hospital, Bangkok 10400, Thailand 2Department of Microbiology, Phramongkutklao College of Medicine, Bangkok 10400, Thailand 3Biochemical Engineering and Pilot Plant Research and Development Unit (BEC), King Mongkutâs University of Technology Thonburi, Bangkok  10400, Thailand Background: Nowadays, there are many methods to reduce microorganisms in the air, such as dehumidifier, air purifier or humidity  and temperature controller.",Non-OADS,/arxiv_data1/oa_pdf/0d/e9/apa-4-113.PMC4005345.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/0d/e9/apa-4-113.PMC4005345.pdf
"Asia Pacific allergy114 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.113INTRODUCTION Allergic rhinitis, asthma and respiratory infections are major public  health problems in many countries, especially in Thailand where  its location is in the tropical zone.",Non-OADS,/arxiv_data1/oa_pdf/0d/e9/apa-4-113.PMC4005345.pdf
"The efficacy of the Precise Climate Controller115       apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.113of the air sample, the daily RH and the temperature inside the  testing room were recorded on 7 AM and 5 PM, consecutively for  45 days.",OADS,/arxiv_data1/oa_pdf/0d/e9/apa-4-113.PMC4005345.pdf
Asia Pacific allergy116 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.113RESULTS The room at Phramongkutklao Hospital was used as a closed  system in this study.,Non-OADS,/arxiv_data1/oa_pdf/0d/e9/apa-4-113.PMC4005345.pdf
The efficacy of the Precise Climate Controller117 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.113According to the study of Bernstein [14] reported the first study to  investigate the effect of dehumidification in conjunction with HEPA  filtration [15].,Non-OADS,/arxiv_data1/oa_pdf/0d/e9/apa-4-113.PMC4005345.pdf
Asia Pacific allergy118 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.1131986;65:351-61.,Non-OADS,/arxiv_data1/oa_pdf/0d/e9/apa-4-113.PMC4005345.pdf
"Case ReportAsia Pacific allergypISSN 2233-8276 Â· eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2014.4.2.126 Asia Pac Allergy 2014;4:126-128Successful prevention of recurrent anaphylactic  events with anti-immunoglobulin E therapy Jaechun Lee* Department of Internal Medicine, Jeju National University School of Medicine, Jeju 690-756, Korea Anaphylaxis is a fatal and systemic allergic reaction, which can be prevented by avoiding exposure to a causative agent.",Non-OADS,/arxiv_data1/oa_pdf/d4/a8/apa-4-126.PMC4005346.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/d4/a8/apa-4-126.PMC4005346.pdf
"Prevention of anaphylaxis with anti-IgE therapy127 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.126 CASE REPORT A 41-year-old man visited an emergency department (ER)  because of abrupt onset of swollen lips, hives over the whole  body, shortness of breath, abdominal cramping pain, diarrhea,  and dizziness, which had started minutes after eating his usual  dinner.",Non-OADS,/arxiv_data1/oa_pdf/d4/a8/apa-4-126.PMC4005346.pdf
Lee JAsia Pacific allergy128 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.126REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/d4/a8/apa-4-126.PMC4005346.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 Â· eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.2.86 Asia Pac Allergy 2014;4:86-90Pholcodine consumption and immunoglobulin   E-sensitization in atopics from Australia, Korea,  and Japan Constance H. Katelaris1,*, Motohiro Kurosawa2, Hee-Bom Moon3, Magnus Borres4, Erik Florvaag5,6, and Stig Gunnar Olof Johansson7 1Campbelltown Hospital, University of Western Sydney, Sydney 2560, Australia  2Gunma Institute for Allergy and Asthma, Tatebayashi-Kosei Hospital, Tatebayashi 374-0055, Japan 3Department of Internal Medicine, Asan Medical Center, University of Ulsan Collage of Medicine, Seoul 138-736, Korea  4Department of Womenâs and Childrenâs Health, Uppsala University, Thermo Fisher Scientific, Uppsala 751 05, Sweden 5Laboratory of Clinical Biochemistry, Department of Occupational Medicine, Haukeland University Hospital, Bergen 0027, Norway 6Department of Clinical Science, University of Bergen, Bergen N-5020, Norway  7Department of Medicine, Clinical Immunology and Allergy Unit, Karolinska University Hospital, Stockholm SE-141 86, Sweden Background: Accumulating data indicates that pholcodine (PHO)-consuming countries have higher sero-prevalences of  immunoglobulin E (IgE)-antibodies to PHO and suxamethonium (SUX) and increased frequencies of IgE-mediated anaphylaxis to  neuromuscular blocking agents (NMBAs) than nonconsuming.",Non-OADS,/arxiv_data1/oa_pdf/e6/22/apa-4-86.PMC4005347.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/e6/22/apa-4-86.PMC4005347.pdf
"Pholcodine consumption and IgE-sensitization in Australia, Korea, and Japan87 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.86 INTRODUCTION During the past decade, an increasing amount of data has  accumulated indicating that pholcodine (PHO) consuming countries  have higher serological prevalences of immunoglobulin E (IgE)- antibodies to PHO, and suxamethonium (SUX), than nonconsuming  [1].",Non-OADS,/arxiv_data1/oa_pdf/e6/22/apa-4-86.PMC4005347.pdf
Asia Pacific allergy88 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.86IgE values were not available for the Korean samples and not for  the Australian sample no.,OADS,/arxiv_data1/oa_pdf/e6/22/apa-4-86.PMC4005347.pdf
"Pholcodine consumption and IgE-sensitization in Australia, Korea, and Japan89 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.86figures on prevalences of anaphylaxis must be evaluated carefully.",Non-OADS,/arxiv_data1/oa_pdf/e6/22/apa-4-86.PMC4005347.pdf
"Asia Pacific allergy90 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.86J, Seneviratne SL, Guttormsen AB.",OADS,/arxiv_data1/oa_pdf/e6/22/apa-4-86.PMC4005347.pdf
Available from:http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/e6/22/apa-4-86.PMC4005347.pdf
"EditorialAsia Pacific allergypISSN 2233-8276 Â· eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2014.4.2.73 Asia Pac Allergy 2014;4:73-74Rare diseases and expensive drugs Constance H. Katelaris* Immunology & Allergy, University of Western Sydney and Head of Unit, Campbelltown Hospital, Sydney 2560, Australia Immunologists/allergists are a physician group that is familiar with  caring for patients with rare diseases.",Non-OADS,/arxiv_data1/oa_pdf/2c/4e/apa-4-73.PMC4005348.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/2c/4e/apa-4-73.PMC4005348.pdf
"apallergy.org  Katelaris CHAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2014.4.2.7374    recognition of the condition and, in many countries, lack of access  to specific tests.",Non-OADS,/arxiv_data1/oa_pdf/2c/4e/apa-4-73.PMC4005348.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 Â· eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.2.106 Asia Pac Allergy 2014;4:106-112Penicillin allergy evaluation: experience from a drug  allergy clinic in an Arabian Gulf Country, Kuwait Mona Al-Ahmad*,â , Tito Rodriguez Bouzaâ , and Nermina Arifhodzic Drug Allergy Unit, Department of Allergy, Al-Rashed Allergy Center, Sulaibikhat 90806, Kuwait Background: Hypersensitivity to penicillin has been studied worldwide, but data regarding patterns of sensitization in Arabian Gulf  countries are scarce.",Non-OADS,/arxiv_data1/oa_pdf/22/96/apa-4-106.PMC4005349.pdf
http://apallergy.org INTRODUCTION Hypersensitivity reactions to betalactams are a frequent cause  for allergy consultations worldwide [1-6].,Non-OADS,/arxiv_data1/oa_pdf/22/96/apa-4-106.PMC4005349.pdf
"Penicillin allergy evaluation in Kuwait107 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.106 amoxicillin, 4.5% with ampicillin and 1.6% with penicillin [1].",Non-OADS,/arxiv_data1/oa_pdf/22/96/apa-4-106.PMC4005349.pdf
Asia Pacific allergy108 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.106after suspected drug reaction and 5 days after H1-antihistamines  withdrawal.,OADS,/arxiv_data1/oa_pdf/22/96/apa-4-106.PMC4005349.pdf
Penicillin allergy evaluation in Kuwait109 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.106amoxicillin.,Non-OADS,/arxiv_data1/oa_pdf/22/96/apa-4-106.PMC4005349.pdf
Asia Pacific allergy110 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.106other studies are shown in Table 4.,OADS,/arxiv_data1/oa_pdf/22/96/apa-4-106.PMC4005349.pdf
Penicillin allergy evaluation in Kuwait111       apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.106REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/22/96/apa-4-106.PMC4005349.pdf
Asia Pacific allergy112 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.10626.,Non-OADS,/arxiv_data1/oa_pdf/22/96/apa-4-106.PMC4005349.pdf
"Current ReviewAsia Pacific allergypISSN 2233-8276 Â· eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.2.75 Asia Pac Allergy 2014;4:75-85Epidemiology of adult asthma in Asia: toward a  better understanding Woo-Jung Song1,2, Min-Gyu Kang1,2, Yoon-Seok Chang1,2,3, and Sang-Heon Cho1,2,* 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea 2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 110-799, Korea 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-707, Korea Asia is the worldâs most dynamic area.",Non-OADS,/arxiv_data1/oa_pdf/ef/97/apa-4-75.PMC4005350.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/ef/97/apa-4-75.PMC4005350.pdf
"Asia Pacific allergy76 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.75Respiratory Health Survey (ECRHS) [7], we might simply expect that  asthma is also increasing among Asian adult populations.",Non-OADS,/arxiv_data1/oa_pdf/ef/97/apa-4-75.PMC4005350.pdf
Adult asthma epidemiology in Asia77 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.75Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/apa-4-75.PMC4005350.pdf
Asia Pacific allergy78 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.75 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/apa-4-75.PMC4005350.pdf
Adult asthma epidemiology in Asia79 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.75Table 2.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/apa-4-75.PMC4005350.pdf
Asia Pacific allergy80 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.75 Table 2.,OADS,/arxiv_data1/oa_pdf/ef/97/apa-4-75.PMC4005350.pdf
Adult asthma epidemiology in Asia81 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.75glimpse of geographical variation of asthma prevalence in Asian  countries (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/apa-4-75.PMC4005350.pdf
"Asia Pacific allergy82 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.75smoking [31, 33]), dietary or nutritional factors (vitamin D level  [50], kimchi [44] or monosodium glutamate intake [16]), pollutant  exposure [51, 52], psychiatric disorder [12], clonorchis infection [53],  rhinitis [54], or staphylococcal enterotoxin sensitization [21].",Non-OADS,/arxiv_data1/oa_pdf/ef/97/apa-4-75.PMC4005350.pdf
Adult asthma epidemiology in Asia83 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.75TOWARD A BETTER UNDERSTANDING OF  ASTHMA IN ASIANS Here we summarized the current status of epidemiological  research on adult asthma in Asia.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/apa-4-75.PMC4005350.pdf
Available from: http://en.wikipedia.org/ wiki/Asia .2.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/apa-4-75.PMC4005350.pdf
Asia Pacific allergy84 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.75determinants based on European Community Respiratory Health  Survey in the United Arab Emirates.,OADS,/arxiv_data1/oa_pdf/ef/97/apa-4-75.PMC4005350.pdf
Adult asthma epidemiology in Asia85 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.75children and adults of Bangladesh: findings of the National Asthma  Prevalence Study.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/apa-4-75.PMC4005350.pdf
"Educational & Teaching MaterialAsia Pacific allergypISSN 2233-8276 Â· eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2014.4.2.119 Asia Pac Allergy 2014;4:119-125Radiocontrast media hypersensitivity in the Asia  Pacific region Suh-Young Lee1,2,3, Kyoung-Whan Lim1,2,3, and Yoon-Seok Chang1,2,3,* 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea 2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 110-744, Korea 3 Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-707,  Korea Radiocontrast media (RCM) is a major cause of drug hypersensitivity reactions as the medical application of RCM is increasing  recently.",Non-OADS,/arxiv_data1/oa_pdf/fa/34/apa-4-119.PMC4005351.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/fa/34/apa-4-119.PMC4005351.pdf
"Lee SY, et al.Asia Pacific allergy120 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.119been published including the prevalence clinical manifestations,  diagnostic tests and preventions [4, 6, 7].",OADS,/arxiv_data1/oa_pdf/fa/34/apa-4-119.PMC4005351.pdf
"RCM hypersensitivity in Asia Pacific121 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.119[1, 2, 4, 6-9].",Non-OADS,/arxiv_data1/oa_pdf/fa/34/apa-4-119.PMC4005351.pdf
"Lee SY, et al.Asia Pacific allergy122 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.119significant risk of the RCM hypersensitivity reactions (odds ratio,  2.46; p = 0.005) [13].",OADS,/arxiv_data1/oa_pdf/fa/34/apa-4-119.PMC4005351.pdf
RCM hypersensitivity in Asia Pacific123 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.119skin test to screen RCM hypersensitivity before the administration  of RCMs [4].,Non-OADS,/arxiv_data1/oa_pdf/fa/34/apa-4-119.PMC4005351.pdf
"Lee SY, et al.Asia Pacific allergy124 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.119exposure), delayed reactions (after an hour to 7 days), and severe  life threatening reactions (0.04â0.28%) are possible reactions.",Non-OADS,/arxiv_data1/oa_pdf/fa/34/apa-4-119.PMC4005351.pdf
RCM hypersensitivity in Asia Pacific125 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.11922.,Non-OADS,/arxiv_data1/oa_pdf/fa/34/apa-4-119.PMC4005351.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 Â· eISSN 2233-8268  http://dx.doi.org/10.5415/apallergy.2014.4.2.91 Asia Pac Allergy 2014;4:91-98Association of airborne Aspergillus  with asthma  exacerbation in Southern Pakistan Ali Bin Sarwar Zubairi1, Iqbal Azam2, Safia Awan1, Afia Zafar3, and Asif Ali Imam1,* Departments of 1Medicine, 2Community Health Sciences, and 3Pathology and Microbiology, Aga Khan University, Karachi 74800, Pakistan Background: Exposure to airborne fungi has been related with exacerbation of asthma in adults and children leading to increased  outpatient, emergency room visits, and hospitalizations.",Non-OADS,/arxiv_data1/oa_pdf/2f/fa/apa-4-91.PMC4005352.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/2f/fa/apa-4-91.PMC4005352.pdf
"Asia Pacific allergy92 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.91INTRODUCTION Aeroallergens, especially indoor allergens have been strongly  associated with asthma and this risk is higher when the exposure  is perennial [1-5].",Non-OADS,/arxiv_data1/oa_pdf/2f/fa/apa-4-91.PMC4005352.pdf
"Fungal spores in asthma93       apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.91 tract infection, change of season, indoor smoking, allergen    exposure, and site of enrollment (e.g., outpatient clinic,    emergency room, or inpatient).",Non-OADS,/arxiv_data1/oa_pdf/2f/fa/apa-4-91.PMC4005352.pdf
"Asia Pacific allergy94 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.91exacerbations were identified, out of which 391 agreed to  participate in the study (Fig.",OADS,/arxiv_data1/oa_pdf/2f/fa/apa-4-91.PMC4005352.pdf
Fungal spores in asthma95 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.91July (Fig.,Non-OADS,/arxiv_data1/oa_pdf/2f/fa/apa-4-91.PMC4005352.pdf
Asia Pacific allergy96 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.91children and adults.,Non-OADS,/arxiv_data1/oa_pdf/2f/fa/apa-4-91.PMC4005352.pdf
Fungal spores in asthma97       apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.91factor for life-threatening asthma.,Non-OADS,/arxiv_data1/oa_pdf/2f/fa/apa-4-91.PMC4005352.pdf
The global initiative for asthma; c2012 [cited 2012 Dec 10] Available  from: http://www.ginasthma.org/documents/4.,Non-OADS,/arxiv_data1/oa_pdf/2f/fa/apa-4-91.PMC4005352.pdf
Asia Pacific allergy98 apallergy.org http://dx.doi.org/10.5415/apallergy.2014.4.2.91of respiratory health effects with dampness and mold in homes.,Non-OADS,/arxiv_data1/oa_pdf/2f/fa/apa-4-91.PMC4005352.pdf
Available from: http://brasil500anos.ibge.gov.br/en/,Non-OADS,/arxiv_data1/oa_pdf/82/c9/main.PMC4005503.pdf
"WorldHealth Organization, Regional Office for South-East Asia, 2011. http://apps.searo.who.int/pds_docs/B4751.pdf  6.",Non-OADS,/arxiv_data1/oa_pdf/e6/d6/main.PMC4005504.pdf
Available from: http://www.basg.gv.at/uploads/media/110207_StandardSurveillanceDOCO.pdf  8.,Non-OADS,/arxiv_data1/oa_pdf/c6/16/main.PMC4005507.pdf
Available from: http://www1.inca.gov.br/conteudo_view.asp?ID = 677.,Non-OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://www.blog.saude.gov.br/entenda-como-funciona-o-redome/.,Non-OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://www1.inca.gov.br/conteudo_view.asp?ID = 64 10.,Non-OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://www.abrale.org.br/doencas/transplante/index.php?area = transplante 11.,OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://brasil500anos.ibge.gov.br/en/ 14.,Non-OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://www.ibge.gov.br/cidadesat/topwindow.htm?1 15.,Non-OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://www.sidra.ibge.gov.br/bda/tabela/listabl.asp?z = t&c = 3175 16.,Non-OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://www.ibge.gov.br/cidadesat/painel/painel.php?,Non-OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://www.quantitativeskills.com/sisa/ 24.,Non-OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://www.fearp.usp.br/pesquisa/images/Anexos/Publicacoes/Textos_discussao/REC/2001/wpe26.pdf 26.,Non-OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://www.abep.nepo.unicamp.br/docs/anais/pdf/2000/Todos/NovosEspa%C3%A7osdaImigra%C3%A7aonoBrasilAnos80e90.pdf 27.,OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://www.ibge.gov.br/estadosat/temas.php?sigla = sp&tema = censodemog2010_migra 28.,OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://brasil500anos.ibge.gov.br/en/territorio-brasileiro-e-povoamento/alemaes/os-imigrantes-alemaes-no-brasil 29.,Non-OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://www.cidadao.pr.gov.br/modules/conteudo/conteudo.php?conteudo = 77.,OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Available from: http://www.mg.gov.br/governomg/portal/m/governomg/conheca-minas/5657-historia/ 5146/5044.,Non-OADS,/arxiv_data1/oa_pdf/b1/1d/main.PMC4005508.pdf
Sistema de InformaÃ§Ã£o de Agravos de NotificaÃ§Ã£o â Sinan / Datasus / MinistÃ©rio da SaÃºde â avaliable from: http://dtr2004.saude.gov.br/sinanweb/tabnet/tabnet?sinannet/dengue/ bases/denguebrnet.def.,OADS,/arxiv_data1/oa_pdf/3d/cb/main.PMC4005509.pdf
Available from: http://www.pcbs.gov.ps/site/512/default.aspx?tabID=   512&lang=en&ItemID=788&mid=3171&wversion=Staging 1 9.,OADS,/arxiv_data1/oa_pdf/1f/75/main.PMC4005512.pdf
"Available from: http://www.puertogaitan-meta.gov.co/in - dex.shtml   Brochero H, QuiÃ±ones ML 2008.",Non-OADS,/arxiv_data1/oa_pdf/c9/43/0074-0276-mioc-108-08-01045.PMC4005547.pdf
"El Meta: un territorio de oportunidades ,   IGAC, Available from: http://www.meta.gov.co/ .",Non-OADS,/arxiv_data1/oa_pdf/c9/43/0074-0276-mioc-108-08-01045.PMC4005547.pdf
"Available  from:  http://www.puertogaitan-meta.gov.co/index.shtml   RejmÃ¡nkovÃ¡ E, Rubio-Palis Y, Villegas L 1999.",Non-OADS,/arxiv_data1/oa_pdf/c9/43/0074-0276-mioc-108-08-01045.PMC4005547.pdf
2004) (available  from: ftp://ext-ftp.fao.org/SD/Reserved/Agromet/New_ LocClim/) and (ii) the mean annual temperature (Tmean)  obtained from the WorldClim v. 1.4 database at a resolu - tion of 30 s (Hijmans et al.,OADS,/arxiv_data1/oa_pdf/09/50/0074-0276-mioc-108-08-00997.PMC4005556.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/40/gft476.PMC4005560.pdf
Available from: http://www.eraedta2012.org/images/05_Cannata- Andia_Results_from_the_ COSMOS_study.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/22/40/gft476.PMC4005560.pdf
References   1. http://globocan.iarc.fr   2.,Non-OADS,/arxiv_data1/oa_pdf/65/f7/CHSJ-40-1-023.PMC4005602.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/fb/gku147.PMC4005639.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/50/gku131.PMC4005644.pdf
The autoradiography was quantiï¬ed with thesoftware GelEval (http://www.frogdance.dundee.ac.uk/).,OADS,/arxiv_data1/oa_pdf/77/50/gku131.PMC4005644.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/f5/gku152.PMC4005647.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/eb/gku155.PMC4005648.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/35/gku127.PMC4005655.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/6e/gku208.PMC4005657.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/f7/gku150.PMC4005658.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/2a/gku154.PMC4005660.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/f8/gku111.PMC4005661.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/98/gku108.PMC4005665.pdf
"Sequence alignment of LeuRSs For phylogenetic analysis of LeuRSs covering three domains, 63 protein sequences of various LeuRSs fromrepresentative species were obtained from the NCBIdatabase (http://www.ncbi.nlm.nih.gov/protein/).",OADS,/arxiv_data1/oa_pdf/eb/98/gku108.PMC4005665.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/59/gku121.PMC4005667.pdf
We translated this isoform-based classiï¬er to an RT-qPCR based assay for molecular classiï¬cation of GBM patients and furthervalidated the signature on 206 independent samples from University of Pennsylvania Brian Tumor Tissue Bank.MATERIALS AND METHODS Preprocessing of TCGA exon-array Data We downloaded the unprocessed Affymetrix Exon-array datasets for 419 GBM samples and 10 normal brain samples (control samples) from the TCGA data portal (https://tcga-data.nci.nih.gov/tcga).,OADS,/arxiv_data1/oa_pdf/e5/59/gku121.PMC4005667.pdf
âsurvivalâ (http://cran.r-project.org/web/packages/ survival/index.html) was used to do the analysis (17).,OADS,/arxiv_data1/oa_pdf/e5/59/gku121.PMC4005667.pdf
The PIGExClass algorithm is available as a set of scripts at http://bioinformatics.wistar.upenn.edu/PIGEx Class.,OADS,/arxiv_data1/oa_pdf/e5/59/gku121.PMC4005667.pdf
"The classiï¬cation model generated from the training set was applied to the test set.RNA-seq data analysis The TCGA GBM paired-end RNA-seq aligned bam ï¬les, for a total of 155 patient samples, were downloaded from https://cghub.ucsc.edu/cghub/data/analysis/download.",OADS,/arxiv_data1/oa_pdf/e5/59/gku121.PMC4005667.pdf
The RNA-seq bam ï¬les were converted to raw fastq ï¬les by Picard tools (http://picard.sourceforge.net/).,OADS,/arxiv_data1/oa_pdf/e5/59/gku121.PMC4005667.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/81/gku113.PMC4005671.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/4e/gku124.PMC4005672.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/b0/gku110.PMC4005675.pdf
"Exploration of the 3D structures was performed using the following tools: Dali server (61), I-TASSER (62) andSwiss-modeling servers (63), PyMOL Molecular Graphics System (http://www.pymol.org) (64).",OADS,/arxiv_data1/oa_pdf/93/b0/gku110.PMC4005675.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/e2/gku136.PMC4005685.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/11/gku139.PMC4005687.pdf
"Data from the ENCODE project (http://genome.ucsc.edu/ENCODE) demonstrate that HSIII and HSV are formed in multiple cell types, while our data reveal the formation of an additional HS, HSIV, is speciï¬c to the placenta (4).ChIP analyses of histone H3 and H4 acetylation along with H3K4-di- and tri-methylation in placental chromatin indicate that these âactiveâ epigenetic modiï¬cations arelocalized to the HSIII-V region and to the segments of the gene cluster encompassing each of the placental genes (15).",OADS,/arxiv_data1/oa_pdf/74/11/gku139.PMC4005687.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/6b/gku148.PMC4005688.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/74/gku149.PMC4005690.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/1c/gku132.PMC4005693.pdf
"Construction of the RF ZFP regression model Based on a pilot study and previous work with homeodomain recognition modeling (85), we developeda recognition modeler based on a RF regressionapproach (84) using the ârandomForestâ module fromtheRpackage [http://www.r-project.org/(87)].",OADS,/arxiv_data1/oa_pdf/96/1c/gku132.PMC4005693.pdf
Construction of ZFP recognition motif predictions We established a Web site that will predict the binding motif for an input ZFP containing any number of ï¬ngers (http://stormo.wustl.edu/ZFModels/).,OADS,/arxiv_data1/oa_pdf/96/1c/gku132.PMC4005693.pdf
This model is accessible to the community though our Web site (http://stormo.wustl.edu/ZFModels/).,Non-OADS,/arxiv_data1/oa_pdf/96/1c/gku132.PMC4005693.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/31/gku145.PMC4005697.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/87/gku119.PMC4005698.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/a8/gku129.PMC4005699.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Atribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/ >.,Non-OADS,/arxiv_data1/oa_pdf/3e/6e/S1352465813000660a.PMC4005778.pdf
Plant Signal Behav 2013:8: e25059; http://dx.doi.org/10.4161/psb.25059Introduction The use of alternative hosts to understand pathogenic processes  is a strategy widely used since the earliest microbiological stud - ies on human diseases.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Supplemental Material Supplemental material may be found here: http://www.landesbioscience.com/journals/psb/article/25059/Bioinformatic searches.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
"Additionally, we performed in silico searches of genes encod - ing transcription factors using online programs UniProt, 63  KEGG,64 Pfam,65 SUPERFAMILY66 and MIPS Ustilago may - dis DataBase (http://mips.helmholtz-muenchen.de/genre/proj/ ustilago/).",OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Antimicrob Agents Chemother 1986; 29:579-83; PMID:3010846; http://dx.doi.org/10.1128/ AAC.29.4.579 2.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Eukaryot Cell  2003; 2:1053-60; PMID:14555488; http://dx.doi.org/10.1128/EC.2.5.1053-1060.2003 3.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
J Microbiol Methods  2003; 53:113-22; PMID:12609730; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Nat Protoc 2008; 3:435- 45; PMID:18323815; http://dx.doi.org/10.1038/nprot.2007.499 6.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Cell Host  Microbe 2007; 1:263-73; PMID:18005707; http://dx.doi.org/10.1016/j.chom.2007.05.005 7.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Phytopathology  2005; 95:480-8; PMID:18943312; http://dx.doi.org/10.1094/PHYTO-95-0480 9.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Nature  2006; 444:97-101; PMID:17080091; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Fungal Genet Biol 2012; 49:765-71; PMID:22921263; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Annu Rev Phytopathol 2009; 47:423-45; PMID:19400641; http://dx.doi.org/10.1146/ annurev-phyto-080508-081923 15.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Science  2010; 328:89-92; PMID:20360107; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
PLoS Pathog 2010; 6:e1001035; PMID:20700446; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Genome Res 2003; 13:1675- 85; PMID:12840044; http://dx.doi.org/10.1101/gr.910003 18.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
PLoS Pathog 2012; 8:e1002684;  PMID:22589719; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Mol Plant Microbe Interact 2010; 23:1118-29; PMID:20687802; http://dx.doi.org/10.1094/ MPMI-23-9-1118 20.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
PLoS Pathog 2009; 5:e1000290; PMID:19197359; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Mol  Microbiol 2011; 81:751-66; PMID:21692877; http://dx.doi.org/10.1111/j.1365-2958.2011.07728.x 22.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Microbiology  2006; 152:3607-12; PMID:17159213; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Mol Genet Genomics 2008; 279:27-39; PMID:17917743; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
FEMS Microbiol  Rev 2012; 36:59-77; PMID:21729109; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Curr Biol 2000; 10:751-7;  PMID:10898976; http://dx.doi.org/10.1016/S0960-9822(00)00560-1 27.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Phytochemistry  2001; 58:33-41; PMID:11524110; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
PLoS Pathog 2011; 7:e1002235; PMID:21909277;  http://dx.doi.org/10.1371/journal.ppat.1002235 29.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Eukaryot Cell  2012; 11:368-80; PMID:22247264; http://dx.doi.org/10.1128/EC.05191-11 30.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Fungal Genet Biol 2008; 45:S63- 70; PMID:18456523; http://dx.doi.org/10.1016/j.fgb.2008.03.012 61.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Fungal Genet Biol  2008; 45:S71-6; PMID:18508396; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
FEMS Yeast Res  2013; 13:74-84; PMID:23167842; http://dx.doi.org/10.1111/1567-1364.12011 63.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Nucleic Acids Res 1999; 27:29-34;  PMID:9847135; http://dx.doi.org/10.1093/nar/27.1.29 65.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Nucleic Acids Res 2012; 40:290-301; PMID:21896617; http://dx.doi.org/10.1093/nar/ gkr1065 66.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
J Mol Biol 2001; 313:903- 19; PMID:11697912; http://dx.doi.org/10.1006/ jmbi.2001.5080 67.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Mol  Microbiol 2001; 41:337-48; PMID:11489122; http://dx.doi.org/10.1046/j.1365-2958.2001.02528.x 68.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Mol Microbiol 2009; 72:683-98; PMID:19400774;  http://dx.doi.org/10.1111/j.1365-2958.2009.06676.x 69.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Plant  Cell 2007; 19:2293-309; PMID:17616735; http://dx.doi.org/10.1105/tpc.107.052332 70.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Fungal  Genet Biol 1998; 24:364-76; PMID:9756717; http://dx.doi.org/10.1006/fgbi.1998.1078 72.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Mol Plant Microbe Interact 2000; 13:781- 6; PMID:10875339; http://dx.doi.org/10.1094/ MPMI.2000.13.7.781 74.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
EMBO J  1997; 16:1934-42; PMID:9155019; http://dx.doi.org/10.1093/emboj/16.8.193445.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Mol Microbiol 2002; 44:841-53;  PMID:11994163; http://dx.doi.org/10.1046/j.1365- 2958.2002.02926.x 47.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Mol Biol Cell 2003; 14:1182-94; PMID:12631733;  http://dx.doi.org/10.1091/mbc.E02-03-0167 48.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
J Biol Chem 2002; 277:50176-82;  PMID:12364327; http://dx.doi.org/10.1074/jbc.M208374200 49.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
T rends Plant Sci 2002; 7:352-6; PMID:12167330; http://dx.doi.org/10.1016/ S1360-1385(02)02297-5 51.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Proc Natl Acad Sci USA  1989; 86:5878-82; PMID:16594058; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Mol Gen Genet 1999; 262:468-72; PMID:10589834;  http://dx.doi.org/10.1007/s004380051107 53.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Mycol Res 1990; 94:1059-64; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Fungal Genet Biol 1996; 20:153-67; PMID:8810520;  http://dx.doi.org/10.1006/fgbi.1996.0030 55.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Bioinformatics 2003; 19:185-93; PMID:12538238;  http://dx.doi.org/10.1093/bioinformatics/19.2.185 57.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Biostatistics 2003; 4:249-64;  PMID:12925520; http://dx.doi.org/10.1093/biostatis-tics/4.2.249 58.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Nucleic Acids Res 2004; 32:5539-45; PMID:15486203; http://dx.doi.org/10.1093/nar/ gkh89431.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
PLoS ONE  2012; 7:e29707; PMID:22276126; http://dx.doi.org/10.1371/journal.pone.0029707 32.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Infect Immun 2004; 72:2390-4; PMID:15039366; http://dx.doi.org/10.1128/ IAI.72.4.2390-2394.2004 33.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Infect Immun  2005; 73:5022-30; PMID:16041017; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Mol Microbiol 2001; 42:1047-63;  PMID:11737646; http://dx.doi.org/10.1046/j.1365-2958.2001.02699.x 35.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Microbiology 1995; 141:695-703; http://dx.doi.org/10.1099/13500872-141-3-695 37.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
New Phytol 2002; 156:103-12;  http://dx.doi.org/10.1046/j.1469-8137.2002.00487.x 38.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Curr Microbiol  2012; 65:85-90; PMID:22538468; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Mol Microbiol 2010; 76:517- 34; PMID:20384682; http://dx.doi.org/10.1111/ j.1365-2958.2010.07119.x 40.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
J Biol Chem 2005; 281:90- 8; PMID:16263704; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Infect Immun  2005; 73:4571-80; PMID:16040968; http://dx.doi.org/10.1128/IAI.73.8.4571-4580.2005 43.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Eukaryot Cell 2007; 6:222-34; PMID:17142566;  http://dx.doi.org/10.1128/EC.00182-06 44.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Plant Cell 2009; 21:3397-412;  PMID:19880800; http://dx.doi.org/10.1105/tpc.109.065839,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Eukaryot Cell  2012; 11:129-40; PMID:22140230; http://dx.doi.org/10.1128/EC.05206-11 84.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Eukaryot Cell 2005; 4:999-1008; PMID:15947192;  http://dx.doi.org/10.1128/EC.4.6.999-1008.2005 86.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Eukaryot Cell  2005; 4:379-91; PMID:15701800; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Microbiology 2012; 158:674-84; PMID:22222500;  http://dx.doi.org/10.1099/mic.0.055954-0 80.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Eukaryot  Cell 2003; 2:609-17; PMID:12796306; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Genes Dev 2004; 18:3117-30; PMID:15601825; http://dx.doi.org/10.1101/gad.314904 82.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
PLoS Pathog  2012; 8:e1002563; PMID:22416226; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
Mol Microbiol 2001; 41:1365-79;  PMID:11580841; http://dx.doi.org/10.1046/j.1365- 2958.2001.02606.x 77.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
FEMS Yeast Res 2009; 9:923-35; PMID:19624748; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
FEMS Yeast Res 2010; 10:928-40; PMID:20840600; http://dx.doi.org/10.1111/j.1567-1364.2010.00675.x,OADS,/arxiv_data1/oa_pdf/43/0e/psb-8-e25059.PMC4005800.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/c6/ehu053.PMC4006092.pdf
http://patientinfo.myesr .org/html_frontend/index.php?module=article&action=&article_id=166 (31 October 2013).,Non-OADS,/arxiv_data1/oa_pdf/ed/c6/ehu053.PMC4006092.pdf
"Royal Pharmaceutical Society of Great Britain -   http://www.rpsb.org.uk     Corresponding Author : Daniela Cornelia CÄlina, Faculty of Pharmacy, University of Medicine  and Pharmacy  of Craiova, 2-4 Petru Rares Street, Craiova 200349, Romania, e -mail: calinadaniela@gmail.com  This is an open -access article distributed under the terms of the    Creative Commons Attribution -NonCommercial -ShareAlike 4.0 International Public License   DOI: 10.12865/CHSJ.40.01.10  59",Non-OADS,/arxiv_data1/oa_pdf/05/12/CHSJ-40-1-057.PMC4006339.pdf
"Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Cost-Utility Analysis of Neonatal Screening Program, Shiraz University of Medical Sciences, Shiraz, Iran, 2010 Nahid Hatam1, PhD;Samad Shirvani2,MSc; Mehdi Javanbakht2,PhD; Mehrdad Askarian*3, MD, MPH; Mohsen Rastegar4, MD 1.School of Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran 2.StudentResearchCommittee , School of Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran 3.Department of Community Medicine, Shiraz University of Medical Sciences, Shiraz, Iran 4.GeneralPractitioner inControlandSurveillance of Diseases ,Unit ofVice-Chancellor for Health ,Shiraz University of Medical Sciences, Shiraz, Iran Received: Dec05, 2012; Accepted: Mar18, 2013;FirstOnlineAvailable :Jun12,2013 Abstract Objective :The most important cause of infant mortality during the first month of life is related to congenital abnormalities.",Non-OADS,/arxiv_data1/oa_pdf/8d/05/IJPD-23-493.PMC4006495.pdf
"494 Cost-Utility Analysis of Neonatal Screening Pro gram Iran J Pediatr; Vol 23 (No 5), Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )these symp toms are weak and, consequently, diagnosis of these diseases can be delayed for months and even years[2].",Non-OADS,/arxiv_data1/oa_pdf/8d/05/IJPD-23-493.PMC4006495.pdf
"495 Hatam N ,et al Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir ) Fig.",Non-OADS,/arxiv_data1/oa_pdf/8d/05/IJPD-23-493.PMC4006495.pdf
"496 Cost-Utility Analysis of Neonatal Screening Pro gram Iran J Pediatr; Vol 23 (No 5), Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )who were infected by the four mentioned diseases.",Non-OADS,/arxiv_data1/oa_pdf/8d/05/IJPD-23-493.PMC4006495.pdf
"497 Hatam N ,et al Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 2:The results of time trade off in Shiraz University of Medical Sciences, 2010 DiseaseScreening statusNumber of interviewed nursesMean score of utility(SD)Maximum Minimum PhenylketonuriaUnscreened 36 0.397 (0.2348) 1 0 Screened 36 0.849(0.2068) 1 0.3 HypothyroidismUnscreened 36 0.469 (0.284 7) 1 0 Screened 36 0.899 (0.1697) 1 0.3 GalactosemiaUnscreened 36 0.475(0.2771) 1 0 Screened 36 0.896 (0.1514) 1 0.4 FavismUnscreened 36 0.793 (0.2715) 1 0 Screened 36 0.975 (0.0485) 1 0.8 SD:Standard Deviation The results obtained from calculation of ICER for the four mentioned diseases are presented in Table 3.",Non-OADS,/arxiv_data1/oa_pdf/8d/05/IJPD-23-493.PMC4006495.pdf
"498 Cost-Utility Analysis of Neonatal Screening Pro gram Iran J Pediatr; Vol 23 (No 5), Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )present study.",Non-OADS,/arxiv_data1/oa_pdf/8d/05/IJPD-23-493.PMC4006495.pdf
"499 Hatam N ,et al Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )analysis of the two variables of cost and utility also revealed 129 .258.720,26 Rials ($12 .603) saving per patient in the best scenario; ie, maximum utility and minimum costs.",OADS,/arxiv_data1/oa_pdf/8d/05/IJPD-23-493.PMC4006495.pdf
"500 Cost-Utility Analysis of Neonatal Screening Pro gram Iran J Pediatr; Vol 23 (No 5), Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )completely receive the treatment and observe the special food diets in case of phenylketonuria and galactosemia; of course, these diets may not be followed during the adolescence.",Non-OADS,/arxiv_data1/oa_pdf/8d/05/IJPD-23-493.PMC4006495.pdf
http://apps.who.int/gb/archive/ pdf_files/EB116/B116_3 -en.pdf.,OADS,/arxiv_data1/oa_pdf/8d/05/IJPD-23-493.PMC4006495.pdf
http://fhc.sums.ac.ir/files/gh -vagir/screening.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/05/IJPD-23-493.PMC4006495.pdf
"Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )    Alpha 1 Antitrypsin Deficiency in Infants with Neonatal Cholestasis    Maryam Monajemzadeh 1,2 , MD; Reza Shahsiah 1 ,	MD; Mohammad Vasei 1 ,	MD; Parin Tanzifi 1 ,	MD,                                   Nima Rezaei 3,4 ,	MD, PhD; Mehri Najafi 5,6 ,	MD, Narjes Soleimanifar 1 , Maryam Eghbali 1    1.",Non-OADS,/arxiv_data1/oa_pdf/b1/93/IJPD-23-501.PMC4006496.pdf
"    502   Alpha 1 Antitrypsin Deficiency in  I nfants with  N eonatal  C holestasis     Iran J Pediatr; Vol 23 (No  5 ) ,  Oct   2 013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  long	arm	of	chromosome	14	which	is	inherited	as	 autosomal	codominant	fashion [6-8] .",Non-OADS,/arxiv_data1/oa_pdf/b1/93/IJPD-23-501.PMC4006496.pdf
"     503  Monajemzadeh M , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 1:	Primers	and	polymerase	chain	reaction	product	characteristics	 Primer name  Sequence 5'--> 3'  Product size (bp)  ATS Forward  ATACCTGGGCAATGCCAC	 150	 ATS Reverse  AGCTTCTTGGTCACCCTCAG	 ATZ Forward  GGGATCAGCCTTACAACGTG	 154	 ATZ Reverse  GGGTTTGTTGAACTTGACCTC	 													ATS:	Alpha	one	antitrypsin	S	allele;	ATZ:	Alpha	one	antitrypsin	Z	allele		 Diagnostics,	Indianapolis,	IN),	as	instructed	by	the	 manufacturer.",Non-OADS,/arxiv_data1/oa_pdf/b1/93/IJPD-23-501.PMC4006496.pdf
"    504   Alpha 1 Antitrypsin Deficiency in  I nfants with  N eonatal  C holestasis     Iran J Pediatr; Vol 23 (No  5 ) ,  Oct   2 013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 3: Demographic	data	of	cases	after	biopsy	and	final	diagnosis   Final diagnosis   (based on pathology findings and clinical data)  Mean (SD) age at biopsy  (days)  Gender  Idiopathic neonatal hepatitis  62	(18)		 Female:	32	 Male:	41	 Neonatal hepatitis in favor of Metabolic liver disease  57	(15)		 Female:		5	 Male:	4	 Paucity of intrahepatic bile ducts  68	(12)		 Female:	1	 Male:	2	 Granulomatous hepatitis and CMV infection  48	and	67		 Female:	1	 Male:	1	 									SD:	Standard	Deviation	 median	age	of	60	days	(mean	age	of	62Â±31	days,	 ranging	 from	 7	 to	 120	 days).",Non-OADS,/arxiv_data1/oa_pdf/b1/93/IJPD-23-501.PMC4006496.pdf
"     505  Monajemzadeh M , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  white	populations	(9%	MS,	3%	MZ) [19] .",Non-OADS,/arxiv_data1/oa_pdf/b1/93/IJPD-23-501.PMC4006496.pdf
"    506   Alpha 1 Antitrypsin Deficiency in  I nfants with  N eonatal  C holestasis     Iran J Pediatr; Vol 23 (No  5 ) ,  Oct   2 013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  adult	patients,	which	cannot	be	compared	to	our	 result.",Non-OADS,/arxiv_data1/oa_pdf/b1/93/IJPD-23-501.PMC4006496.pdf
"     507  Monajemzadeh M , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  22.",Non-OADS,/arxiv_data1/oa_pdf/b1/93/IJPD-23-501.PMC4006496.pdf
"Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Measuring New Born Foot Length to Identify Small Babies in Need of Extra Care:    a Cross-Sectional Hospital Based Study   Satarupa Mukherjee*, MBBS; Prithwish Roy, MBBS; Souvik Mitra, MD; Moumita Samanta, MD;                             Sukanta Chatterjee, MD   Department of Pediatrics, Medical College and Hospital, Kolkata, India   Received: Jul 27, 2012 ; Accepted: Feb 24, 2013; First Online Available: Mar 06, 2013   Abstract   Objective:  The neonatal mortality rate (NMR) continues to remain quite high, one important cause being  preterm deliveries.",Non-OADS,/arxiv_data1/oa_pdf/d3/e6/IJPD-23-508.PMC4006497.pdf
"     509  Mukherjee S, et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  care.",Non-OADS,/arxiv_data1/oa_pdf/d3/e6/IJPD-23-508.PMC4006497.pdf
"    510   Foot Length  f or Scr eening Babies  in Need o f Extra Care    Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  sensi speci   00.20.40.60.811.2 3.3 4 .45 4 .95 5 .45 5 .65 5 .85 6 .05 6 .25 6 .45 6 .65 6 .85 7 .05 7 .25 7 .45 7 .65 7 .85 8 .05 8 .25 8 .45 8 .65 8 .85 9 .05 1 0.2   Fig.",Non-OADS,/arxiv_data1/oa_pdf/d3/e6/IJPD-23-508.PMC4006497.pdf
"     511  Mukherjee S, et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  project had trained birth attendants as the main  anchor for delivery of neonatal care.",Non-OADS,/arxiv_data1/oa_pdf/d3/e6/IJPD-23-508.PMC4006497.pdf
"    512   Foot Length  f or Scr eening Babies  in Need o f Extra Care    Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Acknowledgment   This study has been approved by the Institutional Ethics  Committee, Medical College, Kolkata, India.",Non-OADS,/arxiv_data1/oa_pdf/d3/e6/IJPD-23-508.PMC4006497.pdf
"Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Cardiovascular Involvement in Children with Osteogenesis Imperfecta Hamdollah Karamifar , MD;Homa Ilkhanipoor *, MD;Gholamhossein Ajami , MD;Zohreh Karamizadeh , MD; Gholamhossein Amirhakimi , MD;Ali-Mohammad Sha kiba, MD Department of Pediatric s,Namazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran Received: Dec15, 2012; Accepted: Jun04, 2013;First Online Available :Jul14,2013 Abstract Objective :Osteogenesis imperfecta is a hereditary dise ase resulting from mutation in type I procollagen genes.",Non-OADS,/arxiv_data1/oa_pdf/7f/d3/IJPD-23-513.PMC4006498.pdf
"514 Cardiovascular Involvement in Children with Osteogenesis Imperfecta Iran J Pediatr; Vol 23 (No 5), Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )widely used.",Non-OADS,/arxiv_data1/oa_pdf/7f/d3/IJPD-23-513.PMC4006498.pdf
"516 Cardiovascular Involvement in Children with Osteogenesis Imperfecta Iran J Pediatr; Vol 23 (No 5), Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 3: Aortic dimensions at aorta annuls, sinotubular junction, ascending aorta and descending aorta and corrected values for BSA in osteogenesis imperfecta  and control groups ParameterOsteogenesis Imperf ecta Group(n= 24)ControlGroup (n=24)P.value Aorta annulus (cm) 1.25 (0.35) 1.21 (0.36) 0.6 Aorta annulus/BSA (cm/m2) 2.38 (0.41) 1.84 (0.37) <0.01 Sinotubular junction (cm) 1.27 (0.37) 1.36 (0.40) 0.5 Sinotubular junction/BSA (cm/m2) 2.41 (0.51) 2.07 (0.44) 0.01 Ascending aorta (cm) 1.30 (0.31) 1.17 (0.36) 0.2 Ascending aorta/BSA (cm/m2) 2.53 (0.69) 1.77 (0.27) <0.01 Descending aorta (cm) 0.89 (0.20) 0.86 (0.25) 0.6 Descending aorta/BSA (cm/m2) 1.74 (0.41) 1.32 (0.21) <0.01 BSA: body surface a rea and patent ductus arteriosus (PDA).",Non-OADS,/arxiv_data1/oa_pdf/7f/d3/IJPD-23-513.PMC4006498.pdf
"518 Cardiovascular Involvement in Children with Osteogenesis Imperfecta Iran J Pediatr; Vol 23 (No 5), Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )8.Eufemia P, Celli M, Versacci P, et al.",Non-OADS,/arxiv_data1/oa_pdf/7f/d3/IJPD-23-513.PMC4006498.pdf
"Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )A Novel Method for Quantification of Left Ventricular Noncompaction Using Two - Dimensional Echocardiography in Children Ahmad G hameiKhosroshahi1, MD; Keyhan Sayadpour Zanjani*2, MD; Armen Kocharian2, MD; Aliakbar Zeinaloo2, MD; Abdolrazagh Kiani2, MD;Elaheh Malakan Rad2, MD 1.Department of Pediatric s, Urmia University of Medical Sciences, Urmia, Iran 2.Department of Pediatric s, Tehran University of Medical Sciences, Tehran, Iran Received: Sep28, 2012; Accepted: May08, 2013;FirstOnlineAvailable :Jun10,2013 Abstract Objective :Although there are several echocardiographic criteria, there is not yet a general consensus about the diagnosis of left ventricular noncompaction.",Non-OADS,/arxiv_data1/oa_pdf/07/5a/IJPD-23-519.PMC4006499.pdf
"520 A Novel Method for Quantification of Left Ventricular Noncompaction Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )noncompaction (HT/NC) instead[5].",Non-OADS,/arxiv_data1/oa_pdf/07/5a/IJPD-23-519.PMC4006499.pdf
"521 Khosroshahi GA,et al Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Te hran University of Medical Sciences (http://ijp.tums.ac.ir ) Fig.1:The parameters required to calculate the percentage of hy pertrabeculated/noncompacted myocardium.",Non-OADS,/arxiv_data1/oa_pdf/07/5a/IJPD-23-519.PMC4006499.pdf
"522 A Novel Method for Quantification of Left Ventricular Noncompaction Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 2:Left ventricular hypertrabeculation/noncompaction percentage at three different levels in the left ventricle LevelControl Mean (SD)DCMP Mean (SD)LVNC Mean (SD)P.value* Apical 1.75(2.25) 9.76(7.35) 31.3(21.6) <0.001 Papillary Muscle 4.22(3.78) 7.91(6.35) 32.5(20.1) 0.02 Mitral Valve 4.80(6.09) 8.89(8.23) 40.7(38.0) 0.049 Average 3.59(2.27) 8.86(5.52) 34.7(26.1) <0.001 SD: Standard Deviation; DCMP:dilated cardiomyopath y; LVNC:left ventricular noncompaction; * comparing the averages in DCMP and control groups described and based on X -to-Y ratios at 3 levels (mitral valve, papillary muscle, and apex)[6].",Non-OADS,/arxiv_data1/oa_pdf/07/5a/IJPD-23-519.PMC4006499.pdf
"523 Khosroshahi GA,et al Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Te hran University of Medical Sciences (http://ijp.tums.ac.ir )ischemic heart disease, DCM, valvular heart disease, and left ventricular hypertrophy patients, and normal subjects[17].",Non-OADS,/arxiv_data1/oa_pdf/07/5a/IJPD-23-519.PMC4006499.pdf
"524 A Novel Method for Quantification of Left Ventricular Noncompaction Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/07/5a/IJPD-23-519.PMC4006499.pdf
"Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Posterior Urethral Valves; A single Center Experience   Alireza Mirshemirani* 1 , MD; Ahmad Khaleghnejad 1 , MD; Mohsen Rouzrokh 1 , MD; Afsaneh Sadeghi 2 , MD;  Leila Mohajerzadeh 1 , MD; Mustafa Sharifian 3 , MD    1.",Non-OADS,/arxiv_data1/oa_pdf/25/73/IJPD-23-531.PMC4006501.pdf
"    532   Posterior Urethral Valves     Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  urethra (Type 1), Valves as leaflets radiating from  the verumontanum proximally to the bladder neck  (Type 2.)",Non-OADS,/arxiv_data1/oa_pdf/25/73/IJPD-23-531.PMC4006501.pdf
"     533  Mirshemirani A , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 1:  Symptoms and signs in posterior urethral valves patients  Symptoms  Frequency   Dribbling and poor stream  50 (51%)  Urinary tract infection  40 (40.8%)  Fever  5 (5.1%)  Hematuria  2 (2.1%)  Hypertension  1 (1%)  Total  98 (100%)    patients to relieve obstruction, normal urine  stream, and correction of urea, creatinine and  electrolytes.",Non-OADS,/arxiv_data1/oa_pdf/25/73/IJPD-23-531.PMC4006501.pdf
"    534   Posterior Urethral Valves     Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 3:  Long term outcome of posterior urethral valves   %   Patients (n=98)   Outcome   46   45   Acute  r enal  f ailure    15.3   15   Residual valve   7.1   7   Stricture    6.",Non-OADS,/arxiv_data1/oa_pdf/25/73/IJPD-23-531.PMC4006501.pdf
"     535  Mirshemirani A , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  References  1.",Non-OADS,/arxiv_data1/oa_pdf/25/73/IJPD-23-531.PMC4006501.pdf
"Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Migraine and Tension-Type Headache in Children and Adolescents Presenting to  Neurology Clinics   Azita Tavasoli* 1 , MD; Mehran Aghamohammadpoor 2 , MD; Meygol Taghibeigi 3 , MD    1.",Non-OADS,/arxiv_data1/oa_pdf/ad/eb/IJPD-23-536.PMC4006502.pdf
"     537  Tavasoli A , et al   Iran J Pediatr; Vol 23 (N o  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  examinations are normal and no clear underlying  cause is evident [3,7] .",Non-OADS,/arxiv_data1/oa_pdf/ad/eb/IJPD-23-536.PMC4006502.pdf
    538   Migraine and Tension - Type Headache in  Children and Adolescents     Iran J Pediatr; Vol 23 (No  5 ) ;  O ct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 2: The clinical presentations of aura in patients with migraine  Type of aura  Numbers of patients  Visual disturbance  5  Confusion   3  Vertigo   2  Monoparesis   2  Paresthesia in extremities   2  Dysarthria   2  Lightheadedness   1  Hemiparesis   1    Table 2.,Non-OADS,/arxiv_data1/oa_pdf/ad/eb/IJPD-23-536.PMC4006502.pdf
"     539  Tavasoli A , et al   Iran J Pediatr; Vol 23 (N o  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  no gender differences were seen between the  patients with migraine or tension-type headache  in the age group 4-9 years.",Non-OADS,/arxiv_data1/oa_pdf/ad/eb/IJPD-23-536.PMC4006502.pdf
    540   Migraine and Tension - Type Headache in  Children and Adolescents     Iran J Pediatr; Vol 23 (No  5 ) ;  O ct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Acknowledgment  This manuscript is prepared according to the thesis of  Meigol Taghibeigi (code 4887) documented in year  2010 for acquisition of degree of general  physician.,Non-OADS,/arxiv_data1/oa_pdf/ad/eb/IJPD-23-536.PMC4006502.pdf
"Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Is Pneumothorax Size on Chest X-Ray a Predictor of Neonatal Mortality?",Non-OADS,/arxiv_data1/oa_pdf/3a/12/IJPD-23-541.PMC4006503.pdf
"    542   Is Pneumothorax Size on Chest X - Ray  a   Predictor of Neonatal Mortality    Iran J Pe diatr; Vol 23 (No  5 ), Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  significance of this calculation in neonates is still  unknown.",Non-OADS,/arxiv_data1/oa_pdf/3a/12/IJPD-23-541.PMC4006503.pdf
"     543  Arun Ozer E , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )    Fig.",Non-OADS,/arxiv_data1/oa_pdf/3a/12/IJPD-23-541.PMC4006503.pdf
"    544   Is Pneumothorax Size on Chest X - Ray  a   Predictor of Neonatal Mortality    Iran J Pe diatr; Vol 23 (No  5 ), Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )    Table 2: Statistical analysis of significance in predicting mortality   Variables  Survivors   (n=42)  Non-survivors   (n=18)  P. value  Gestational age (week)* 34.5 (0.7) 31.3 (0.8) 0.006  Birth weight (g)*  2575 (134)   1716 (177)  0.001  Gender (male/ female) 33/9 12/6 0.3  Type of delivery (vaginal vs C/S)  12/30  5/13  0.9  Resuscitation at birth 28 16 0.07  Surfactant therapy  16  10  0.2  Time of diagnosis (hour)* 31.6 (6.9) 49.7 (16.6) 0.2  Mechanical ventilation  19  18  0.006  Chest tube insertion 19 16 0.01  Pneumothorax size (%)  16.4 (1.4)  31.1 (2.8)  < 0.001  * Data are presented as mean (Â±standard deviation)  that only pneumothorax size was the independent  prognostic factor ( P=0.02).",Non-OADS,/arxiv_data1/oa_pdf/3a/12/IJPD-23-541.PMC4006503.pdf
"     545  Arun Ozer E , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  ray is also a less expensive method.",Non-OADS,/arxiv_data1/oa_pdf/3a/12/IJPD-23-541.PMC4006503.pdf
"Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Mortality Risk Prediction by Application of Pediatric Risk of Mortality Scoring  System in Pediatric Intensive Care Unit   Ali Khajeh 1 , MD; Noor Mohammad Noori 1 , MD; Mohsen Reisi 1 , MD; Afshin Fayyazi 2 , MD;                                                 Mahdi Mohammadi 1 , PhD; Ghasem Miri-Aliabad 1 *, MD   1.",Non-OADS,/arxiv_data1/oa_pdf/b5/1b/IJPD-23-546.PMC4006504.pdf
"     547  Khajeh A , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  score is used in PICU and needs observation  during the first 24 hours of admission.",Non-OADS,/arxiv_data1/oa_pdf/b5/1b/IJPD-23-546.PMC4006504.pdf
"    548   Mortality Risk Prediction by Application of  PRISM    Iran J Pediatr; Vol   23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 2: Outcome based on the type of disease  Median Survival (month)  Mortality (%)  no  Underlying Disease  35  10 (15.2)  66  Neurologic  12  14 (25)  56  Infectious  -  7 (21.2)  33  Hematologic and malignant disorders  13  6 (18.2)  33  Respiratory  10  6 (28.6)  21  Renal and metabolic  25  4 (33.3)  12  Gastrointestinal         According to time and rate of mortality, seven  (87.5%) of the eight patients who were admitted  at day 0-0.33 to PICU died.",Non-OADS,/arxiv_data1/oa_pdf/b5/1b/IJPD-23-546.PMC4006504.pdf
"     549  Khajeh A , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 4: Predictive model for the patient situation in hospitalized PICU patients  Alive  Deaths  Total No  PRISM  Score  Expected  Observed  Expected (%)  Observed (%)  140.1  141  16.9 (10.8)  16 (10.2)  157  1-10  29.8  28  15.2 (33.8)  17 (37.8)  45  11-20  4.1  5  14.9 (78.4)  14 (73.7)  19  21-30  PICU: Pediatric intensive care unit; Hosmer-Lemeshow Chi-square=0.62; df=3; P. value=0.8       Qureshi et al [9]  indicate that by use of statistical  analyses such as Hosmer, odds ratio, Spearman  correlation test, ROC, Lemeshow Goodness-of-Fit,  PRISM scoring system is a good predictor of  mortality rate in PICU.",Non-OADS,/arxiv_data1/oa_pdf/b5/1b/IJPD-23-546.PMC4006504.pdf
"    550   Mortality Risk Prediction by Application of  PRISM    Iran J Pediatr; Vol   23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Acknowledgment  We acknowledge the Children and Adolescent Health  Research Center and Clinical Research Development  Center of Ali-ebne-Abitaleb Hospital, Zahedan, Iran, for  their assistance in preparing the manuscript.",Non-OADS,/arxiv_data1/oa_pdf/b5/1b/IJPD-23-546.PMC4006504.pdf
"Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Association between Helicobacter pylori , cagA , and vacA  Status and Clinical  Presentation in Iranian Children  Mandana Rafeey, MD; Reza Ghotaslou*, MD, PhD; Morteza Milani, PhD; Nima Farokhi, MD;                                          Morteza Ghojazadeh, MD, PhD    Tabriz University of Medical Sciences, Tabriz, Iran   Received: Jan 19, 2013 ; Accepted: Jun 29, 2013; First Online Available: Aug 15, 2013   Abstract   Objective:  Seroprevalence of H. pylori  infection in Iran exceeds 65% of pediatric population.",Non-OADS,/arxiv_data1/oa_pdf/39/00/IJPD-23-551.PMC4006505.pdf
"    552   Association  between   Helicobacter Pylori, Caga, and Vaca Status and Clinical Presentation in Children    Iran J Pediatr; Vol 23 (No  5 ) , Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  not predict the presence of a clinically significant  outcome [10] .",Non-OADS,/arxiv_data1/oa_pdf/39/00/IJPD-23-551.PMC4006505.pdf
"     553  Rafeey M , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 1: Demographic characteristics of patients, endoscopic and histopathology findings (n=106)   Frequency (%)  Levels   Variables   52 (49.1)  Male  Gender  54 (50.9)  Female  4 (3.8) Ulcer   Endoscopic finding 104 (98.1) Erythema  10 (9.4) Congestion  8 (7.5) Erosion  53 (50) Nodular gastritis  15 (14.2)  Acute gastritis   Pathologic finding  81 (76.4)  Chronic gastritis  82 (77.4)  Duodenitis  3 (2.8)  Atrophy  95 (89.6)  Esophagitis  62 (58.5) Negative   H. pylori  density 39 (36.8) Mild positive  4 (3.8) Moderate positive  1 (0.9) Severe positive  88 (83)  Recurrent epigastric pain  Chief complaint   24 (22.6)  Vomiting  5 (4.7)  Chronic diarrhea  22 (20.8)  Failure to thrive  8 (7.5)  GI bleeding    adjusted by age ( P=0.8), sex ( P=0.2) and other  demographic data.",Non-OADS,/arxiv_data1/oa_pdf/39/00/IJPD-23-551.PMC4006505.pdf
"    554   Association  between   Helicobacter Pylori, Caga, and Vaca Status and Clinical Presentation in Children    Iran J Pediatr; Vol 23 (No  5 ) , Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )    Table 3:  Comparison of demographic data and vacA subgroups  P. value  M2 (%)   M1 (%)  S2 (%)  S1 (%)   Level   Variables   0.5  8.72 (1.45)  9.63 (1.89)  8.09 (1.09)  9.36 (1.21)  Mean(SE)  Age (years)   0.01 15 (60) 1 (12.5) 8 (72.7) 8 (36.4) Male Gender 10 (40) 7 (87.5) 3 (27.3) 14 (63.6) Female  0.5  1 (4)  0 (0)  1 (9.1)  0 (0)  Congestion   Endoscopic  finding  0.4  1 (4)  1 (12.5)  0 (0)  2 (9.1)  Erosion  0.4  2 (8)  0 (0)  1 (9.1)  1 (4.5)  Ulcer   0.5  24 (96)  8 (100)  11 (100)  21 (95.5)  Erythema  0.07  13 (52)  7 (87.5)  7 (63.6)  13 (59.1)  Nodular gastritis  0.4 15 (60) 6 (75) 6 (54.5) 15 (68.6) Chronic gastritis   Pathologic  finding 0.6 9 (36) 2 (25) 5 (45.5) 6 (27.3) Acute gastritis  0.6 16 (64) 6 (75) 9 (81.8) 13 (59.1) Duodenitis  0.7 23 (92) 7 (87.5) 11 (100) 19 (86.4) Esophagitis  0.6 1 (4) 0 (0) 1 (9.1) 0 (0) Atrophy  0.8  8 (32)  4 (50)  3 (27.3)  9 (40.9)  Negative   H. pylori  density  15 (60)  4 (50)  7 (63.6)  12 (54.5)  Mild positive  1 (4)  0 (0)  1 (9.1)  0 (0)  Moderate positive  1 (4)  0 (0)  0 (0)  1 (4.5)  Severe positive  0.2 21 (84) 8 (100) 11 (100) 18 (81.8) Epigastric pain  Chief  complaint  <0.001 3 (12) 6 (75) 1 (9.1) 8 (36.4) Vomiting  0.6 1 (4) 0 (0) 0 (0) 1 (4.5) Chronic diarrhea  0.6 5 (20) 1 (12.5) 2 (18.2) 4 (18.2) Failure to thrive  0.3 3 (12) 0 (0) 1 (9.1) 2 (9.1) GI bleeding  0.7  17 (68)  7 (87.5)  5 (45.5)  19 (80.4)    cagA    were rather significantly more common ( P=0.07)  in patients with nodular gastritis.",Non-OADS,/arxiv_data1/oa_pdf/39/00/IJPD-23-551.PMC4006505.pdf
"     555  Rafeey M , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )       Our results revealed that cagA  and vacA   subtype m1 H. pylori  strains were especially  associated with nodular gastritis in Azerbaijan  province.",Non-OADS,/arxiv_data1/oa_pdf/39/00/IJPD-23-551.PMC4006505.pdf
"    556   Association  between   Helicobacter Pylori, Caga, and Vaca Status and Clinical Presentation in Children    Iran J Pediatr; Vol 23 (No  5 ) , Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  gastritis, duodenal ulcer or gastric carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/39/00/IJPD-23-551.PMC4006505.pdf
"Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Effect of Oral Ondansetron on Decreasing the Vomiting Associated with Acute  Gastroenteritis in Iranian Children  Kioomars   Golshekan, MD; Hamidreza Badeli*, MD; Saman Rezaieian, MD; Haniyeh Mohammadpour, MD;                   Afagh Hassanzadehrad, BS    Pediatrics Growth Disorders Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran  Received: Oct 13, 2012 ; Accepted: Jun 21, 2013; First Online Available: Jul 24, 2013   Abstract   Objective:  The aim of this study was to determine the effect of oral ondansetron in decreasing the vomiting  due to acute gastroenteritis in children.",Non-OADS,/arxiv_data1/oa_pdf/9e/67/IJPD-23-557.PMC4006506.pdf
"    558   Effect of oral Ondansetron on Decreasing the Vomiting      Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  particular, between 2% and 23% of children with  gastroenteritis received prescriptions for  antiemetic medications [7]  and many physicians  believe that vomiting is a contraindication to oral  rehydration therapy (ORT) [8] .",Non-OADS,/arxiv_data1/oa_pdf/9e/67/IJPD-23-557.PMC4006506.pdf
"     559  Golshekan K,  et al   Iran J Pediatr; Vol 23 (No  5 ), Oct  2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 1: Approximate amount of oral rehydration therapy to give in the first 4 hours [16]    Age  Less than 4  months  4 â   11  months  12 â   23  months  2  â   4  years  5  â   14  years  15 years or  older  Weight   Less than 5 kg   5 - 7.9 kg   8 - 10.9 kg   11 - 15.9   kg   16 - 29.9   kg   30 kg or more   In ml   200 - 400   400 - 600   600 - 800   800 - 1200   1200 - 2200   2200 - 4000        Thirty minutes after the medication was given,  ORT was initiated and continued based on the  WHO recommendations on ORT.",Non-OADS,/arxiv_data1/oa_pdf/9e/67/IJPD-23-557.PMC4006506.pdf
"    560   Effect of oral Ondansetron on Decreasing the Vomiting      Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )     Findings  During the study period, 202 patients aged 1 to 10  years were approached for study enrollment and  176 eligible patients were randomly assigned to  two treatment groups.",Non-OADS,/arxiv_data1/oa_pdf/9e/67/IJPD-23-557.PMC4006506.pdf
"     561  Golshekan K,  et al   Iran J Pediatr; Vol 23 (No  5 ), Oct  2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 3: Primary outcomes of the study of the study in the ondansetron and placebo groups    Outcome    Ondansetron  Placebo  P. value  No of vomiting episodes during ED stay (4 hours)  Persistent vomiting  Vomiting cessation  10  78  14  74  >0.05  No of vomiting episodes during 48 hours follow-up  Persistent vomiting  Vomiting cessation  22  60  31  52  >0.05  Failure in oral re-hydration therapy  Fail  Success  12  70  24  59  0.04  Failure in oral re-hydration therapy  according to  sex   Male  Fail  Success  7  44  18  31  0.01  Female  Fail    Success  5  26  6  28  >0.05  Failure in oral re-hydration therapy  according to age range  â¤2 yr  Fail  Success  7  37  9  28  >0.05  2-3 yr    Fail  Success  2  11  9  9  0.047  3-4 yr  Fail  Success  1  6  4  8  >0.05  4-5 yr  Fail  Success  1  6  1  6  >0.05  5-10 yr    Fail  Success  1  10  1  8  >0.05  Failure in oral re-hydration therapy  according to weight   â¤10 kg  Fail  Success  3  8  1  7  >0.05  10-20 kg  Fail  Success  6  49  21  40  0.004  â¥20 kg  Fail  Success  3  13  2  12  >0.05  Beginning of diarrhea and vomiting  â¤6  Fail  Success  0  9  4  4  0.03  6-12  Fail  Success  6  40  14  36  0.08  12-18  Fail  Success  4  17  4  14  >0.05  18-24  Fail  Success  2  4  2  5  >0.05  No.",Non-OADS,/arxiv_data1/oa_pdf/9e/67/IJPD-23-557.PMC4006506.pdf
"    562   Effect of oral Ondansetron on Decreasing the Vomiting      Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 5: Effect of confounding factors on failure of oral rehydration therapy by regression logistic   Parameter   Exp   ( Î² )   S.E   P .",Non-OADS,/arxiv_data1/oa_pdf/9e/67/IJPD-23-557.PMC4006506.pdf
"     563  Golshekan K,  et al   Iran J Pediatr; Vol 23 (No  5 ), Oct  2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  2.",Non-OADS,/arxiv_data1/oa_pdf/9e/67/IJPD-23-557.PMC4006506.pdf
Available at:  http://www.cincinnatichildrens.org/svc/alpha/h/  health-policy/ev-based/gastro.htm.,Non-OADS,/arxiv_data1/oa_pdf/9e/67/IJPD-23-557.PMC4006506.pdf
"Iran J Pediatr; Vol 23 (No  5 ) , Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Effectiveness of Regular Breathing Technique (Hey-Hu) on Reduction of  Intrathecal Injection Pain in Leukemic Children: A Randomized Clinical Trial   Zahra Pourmovahed *1 , MSc; Khadije Dehghani 1 , MSc; Asghar Sherafat 2 , MSc    1.",Non-OADS,/arxiv_data1/oa_pdf/49/df/IJPD-23-564.PMC4006507.pdf
"     565  Pourmovahed Z,  et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  pain control in invasive procedures significantly  reduce pain and stress.",Non-OADS,/arxiv_data1/oa_pdf/49/df/IJPD-23-564.PMC4006507.pdf
"    566   Effectiveness of Regul ar Breathing Technique  on Reduction of  IT Inj ection Pain     Iran J Pediatr; Vol 2 3 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )    Fig.",Non-OADS,/arxiv_data1/oa_pdf/49/df/IJPD-23-564.PMC4006507.pdf
"     567  Pourmovahed Z,  et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Table 2:  Mean pain intensity according to age group in in the study and control groups  Age group  Comparison Group    Below 10 years  Above 10 years  Total  Mean (SD)  Mean (SD)  Mean (SD)  Regular breathing  3.92 (1.17)  1.86 (1.51)  2.98 (1.68)  Control  3.86 (1.25)  3.61 (1.50)  3.80 (1.30)  Total  3.89 (1.20)  2.50 (1.71)  3.39 (1.55)  P. value  0.9  0.004  0.01                                  SD: Standard Deviation   the effectiveness of Hey-Hu breathing technique in  reduction of pain intensity.",Non-OADS,/arxiv_data1/oa_pdf/49/df/IJPD-23-564.PMC4006507.pdf
"    568   Effectiveness of Regul ar Breathing Technique  on Reduction of  IT Inj ection Pain     Iran J Pediatr; Vol 2 3 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  References  1.",Non-OADS,/arxiv_data1/oa_pdf/49/df/IJPD-23-564.PMC4006507.pdf
"Iran J Pediatr; Vol 23 (No 5), Oct 2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )   The Effect of Positive Family History of Autoimmunity in Juvenile Idiopathic  Arthritis Characteristics; a Case Control Study   Mehdi Khani1, MD; Vahid  Ziaee*2,3,4, MD; Mohamad -Hassan Moradinejad3,4, MD; Nima Parvaneh3,5, MD   1.",Non-OADS,/arxiv_data1/oa_pdf/71/f5/IJPD-23-569.PMC4006508.pdf
"   570   Positive Family History of Autoimmunity in JIA    Iran J Pediatr; Vol 23 (No  5), Oct 2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )   clearly understood but it  is believed to be an  autoimmune disease, in which genes and  environmental factors both are responsible for its  development[4].",Non-OADS,/arxiv_data1/oa_pdf/71/f5/IJPD-23-569.PMC4006508.pdf
"   571  Khani M , et al  Iran J Pediatr; Vol 23 (No 5), Oct 2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )   Table  1: Autoimmune disease in patientsâ families   Variable  no ( %)  Rheumatoid Arthritis or Juvenile Idiopathic Arthritis  8 (50)   Systemic Lupus Erythematous  2 (12.5 )  Graves  disease  2 (12.5)   Behcet disease  1 (6.25)   Dermatomyositis  1 (6.25)   Polychondritis  1 (6.25)   Psoriasis  1 (6.25)          Table 2 compares two series of patients with  and without family history.",Non-OADS,/arxiv_data1/oa_pdf/71/f5/IJPD-23-569.PMC4006508.pdf
"   572   Positive Family History of Autoimmunity in JIA    Iran J Pediatr; Vol 23 (No  5), Oct 2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )   was lacking, 4 patients were missing data for ADA  study, 8 patients were  missing data for ADA study.",Non-OADS,/arxiv_data1/oa_pdf/71/f5/IJPD-23-569.PMC4006508.pdf
"   573  Khani M , et al  Iran J Pediatr; Vol 23 (No 5), Oct 2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )   Conclusion   JIA patients with family history of autoimmune  disease have some differences with population - based JIA patients according to age of onset,  duration of acti ve disease, subtype, ANA, ADA, and  these findings are somehow similar to studies on  familial JIA but also different from them with  respect to duration of active disease, subtype and  ANA.",Non-OADS,/arxiv_data1/oa_pdf/71/f5/IJPD-23-569.PMC4006508.pdf
"Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Intrasphincteric Botulinum Toxin Injection in Treatment ofChronicIdiopathic Constipation in Children Javad Ahmadi , MD;Saeedeh Azary , MD;Bahar Ashjaei *, MD;Pedram Paragomi , MD;Amin Khalifeh -Soltani, MD Department of Pediatric Surgery, Childrenâs M edical Center, Tehran University of Medical Science s, Tehran, Iran Received: Jan 06, 2012 ; Accepted: Dec 15, 2012 ;FirstOnlineAvailable :Oct 02, 2013 Abstract Objective :Injection of botulinum toxin into the anal sphincter is a novel and safe new trea tment of chronic idiopathic constipation and anal fissure in children.",Non-OADS,/arxiv_data1/oa_pdf/c2/c3/IJPD-23-574.PMC4006509.pdf
"576 Intrasphincteric Botulinum Toxin Injection in chronic Constipation Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 1:Symptoms of chronic constipation before and after botox injection SymptomsBeforebotox injectionAfterbotox injectionP.value painful defecation 87.5 % 15 % 0.0001 Stool condensation 80 % 27.5 % 0.0001 Soiling 62.5% 7.5 % 0.0001 Defecation interval more than 3 days 100 % 15 % 0.0001 to 15% after botox injection.",Non-OADS,/arxiv_data1/oa_pdf/c2/c3/IJPD-23-574.PMC4006509.pdf
"578 Intrasphincteric Botulinum Toxin Injection in chronic Constipation Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Hirschsprungâs disease.",Non-OADS,/arxiv_data1/oa_pdf/c2/c3/IJPD-23-574.PMC4006509.pdf
"Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Outcome of Very Low Birth Weight Infants Over 3 Years Report From an Iranian Center Seyyed-Abolfazl Afjeh, MD*1; Mohammad -Kazem Sabzehei, MD2; Minoo Fallahi, MD1; Fatemeh Esmaili, BS1 1.Mahdieh Medical Center, Shahid Beheshti University of Medical Science s, Tehran, Iran 2.Hamedan University of Medical Sciences, Hamedan, Iran Received: Dec17, 2012; Accepted: Jul10, 2013;FirstOnlineAvailable :Sep27,2013 Abstract Objective :Very low birth weight (VLBW) infants are at high risk for morbidity and mortali ty.This article determine sthe frequency of disease ,rate odsurvival, complications and risk factors for morbidity and mortality in VLBW neonates admitted toa level III neonatal intensive care unit (NICU) at Mahdieh Hospital in Tehran.",Non-OADS,/arxiv_data1/oa_pdf/02/34/IJPD-23-579.PMC4006510.pdf
"580 Outcome of VLBW Infants Over 3 Years, Report From an Iranian Center Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )of this study is to determine the frequency of disease,rate ofsurvival, complications and risk factors for morbidity and mortality in VLBW neonates admitted toa level III neonatal intensive care unit at Mahdieh Hospita l in Tehran.",Non-OADS,/arxiv_data1/oa_pdf/02/34/IJPD-23-579.PMC4006510.pdf
"581 Afjeh SA,et al Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table1:Demographic and perinatal characteristics of study population Characteristic No.",Non-OADS,/arxiv_data1/oa_pdf/02/34/IJPD-23-579.PMC4006510.pdf
"582 Outcome of VLBW Infants Over 3 Years, Report From an Iranian Center Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table2:Antenatal and perinatal risk factors (variables) in dead and alive neonates Parameter Characteristic Alive (n=400) Dead (n=164) OR 95%CI P.Value GenderFemale 201 (73.4%) 73 (26.6%) 10.87-1.81 0.2Male 199 (68.6%) 91 (31.4%) 1.26 Birth weight (gm)1275.53(189.15) 944.45(253.37) 0.54 <=750 3 (7.1%) 39 (92.9%) 167.63 0.48-0.6<0.001 751-1000 46 (43.8%) 59 (56.2%) 16.54 47.38-593.14 <0.001 1001-1250 106 (69.3%) 47 (30.7%) 5.72 9.03-30.3 <0.001 1251-1500 245 (92.8%) 19 (7.2%) 1 3.2-10.21 <0.001 Gestational age (w)30.55(2.25) 27.56(2.03) 0.49 â¤28 72 (36.7%) 124 (63.3%) 6.89 0.43-0.56 <0.001 29-32 264 (87.7%) 37 (12.3%) 0.56 0.76-62.83 0.09 33-36 60 (96.8%) 2 (3.2%) 0.13 0.06-5.15 0.6 â¥ 37 4 (80%) 1 (20%) 1 0.01-1.8 0.1 Gestational age<28w 27 (24.5%) 83 (75.5%) 14.16 8.62-23.25 <0.001 â¥28w 373 (82.2%) 81 (17.8%) Delivery modeCesarean 314 (75.5%) 102 (24.5%) 1 1.49-3.3<0.001 Vaginal 86 (58.1%) 62 (41.9%) 2.22 PrimigravidaYes 230 (71.2%) 93 (28.8%) 0.97 0.67-1.4 0.9 No 170 (70.5%) 71 (29.5%) PluralitySingleton 233 (69.8%) 101 (30.2%) 1 0.6-1.26 0.5 Multiple 167 (72.6%) 63 (27.4%) 0.87 Maternal age 28.26(5.61) 28.3(6.98) 1 0.97-1.03 0.9 Maternal age<20yrs 15 (60%) 10 (40%)1.67 0.73-3.79 0.2â¥20yrs 385 (71.4%) 154 (28.6%) Maternal diseaseYes 242 (72.9%) 90 (27.1%)0.79 0.55-1.15 0.2No 158 (68.1%) 74 (31.9%) PreeclampciaYes 100 (80%) 25 (20%)0.54 0.33-0.87 0.01No 300 (68.3%) 139 (31.7%) PROMYes 40 (81.6%) 9 (18.4%)0.52 0.25-1.1 0.09No 360 (69.9%) 155 (30.1%) Prolonged laborYes 28(84.8%) 5 (15.2%)0.42 0.16-1.1 0.08No 372 (70.1%) 159 (29.9%) InfertilityYes 92 (69.2%) 41 (30.8%)1.12 0.73-1.7 0.6No 308 (71.5%) 123 (28.5%) ChorioamnionitisYes 3 (27.3%) 8 (72.7%)6.79 1.78-25.91 0.005No 397 (71.8%) 156 (28.2%) Abruption placentaYes 37 (62.7%) 22 (37.3%)1.52 0.87-2.67 0.1No 363 (71.9%) 142 (28.1%) Meconium stain amniotic fluidYes 11 (68.8%) 5 (31.3%)1.11 0.38-3.25 0.8No 389 (71%) 159 (29%) Apgar score at five minute 6.91(1.78) 5.02(2.13) 0.53 0.46-0.6<0.001 Apgar score (5â)â¥6 317 (81.7%) 71 (18.3%) 13.38-7.41 <0.001<6 83 (47.2%) 93 (52.8%) 5 Resuscitation at birthYes 126 (51.2%) 120 (48.8%)5.93 3.96-8.89 <0.001No 274 (86.2%) 44 (13.8%) Intubation at delivery roomYes 18 (26.1%) 51 (73.9%)9.58 5.38-17.05 <0.001No 382 (77.2%) 113 (22.8%) CI: Confidence Interval variables associated with the risk of neonatal death were, maternal pre -eclampsia or hemorrhage, vaginal delivery, A pgar<6 at 5 minutes, need for intubation at birth, NCPAP, surfactant replaceme nt therapy , CLD, intractable seizures and hematological abnormalities, (Table 4).Overall survival was 70.9%; in ELBW newborns this figure was 33.3% rising to 84.1% in infants weighing between 1001 -1500 grams.",Non-OADS,/arxiv_data1/oa_pdf/02/34/IJPD-23-579.PMC4006510.pdf
"583 Afjeh SA,et al Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 3:Mortality rates according to the disease/treatment characteristics in neonatal period Characteristic Alive (n=400) Dead (n=164) OR 95%CI p-Value Respiratory distress syndromeYes 252 (62.2%) 153 (37.8%)8.174.29-15.56 <0.001No 148 (93.1%) 11 (6.9%) Surfactant therapyYes 229 (62.6%) 137 (37.4%)3.79 2.4-5.99 <0.001No 171 (86.4%) 27 (13.6%) Intubation -Surfactant - ExtubationYes 123 (85.4 %) 21 (14.6%)0.33 0.2-0.55 <0.001No 277 (66%) 143 (34%) Nasal continuous positive airway pressureYes 166 (76.5%) 51 (23.5%)0.64 0.43-0.94 0.02No 234 (67.4%) 113 (32.6%) Mechanical ventilationYes 19 (50%) 19 (50%)2.63 1.35-5.1 0.004No 381 (72.4%) 145 (27.6%) Mechanical Ventilation + SurfactantYes 134 (50.2%) 133 (49.8%)8.525.47-13.26 <0.001No 266 (89.6%) 31 (10.4%) Patent Ductus ArteriosusYes 131 (71.6%) 52 (28.4%)0.95 0.65-1.41 0.81No 269 (70.6%) 112 (29.4%) Necrotizing enterocolitis â¥ 2Yes 3 (50%) 3 (50%)2.470.49-12.35 0.27No 397 (71.1%) 161 (28.9%) Intra-ventricular hemorrhage (All Grade)Yes 139 (73.5%) 50 (26.5%)2.78 1.24-6.24 0.01No 261 (69.6%) 114 (30.4%) Periventricular leukomalaciaYes 4(57.1%) 3 (42.9%)1.84 0.41-8.33 0.43No 396 (71.1%) 161 (28.9%) PneumothoraxYes 20 (35.1%) 37 (64.9%)5.54 3.1-9.89 <0.001No 380 (75%) 127 (25%) Pulmonary hemorrhageYes 16 (17.4%) 76 (82.6%)20.7311.53-37.27 <0.001No 384 (81.4%) 88 (18.6%) Chronic Lung DiseaseYes 84 (81.6%) 19 (18.4%)0.49 0.29-0.84 0.01No 316 (68.5%) 145 (31.5%) Renal failureYes 42 (47.7%) 46 (52.3%)3.32 2.08-5.3 <0.001No 358 (75.2%) 118 (24.8%) SeizureYes 36 (37.9%) 59 (62.1%)5.68 3.56-9.07 <0.001No 364 (77.6%) 105 (22.4%) Gastrointestinal bleedingYes 11 (29.7%) 26 (70.3%)6.663.21-13.84 <0.001No 389 (73.8%) 138 (26.2%) ApneaYes 155 (73.5%) 56 (26.5%)0.82 0.56-1.2 0.31No 245 (69.4%) 108 (30.6%) Infection (Pneumonia +/ - Meningitis +/ -Sepsis)Yes 106 (71.1%) 43 (28.9%)0.99 0.65-1.49 0.95No 294 (70.8%) 121 (29.2%) AnemiaYes 211 (82.7%) 44 (17.3%)0.33 0.22-0.49 <0.001No 189 (61.2%) 120 (38.8%) Hematologic complicationYes 232 (75.8%) 74 (24.2%)0.60.41-0.86 0.006No 168 (65.1%) 90 (34.9%) Metabolic complicationYes 258 (66.3%) 131 (33.7%)2.18 1.42-3.37 <0.001No 142 (81.1%) 33 (18.9%) Surgical operationYes 9 (69.2%) 4 (30.8%)1.09 0.33-3.58 0.89No 391 (71%) 160 (29%) CI: Confidence Interva l Discussion Prevalence of VLBW neonates (4.3%) and ELBW infants (1,1%) in our study is comparable to reports from other countries; world -wide prevalence of VLBW babies has been reported between 5 -7% and that of ELBW as 1%; however, studies from the Unite d States set the figures at 1.1% and 0.7% respectively[1,8].This study was done in a level III NICU in a hospital that is a referral center for high risk pregnancies,therefore, our figures are not representative of nation-wide prevalence of very low birt h weight infants, that is about 0.98% in our country with birth rate of 1.3% and NMR around 17/1000 live birthsaccording to UNICEF report at 2009 .",Non-OADS,/arxiv_data1/oa_pdf/02/34/IJPD-23-579.PMC4006510.pdf
"584 Outcome of VLBW Infants Over 3 Years, Report From an Iranian Center Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 4:Multiple regression analysis with adjusted estimates of odds ratio (95% CI) Characteristic OR 95%CI P.Value Birth weight (gm) <=750 11.09 3.83-32.08 <0.001 751-1000 63.53 17.07-236.45 <0.001 1001-1250 11.09 3.83-32.08 <0.001 1251-1500 1 Vaginal delivery mode 2.55 1.05-6.18 0.04 Preeclampcia 0.34 0.12-0.95 0.04 Maternal Bleeding(placenta abruption)5.18 1.41-19.07 0.01 Apgar score <6 in 5 minute 3.51 1.41-8.73 0.007 Intubation at delivery room 3.52 1.04-11.94 0.04 nCPAP 0.27 0.11-0.63 0.003 Mechanical ventilation +Surfactant 47.08 14.35-154.42 <0.001 Mechanical ventilation only 35.75 6.56-194.77 <0.001 Pulmonary hemorrhage 45.57 14.38-144.41 <0.001 Chronic Lung Disease 0.05 0.02-0.16 <0.001 Gastrointestinal bleeding 11.66 3.03-44.88 <0.001 Seizure 3.82 1.42-10.24 0.008 Hematologic complication 0.12 0.05-0.31 <0.001 CI: Confidence Interval; nCPAP: Nasal continuous positive airway pressure PROM (8.7%), prolonged labor (5.9%) and chorioamnionitis (2%) (T able1).",Non-OADS,/arxiv_data1/oa_pdf/02/34/IJPD-23-579.PMC4006510.pdf
"585 Afjeh SA,et al Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Table 6: Distribution of died babies in relation of birth weight and primary cause of death Characteristic Birth weight groups Cause of death 501-750 751-1000 1001-1250 1251-1500Total(n=164) Respiratory failure 30 (76.9%) 47 (79.7%) 32 (68.1%) 13 (68.4%) 122 (74.4%) Sepsis 2 (5.1%) 0 (0%) 1 (2.1%) 1 (5.3%) 4 (2.4%) Congenital anomalies 0 (0%) 0 (0%) 1 (2.1%) 1 (5.3%) 2 (1.2%) Others 7 (17.9%) 12 (20.3%) 13 (27.7%) 4 (21.1%) 36 (22.0%) needed endotracheal intubation 51 (73.9%) died later during hospital course showing that improvement of quality of post -resuscitation care is needed in our NICU.",Non-OADS,/arxiv_data1/oa_pdf/02/34/IJPD-23-579.PMC4006510.pdf
"586 Outcome of VLBW Infants Over 3 Years, Report From an Iranian Center Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )VLBW infants in our study is comparable to other studies around the world, a decline in the mortality and mobidity of these newborns (especially the ELBW neonates) can only be made possible through optimizing perinatal care including regionalization, CPR at birth, early NCPAP and quality improved collaborative (QIC) in our NICU .",Non-OADS,/arxiv_data1/oa_pdf/02/34/IJPD-23-579.PMC4006510.pdf
Available at: http://www.un.org/millenniumgoals/2008highleve l/pdf/newsroom/Goal%204%20FINAL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/02/34/IJPD-23-579.PMC4006510.pdf
"587 Afjeh SA,et al Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )20.Afjeh SA, Sabzehei MK.",Non-OADS,/arxiv_data1/oa_pdf/02/34/IJPD-23-579.PMC4006510.pdf
"Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Cholelithiasis in Childhood: A Cohort Study in North of Iran  Mohammad-Reza Esmaeili Dooki 1* , MD; Alireza Norouzi 2 , MD    1.",Non-OADS,/arxiv_data1/oa_pdf/94/28/IJPD-23-588.PMC4006511.pdf
"     589  Esmaeili Dooki M R , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Subjects and Methods   This cohort study was performed on children with  cholelithiasis in Amirkola Childrenâs Hospital from  2000 to 2011.",Non-OADS,/arxiv_data1/oa_pdf/94/28/IJPD-23-588.PMC4006511.pdf
"    590   Cholelithiasis in Childhood   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  radiolucent stones received Ursodeoxycholic acid  (UDCA).",Non-OADS,/arxiv_data1/oa_pdf/94/28/IJPD-23-588.PMC4006511.pdf
"     591  Esmaeili Dooki M R , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  without relapse.",Non-OADS,/arxiv_data1/oa_pdf/94/28/IJPD-23-588.PMC4006511.pdf
"    592   Cholelithiasis in Childhood   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  19.",Non-OADS,/arxiv_data1/oa_pdf/94/28/IJPD-23-588.PMC4006511.pdf
"Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Correlation between QRS Duration, Pulmonary Insufficiency and Right Ventricle  Performance in Totally Corrected Tetralogy of Fallot    Asadolah Tanasan 1 , MD; Armen Kocharian 2,3 , MD; Keyhan Sayadpour Zanjani* 2,3 , MD;                                                                         Farah K. Payravian 4 , MD;   Sadat Torabian 5 , MD     1.",Non-OADS,/arxiv_data1/oa_pdf/e9/7d/IJPD-23-593.PMC4006512.pdf
"    594   QRS duration, Pulmonary Insufficiency and Right Ventricle Performance in TOF    Iran J Pediat r; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  Subjects and Methods   Children with corrected TOF who visited our  outpatient clinic from March 2008 to August 2010  were enrolled in this study.",Non-OADS,/arxiv_data1/oa_pdf/e9/7d/IJPD-23-593.PMC4006512.pdf
"     595  Tanasan A , et al   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  duration â¥160 ms but PRi >0.5.",Non-OADS,/arxiv_data1/oa_pdf/e9/7d/IJPD-23-593.PMC4006512.pdf
"    596   QRS duration, Pulmonary Insufficiency and Right Ventricle Performance in TOF    Iran J Pediat r; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences  (http://ijp.tums.ac.ir )  4.",Non-OADS,/arxiv_data1/oa_pdf/e9/7d/IJPD-23-593.PMC4006512.pdf
"Iran J Pediatr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Tailgut Cyst inan Infant with Imperforate Anus: aCase Report S Mohammad -Ali Raisolsadat1,MD;Nona Zabolinejad2*,MD;Fariba Tabrizian -Namini3,MD;ParisaFaraji1 1.Department of Pediatric Surgery, Aria Hospital, Islamic Azad University, Mash had Branc h,Iran 2.Department of Pathology,Dr.SheikhChildrenâsHospital,Mashhad University of Medical Sciences, Mashhad, Iran 3.Department of Pediatrics ,22 Bahman Hospital, Islamic Azad University, Mashhad Branch, Iran Received: Apr15, 2012; Accepted: Aug19, 2012;Online Available :Jun23, 2013 Abstract Backgrou nd:Tailgut cyst (TGC) is a rare congenital lesion that originates from remnants of the embryonic post-anal gut.",Non-OADS,/arxiv_data1/oa_pdf/b2/9e/IJPD-23-597.PMC4006513.pdf
"598 Tailgut Cyst with Imperforate Anus ; a Case Report Iran J Pedi atr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )exploration for distal part of the rectum, a well- demarcated cystic mass adherent to the distal part Fig.1:Well-demarcated cystic  mass in presacral space, adherent to distal part of  the rectum of rectum posteriorly measuring 4Ã3cm was detected (Fig.1).",Non-OADS,/arxiv_data1/oa_pdf/b2/9e/IJPD-23-597.PMC4006513.pdf
"2 Tailgut Cyst with Imperforate Anus ; a Case Report Iran J Pedi atr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Fig.2:A.Multilocular cyst lined by squamous,transitional and columnar epithelia (right).B.Pseudostratified columnar epithelium wit h goblet cells and underlying fibrous stroma (left).",Non-OADS,/arxiv_data1/oa_pdf/b2/9e/IJPD-23-597.PMC4006513.pdf
"600 Tailgut Cyst with Imperforate Anus ; a Case Report Iran J Pedi atr; Vol 23 (No 5),Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )References 1.GÃ¶nÃ¼l II,BaÄlan T ,Pala I,et al.Diagnostic challenge for both pathologists and clinicians.",Non-OADS,/arxiv_data1/oa_pdf/b2/9e/IJPD-23-597.PMC4006513.pdf
"   602  Letter s to Editor   Iran J Pediatr; Vol 23 (No 5), Oct  2013   Published by: Tehran University of M edical Sciences (http://ijp.tums.ac.ir )   administered intravenously and changed to  ceftazidime (0.5  gr, twice a day) upon receiving  the antimicrobial susceptibility test report.",Non-OADS,/arxiv_data1/oa_pdf/cf/0a/IJPD-23-601.PMC4006514.pdf
"   603  Letter s to Editor     Iran J Pediatr; Vol 23 (No 5), Oct  2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )   References   1.",Non-OADS,/arxiv_data1/oa_pdf/cf/0a/IJPD-23-601.PMC4006514.pdf
"     603  Letter s   to Editor   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )    References  1.",Non-OADS,/arxiv_data1/oa_pdf/37/47/IJPD-23-603.PMC4006515.pdf
"    604  Letters to Editor   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )    hypothesized that IFN-Î³ might play a possible role  in the immuno-inï¬ammatory process of childhood  DCM, although it is not clear whether these act to  preserve or protect against further inï¬ammatory  injury.",Non-OADS,/arxiv_data1/oa_pdf/37/47/IJPD-23-603.PMC4006515.pdf
"     605  Letter s   to Editor   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )    Cystic Fibrosis: From Protein-Energy  Malnutrition to Obesity with Dyslipidemia  Ieda Regina Lopes Del Ciampo, PhD*, Regina  Sawamura, PhD; Maria Inez Machado Fernandes, PhD    Department of Pediatrics, Pediatrics Gastroenterology School  of Medicine of RibeirÃ£o Preto University of SÃ£o Paulo, Brazil     Received: May  17, 2013 ; Accepted: Jun 05, 2013 ;   First Online Available: Jul 01, 2013    Advances in early diagnosis and treatment have  increased the survival of patients with cystic  fibrosis (CF) to 30-40 years of age [1] .",Non-OADS,/arxiv_data1/oa_pdf/90/02/IJPD-23-605.PMC4006516.pdf
"    606  Letters to Editor   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )                  Fig.",Non-OADS,/arxiv_data1/oa_pdf/90/02/IJPD-23-605.PMC4006516.pdf
In:  http://www.cff.org/LivingWithCF/Quality  Improvement/PatientRegistryReport.,Non-OADS,/arxiv_data1/oa_pdf/90/02/IJPD-23-605.PMC4006516.pdf
"     607  Letter s   to Editor   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )    Severe Hemolytic Disease of the Newborn  Caused by Anti-M Antibodies  Eduardo Alfredo Duro, MD, MPH; Liliana Desalvo, MD;  Sandra Kuret   Facultad de Medicina, Universidad de Buenos Aires  Received: Aug  23, 2012 ; Accepted: Mar 09, 2013 ;   First Online Available: Jul 31, 2013    Anti-MÂ´s are naturally occurring antibodies   described by Wolff and Johnsson in 1933.",Non-OADS,/arxiv_data1/oa_pdf/77/39/IJPD-23-607.PMC4006517.pdf
"    608  Letters to Editor   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )    hyperbilirubinemia, especially in cases of  suspected rare blood groups causing HDN.",Non-OADS,/arxiv_data1/oa_pdf/77/39/IJPD-23-607.PMC4006517.pdf
"    608  Letters to Editor   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )    hyperbilirubinemia, especially in cases of  suspected rare blood groups causing HDN.",Non-OADS,/arxiv_data1/oa_pdf/3b/99/IJPD-23-608.PMC4006518.pdf
"     609  Letter s   to Editor   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )        Fig.",Non-OADS,/arxiv_data1/oa_pdf/3b/99/IJPD-23-608.PMC4006518.pdf
"610 Lettersto Editor Iran J Pediatr; Vol 23 (No 5), Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )Validity and Reliability of Spatio -Temporal Gait Parameters in Adolescents Antonino Marco Cuccia Department of Surgical and Oncological Disciplines, University of Palermo, Italy Received: Mar 06, 2013; Accepted: Jun 17, 2013 ; First Online Available: Aug15, 2013 Gait isacomplex activity based on information captured by periphery receptors and elaborated at the level of central nervous system .The age of 6 years seems to constitute a turning point in locomotor control[1].From about 7 -8 years of lif e no difference to the adult pattern could be observed[2], even if recent studies have implied that gait maturation may continue beyond the age of 8 years and may not be complete until 13 years of age[3,4].",Non-OADS,/arxiv_data1/oa_pdf/2e/95/IJPD-23-610.PMC4006519.pdf
"611Lettersto Editor Iran J Pediatr; Vol 23 (No 5), Oct2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )age-specific anthropometric data.",Non-OADS,/arxiv_data1/oa_pdf/2e/95/IJPD-23-610.PMC4006519.pdf
"     611  Letter s   to Editor   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )    age-specific anthropometric data.",Non-OADS,/arxiv_data1/oa_pdf/8a/d5/IJPD-23-611.PMC4006520.pdf
"    612  Letters to Editor   Iran J Pediatr; Vol 23 (No  5 ),  Oct   2013   Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir )        Fig.",Non-OADS,/arxiv_data1/oa_pdf/8a/d5/IJPD-23-611.PMC4006520.pdf
"OncoImmunology 2013;  2:e27499; http://dx.doi.org/10.4161/onci.27499Chemotherapy engages multiple pathways  leading to IL-1Î² production by myeloid leukocytes Christina a ntonopoulos1 and George r Dubyak1,2,3* 1Department of Pathology; Case w estern r eserve u niversity s chool of Medicine; Cleveland, O h usa ; 2Department of Physiology and Biophysics; Case w estern r eserve  university s chool of Medicine; Cleveland, O h usa ; 3Case Comprehensive Cancer Center; Case w estern r eserve u niversity s chool of Medicine; Cleveland, O h usa Keywords:  inflammasome, caspase-8, caspase-1, IL-1 Î², chemotherapy, ripoptosome Interleukin-1 Î² (IL-1 Î²) can limit tumor growth by promoting T cell-mediated antitumor immune responses.",Non-OADS,/arxiv_data1/oa_pdf/83/88/onci-3-e27499.PMC4006851.pdf
Nat Immunol 2012; 13:343- 51; PMID:22430787 ; http://dx.doi.org/10.1038/ ni.2224 2.,Non-OADS,/arxiv_data1/oa_pdf/83/88/onci-3-e27499.PMC4006851.pdf
Front Immunol 2013; 4:370; PMID:24273542 ; http://dx.doi.org/10.3389/ fimmu.2013.00370 3.,Non-OADS,/arxiv_data1/oa_pdf/83/88/onci-3-e27499.PMC4006851.pdf
Nat Med  2009; 15:1170-8 ;  PMID:19767732 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/88/onci-3-e27499.PMC4006851.pdf
Nat Rev Immunol  2013; 13:397-411;  PMID:23702978 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/88/onci-3-e27499.PMC4006851.pdf
Cancer Biol Ther  2011; 11:1008-16;  PMID:21464611 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/83/88/onci-3-e27499.PMC4006851.pdf
Immunity 2012; 36:401-14; PMID:22342844 ;  http://dx.doi.org/10.1016/j.immuni.2012.01.009 7.,OADS,/arxiv_data1/oa_pdf/83/88/onci-3-e27499.PMC4006851.pdf
Nat Med 2013; 19:57-64; PMID:23202296 ;  http://dx.doi.org/10.1038/nm.29998.,OADS,/arxiv_data1/oa_pdf/83/88/onci-3-e27499.PMC4006851.pdf
Immunity  2012 ; 36 :215-27;  PMID:22365665 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/83/88/onci-3-e27499.PMC4006851.pdf
"OncoImmunology 2013; 2:e27456; http://dx.doi.org/10.4161/onci.27456The immune landscape of human tumors Implications for cancer immunotherapy Gabriela Bindea1,2,3, Bernhard Mlecnik1,2,3, helen K a ngell1,2,3,4, JÃ©rÃ´me Galon1,2,3,* 1INserM u 872; Laboratory of Integrative Cancer Immunology; Paris, France; 2universitÃ© Paris Descartes; Paris, France;   3Cordeliers r esearch Centre; u niversitÃ© Pierre et Marie Curie Paris 6; Paris, France; 4Molecular Pathology Group; a straZeneca; a lderley Park; Cheshire, u K Keywords:  immunoscore, immune landscape, cancer, prognosis, bioinformatics understanding the spontaneous immune response of cancer patients is critical for the design of efficient anticancer  immunotherapies.",Non-OADS,/arxiv_data1/oa_pdf/bc/c4/onci-3-e27456.PMC4006852.pdf
Science 2011;  331:1565-70 ;  PMID:21436444 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/c4/onci-3-e27456.PMC4006852.pdf
Science  2006 ; 313:1960 - 4; PMID:17008531 ; http://dx.doi.org/10.1126/ science.11291393.,OADS,/arxiv_data1/oa_pdf/bc/c4/onci-3-e27456.PMC4006852.pdf
Cancer Res 2007 ; 67:1883 -6;  PMID:17332313 ; http://dx.doi.org/10.1158/0008- 5472.CAN-06-4806 4.,Non-OADS,/arxiv_data1/oa_pdf/bc/c4/onci-3-e27456.PMC4006852.pdf
Nat Rev Cancer 2012 ; 12:298- 306; PMID:22419253 ; http://dx.doi.org/10.1038/ nrc32456.,Non-OADS,/arxiv_data1/oa_pdf/bc/c4/onci-3-e27456.PMC4006852.pdf
J Pathol   2014 ; 232:199-209; PMID:24122236 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/c4/onci-3-e27456.PMC4006852.pdf
Immunity  2013 ; 39:49-60; PMID:23890063 ;  http://dx.doi.org/10.1016/j.immuni.2013.07.002 8.,OADS,/arxiv_data1/oa_pdf/bc/c4/onci-3-e27456.PMC4006852.pdf
Immunity  2013 ; 39:1- 10; PMID:23890059 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bc/c4/onci-3-e27456.PMC4006852.pdf
Bioinformatics   2013 ; 29:661-3; PMID:23325622 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/c4/onci-3-e27456.PMC4006852.pdf
Immunity   2013 ; 39:782-95; PMID:24138885 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/c4/onci-3-e27456.PMC4006852.pdf
OncoImmunology 2014; 3:e27574; http://dx.doi.org/10.4161/onci.27574Why should we need the gut microbiota   to respond to cancer therapies?,Non-OADS,/arxiv_data1/oa_pdf/5d/a1/onci-3-e27574.PMC4006853.pdf
Nat Rev Microbiol 2011; 9:279-90;  PMID:21407244 ; http://dx.doi.org/10.1038/ nrmicro2540 2.,OADS,/arxiv_data1/oa_pdf/5d/a1/onci-3-e27574.PMC4006853.pdf
JAMA 2004; 291:827-35; PMID:14970061 ; http://dx.doi.org/10.1001/ jama.291.7.827 3.,Non-OADS,/arxiv_data1/oa_pdf/5d/a1/onci-3-e27574.PMC4006853.pdf
"Cancer Res 2006; 66:6219-24;  PMID:16778196 ; http://dx.doi.org/10.1158/0008- 5472.CAN-05-4592 4. van Vliet MJ, Harmsen HJ, de Bont ES, Tissing WJ.",Non-OADS,/arxiv_data1/oa_pdf/5d/a1/onci-3-e27574.PMC4006853.pdf
PLoS Pathog 2010; 6:e1000879; PMID:20523891 ;  http://dx.doi.org/10.1371/journal.ppat.10008795.,Non-OADS,/arxiv_data1/oa_pdf/5d/a1/onci-3-e27574.PMC4006853.pdf
Oncoimmunology 2013; 2:e22246;  PMID:23482454 ; http://dx.doi.org/10.4161/ onci.22246 6.,Non-OADS,/arxiv_data1/oa_pdf/5d/a1/onci-3-e27574.PMC4006853.pdf
Oncoimmunology 2013; 2:e22059;   PMID:23483796 ; http://dx.doi.org/10.4161/ onci.22059 7.,Non-OADS,/arxiv_data1/oa_pdf/5d/a1/onci-3-e27574.PMC4006853.pdf
Oncoimmunology  2013; 2:e22664;  PMID:23482679 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/a1/onci-3-e27574.PMC4006853.pdf
Cancer Res 2011; 71:661-5;  PMID:21148486 ; http://dx.doi.org/10.1158/0008- 5472.CAN-10-1259 9.,Non-OADS,/arxiv_data1/oa_pdf/5d/a1/onci-3-e27574.PMC4006853.pdf
Science 2013; 342:967- 70; PMID:24264989 ; http://dx.doi.org/10.1126/ science.1240527,Non-OADS,/arxiv_data1/oa_pdf/5d/a1/onci-3-e27574.PMC4006853.pdf
"OncoImmunology 2013; 2:e27569; http://dx.doi.org/10.4161/onci.27569RB1-mediated cell-autonomous and host- dependent oncosuppressor mechanisms   in radiation-induced osteosarcoma Maya Kansara1,* and David M Thomas1,2 1Peter MacCallum Cancer Centre; s arcoma Genomics and Genetics Laboratory, r esearch Division; Melbourne, VIC australia;   2The Kinghorn Cancer Centre and Garvan Institute; s ydney, N sw australia Keywords:  interleukin-6, natural killer T cells, radiation, retinoblastoma 1,  senescence, senescence-associated secretory phenotype (SASP) The mechanisms by which retinoblastoma 1 ( rB1) mediates oncosuppressive functions are still being elucidated.",Non-OADS,/arxiv_data1/oa_pdf/f9/6e/onci-3-e27569.PMC4006854.pdf
Sarcoma 2012; 2012:417271; http://dx.doi.org/10.1155/2012/417271 ; PMID:22566751 3.,Non-OADS,/arxiv_data1/oa_pdf/f9/6e/onci-3-e27569.PMC4006854.pdf
Genes Dev 2008;  22:1662-76; http://dx.doi.org/10.1101/gad.1656808 ;  PMID:18559481,OADS,/arxiv_data1/oa_pdf/f9/6e/onci-3-e27569.PMC4006854.pdf
J Biol Chem 2003;  278:14897-905; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f9/6e/onci-3-e27569.PMC4006854.pdf
J Clin Invest 2012; 122:2601-12; http://dx.doi.org/10.1172/JCI45785 ;  PMID:227063087.,OADS,/arxiv_data1/oa_pdf/f9/6e/onci-3-e27569.PMC4006854.pdf
Cell 2008; 133:1019-31; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f9/6e/onci-3-e27569.PMC4006854.pdf
Ann Surg  Oncol 2007; 14:2887-95; http://dx.doi.org/10.1245/ s10434-007-9483-8 ; PMID:17653803 10.,Non-OADS,/arxiv_data1/oa_pdf/f9/6e/onci-3-e27569.PMC4006854.pdf
J Immunother Emphasis Tumor Immunol  1993; 14:286-92;  PMID:8280710 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/6e/onci-3-e27569.PMC4006854.pdf
"OncoImmunology 2013; 2:e27616;http://dx.doi.org/10.4161/onci.27616Immunosurveillance of senescent cancer cells   by natural killer cells alexandre Iannello and David h  raulet* Department of Molecular and Cell Biology; u niversity of California at Berkeley; Berkeley, C a usa   Cancer r esearch Laboratory; u niversity of California at Berkeley; Berkeley, C a usa Keywords:  NK cell, chemokine, NKG2D, senescence, p53 we recently dissected how senescent tumors can trigger complementing signaling pathways that mobilize natural killer  (NK) cells to eliminate malignant cells.",Non-OADS,/arxiv_data1/oa_pdf/3c/06/onci-3-e27616.PMC4006855.pdf
Nat Rev Cancer 2010;  10:51-7;  PMID:20029423 ; http://dx.doi.org/10.1038/ nrc2772 2.,Non-OADS,/arxiv_data1/oa_pdf/3c/06/onci-3-e27616.PMC4006855.pdf
Cold Spring Harb Perspect Biol 2009; 1:a001883;   PMID:20066118 ; http://dx.doi.org/10.1101/cshper - spect.a001883 3.,Non-OADS,/arxiv_data1/oa_pdf/3c/06/onci-3-e27616.PMC4006855.pdf
Cancer Res  2006; 66:2881-4;  PMID:16540631 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/06/onci-3-e27616.PMC4006855.pdf
J Exp Med  2013; 210:2057-69;  PMID:24043758 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/06/onci-3-e27616.PMC4006855.pdf
Nature  2007; 445:656-60;  PMID:17251933 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/06/onci-3-e27616.PMC4006855.pdf
Cell  2008; 134:657-67;  PMID:18724938 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3c/06/onci-3-e27616.PMC4006855.pdf
Annu Rev Immunol 2013; 31:413-41; PMID:23298206 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-095951 9.,Non-OADS,/arxiv_data1/oa_pdf/3c/06/onci-3-e27616.PMC4006855.pdf
Annu Rev Physiol 2013; 75:685-705;   PMID:23140366 ; http://dx.doi.org/10.1146/ annurev-physiol-030212-183653 10.,Non-OADS,/arxiv_data1/oa_pdf/3c/06/onci-3-e27616.PMC4006855.pdf
Immunol Rev 2007; 220:169-82;  PMID:17979846 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/06/onci-3-e27616.PMC4006855.pdf
"OncoImmunology 2013; 2:e27441; http://dx.doi.org/10.4161/onci.27441Push and release TLR9 activation plus STAT3 blockade   for systemic antitumor immunity Marcin Kortylewski1,* and y a-huei Kuo2 1Department of Cancer Immunotherapeutics & Tumor Immunology; Beckman r esearch Institute; City of h ope National Medical Center; Duarte, C a usa ;  2Division of h ematopoietic s tem Cell & Leukemia r esearch; Beckman r esearch Institute; City of h ope National Medical Center; Duarte, C a usa Keywords:  acute myeloid leukemia, cancer immunotherapy, immune checkpoint, immunogenicity, siRNA, STAT3, TLR9 Proper immunostimulation (âpushâ) and immune checkpoint blockade (âreleaseâ) are both critical for the efficacy of  anticancer immunotherapy.",Non-OADS,/arxiv_data1/oa_pdf/24/12/onci-3-e27441.PMC4006856.pdf
Nat Rev Cancer  2012; 12:252-64;  PMID:22437870 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/12/onci-3-e27441.PMC4006856.pdf
Nat Rev Cancer 2009; 9:798-809; PMID :19851315 ;  http://dx.doi.org/10.1038/nrc2734 3.,Non-OADS,/arxiv_data1/oa_pdf/24/12/onci-3-e27441.PMC4006856.pdf
Nat Biotechnol 2009; 27:925- 32; PMID:19749770 ; http://dx.doi.org/10.1038/ nbt.1564 4.,Non-OADS,/arxiv_data1/oa_pdf/24/12/onci-3-e27441.PMC4006856.pdf
J Clin Oncol 2009; 27:4422-32; PMID:19667270 ; http://dx.doi.org/10.1200/ JCO.2008.21.3264 6.,Non-OADS,/arxiv_data1/oa_pdf/24/12/onci-3-e27441.PMC4006856.pdf
Blood 2013; 121:1304- 15; PMID:23287859 ; http://dx.doi.org/10.1182/ blood-2012-07-442590 7.,Non-OADS,/arxiv_data1/oa_pdf/24/12/onci-3-e27441.PMC4006856.pdf
Nat Med 1997; 3:730-7; PMID:9212098 ; http://dx.doi.org/10.1038/ nm0797-730 9.,Non-OADS,/arxiv_data1/oa_pdf/24/12/onci-3-e27441.PMC4006856.pdf
Cancer Res 2012; 72:3948-57; PMID:22673234 ;  http://dx.doi.org/10.1158/0008-5472.CAN-11-4134 10.,Non-OADS,/arxiv_data1/oa_pdf/24/12/onci-3-e27441.PMC4006856.pdf
Cancer Res 2012; 72:4440-8;  PMID:22728650 ; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3619,Non-OADS,/arxiv_data1/oa_pdf/24/12/onci-3-e27441.PMC4006856.pdf
"OncoImmunology 2014; 3:e27897;  http://dx.doi.org/10.4161/onci.27897Role of the complement system   in NK cell-mediated antitumor T-cell responses valÃ©rieÂ Janelle andÂ  alainÂ Lamarre* Immunovirology Laboratory; Institut national de la recherche scientifique; IN rs-Institut armand-Frappier; Laval, QC Canada;   Biomed r esearch Center; Department of Biology; u niversitÃ© du QuÃ©bec Ã  MontrÃ©al; MontrÃ©al, QC Canada Keywords: cancer, complement, immunotherapy, melanoma, NK cells The role of the complement system in oncogenesis and tumor progression remains poorly understood.",Non-OADS,/arxiv_data1/oa_pdf/40/cd/onci-3-e27897.PMC4006857.pdf
Mol Immunol 2005; 42:581-7;  PMID :15607817 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/40/cd/onci-3-e27897.PMC4006857.pdf
Mol Immunol 2003; 40:109- 23; PMID:12914817 ; http://dx.doi.org/10.1016/ S0161-5890(03)00112-3 3.,Non-OADS,/arxiv_data1/oa_pdf/40/cd/onci-3-e27897.PMC4006857.pdf
J Exp Med  1997; 186:1957-63;  PMID:9396764 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/cd/onci-3-e27897.PMC4006857.pdf
Blood 2005; 106:566-71; PMID:15784725 ;  http://dx.doi.org/10.1182/blood-2004-10-4035 6.,Non-OADS,/arxiv_data1/oa_pdf/40/cd/onci-3-e27897.PMC4006857.pdf
Cancer Immunol Immunother  2008; 57:1197-206;  PMID:18214474 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/cd/onci-3-e27897.PMC4006857.pdf
Blood 2003; 101:611- 20; PMID:12393562 ; http://dx.doi.org/10.1182/ blood-2002-06-1769 9.,Non-OADS,/arxiv_data1/oa_pdf/40/cd/onci-3-e27897.PMC4006857.pdf
J Clin Invest 2006; 116:2777-90; PMID:17016559 ; http://dx.doi.org/10.1172/ JCI28828 10.,Non-OADS,/arxiv_data1/oa_pdf/40/cd/onci-3-e27897.PMC4006857.pdf
Nat Immunol 2008; 9:1225-35;  PMID:18820683 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/cd/onci-3-e27897.PMC4006857.pdf
"OncoImmunology 2013; 2:e27588;  http://dx.doi.org/10.4161/onci.27588Implementing combinatorial   immunotherapeutic regimens against cancer The concept of immunological conditioning Dominik Wolf*, a nnkristin Heine and Peter Brossart* 1Medical Clinic III; Department of Oncology, Hematology and r heumatology; University Hospital Bonn (UKB); Bonn, Germany Keywords:  Immunotherapy, Cancer, Combination, Adjuvant, Conditioning Harnessing the host immune system to eradicate cancer  has a high therapeutic potential.",Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Annu Rev Immunol 1994; 12:337- 65; PMID:8011285 ; http://dx.doi.org/10.1146/ annurev.iy.12.040194.002005 2.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Annu Rev Immunol 2009; 27:83-117;  PMID:19007331 ; http://dx.doi.org/10.1146/ annurev.immunol.021908.132544 3.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Nat Med  2004 ; 10 :909-15;  PMID:15340416 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Ann Oncol 2006; 17:563-70; PMID:16418308 ; http://dx.doi.org/10.1093/ annonc/mdj138 5.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
J Clin Oncol 2012; 30:1835-41; PMID:22529253 ;  http://dx.doi.org/10.1200/JCO.2011.40.2271 6.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Immunity 2012; 37:1-2; PMID:22840835 ;  http://dx.doi.org/10.1016/j.immuni.2012.07.010 7.,OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Annu Rev Immunol 2007; 25:267- 96; PMID:17134371 ; http://dx.doi.org/10.1146/ annurev.immunol.25.022106.141609 8.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
N Engl J Med 2010; 363:711-23;  PMID:20525992 ; http://dx.doi.org/10.1056/ NEJMoa1003466 11.,OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
N Engl J Med 2011; 364:2517-26;  PMID:21639810 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
N Engl J Med 2013; 369:134-44;  PMID:23724846 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
N Engl J Med  2013; 369:122-33;  PMID:23724867 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
J Clin Oncol  2010; 28:1099-105;  PMID:20100959 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
J Clin Oncol  2006; 24:3089-94;  PMID:16809734 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
"N Engl J Med 2010; 363:411-22; PMID:20818862 ; http://dx.doi.org/10.1056/ NEJMoa1001294 18. van der Bruggen P, Traversari C, Chomez P, Lurquin  C, De Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cyto - lytic T lymphocytes on a human melanoma.",Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Science 1991; 254:1643-7;  PMID:1840703 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Cancer Immunol Immunother  2005; 54:187-207;  PMID :15309328 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
J Exp Med 1995; 182:885-9; PMID:7650492 ; http://dx.doi.org/10.1084/ jem.182.3.885 21.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Blood 2005; 105:3199-205; PMID :15618468 ;  http://dx.doi.org/10.1182/blood-2004-09-3556 23.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Nat Rev Immunol  2012; 12:557-69;  PMID:22790179 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Nucleic Acids Res 2008; 36:W519-22;  PMID:18440979 ; http://dx.doi.org/10.1093/nar/ gkn229 26.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Nat Med 2012; 18:1254-61; PMID:22842478 ;  http://dx.doi.org/10.1038/nm.2883 28.,OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Nat Rev Cancer 2008; 8:351- 60; PMID:18418403 ; http://dx.doi.org/10.1038/ nrc2373 29.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Mol Ther  2006; 13:280-8;  PMID:16219490 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Mol Ther 2011; 19:990- 9; PMID:21189474 ; http://dx.doi.org/10.1038/ mt.2010.289 31.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Cancer Res 2011; 71:1253-62; PMID:21216894 ;  http://dx.doi.org/10.1158/0008-5472.CAN-10-2693 32.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Cancer Res 2006; 66:5910-8; PMID:16740731 ;  http://dx.doi.org/10.1158/0008-5472.CAN-05-3905 33.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
J Immunother 2004;  27:354-67;  PMID :15314544 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Semin Oncol 2012; 39:348-57;  PMID:22595057 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Annu Rev Immunol 2003; 21:335-76;  PMID:12524386 ; http://dx.doi.org/10.1146/ annurev.immunol.21.120601.141126 37.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Nat Immunol 2009; 10:241-7;  PMID:19221555 ; http://dx.doi.org/10.1038/ni.1703 38.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Cancer Res 2010; 70:5293-304; PMID:20551064 ;  http://dx.doi.org/10.1158/0008-5472.CAN-10-0825 41.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Cancer Res 2013; 73:1709-20; PMID:23338611 ; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3850 42.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Science 2011; 331:1565- 70; PMID:21436444 ; http://dx.doi.org/10.1126/ science.1203486 44.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Clin Cancer Res 2007; 13:5256-61;  PMID:17875753 ; http://dx.doi.org/10.1158/1078- 0432.CCR-07-0892 45.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Cancer Res 2012; 72:3125-30; PMID:22721837 ;  http://dx.doi.org/10.1158/0008-5472.CAN-11-4094 46.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
J Clin Rheumatol 2012; 18:155-8; PMID:22456519 ;  http://dx.doi.org/10.1097/RHU.0b013e31824ea103 47.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Immunity 1997; 7:885-95; PMID:9430233 ; http://dx.doi.org/10.1016/ S1074-7613(00)80406-9 48.,OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
J Exp Med 2010; 207:637-50; PMID :20156971 ;  http://dx.doi.org/10.1084/jem.20091918 49.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
J Clin Oncol  2013; 31:499-506;  PMID:23248252 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
"Lancet Oncol 2012; 13:501- 8; PMID:22326924 ; http://dx.doi.org/10.1016/ S1470-2045(12)70006-2 51. van den Eertwegh AJ, Versluis J, van den Berg HP,  Santegoets SJ, van Moorselaar RJ, van der Sluis  TM, Gall HE, Harding TC, Jooss K, Lowy I, et  al.",OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Lancet Oncol 2012; 13:509-17;  PMID:22326922 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Cancer Immunol Immunother 2013; 62:245-56;  PMID:22878899 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Cancer  2010; 116:1757-66;  PMID:20143437 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Prostate 2009; 69:1694-703;  PMID:19670224 ;  http://dx.doi.org/10.1002/pros.21020 55.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa1200690 57.,OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Nat Med  2009; 15:1170-8 ;  PMID:19767732 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Science 2011; 334:1573-7;  PMID:22174255 ; http://dx.doi.org/10.1126/ science.1208347 59.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Clin Cancer Res  2008; 14:3536-44;  PMID:18519787 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Clin Cancer Res 2007; 13:3933-41;  PMID:17606727 ; http://dx.doi.org/10.1158/1078- 0432.CCR-06-2903 63.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Cancer Immunol Immunother 2012; 61:1441- 50; PMID:22310929 ; http://dx.doi.org/10.1007/ s00262-012-1204-x,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Proc Natl Acad Sci U S A  2005; 102:13622-7;  PMID:16174751 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
J Immunother 2010; 33:991-8; PMID:20948437 ;  http://dx.doi.org/10.1097/CJI.0b013e3181f4c208 66.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Cancer Res  2013; 73:539-49;  PMID:23108136 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Clin Cancer Res 2009; 15:2148-57;  PMID:19276286 ; http://dx.doi.org/10.1158/1078- 0432.CCR-08-133268.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Blood 2008; 111:5610-20; PMID:18310500 ; http://dx.doi.org/10.1182/ blood-2007-02-075945 69.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Clin Cancer Res 2013;  19:1225-31;  PMID:23307859 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Nature 2008; 453:410-4; PMID:18418378 ;  http://dx.doi.org/10.1038/nature06868 71.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Proc Natl Acad Sci U S A 2012;  109:17561-6;  PMID:23045683 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Cancer Res 2011; 71:6350-9;  PMID:21878530 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
J Clin Invest 2007; 117:1167-74;  PMID:17476346 ; http://dx.doi.org/10.1172/ JCI31202 74.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
Nat Clin Pract Oncol  2006; 3:668-81;  PMID:17139318 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/de/onci-3-e27588.PMC4006858.pdf
"OncoImmunology 2013; 2:e27573; http://dx.doi.org/10.4161/onci.27573The short and sweet of T-cell therapy Restraining glycolysis enhances the formation of  immunological memory and antitumor immune responses Madhusudhanan s ukumar1,* and Luca Gattinoni2,* 1surgery Branch; Center for Cancer r esearch; National Institutes of h ealth; Bethesda, MD usa ;  2experimental Transplantation and Immunology Branch; National Institutes of h ealth; Bethesda, MD usa Keywords:  memory T cells, CD8+ T cells, immune metabolism, glycolysis, adoptive immunotherapy upon antigenic stimulation, naÃ¯ve CD8+ T cells divert their bioenergetic metabolism from oxidative phosphorylation  to aerobic glycolysis.",Non-OADS,/arxiv_data1/oa_pdf/29/db/onci-3-e27573.PMC4006859.pdf
Nat Rev Cancer 2012; 12:671-84; PMID:22996603 ;  http://dx.doi.org/10.1038/nrc3322 2.,Non-OADS,/arxiv_data1/oa_pdf/29/db/onci-3-e27573.PMC4006859.pdf
Annu Rev Immunol  2013; 31:259-83;  PMID:23298210 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/29/db/onci-3-e27573.PMC4006859.pdf
Immunity 2012; 36:68-78;  PMID:22206904 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/29/db/onci-3-e27573.PMC4006859.pdf
Cell 2013; 153:1239-51; PMID:23746840 ;  http://dx.doi.org/10.1016/j.cell.2013.05.016 6.,OADS,/arxiv_data1/oa_pdf/29/db/onci-3-e27573.PMC4006859.pdf
J Exp Med  2011; 208:1367-76;  PMID:21708926 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/29/db/onci-3-e27573.PMC4006859.pdf
J Clin Invest 2013; 123:4479-88; PMID:24091329 ; http://dx.doi.org/10.1172/ JCI695898.,Non-OADS,/arxiv_data1/oa_pdf/29/db/onci-3-e27573.PMC4006859.pdf
Nat Immunol 2013; 14:1173-82; PMID:24076634 ;  http://dx.doi.org/10.1038/ni.2714 9.,Non-OADS,/arxiv_data1/oa_pdf/29/db/onci-3-e27573.PMC4006859.pdf
Nat Immunol 2014; 15:88-97; PMID:24165795 ; http://dx.doi.org/10.1038/ni.2771,Non-OADS,/arxiv_data1/oa_pdf/29/db/onci-3-e27573.PMC4006859.pdf
"OncoImmunology 2014; 3:e28288; http://dx.doi.org/10.4161/onci.28288The transmembrane channel-like protein family  and human papillomaviruses Insights into epidermodysplasia verruciformis   and progression to squamous cell carcinoma Jaime s  horton1,2 and Alexander J s tokes1,2,3,* 1Laboratory of e xperimental Medicine; John A. Burns s chool of Medicine; h onolulu, h I us A;   2Department of Cell and Molecular Biology; John A. Burns s chool of Medicine; h onolulu, h I us A; 3Chaminade u niversity; h onolulu, h I us A Keywords:  Epidermodysplasia verruciformis, TMC8, TMC6, EVER1, EVER2, papillomavirus,   cutaneous squamous cell carcinoma Abbreviations:  AEV, acquired epidermodysplasia verruciformis; CMI, cell-mediated immunity;   CSCC, cutaneous squamous cell carcinoma; ERCC3, excision repair cross-complementing rodent repair deficiency,  complementation group 3; ER, endoplasmic reticulum; EV, epidermodysplasia verruciformis; FADD, Fas-associated protein with  death domain; FasL, Fas ligand; HPV, human papillomavirus; MST1, macrophage stimulating 1;   MT, mechanotransducer; MTF-1, metal-responsive transcription factor 1; NF- ÎºB, nuclear factor kappa B;   NK, natural killer; NMSC, non-melanoma skin cancer; ORF, open reading frame; pRb: retinoblastoma protein;   PBMC, peripheral blood mononuclear cell; RHOH, ras homolog gene family member H;   RIPK1, receptor-interacting serine/threonine protein kinase 1; STK4, serine/threonine kinase 4;   TGFÎ², transforming growth factor beta; TMC6/EVER1, transmembrane channel-like 6;   TMC8/EVER2, transmembrane channel-like 8;TNF Î±, tumor necrosis factor alpha;   TRADD, TNF receptor type 1-associated death domain; TRAIL, TNF-related apoptosis-inducing ligand;   UVR, ultraviolet radiation; XPB, xeroderma pigmentosum type B; XRCC1, x-ray repair cross-complementing protein 1;   YAP, yes-associated protein; Zn2+, zinc; ZnT-1: zinc transporter 1 Epidermodysplasia verruciformis ( eV) is a rare genodermatosis characterized by increased sensitivity to infection by  the Î²-subtype of human papillomaviruses ( Î²-hPVs), causing persistent, tinea versicolor-like dermal lesions.",Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Virology 2010; 401:70- 9; PMID:20206957 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Semin Immunol 2006; 18:362-74; PMID:17011789 ;  http://dx.doi.org/10.1016/j.smim.2006.07.008 4.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Arch  Dermatol 2002; 138:649-54; PMID:12020228 ;  http://dx.doi.org/10.1001/archderm.138.5.649 5.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
South Med J 2003; 96:613-5;  PMID:12938792 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Virus Res  2009; 143:195-208;  PMID:19540281 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Invest Dermatol 1997; 108:712-5;  PMID:9129220 ; http://dx.doi.org/10.1111/1523- 1747.ep12292090 8.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Virol 2013; 87:12158-65; PMID:24006432 ;  http://dx.doi.org/10.1128/JVI.01510-139.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Vaccine 2006; 24(Suppl 1):S16-22;  PMID:16219398 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Curr Opin Virol 2013; 3:416- 21; PMID:23816390 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Clin Dermatol 1997; 15:181- 98; PMID:9167903 ; http://dx.doi.org/10.1016/ S0738-081X(97)00008-4 14.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Virology 2013; 443:69-79; PMID:23706308 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Virus Res 2012; 163:609- 16; PMID:22230316 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Virol 2006; 80:12420- 4; PMID:17020941 ; http://dx.doi.org/10.1128/ JVI.02576-0517.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Virus Res 2012; 169:48-53; PMID:22776252 ;  http://dx.doi.org/10.1016/j.virusres.2012.06.028 20.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Dermatol Sci 2011; 62:84-90;  PMID:21458245 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Dermatol Sci 2011; 64:7-15; PMID:21763111 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Virol  2006; 80:11153-64;  PMID:16971438 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
PLoS One 2012; 7:e41743;  PMID:22911850 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Arch Derm Syphilol 1922; 141:193;  http://dx.doi.org/10.1007/BF01938833 27.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Invest Dermatol 1984; 83(Suppl):18s-25s;  PMID:6330217 ; http://dx.doi.org/10.1111/1523- 1747.ep12281128 28.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Invest Dermatol  1998; 110:752-5;  PMID:9579540 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Clin Microbiol 2003; 41:2509-14;  PMID:12791874 ; http://dx.doi.org/10.1128/ JCM.41.6.2509-2514.2003 31.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Invest Dermatol  1998; 111:696-701;  PMID:9764856 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J  Invest Dermatol 1998; 110:311-7; PMID:9540967 ;  http://dx.doi.org/10.1046/j.1523-1747.1998.00164.x 34.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Invest Dermatol  1999; 112:259-63;  PMID:10084299 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Nat Genet 2002; 32:579-81; PMID:12426567 ;  http://dx.doi.org/10.1038/ng1044 36.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Invest Dermatol  2000; 114:1148-53;  PMID:10844558 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
PLoS One  2012; 7:e44010;  PMID:22952854 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Blood  2012; 119:3458-68;  PMID:22174160 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Br J Cancer 2011; 104:24- 32; PMID:21102585 ; http://dx.doi.org/10.1038/ sj.bjc.6606011 41.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Clin Invest 2012; 122:3239-47; PMID:22850876 ;  http://dx.doi.org/10.1172/JCI62949 43.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Invest  Dermatol 2008; 128:732-5;  PMID:17960179 ;  http://dx.doi.org/10.1038/sj.jid.5701124 45.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
"J Am Acad Dermatol 1990; 22:423-7; PMID :2155952 ;  http://dx.doi.org/10.1016/0190-9622(90)70058-P 47. Cooper KD, Androphy EJ, Lowy D, Katz SI.",OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Invest Dermatol 1990; 94:769-76; PMID:2162366 ; http://dx.doi.org/10.1111/1523- 1747.ep1287463148.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Arch Dermatol  1977; 113:495-9;  PMID:848981 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Dermatologica 1976 ; 153:218-27;  PMID:1017532 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Dermatologica 1981; 162:141-7; PMID:6265297 ;  http://dx.doi.org/10.1159/000250262 52.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Am Acad Dermatol  1986; 15:966-73;  PMID:3491095 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Clin Immunol  2013; 33:14-21;  PMID:22903682 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Am J Med Sci 1992;  304:174-9;  PMID:1335684 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Am Acad Dermatol  2009; 60:315-20;  PMID:19150275 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Arch Dermatol 2011; 147:590-6;  PMID:21242344 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Cutan Pathol 2002; 29:480-9;  PMID:12207742 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Am Acad Dermatol 2007;  57(Suppl):S78-80;  PMID:17938030 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Australas J Dermatol  2009; 50:44-7;  PMID:19178492 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Eur Acad Dermatol Venereol 2003; 17:394-8;  PMID:12834447 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Dis Markers 2010; 29:199-206;  PMID:21178278 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Infect Dis 2007; 196:876-83;  PMID:17703418 ; http://dx.doi.org/10.1086/521031 66.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Trends Genet 1997; 13:410-4; PMID:9351343 ;  http://dx.doi.org/10.1016/S0168-9525(97)01246-8 68.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Invest Dermatol 2001; 117:935-42;  PMID:11676835 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
EMBO J 1999; 18:5359-69; PMID:10508168 ;  http://dx.doi.org/10.1093/emboj/18.19.5359 71.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Arch Virol 2005; 150 :145-51;  PMID :15654507 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Int J Cancer 2002; 101:61- 8; PMID:12209589 ; http://dx.doi.org/10.1002/ ijc.10576 73.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Adv Exp Med Biol 2008;  624:283-95;  PMID:18348464 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Br J Cancer 2002; 87:319- 23; PMID:12177802 ; http://dx.doi.org/10.1038/ sj.bjc.660043176.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Genes Dev 2000; 14:3065-73;  PMID:11114894 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Apoptosis 2007; 12:549- 60; PMID:17195958 ; http://dx.doi.org/10.1007/ s10495-006-0004-1 78.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
PLoS One 2011; 6:e27655;  PMID:22110707 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Carcinogenesis 2010;  31:2155-64 ;  PMID:20884685 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Exp Dermatol 2011; 20:71-3;  PMID :21158941 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Toxicology 2003; 189:21-39; PMID:12821280 ; http://dx.doi.org/10.1016/ S0300-483X(03)00150-1 82.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
PLoS Pathog 2012; 8:e1002807; PMID:22807682 ;  http://dx.doi.org/10.1371/journal.ppat.1002807 83.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
EMBO J 2002; 21:4741- 8; PMID:12198176 ; http://dx.doi.org/10.1093/ emboj/cdf443 84.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Genomics  2003; 82:300-8;  PMID:12906855 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Nat Genet 2002; 30:277- 84; PMID:11850618 ; http://dx.doi.org/10.1038/ ng842 88.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Nat Genet 2002; 30:257-8;  PMID:11850623 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Int J Mol Med 2009; 24:51-5; PMID:19513534 ; http://dx.doi.org/10.3892/ ijmm_00000205 90.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Nature 1980; 288:159-61;  PMID:7432512 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Nature  2013; 494:95-9;  PMID:23364694 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Gen Physiol  2013; 142:493-505;  PMID:24127526 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Nucleic Acids Res  2010; 38:W576-81;  PMID:20542909 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Antioxid Redox Signal 2010; 12:53-91;  PMID:19634988 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Clin Exp Dermatol  2005; 30:573-4;  PMID:16045695 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Exp Med 2008; 205:35- 42; PMID :18158319 ; http://dx.doi.org/10.1084/ jem.20071311 100.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Gen Virol 1995; 76:1945-58; PMID:7636475 ;  http://dx.doi.org/10.1099/0022-1317-76-8-1945 101.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Virol 2008; 82:11486-94;  PMID:18787005 ; http://dx.doi.org/10.1128/ JVI.01314-08,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
J Virol 2004; 78:13613-26; PMID:15564472 ; http://dx.doi.org/10.1128/ JVI.78.24.13613-13626.2004 104.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Int J Cancer 2012; 130:349-55; PMID:21387292 ;  http://dx.doi.org/10.1002/ijc.26016106.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Int J Dermatol  2003; 42:296-300;  PMID:12694498 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
PLoS One 2012; 7:e39995; PMID:22761942 ;  http://dx.doi.org/10.1371/journal.pone.0039995 108.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Cell Death Dis 2013; 4:e499;  PMID:23429285 ; http://dx.doi.org/10.1038/ cddis.2013.27109.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
Nat Rev Immunol  2004; 4:46-54;  PMID:14704767 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/d6/onci-3-e28288.PMC4006860.pdf
"A diagnosis of a malignant neoplasm after surgery was the  major outcome of interest and was identiï¬  ed by one or more  of the  ICD-9-CM   codes listed in any of the Medicare ï¬  les  in follow-up (see Supplemental Digital Content Appendix 1, available at  http://links.lww.com/BRS/A801 ).",Non-OADS,/arxiv_data1/oa_pdf/ea/ae/spne-38-1862.PMC4006942.pdf
"The latter codes included site-speciï¬  c procedure  codes (see Supplemental Digital Content Appendix 1, avail-able at  http://links.lww.com/BRS/A801 ) as well as procedure  codes for radiation therapy and chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/ea/ae/spne-38-1862.PMC4006942.pdf
"Using a criterion of a diagnosis on 2 or more different dates, we identiï¬  ed 18,942 cancer cases, with  similar frequencies in rhBMP-treated (12.0%) and other patients (13.1%) (see Supplemental Digital Content Appen-dix 2, available at  http://links.lww.com/BRS/A801 ).",Non-OADS,/arxiv_data1/oa_pdf/ea/ae/spne-38-1862.PMC4006942.pdf
"Using the most stringent deï¬  nition of 2 or more diagnoses and cancer treat- ment codes, we identiï¬  ed 14,362 cases with an incidence of  8.7% and 10.0% in rhBMP-treated and untreated patients, respectively (see Supplemental Digital Content Appendix 3, available at  http://links.lww.com/BRS/A801 ).",Non-OADS,/arxiv_data1/oa_pdf/ea/ae/spne-38-1862.PMC4006942.pdf
http://seer.cancer.,Non-OADS,/arxiv_data1/oa_pdf/ea/ae/spne-38-1862.PMC4006942.pdf
https://www.infusebonegraft.com/infuse_indications.,Non-OADS,/arxiv_data1/oa_pdf/ea/ae/spne-38-1862.PMC4006942.pdf
"1-5 (2014) http://dx.doi.org/10.5487/TR.2014.30.1.001 plSSN: 1976-8257 eISSN: 2234-2753 Review ArticleOpen Access Human Tumor Xenograft Models  for Preclinical Assessment of Anticancer Drug Development Joohee Jung College of Pharmacy, Duksung Womenâs University, Seoul, Korea (Received December 19, 2013; Revised February 25, 2014; Accepted March 17, 2014) Xenograft models of human cancer play an important role in the screening and evaluation of candidates for new anticancer agents.",Non-OADS,/arxiv_data1/oa_pdf/88/06/toxicr-30-1.PMC4007037.pdf
"13-18 (2014) http://dx.doi.org/10.5487/TR.2014.30.1.013 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access Inhallation of e-Cigarette Cartridge Solution Aggravates Allergen-induced  Airway Inflammation and Hyper-responsiveness in Mice Heung Bin Lim1 and Seung Hyung Kim2 1Department of Industrial Crop Science and Technology, Chungbuk National University, Cheongju, Chungbuk, Korea 2Institute of Traditional Medicine and Bios cience, Daejeon University, Daejeon, Korea (Received December 26, 2013; Revised March 19, 2014; Accepted March 22, 2014) Electronic cigarettes (e-cigarettes) are becoming incr easingly popular worldwide and their cellular effects warrant further evaluati on.",Non-OADS,/arxiv_data1/oa_pdf/03/21/toxicr-30-13.PMC4007038.pdf
"27-32 (2014) http://dx.doi.org/10.5487/TR.2014.30.1.027 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access A Probiotic Preparation Duolac-Gold Ameliorates Dextran Sulphate  Sodium-induced Mouse Colitis by Downregulating the Expression of IL-6 Hyunho Y oonâ ,  Ye o - S a n g  Yo o nâ , Min-Soo Kim, Myung-Jun Chung and Do-Y oung Yum R&D Center, Cellbiotech Co. Ltd., Gimpo, Korea (Received January 28, 2014; Revised March 18, 2014; Accepted March 19, 2014) Probiotics are live microorganisms that confer a h ealth benefit on the host.",Non-OADS,/arxiv_data1/oa_pdf/0d/97/toxicr-30-27.PMC4007040.pdf
"33-38 (2014) http://dx.doi.org/10.5487/TR.2014.30.1.033 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access Expression and Characterization of Truncated Recombinant Human Cytochrome P450 2J2 Hyoung-Goo Park, Y oung-Ran Lim, Songhee Han and Donghak Kim Department of Biological Sciences, Konkuk University, Seoul, Korea (Received March 17, 2014; Revised March 19, 2014; Accepted March 28, 2014) The human cytochrome P450 2J2 catalyzes an epoxygenase reaction to oxidize various fatty acids includ- ing arachidonic acid.",Non-OADS,/arxiv_data1/oa_pdf/0c/69/toxicr-30-33.PMC4007041.pdf
"39-44 (2014) http://dx.doi.org/10.5487/TR.2014.30.1.039 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access Association between Urinary Bisphenol A and Waist Circumference in Korean Adults Ahra Koâ , Myung-Sil Hwangâ , Jae-Hong Park, Hui-Seung Kang, Hee-Seok Lee and Jin-Hwan Hong Food Safety Risk Assessment Division, Na tional Institute of Food and Drug Safety Evaluation, Chungcheongbuk-do, Korea (Received February 24, 2014; Revised March 20, 2014; Accepted March 24, 2014) Bisphenol A (BPA) is widely used in the production of polycarbonate plastics, epoxy resins, and food and beverage containers.",Non-OADS,/arxiv_data1/oa_pdf/55/0e/toxicr-30-39.PMC4007042.pdf
"45-48 (2014) http://dx.doi.org/10.5487/TR.2014.30.1.045 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access Inhibitory Activities of Palmatine from Coptis chinensis Against Helicobactor pylori  and Gastric Damage Joohee Jung1, Jae Sue Choi2 and Choon-Sik Jeong1 1College of Pharmacy, Duksung Womenâs University, 33, 144-gil, Samyang-ro, Dobong-gu, Seoul, Korea 2Division of Food Science and Biotechnology, Pukyoung Na tional University, 45, Yongso-ro, Nam-gu, Busan, Korea (Received February 27, 2014; Revised March 19, 2014; Accepted March 19, 2014) Helicobacter pylori  (H. pylori ) is the most important factor of gast ric disease in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/62/ae/toxicr-30-45.PMC4007043.pdf
"49-54 (2014) http://dx.doi.org/10.5487/TR.2014.30.1.049 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access Hepatoprotective Effect of Aged Black Garlic Extract in Rodents Jung Hyu Shin1, Chang Woo Lee1, Soo Jin Oh1, Jieun Yun1, Moo Rim Kang1, Sang-Bae Han2, Heungsik Park3, Jae Chul Jung3, Y oon Hoo Chung4 and Jong Soon Kang1 1Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Cheongwon, Chungbuk, Korea 2College of Pharmacy, Chungbuk National University, Cheongju, Korea 3Novarex Co., Ltd., Ochang, Cheongwon, Chungbuk, Korea 4Namhaegun Blackgarlic Co., Ltd., 176-40, Seolcheon-ro, Seolcheon-myeon, Namhae-gun, Gyeongsangnam-do, Korea (Received March 18, 2014; Revised March 24, 2014; Accepted March 26, 2014) In this study, we investigated the hepatoprotective effects of aged black garlic (ABG) in rodent models of liver injury.",Non-OADS,/arxiv_data1/oa_pdf/35/65/toxicr-30-49.PMC4007044.pdf
"55-63 (2014) http://dx.doi.org/10.5487/TR.2014.30.1.055 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access Studies on the Toxicity and Distribution of Indium Compounds According  to Particle Size in Sprague-Dawley Rats Cheol Hong Lim, Jeong-Hee Han, Hae-Won Cho and Mingu Kang Toxicity Research Team, Occupational Safety and Health Research Institute, KOSHA, Exporo, Yuseong-Gu, Daejeon, Korea (Received March 18, 2014; Revised March 30, 2014; Accepted March 30, 2014) Objectives: The use of indium compounds, especially those of small size, for the production of semicon- ductors, liquid-crystal panels, etc., has increased recen tly.",Non-OADS,/arxiv_data1/oa_pdf/3c/02/toxicr-30-55.PMC4007045.pdf
"7-11 (2014) http://dx.doi.org/10.5487/TR.2014.30.1.007 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access A Rapid Method for Estimating the Levels of Urinary Thiobarbituric Acid  Reactive Substances for Environmental Epidemiologic Survey Han-Na Kil1,2, Sang-Y ong Eom1, Jung-Duck Park3, Toshihiro Kawamoto4, Y ong-Dae Kim1 and Heon Kim1 1Department of Preventive Medi cine and Medical Research Institute, College of Medicine, Chungbuk National University, Cheongju, Korea 2Division of Biobank for Health Science, Center for Genome Science, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Osong, Korea 3Department of Preventive Medicine, Chung-Ang University, College of Medicine, Seoul, Korea 4Department of Environmental Health, University of Occupational and Environmental Health, Kitakyushu, Japan (Received November 20, 2013; Revised February 6, 2014; Accepted February 13, 2014) Malondialdehyde (MDA), used as an oxidative stress marker, is commonly assayed by measuring the thiobarbituric acid reactive substances (TBARS) usin g HPLC, as an indicator of the MDA concentration.",Non-OADS,/arxiv_data1/oa_pdf/0b/65/toxicr-30-7.PMC4007046.pdf
"In addition, the identified mutation had not been documen- ted in database of single nucleotide polymorphisms (dbSNP) or in the 1000 genomes project dataset (http://browser.1000genomes.org).",OADS,/arxiv_data1/oa_pdf/7a/5e/srep04836.PMC4007070.pdf
The PAX6 Allelic Variant Database [http://pax6.hgu.mrc.ac.uk/] 11.,Non-OADS,/arxiv_data1/oa_pdf/7a/5e/srep04836.PMC4007070.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4836 | DOI: 10.1038/srep04836 4",Non-OADS,/arxiv_data1/oa_pdf/7a/5e/srep04836.PMC4007070.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Figure 4 |(a) Optical micrograph of a fabricated 10 mm pitch CN array on a 10 310 mm Si substrate and the corresponding (b) scanning electron micrograph (Scale bar: 15 mm).",Non-OADS,/arxiv_data1/oa_pdf/b5/c4/srep04840.PMC4007073.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c8/73/srep04847.PMC4007074.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4847 | DOI: 10.1038/srep04847 9",Non-OADS,/arxiv_data1/oa_pdf/c8/73/srep04847.PMC4007074.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cf/3f/srep04838.PMC4007075.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4838 | DOI: 10.1038/srep04838 5",Non-OADS,/arxiv_data1/oa_pdf/cf/3f/srep04838.PMC4007075.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4875 | DOI: 10.1038/srep04875 7",Non-OADS,/arxiv_data1/oa_pdf/8c/36/srep04875.PMC4007076.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/84/76/srep04874.PMC4007078.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4874 | DOI: 10.1038/srep04874 8",Non-OADS,/arxiv_data1/oa_pdf/84/76/srep04874.PMC4007078.pdf
Dyslexia was evaluated based on the ICD-10 criteria (also adopted by the Consensus Conference onlearning disabilities of the Italian Superior Institute of Health 40[http://www.snlg-iss.,Non-OADS,/arxiv_data1/oa_pdf/95/0f/srep04869.PMC4007079.pdf
"Stimuli and procedure .Two lists (A and B, see Appendix) of 50 five-letter novel words were derived from two lists of words, which were matched for age of acquisition, frequency (based on CoLFIS database 43[http://linguistica.sns.it/CoLFIS/ Home.htm]), bigram frequency and initial phoneme.",OADS,/arxiv_data1/oa_pdf/95/0f/srep04869.PMC4007079.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/95/0f/srep04869.PMC4007079.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4869 | DOI: 10.1038/srep04869 8",Non-OADS,/arxiv_data1/oa_pdf/95/0f/srep04869.PMC4007079.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4845 | DOI: 10.1038/srep04845 9",Non-OADS,/arxiv_data1/oa_pdf/c2/0d/srep04845.PMC4007080.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/52/5e/srep04839.PMC4007083.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4839 | DOI: 10.1038/srep04839 8",Non-OADS,/arxiv_data1/oa_pdf/52/5e/srep04839.PMC4007083.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/60/e8/srep04877.PMC4007088.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4877 | DOI: 10.1038/srep04877 7",Non-OADS,/arxiv_data1/oa_pdf/60/e8/srep04877.PMC4007088.pdf
URL http://publicdata.norc.,OADS,/arxiv_data1/oa_pdf/71/28/srep04870.PMC4007089.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/71/28/srep04870.PMC4007089.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4870 | DOI: 10.1038/srep04870 9",Non-OADS,/arxiv_data1/oa_pdf/71/28/srep04870.PMC4007089.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/50/3b/srep04778.PMC4007091.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4778 | DOI: 10.1038/srep04778 7",Non-OADS,/arxiv_data1/oa_pdf/50/3b/srep04778.PMC4007091.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0e/71/srep04841.PMC4007093.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4841 | DOI: 10.1038/srep04841 7",Non-OADS,/arxiv_data1/oa_pdf/0e/71/srep04841.PMC4007093.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/00/f6/srep04753.PMC4007094.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4753 | DOI: 10.1038/srep04753 6",Non-OADS,/arxiv_data1/oa_pdf/00/f6/srep04753.PMC4007094.pdf
http://en.wikipedia.org/wiki/Binary_fission (1st October 2013) 18.,Non-OADS,/arxiv_data1/oa_pdf/a4/30/srep04865.PMC4007095.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a4/30/srep04865.PMC4007095.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4865 | DOI: 10.1038/srep04865 6",Non-OADS,/arxiv_data1/oa_pdf/a4/30/srep04865.PMC4007095.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5a/2e/srep04868.PMC4007096.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4868 | DOI: 10.1038/srep04868 9",Non-OADS,/arxiv_data1/oa_pdf/5a/2e/srep04868.PMC4007096.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4783 | DOI: 10.1038/srep04783 6",Non-OADS,/arxiv_data1/oa_pdf/2e/8f/srep04783.PMC4007097.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ae/16/els033.PMC4007103.pdf
"With thedevelopment of deep sequencing, the characteriza- tion of entire genomes from hundreds of different populations is becoming a reality (http://dpgp.org/).",Non-OADS,/arxiv_data1/oa_pdf/ae/16/els033.PMC4007103.pdf
Insulin sensitivity Insulin sensitivity was estimated using the homeostasis model assessment(HOMA-%S) (http://www.dtu.ox.ac.uk/homacalculator/index.php).,OADS,/arxiv_data1/oa_pdf/bf/c3/nutd201411a.PMC4007154.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/sCD36 is associated with unhealthy fat distribution L KnÃ¸sgaard et al 6 Nutrition & Diabetes (2014) 1 â 6 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/bf/c3/nutd201411a.PMC4007154.pdf
(Available at: http://meeting.ascopubs.org/cgi/content/ abstract/30/27_suppl/2?sid=007510f1-1d3c-4894-89ca-8a271491d3de).,OADS,/arxiv_data1/oa_pdf/9a/43/bonekey201414.PMC4007167.pdf
(Available at: http://cancerres.aacrjournals.org/cgi/content/meeting_abstract/72/24_MeetingAbstracts/OT2- 3-03?sid=f0763b5d-469a-48da-ae0e-a4c15e0ace37).,Non-OADS,/arxiv_data1/oa_pdf/9a/43/bonekey201414.PMC4007167.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Targeting RANKL in metastasis WC Dougall et al 8 APRIL 2014 |www.nature.com/bonekey",Non-OADS,/arxiv_data1/oa_pdf/9a/43/bonekey201414.PMC4007167.pdf
"By searching predicted target genes of miR-99a overlapped inTargetScan (http://www.targetscan.org) and miRNA database (http://www.microrna.org/microrna/getMirnaForm.do), and subse- quently conï¬rmed in RegRNA (http://regrna.mbc.nctu.edu.tw/index1.php), we found that Ago2 (also known as Eif2c2 ) might be a novel candidate gene targeted by miR-99a (Figure 3a).",OADS,/arxiv_data1/oa_pdf/e8/95/oncsis201411a.PMC4007193.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis)MiR-99a targets Argonaute-2 J Zhang et al 10 Oncogenesis (2014), 1 â 10 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/e8/95/oncsis201411a.PMC4007193.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).miR-18a enhances tumorigenicity in prostate cancer T-I Hsu et al 11 &2014 Macmillan Publishers Limited Oncogenesis (2014), 1 â 11",Non-OADS,/arxiv_data1/oa_pdf/68/fe/oncsis201412a.PMC4007194.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/dMLF acts with DREF to activate JNK signaling pathway H Yanai et al 7 &2014 Macmillan Publishers Limited Oncogenesis (2014), 1 â 7",Non-OADS,/arxiv_data1/oa_pdf/ec/ee/oncsis201413a.PMC4007195.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis)Prognosis and therapy in aggressive breast cancer F Al-Ejeh et al 12 Oncogenesis (2014), 1 â 12 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/3d/ff/oncsis201414a.PMC4007196.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis)RUNX3 is sumoylated by PIAS1 J-H Kim et al 10 Oncogenesis (2014) 1 â 10 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/b3/52/oncsis201415a.PMC4007197.pdf
http://www.nhri.org.tw/nhird/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/ef/a2/bjc2014103a.PMC4007220.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER TAp63 suppress metastasis via miR-133b 2320 www.bjcancer.com | DOI:10.1038/bjc.2014.118,Non-OADS,/arxiv_data1/oa_pdf/46/25/bjc2014118a.PMC4007221.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Ascites-derived pancreatic cancer primary cultures 2276 www.bjcancer.com | DOI:10.1038/bjc.2014.123,Non-OADS,/arxiv_data1/oa_pdf/6c/7e/bjc2014123a.PMC4007225.pdf
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Accessed 13 April 2013).,Non-OADS,/arxiv_data1/oa_pdf/6b/0f/bjc2014127a.PMC4007227.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)COX inhibitors use and risk of EAC in patients with BE BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.127 2387,Non-OADS,/arxiv_data1/oa_pdf/6b/0f/bjc2014127a.PMC4007227.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Smoking and breast cancer risk BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.132 2347,Non-OADS,/arxiv_data1/oa_pdf/94/9f/bjc2014132a.PMC4007228.pdf
Oligonucleotide primers were designed with Primer3 software (http://frodo.wi.mit.edu) (Supplementary Table S1).,OADS,/arxiv_data1/oa_pdf/47/64/bjc2014138a.PMC4007231.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Mutations of CDK8 submodule in uterine leiomyomas BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.138 2249,Non-OADS,/arxiv_data1/oa_pdf/47/64/bjc2014138a.PMC4007231.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Histological grade concordance in core biopsy 2200 www.bjcancer.com | DOI:10.1038/bjc.2014.143,Non-OADS,/arxiv_data1/oa_pdf/81/50/bjc2014143a.PMC4007232.pdf
Available from https://www.gov.uk/organic-systems-and-standards-in-farming (accessed10 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/c8/f5/bjc2014148a.PMC4007233.pdf
Available from https://www.gov.uk/government/organis ations/department-for-environment- food-rural-affairs/series/organic-farming (accessed 19 August 2013).,Non-OADS,/arxiv_data1/oa_pdf/c8/f5/bjc2014148a.PMC4007233.pdf
Available from http://www.soilassociation.org/marketreport (accessed 24 September 2012).,Non-OADS,/arxiv_data1/oa_pdf/c8/f5/bjc2014148a.PMC4007233.pdf
Available from http://www.soilassociation.org/marketreport (accessed 24 September 2012).,Non-OADS,/arxiv_data1/oa_pdf/c8/f5/bjc2014148a.PMC4007233.pdf
Available from http://www.soilassociation.org/marketreport (accessed 19 August 2013).,Non-OADS,/arxiv_data1/oa_pdf/c8/f5/bjc2014148a.PMC4007233.pdf
Available from http://www.soilassociation.org/marketreport (accessed 7 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/c8/f5/bjc2014148a.PMC4007233.pdf
The Expert Committee on Pesticide Residues in Food (2012) Report on the Pesticide Residues Monitoring Programme for Quarter 4 2011.Available from http://www.pesticides.gov.uk/Resources/CRD/PRiF/Documents/Results%20and%20Reports/2012/Q4%202012%20Final.pdf(accessed 19 August 2013).,Non-OADS,/arxiv_data1/oa_pdf/c8/f5/bjc2014148a.PMC4007233.pdf
"Crippa A (2013) Dosresmeta: Performing dose-response meta-analysis, computer software, http://cran.r-project.org/web/packages/dosresmeta/ index.html.",OADS,/arxiv_data1/oa_pdf/72/e1/bjc2014150a.PMC4007234.pdf
"R Core Team (2013) R: A language and environment for statistical computing, computer software, http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/72/e1/bjc2014150a.PMC4007234.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Regulation of malignant mesothelioma by CD26 and SSTR4 BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.151 2245,Non-OADS,/arxiv_data1/oa_pdf/ee/f1/bjc2014151a.PMC4007235.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Folate intake and breast cancer risk 2338 www.bjcancer.com | DOI:10.1038/bjc.2014.155,Non-OADS,/arxiv_data1/oa_pdf/6e/46/bjc2014155a.PMC4007237.pdf
Dose Response (in press); http://doseresponse.metapress.com/media/h07c7jqqvp3qt9qkjj1q/ contributions/m/1/1/3/m11340102g645435.pdf.LDH5 and prostate cancer radiotherapy BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.158 2223,Non-OADS,/arxiv_data1/oa_pdf/e9/bd/bjc2014158a.PMC4007238.pdf
Avialable at: http://www.ctu.mrc.ac.uk/plugins/StudyDisplay/protocols/FOCUS%203%20Protocol%20and%20appendices%20v4%200%20Nov%202010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7a/58/bjc2014182a.PMC4007241.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER MRC FOCUS3 feasibility study 2186 www.bjcancer.com | DOI:10.1038/bjc.2014.182,Non-OADS,/arxiv_data1/oa_pdf/7a/58/bjc2014182a.PMC4007241.pdf
Available at: http://consensus.nih.gov/1990/1990earlystagebreastcancer081html.htm(accessed on 5th October 2013).,OADS,/arxiv_data1/oa_pdf/84/eb/bjc2014183a.PMC4007242.pdf
Available at:http://seer.cancer.gov/publications/survival/surv_breast.pdf (accessed on13th August 2013).,Non-OADS,/arxiv_data1/oa_pdf/84/eb/bjc2014183a.PMC4007242.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Prognostic model in pretreated biliary cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.190 2169,Non-OADS,/arxiv_data1/oa_pdf/34/8f/bjc2014190a.PMC4007244.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)HPV and oesophageal cancer: review and meta-analysis BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.96 2377,Non-OADS,/arxiv_data1/oa_pdf/dc/dc/bjc201496a.PMC4007246.pdf
We screened the  ligands against Lipinski rule of 5 using Molinspiration  (http://www.molinspiration.com/) and their drug  likeness was further confirmed using MarvinSketch  (http://www.chemaxon.com/marvin/sketch/index.jsp).,OADS,/arxiv_data1/oa_pdf/83/61/IJPhS-76-10.PMC4007250.pdf
We utilized  an online server FAFâDrugs (http://mobyle.rpbs.,Non-OADS,/arxiv_data1/oa_pdf/83/61/IJPhS-76-10.PMC4007250.pdf
Availabel from: http://www.who.int/csr/don/2010_02_5/ en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/83/61/IJPhS-76-10.PMC4007250.pdf
Available from: http://articles.timesofindia.,Non-OADS,/arxiv_data1/oa_pdf/83/61/IJPhS-76-10.PMC4007250.pdf
Available from: http://siddhadreams.wordpress.com/2009/08/17/swineâ fluâvsâvitaminâc/.,Non-OADS,/arxiv_data1/oa_pdf/83/61/IJPhS-76-10.PMC4007250.pdf
Available from: http://www.ehow.,Non-OADS,/arxiv_data1/oa_pdf/83/61/IJPhS-76-10.PMC4007250.pdf
Available from:  http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/UCM186224.pdf.,Non-OADS,/arxiv_data1/oa_pdf/83/61/IJPhS-76-10.PMC4007250.pdf
Available from: http://archive.ispub.com/ journal/theâinternetâjournalâofâepidemiology/volumeâ8ânumberâ1/ pharmacoepidemiologyâofâcancerâinâsouthernâindia.html#sthash.,Non-OADS,/arxiv_data1/oa_pdf/6e/4e/IJPhS-76-2.PMC4007252.pdf
Available from:  http://www.usc.edu/hsc/info/pr/hmm/05fall/cancer.html [Last accessed  on 2013 Feb 26].,Non-OADS,/arxiv_data1/oa_pdf/6e/4e/IJPhS-76-2.PMC4007252.pdf
": 3.6.2.1 Compudrug International Inc, Bal Harbor, FL, USA,  http://www.compudrug.com.",Non-OADS,/arxiv_data1/oa_pdf/be/0e/IJPhS-76-31.PMC4007253.pdf
"Available from:  http://www.dndi.org/diseasesâprojects/diseases/vl.html,  [Last accessed on 2013 Oct 6].",Non-OADS,/arxiv_data1/oa_pdf/d0/38/IJPhS-76-92.PMC4007262.pdf
http://www.nal.usda.gov.,Non-OADS,/arxiv_data1/oa_pdf/8f/4c/ABR-3-100.PMC4007340.pdf
Available from: http://www.westgard.com/biodatabase1.htm.,OADS,/arxiv_data1/oa_pdf/e2/43/ABR-3-94.PMC4007341.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c1/ijbsv10p0466.PMC4007360.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/55/38/ijbsv10p0479.PMC4007361.pdf
Materials and methods   Sampling   Specimens of Carcinoscorpius rotundicauda  was  purchased from a pet shop ( http://www.hanqua.,Non-OADS,/arxiv_data1/oa_pdf/55/38/ijbsv10p0479.PMC4007361.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e9/a9/ijbsv10p0490.PMC4007362.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d5/a8/ijbsv10p0500.PMC4007363.pdf
Supplementary Material   Additional File 1:   Supplementary Table 1 -Supplementary Table 4.   http:// www.ijbs.com /v10p05 00s1.pdf   Additional File 2:   Supplementary Figure 1 -Supplementary Figure 3.     http://www.ijbs.com /v10p05 00s2.pdf  Acknowledgments   This study was supported by the National Na t- ural Science Foundation of China (No.,Non-OADS,/arxiv_data1/oa_pdf/d5/a8/ijbsv10p0500.PMC4007363.pdf
URL: http://www.ejomr.org/JOMR/archives/2014/1/e1/v5n1e1ht.pdf doi: 10.5037/jomr.2014.5101 http://www.ejomr.org/JOMR/archives/2014/1/e1/v5n1e1ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c4/14/jomr-05-e1.PMC4007367.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e1/v5n1e1ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c4/14/jomr-05-e1.PMC4007367.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e1/v5n1e1ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c4/14/jomr-05-e1.PMC4007367.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e1/v5n1e1ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c4/14/jomr-05-e1.PMC4007367.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e1/v5n1e1ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c4/14/jomr-05-e1.PMC4007367.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e1/v5n1e1ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c4/14/jomr-05-e1.PMC4007367.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e1/v5n1e1ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c4/14/jomr-05-e1.PMC4007367.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e1/v5n1e1ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c4/14/jomr-05-e1.PMC4007367.pdf
URL:   http://www.cochrane.org/cochrane-interventions-handbook 7.,OADS,/arxiv_data1/oa_pdf/c4/14/jomr-05-e1.PMC4007367.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e1/v5n1e1ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/c4/14/jomr-05-e1.PMC4007367.pdf
"J Oral Maxillofac Res 2014;5(1):e1 URL: http://www.ejomr.org/JOMR/archives/2014/1/e1/v5n1e1ht.pdf doi: 10.5037/jomr.2014.5101 Copyright Â©  Pinchasov G, Juodzbalys G. Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http:// www.ejomr.org ), 1 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/jomr-05-e1.PMC4007367.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/jomr-05-e1.PMC4007367.pdf
URL: http://www.ejomr.org/JOMR/archives/2014/1/e2/v5n1e2ht.pdf doi: 10.5037/jomr.2014.5102  http://www.ejomr.org/JOMR/archives/2014/1/e2/v5n1e2ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/c6/jomr-05-e2.PMC4007368.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e2/v5n1e2ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/c6/jomr-05-e2.PMC4007368.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e2/v5n1e2ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/c6/jomr-05-e2.PMC4007368.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e2/v5n1e2ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/c6/jomr-05-e2.PMC4007368.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e2/v5n1e2ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/c6/jomr-05-e2.PMC4007368.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e2/v5n1e2ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/c6/jomr-05-e2.PMC4007368.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e2/v5n1e2ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/c6/jomr-05-e2.PMC4007368.pdf
"J Oral Maxillofac Res 2014;5(1):e2 URL: http://www.ejomr.org/JOMR/archives/2014/1/e2/v5n1e2ht.pdf doi: 10.5037/jomr.2014.5102 Copyright  Â© Hartlev J, Godtfredsen E, Andersen NT, Jensen T. Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 1 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/6f/c6/jomr-05-e2.PMC4007368.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/6f/c6/jomr-05-e2.PMC4007368.pdf
URL: http://www.ejomr.org/JOMR/archives/2014/1/e3/v5n1e3ht.pdf doi: 10.5037/jomr.2014.5103  http://www.ejomr.org/JOMR/archives/2014/1/e3/v5n1e3ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f5/c0/jomr-05-e3.PMC4007369.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e3/v5n1e3ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f5/c0/jomr-05-e3.PMC4007369.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e3/v5n1e3ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f5/c0/jomr-05-e3.PMC4007369.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e3/v5n1e3ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f5/c0/jomr-05-e3.PMC4007369.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e3/v5n1e3ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f5/c0/jomr-05-e3.PMC4007369.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e3/v5n1e3ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f5/c0/jomr-05-e3.PMC4007369.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e3/v5n1e3ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f5/c0/jomr-05-e3.PMC4007369.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e3/v5n1e3ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f5/c0/jomr-05-e3.PMC4007369.pdf
"J Oral Maxillofac Res 2014;5(1):e3 URL: http://www.ejomr.org/JOMR/archives/2014/1/e3/v5n1e3ht.pdf doi: 10.5037/jomr.2014.5103 Copyright  Â© Pavli M, Farmaki E, Merkourea S, Vastardis H, Sklavounou A, Tzerbos F, Chatzistamou I.",Non-OADS,/arxiv_data1/oa_pdf/f5/c0/jomr-05-e3.PMC4007369.pdf
"Published in the  JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 1 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/f5/c0/jomr-05-e3.PMC4007369.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.27.",Non-OADS,/arxiv_data1/oa_pdf/f5/c0/jomr-05-e3.PMC4007369.pdf
URL: http://www.ejomr.org/JOMR/archives/2014/1/e4/v5n1e4ht.pdf doi: 10.5037/jomr.2014.5104 http://www.ejomr.org/JOMR/archives/2014/1/e4/v5n1e4ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/48/jomr-05-e4.PMC4007370.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e4/v5n1e4ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/48/jomr-05-e4.PMC4007370.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e4/v5n1e4ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/48/jomr-05-e4.PMC4007370.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e4/v5n1e4ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/48/jomr-05-e4.PMC4007370.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e4/v5n1e4ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/48/jomr-05-e4.PMC4007370.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e4/v5n1e4ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/48/jomr-05-e4.PMC4007370.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e4/v5n1e4ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/48/jomr-05-e4.PMC4007370.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e4/v5n1e4ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/48/jomr-05-e4.PMC4007370.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e4/v5n1e4ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/48/jomr-05-e4.PMC4007370.pdf
Available at: http://www.bfsweb.org/onemillion/09%20One%20in%20 a%20Million%20-%20The%20Extent%20of%20Fluoridation.pdf .,Non-OADS,/arxiv_data1/oa_pdf/20/48/jomr-05-e4.PMC4007370.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e4/v5n1e4ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/48/jomr-05-e4.PMC4007370.pdf
J Oral Maxillofac Res 2014;5(1):e4 URL: http://www.ejomr.org/JOMR/archives/2014/1/e4/v5n1e4ht.pdf doi: 10.5037/jomr.2014.5104 Copyright Â©  Khalaf K. Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.,Non-OADS,/arxiv_data1/oa_pdf/20/48/jomr-05-e4.PMC4007370.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/20/48/jomr-05-e4.PMC4007370.pdf
URL: http://www.ejomr.org/JOMR/archives/2014/1/e5/v5n1e5ht.pdf doi: 10.5037/jomr.2014.5105 http://www.ejomr.org/JOMR/archives/2014/1/e5/v5n1e5ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/97/jomr-05-e5.PMC4007371.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e5/v5n1e5ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/97/jomr-05-e5.PMC4007371.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e5/v5n1e5ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/97/jomr-05-e5.PMC4007371.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e5/v5n1e5ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/97/jomr-05-e5.PMC4007371.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e5/v5n1e5ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/97/jomr-05-e5.PMC4007371.pdf
"J Oral Maxillofac Res 2014;5(1):e5 URL: http://www.ejomr.org/JOMR/archives/2014/1/e5/v5n1e5ht.pdf doi: 10.5037/jomr.2014.5105 Copyright Â©  Baziar H, Daneshvar F, Mohammadi A, Jafarzadeh H. Published in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 1 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/d0/97/jomr-05-e5.PMC4007371.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.21.",Non-OADS,/arxiv_data1/oa_pdf/d0/97/jomr-05-e5.PMC4007371.pdf
URL: http://www.ejomr.org/JOMR/archives/2014/1/e6/v5n1e6ht.pdf doi: 10.5037/jomr.2014.5106  http://www.ejomr.org/JOMR/archives/2014/1/e6/v5n1e6ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/02/jomr-05-e6.PMC4007372.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e6/v5n1e6ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/02/jomr-05-e6.PMC4007372.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e6/v5n1e6ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/02/jomr-05-e6.PMC4007372.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e6/v5n1e6ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/02/jomr-05-e6.PMC4007372.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e6/v5n1e6ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/02/jomr-05-e6.PMC4007372.pdf
http://www.ejomr.org/JOMR/archives/2014/1/e6/v5n1e6ht.htm J Oral Maxillofac Res 2014 (Jan-Mar) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7d/02/jomr-05-e6.PMC4007372.pdf
"J Oral Maxillofac Res 2014;5(1):e6 URL: http://www.ejomr.org/JOMR/archives/2014/1/e6/v5n1e6ht.pdf doi: 10.5037/jomr.2014.5106 Copyright  Â© Guarda-Nardini L, Manfredini D, Olivo M, Ferronato G. Published in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 1 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/7d/02/jomr-05-e6.PMC4007372.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/7d/02/jomr-05-e6.PMC4007372.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2d/44/jcav05p0360.PMC4007524.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ce/b0/jcav05p0368.PMC4007525.pdf
HTB- 70 cells were isolated from a 24 year old  female patient and CRL -2302 cells from a 19 year old  male (http://www.lgcstandards -atcc.org).,Non-OADS,/arxiv_data1/oa_pdf/ce/b0/jcav05p0368.PMC4007525.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/08/26/jcav05p0382.PMC4007526.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/06/9a/jcav05p0390.PMC4007527.pdf
http://www.info.pmda.go.jp/go/interview/   1/180188_2391405D1020_1_005_1F.pdf   9.,Non-OADS,/arxiv_data1/oa_pdf/06/9a/jcav05p0390.PMC4007527.pdf
Epirubicin Hydrochloride  Injection [Package insert] ; 2011.  http://www.sagentpharma.com/Products/   Epirubicin/Catalog/Epirubicin_PI.pdf   12.,Non-OADS,/arxiv_data1/oa_pdf/06/9a/jcav05p0390.PMC4007527.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/4d/evu065.PMC4007538.pdf
Supplementary Material Supplementary ï¬gures S1âS4 andtable S1 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/05/4d/evu065.PMC4007538.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/f6/evu061.PMC4007539.pdf
"Data Processing and Assembly Roche 454 pyrosequencing and Illumina short-read data were imported into Geneious 5.6.3 (Biomatters, http://www.gen eious.com , last accessed April 8, 2014) in sff and fastq for- mats, respectively.",OADS,/arxiv_data1/oa_pdf/b2/f6/evu061.PMC4007539.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/e8/evu069.PMC4007540.pdf
"RNA-Seq Analysis Transcriptomic high-throughput sequencing data were ana- lyzed using a bioinformatic pipeline implemented in theMicroScope platform ( http://www.genoscope.cns.fr/agc/mi croscope/ , last accessed April 12, 2014) ( Vallenet et al.",OADS,/arxiv_data1/oa_pdf/8a/e8/evu069.PMC4007540.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/25/evu075.PMC4007542.pdf
"A detailed description of GEMA algorithm is presented in the âGEMA_Instructions.pdfâ available from our web page: http://bpg.utoledo.edu/~afedorov/lab/GEMA.html (last accessed April 17, 2014) whereas a copy of it is presented in the supplementary ï¬le S1 ,Supplementary Material online.",OADS,/arxiv_data1/oa_pdf/a8/25/evu075.PMC4007542.pdf
"The programming codes for GEMA_r01.java GEMA_r1.pl and pseudocodes are freely available from our lab web site http://bpg.utoledo.edu/~a fedorov/lab/GEMA.html (last accessed April 17, 2014).",OADS,/arxiv_data1/oa_pdf/a8/25/evu075.PMC4007542.pdf
"These parameters are thoroughly explained in the User Guide for GEMA (in supplementary ï¬le S1 ,Supplementary Material online, p. 6â9) and also in the GEMA web site (http://bpg.utoledo.edu/~afedorov/lab/GEMA.html ,l a s ta c c e s s e dApril 17, 2014) including GEMA_video_presentation.m4v, GEMA.java pseudocode, and other supplementary materials , Supplementary Material online.",OADS,/arxiv_data1/oa_pdf/a8/25/evu075.PMC4007542.pdf
Supplementary Material Supplementary tables S1 andS2andï¬le S1 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/a8/25/evu075.PMC4007542.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/57/evu056.PMC4007543.pdf
Supplementary Material Supplementary ï¬gures S1âS7 andtables S1âS9 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/cf/57/evu056.PMC4007543.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/b0/evu048.PMC4007547.pdf
"Gene Clustering and Phylogenetic Analyses Amino acid sequences were delineated into clusters with pu- tative shared homology using the Markov clustering (MCL)algorithm ( van Dongen 2000 ) as implemented in the MCLBlastLINE pipeline (available at http://micans.org/mcl , last accessed March 20, 2014).",OADS,/arxiv_data1/oa_pdf/ee/b0/evu048.PMC4007547.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/fb/evu077.PMC4007549.pdf
Available from:http://mesquiteproject.org .,Non-OADS,/arxiv_data1/oa_pdf/d3/fb/evu077.PMC4007549.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/2a/evu059.PMC4007550.pdf
"Four methods imple- mented on the DATAMONKEY web server ( http://www.data- monkey.org/ [last accessed April 15, 2014]; Pond and Frost 2005b ), Single Likelihood Ancestral Counting (SLAC), Fixed Effects Likelihood (FEL), Random Effects Likelihood (REL), and PRoperty Informed Models of Evolution (PRIME), were used.",OADS,/arxiv_data1/oa_pdf/45/2a/evu059.PMC4007550.pdf
"Protein models werebuilt with PHYRE 2 ( http://www.sbg.bio.ic.ac.uk/phyre2 ,l a s t accessed April 7, 2014; Kelley and Sternberg 2009 )f o rt h e following subunits (PDBid of the respective template in paren-thesis): ND2 (3RKO), ND4 (3RKO), ND5 (3RKO), COXI (1V54),COXII (1V55), COXIII (1V54), and CYTB (3CWB).",Non-OADS,/arxiv_data1/oa_pdf/45/2a/evu059.PMC4007550.pdf
Available from: http://beast.bio.ed.ac.uk/software/tracer .,OADS,/arxiv_data1/oa_pdf/45/2a/evu059.PMC4007550.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/c0/evu076.PMC4007552.pdf
"The BLASTN and TBLASTN programs were utilized with the following criteria: Evalue<1E-05 and an amino acid identity above 40%, andthe sequences were downloaded from the databases Phytozome ( http://www.phytozome.net/ , last accessed April 19, 2014) or NCBI (The National Center for Biotechnology Information, http://blast.ncbi.nlm.nih.gov/Blast.cgi , last accessed April 19, 2014).",OADS,/arxiv_data1/oa_pdf/63/c0/evu076.PMC4007552.pdf
"The Pfam ( http://pfam.sanger.ac.uk/ , last accessed April 19, 2014) and SMART ( http://smart.embl-heidelberg.de/ ,l a s t accessed April 19, 2014) databases were employed to detect con- served domains, with 142 DA1-like and seven DAR-like sequences obtained from the 33 plant species examined ( supplementary table S1 ,Supplementary Material online).",OADS,/arxiv_data1/oa_pdf/63/c0/evu076.PMC4007552.pdf
"Ancestral Character-State Reconstruction To reveal the diversiï¬cation process of DA1 family introns during the evolution, we conducted character-state recon- structions of the intron number and size using Mesquite ver- sion 2.75 ( http://mesquiteproject.org , last accessed April 19, 2014).",OADS,/arxiv_data1/oa_pdf/63/c0/evu076.PMC4007552.pdf
"Evaluating Ancestral Duplication Events Synteny analyses were performed in the Plant GenomeDuplication Database ( http://chibba.agtec.uga.edu/duplication/ , last accessed April 19, 2014) using DA1-like ( AthDA1 -like) or Glycine max DA1 (GmaDA1 -like) as queries.",OADS,/arxiv_data1/oa_pdf/63/c0/evu076.PMC4007552.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/e4/evu064.PMC4007553.pdf
Supplementary Material Supplementary ï¬gures S1 andS2a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.oxfordjour- nals.org/ ).are available.,Non-OADS,/arxiv_data1/oa_pdf/8d/e4/evu064.PMC4007553.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ APPENDIX Institutes participating in this study: Japanese Red Cross Asahikawa Hospital; Hokkaido University Hospital; Sapporo Medical University Hospital; Sapporo Hokuyu Hospital; Akita University Hospital; Iwate Medical University; Tohoku University Hospital; Fukushima MedicalUniversity Hospital; Nagaoka Red Cross Hospital; Gunmaken Saiseikai Maebashi Hospital; Tsukuba Memorial Hospital; Chiba University Hospital; Kameda Medical Center; National DefenseMedical College Hospital; Saitama Medical Center, Jichi MedicalUniversity; Keio University Hospital; Tokyo Metropolitan Cancer and Infectious diseases Center, Komagome Hospital; Toranomon Hospital; National Cancer Center Hospital; Tokyo Womenâs MedicalUniversity Hospital; Institute of Medical Science, University ofTokyo; Nippon Medical School Hospital; Kanagawa Cancer Center; Yokohama City University Medical Center; Nagano Red Cross Hospital; Shinshu University Hospital; Toyama Prefectural CentralHospital; Kurobe City Hospital; Kanazawa University Hospital; Shizuoka General Hospital; Japanese Red Cross Shizuoka Hospital; Hamamatsu University Hospital; Hamamatsu Medical Center; AnjoKosei Hospital; Fujita Health University Hospital; Japanese Red CrossNagoya Daiichi Hospital; Japanese Red Cross Nagoya Daini Hospital; Meitetsu Hospital; Nagoya University Hospital; Nara Medical University Hospital; Tenri Hospital; Takanohara Central Hospital;Kyoto University Hospital; Kyoto-Katsura Hospital; Osaka Red CrossHospital; Osaka Medical Center for Cancer and Cardiovascular Diseases; Takatsuki Red Cross Hospital; Seichokai Fuchu Hospital; Kinki University Hospital; Wakayama Medical University Hospital;Hyogo College of Medicine; Institute of Biomedical Research and Innovation; Kurashiki Central Hospital; Okayama Medical Center; Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital;Shimane Prefectural Central Hospital; Yamaguchi University Hospi-tal; Ehime University Hospital; Ehime Prefectural Central Hospital; Kochi Medical School Hospital; Kitakyushu Municipal Medical Center; University of Occupational and Environmental Health;Kyushu Cancer Center; Kyushu Medical Center; Kyushu UniversityHospital; Kurume University Hospital; Ryukyu University Hospital.Transplantation for PMF with BM, PB or UCB M Murata et al 360 Bone Marrow Transplantation (2014) 355 â 360 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/55/59/bmt2013180a.PMC4007589.pdf
"Methods Sample collection and genotyping .Genographic sample collection was conducted according to the ethical protocol of The Genographic Project (https://genographic.nationalgeographic.com/wp-content/uploads/2012/07/Geno2.0_Ethical-Framework.pdf), with oversight provided by the University of Pennsylvania and regional IRBs (speciï¬ed in the original reports from which data analyzed in this study were taken).",OADS,/arxiv_data1/oa_pdf/da/4b/ncomms4513.PMC4007635.pdf
We obtained the HGDP data set available at ftp://ftp.cephb.fr/hgdp supp10/ 44 and the geographical coordinates for each sample45.,OADS,/arxiv_data1/oa_pdf/da/4b/ncomms4513.PMC4007635.pdf
"GPS availability .Data, GPS Rcode and GPS on-line calculator are available on http://chcb.saban-chla.usc.edu/gps/.",OADS,/arxiv_data1/oa_pdf/da/4b/ncomms4513.PMC4007635.pdf
SPAâs code for Linux was obtained from the authorâs website: http://genetics.cs.ucla.edu/spa/binary/linux.zip.,OADS,/arxiv_data1/oa_pdf/da/4b/ncomms4513.PMC4007635.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/nature communications Competing ï¬nancial interests: The authors declare no competing ï¬nancial interests.,Non-OADS,/arxiv_data1/oa_pdf/da/4b/ncomms4513.PMC4007635.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Elhaik, E. et al.",Non-OADS,/arxiv_data1/oa_pdf/da/4b/ncomms4513.PMC4007635.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4513 ARTICLE NATURE COMMUNICATIONS | 5:3513 | DOI: 10.1038/ncomms4513 | www.nature.com/naturecommunications 11 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/da/4b/ncomms4513.PMC4007635.pdf
Dioptric intra - ocular lens (IOL) power of 18 D was calculated using SRK II formula (IOL power = Aâ0.9Kâ2.5LAX) and manufacturer web based programâtoric IOL calcu - lator was used to determine IOL cylinder power and axis alignment (http://www.acrysoftoriccalculator.com).,OADS,/arxiv_data1/oa_pdf/e5/cf/AIM-22-139.PMC4008038.pdf
"Decision Tree Fields,  http://ai.stanford.edu/~bangpe ng/document/iccv11_0981.pdf   [3] Automatic Construction of Decision Trees from Data: A Multi -Disciplinary Survey  SREERAMA K. MURTHY  murthy@scr.siemens.com Siemens Corporate Research, Princeton, NJ 08540, USA.",OADS,/arxiv_data1/oa_pdf/d7/e1/AIM-22-89.PMC4008040.pdf
Â©2014 by Anais Brasileiros de DermatologiaCONTINUING MEDICAL EDUCATION DOI: http://dx.doi.org/10.1590/abd1806-4841.20142450 Abstract: Leprosy is caused by Mycobacterium leprae and has been known since biblical times.,Non-OADS,/arxiv_data1/oa_pdf/df/73/abd-89-02-0205.PMC4008049.pdf
Availabre from:http://www.paho.org/English/AD/DPC/CD/lep-wha-1991.htm.Saude.gov.br [homepage on the Internet].,Non-OADS,/arxiv_data1/oa_pdf/df/73/abd-89-02-0205.PMC4008049.pdf
DisponÃ­vel em: http://portal.saude.gov.br/portal/saude/pro-fissional/visualizar_texto.cfm?idtxt=31200.Brasil.,OADS,/arxiv_data1/oa_pdf/df/73/abd-89-02-0205.PMC4008049.pdf
"DisponÃ­vel em: http://portal.saude.gov.br/portal/arquivos/pdf/portaria_n_3125_hanseniase_2010.pdfTalhari S, Grossi MA, Oliveira ML, Gontijo B, Talhari C, Penna GO.",OADS,/arxiv_data1/oa_pdf/df/73/abd-89-02-0205.PMC4008049.pdf
"[acesso 19 out 2012].DisponÃ­vel em: http://www.ronaldoazze.com.br/fasciculo/fasciculo3.PDFKlioze AM, Ramos-Caro FA.",Non-OADS,/arxiv_data1/oa_pdf/df/73/abd-89-02-0205.PMC4008049.pdf
"2014;89(2):219-28. s Cutaneous tuberculosis: epidemiologic, etiopathogenic  and clinical aspects - Part I* DOI: http://dx.doi.org/10.1590/abd1806-4841.20142334 Abstract: Cutaneous tuberculosis (CTB) is the result of a chronic infection by Mycobacterium tuberculosis, M. bovis and occasionally by the Calmette-Guerin bacillus.",Non-OADS,/arxiv_data1/oa_pdf/2b/a9/abd-89-02-0219.PMC4008050.pdf
http://portal.saude.gov.br/portal/saude/profissional/area.cfm?id_area=1527.,OADS,/arxiv_data1/oa_pdf/2b/a9/abd-89-02-0219.PMC4008050.pdf
s Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis * DOI: http://dx.doi.org/10.1590/abd1806-4841.20142189 Abstract: BACKGROUND : Primary hyperhidrosis (PH) can lead to mood changes due to the inconveniences it causes.,Non-OADS,/arxiv_data1/oa_pdf/92/88/abd-89-02-0230.PMC4008051.pdf
2014;89(2):242-4.242s Lack of compliance: a challenge for digital  dermoscopy follow-up* Guilherme Augusto GadensÂ¹ DOI: http://dx.doi.org/10.1590/abd1806-4841.20142547 Abstract: BACKGROUND : Digital dermoscopy is the gold standard follow-up method for patients with high risk for developing cutaneous malignant melanoma.,Non-OADS,/arxiv_data1/oa_pdf/56/31/abd-89-02-0242.PMC4008053.pdf
ManifestaÃ§Ãµes cutÃ¢neas em indivÃ­duos infectados ou com doenÃ§as 245s Tissue immunostaining for factor XIIIa in dermal dendrocytes  of pityriasis alba skin lesions* Francisca Regina Oliveira Carneiro1Gabriela Borborema do Amaral1 Maiana Darwich Mendes1Juarez AntÃ´nio SimÃµes Quaresma1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142201 Abstract: BACKGROUND : Pityriasis alba affects 1% of the world population and about 9.9% of the children in Brazil.,Non-OADS,/arxiv_data1/oa_pdf/93/cc/abd-89-02-0245.PMC4008054.pdf
Available from: http://www.emedicine.com/ped/topic1813.htm#section~author_information.,Non-OADS,/arxiv_data1/oa_pdf/93/cc/abd-89-02-0245.PMC4008054.pdf
"2014;89(2):250-8. s Fractional Erbium laser in the treatment of photoaging:  randomized comparative, clinical and histopathological study of ablative (2940nm) vs. non-ablative (1540nm)  methods after 3 months* Juliano Borges1Tullia Cuzzi2 Carlos Alberto Mandarim-de-Lacerda3MÃ´nica Manela-Azulay2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142370 Abstract: BACKGROUND : Fractional non-ablative lasers keep the epidermis intact, while fractional ablative lasers remove it, making them theoretically more effective.",Non-OADS,/arxiv_data1/oa_pdf/24/74/abd-89-02-0250.PMC4008055.pdf
"2014;89(2):259-64. s259INVESTIGATION Clinical, epidemiological, and therapeutic profile  of dermatophytosis* Carla AndrÃ©a Avelar Pires1, 2Natasha Ferreira Santos da Cruz 2 Amanda Monteiro Lobato2Priscila Oliveira de Sousa2 Francisca Regina Oliveira Carneiro2Alena Margareth Darwich Mendes2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142569 Abstract:  BACKGROUND : The cutaneous mycoses, mainly caused by dermatophyte fungi, are among the most com- mon fungal infections worldwide.",Non-OADS,/arxiv_data1/oa_pdf/f0/6e/abd-89-02-0259.PMC4008056.pdf
"s266INVESTIGATION Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day* Maria Stella de Mello Ayres Putinatti1Joel Carlos LastÃ³ria1Carlos Roberto Padovani1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142037 Abstract: BACKGROUND : Leprosy can have its course interrupted by type 1 and 2 reactional episodes, the last named of erythema nodosum leprosum (ENL).",Non-OADS,/arxiv_data1/oa_pdf/74/ed/abd-89-02-0266.PMC4008057.pdf
"s274INVESTIGATION Bullous pemphigoid and comorbidities: a case-control  study in Portuguese patients* Vera Barreto Teixeira1Rita Cabral1Maria Manuel Brites1 Ricardo Vieira1AmÃ©rico Figueiredo1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142516 Abstract: BACKGROUND : Although rare, bullous pemphigoid (BP) is the most common autoimmune blistering dis- ease.",Non-OADS,/arxiv_data1/oa_pdf/77/61/abd-89-02-0274.PMC4008058.pdf
Â©2014 by Anais Brasileiros de Dermatologia sEPIDEMIOLOGY AND BIOSTATISTICS APPLIED TO DERMATOLOGY DOI: http://dx.doi.org/10.1590/abd1806-4841.20143388 Abstract: The present paper aims to provide basic guidelines to present epidemiological data using tables and graphs in Dermatology.,Non-OADS,/arxiv_data1/oa_pdf/72/90/abd-89-02-0280.PMC4008059.pdf
2014;89(2):286-91. sREVIEW286 Stem cells in dermatology* DOI: http://dx.doi.org/10.1590/abd1806-4841.20142530 Abstract: Preclinical and clinical research have shown that stem cell therapy could be a promising therapeutic option for many diseases in which current medical treatments do not achieve satisfying results or cure.,Non-OADS,/arxiv_data1/oa_pdf/cf/eb/abd-89-02-0286.PMC4008060.pdf
2014;89(2):293-9. sREVIEW293 Impetigo â review* DOI: http://dx.doi.org/10.1590/abd1806-4841.20142283 Abstract: Impetigo is a common cutaneous infection that is especially prevalent in children.,Non-OADS,/arxiv_data1/oa_pdf/ec/0f/abd-89-02-0293.PMC4008061.pdf
sREVIEW301 Cutaneous melanoma: new advances in treatment* DOI: http://dx.doi.org/10.1590/abd1806-4841.20142540 Abstract: Cutaneous melanoma is a challenge to treat.,Non-OADS,/arxiv_data1/oa_pdf/a2/dd/abd-89-02-0301.PMC4008062.pdf
"DisponÃ­vel em:http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/pele_mela-noma/definicao.Souza RJ, Mattedi AP , Rezende ML, CorrÃªa Mde P , Duarte EM.",OADS,/arxiv_data1/oa_pdf/a2/dd/abd-89-02-0301.PMC4008062.pdf
2014;89(2):318-9. sDERMATOPATHOLOGY318 Psoriasiform Keratosis - Case report* Carla AndrÃ©a Avelar Pires1Brena Andrade de Sousa1 Carla do Socorro Silva do Nascimento1Ana Thais Machado Moutinho1 Mario Fernando Ribeiro de Miranda2Francisca Regina Oliveira Carneiro1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142504 Abstract: Psoriasiform Keratosis is a rare clinic entity.,Non-OADS,/arxiv_data1/oa_pdf/38/82/abd-89-02-0318.PMC4008064.pdf
320sCASEREPORT Alopecia universalis during treatment with leflunomide and adalimumab - Case report* Rosana Lazzarini1Gabriela Cunha Capareli1Roberta Buense1Rute Facchini Lellis1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142944 Abstract: Alopecia areata is a non-scarring form of alopecia that can be localized or widespread.,Non-OADS,/arxiv_data1/oa_pdf/2f/0c/abd-89-02-0320.PMC4008065.pdf
2014;89(2):323-5.Fabry disease: clinical and genotypic aspects of three cases in first degree relatives  323s323CASEREPORT Arthritis and diagnosis of leprosy: a case report and  review of the literature* Tania Rita Moreno de Oliveira Fernandes1Juliana Pedrosa Korinfskin1 Mariana MercÃªs Mesquita EspÃ­ndola1Lis Moreno de Oliveira CorrÃªa2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142857 Abstract: Leprosy is clinically characterized by involvement of peripheral nerves and skin.,Non-OADS,/arxiv_data1/oa_pdf/10/36/abd-89-02-0323.PMC4008066.pdf
"Available from: http://www.who.int/lep/situation/prevalence/en/# Prevedello FC, TÃ¡vora MM.",Non-OADS,/arxiv_data1/oa_pdf/10/36/abd-89-02-0323.PMC4008066.pdf
2014;89(2):326-8.326sCASEREPORT Primary essential cutis verticis gyrata - Case report* Jeane Jeong Hoon Yang1Daniela Tiemi Sano1Silvia Regina Martins1 Antonio JosÃ© Tebcherani1Ana Paula Galli Sanchez1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142949 Abstract: Cutis verticis gyrata is characterized by excessive formation of scalp skin.,Non-OADS,/arxiv_data1/oa_pdf/65/55/abd-89-02-0326.PMC4008067.pdf
Report of two cases and  review of the literature* Songting Wang1Mingshu Zhou2Jianjun Qiao3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142870 Abstract: Kissing nevus is a curious type of nevus that was first described on the eyelids and rarely described on the penis.,Non-OADS,/arxiv_data1/oa_pdf/78/90/abd-89-02-0329.PMC4008068.pdf
"2014;89(2):332-3.332sCASEREPORT Cutaneous larva migrans on the scalp: atypical presentation of a common disease* Carolina Degen Meotti1Glaura Plates1Letycia Lopes Chagas Nogueira2 Renata Anselme da Silva3Karoline Silva Paolini4Elias Moreira Nunes1 Fred Bernardes Filho5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142987 Abstract: Cutaneous larva migrans is a pruritic dermatitis due to the inoculation of helminths larvae in the skin, and it often occurs in children in tropical and subtropical areas.",Non-OADS,/arxiv_data1/oa_pdf/09/a0/abd-89-02-0332.PMC4008069.pdf
2014;89(2):334-6.334sCASEREPORT Scanning electron microscopy of tinea nigra* Isabelle Maffei Guarenti1Hiram Larangeira de Almeida Jr2Aline Hatzenberger LeitÃ£o3 Nara Moreira Rocha4Ricardo Marques e Silva5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142780 Abstract: Tinea nigra is a rare superficial mycosis caused by Hortaea werneckii.,Non-OADS,/arxiv_data1/oa_pdf/ca/c9/abd-89-02-0334.PMC4008070.pdf
"2014;89(2):337-9.337sCASEREPORT Follicular mucinosis - Case report* Paola C. Vieira da Rosa Passos1Manuela Ferrasso Zuchi1 AndrÃ©a Buosi Fabre1Luis Eduardo A. Machado Martins1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142968 Abstract: Follicular mucinosis, also known as alopecia mucinosa, is a cutaneous mucinosis histologically charac- terized by accumulation of dermal type mucin in the pilosebaceous follicle and sebaceous glands.",Non-OADS,/arxiv_data1/oa_pdf/93/8a/abd-89-02-0337.PMC4008071.pdf
"2014;89(2):340-3.340sCASEREPORT Multiple lesions by vampire bat bites in a patient in NiterÃ³i, Brazil - Case report* Fred Bernardes Filho1, 4Gustavo Martins2Gustavo Sabaini Luchi3 Bernard Kawa Kac4JosÃ© Augusto da Costa Nery1,5Luna Azulay-Abulafia1,6 David Rubem Azulay1, 4, 7 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142996 Abstract: Over the last few centuries, the expansion of urbanization brought bats closer to urbanized areas, increasing the risk of accidents by bat bites.",Non-OADS,/arxiv_data1/oa_pdf/a7/3c/abd-89-02-0340.PMC4008072.pdf
"DisponÃ­vel em:http://www.cdc.gov/rabies/specific_groups/doctors/ante_mortem.html.Ciprandi A, Horn F , Termignoni C. Saliva of hematophagous animals: source of new 10. anticoagulants.",Non-OADS,/arxiv_data1/oa_pdf/a7/3c/abd-89-02-0340.PMC4008072.pdf
s Comedo-like openings in melanoma* Bruno SimÃ£o dos Santos1Lucia Helena Soares Ribeiro1 Eloisa Leis Ayres1Enoi Aparecida Guedes Vilar1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142836 Abstract: We describe a case of melanoma with the presence of comedo-like openings at dermoscopy.,Non-OADS,/arxiv_data1/oa_pdf/e3/22/abd-89-02-0344.PMC4008073.pdf
2014;89(2):347-50.Comparative scanning electron microscopy of  bullous diseases* Hiram Larangeira de Almeida Jr1Gabriela Rossi2 Octavio Ruschel Karam3Nara Moreira Rocha4 Ricardo Marques e Silva1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142161 Abstract: The purpose of this study is to compare scanning electron microscopy findings of the blister roof in three distinct bullous diseases: one intraepidermal acantholytic (pemphigus foliaceus); one due to hemidesmo-somal dysfunction (bullous pemphigoid); and one secondary to anchoring fibril dysfunction â type VII collagen(dystrophic epidermolysis bullosa).,Non-OADS,/arxiv_data1/oa_pdf/d1/43/abd-89-02-0347.PMC4008074.pdf
2014;89(2):351-2.Chromoblastomycosis: an exuberant case* NathÃ¡lia Matos Gomes1Thales Costa Bastos2 KÃ¡tia Santana Cruz2FÃ¡bio Francesconi2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142621 Abstract: Chromoblastomycosis is a chronic subcutaneous mycotic infection caused by dematiaceous saprophyt- ic moulds.,Non-OADS,/arxiv_data1/oa_pdf/0c/aa/abd-89-02-0351.PMC4008075.pdf
"No yellow spots, exclamation mark hairs,cadaver hairs or other dermoscopic signs suggestingalopecia areata, were detected.DOI: http://dx.doi.org/10.1590/abd1806-4841.20142740 DISCUSSION CTA is an uncommon disorder, with about 74 cases reported to date.",Non-OADS,/arxiv_data1/oa_pdf/73/1e/abd-89-02-0353.PMC4008076.pdf
"DOI: http://dx.doi.org/10.1590/abd1806-4841.20142696 DISCUSSION Given the clinical appearance of the tumor, diagnostic hypotheses of dermatofibroma, schwanno-ma, leiomyoma, fibrosarcoma and amelanoticmelanoma were formulated.",Non-OADS,/arxiv_data1/oa_pdf/09/28/abd-89-02-0357.PMC4008077.pdf
"DOI: http://dx.doi.org/10.1590/abd1806-4841.20142689 CASE REPORT Twenty-two year-old Caucasoid male, employed at the maintenance sector at UNESPBotucatu, reported that 18 months ago he perceived aprogressive thickening on the bases of his fingers,without other localized symptoms.",Non-OADS,/arxiv_data1/oa_pdf/0b/8b/abd-89-02-0359.PMC4008078.pdf
"5MAS can be classified into three groups according to the preva-SYNDROME IN QUESTION* DOI: http://dx.doi.org/10.1590/abd1806-4841.20142403 FIGURE 1: (A) &(C)Vitiligo of the face, (B) vitiligo and psoriasis of the hands, (C)alope- cia areata of the barb and vitiligo, (D)lichen planuslence of their association with one another: Type 1 comprises myasthenia gravis, thymoma, polymyositisand giant cell myocarditis; Type 2 includes SjÃ¶grenâssyndrome, rheumatoid arthritis, primary biliary cir-rhosis, scleroderma and autoimmune thyroid diseaseand Type 3 groups together autoimmune thyroid dis-ease, myasthenia and/or thymoma, SjÃ¶grenâs syn-drome, pernicious anemia, idiopathic thrombocy-topenic purpura, Addisonâs disease, insulin-depend-ent diabetes, vitiligo, autoimmune hemolytic anemia,systemic lupus erythematosus and dermatitis herpeti-formis.",Non-OADS,/arxiv_data1/oa_pdf/5d/8c/abd-89-02-0361.PMC4008079.pdf
"1At least six syndromes caused by p63 mutations are recognized: Hay-Wells syndrome(AEC), ectrodactyly ectodermal dysplasia clefting syn-drome (EEC), Rapp-Hodgkin syndrome (now consid-ered synonymous with AEC syndrome), limb mammarysyndrome (LMS), acro-dermato-ungual-lacrimal-toothsyndrome (ADULT) and ectrodactyly syndrome(Split-hand/Split-foot malformation).Â²DOI: http://dx.doi.org/10.1590/abd1806-4841.20142806 FIGURE 1:Exulcerations covered with honey-colored hematic crusts mainly on the scalp, chest, and upper limbs, besides right-ear deformity  FIGURE 2:Detail of genital region showing micropenis  Revista2Vol89ingles2_Layout 1  4/2/14  10:05 AM  PÃ¡gina 363",Non-OADS,/arxiv_data1/oa_pdf/b7/13/abd-89-02-0363.PMC4008080.pdf
Â©2014 by Anais Brasileiros de DermatologiaBiologic therapy for psoriasis - still searching for the best target* Teresa Pinto-Almeida1Tiago Torres1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142898 Abstract: Psoriasis is a chronic skin disease that results from the complex interaction between genetic and envi- ronmental factors.,Non-OADS,/arxiv_data1/oa_pdf/6c/fd/abd-89-02-0365.PMC4008081.pdf
Retrospective analysis of melanocytic lesions in children at the National Cancer Institute-RJ* Lislaine Bomm1Ricardo Vianna de Carvalho1 Fernanda Ferreira da Silva Lima1Lidicie Natalia Braga de Oliveira1 Fernanda Tolstoy1Dolival LobÃ£o1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142499 Abstract: Skin cancer is the most common neoplasm in Brazil.,Non-OADS,/arxiv_data1/oa_pdf/37/ba/abd-89-02-0369.PMC4008082.pdf
"Â©2014 by Anais Brasileiros de Dermatologia s372COMMUNICATION DOI: http://dx.doi.org/10.1590/abd1806-4841.20142589 Abstract: Although cases of cutaneous Leishmaniasis have been reported in Brasilia - DF, its mode of transmis- sion is still unknown.",Non-OADS,/arxiv_data1/oa_pdf/dd/1d/abd-89-02-0372.PMC4008083.pdf
"DisponÃ­velem: http://portal.saude.gov.br/portal/arquivos/pdf/gve_7ed_web_atual_lta.pdf.Ranasinghe S, Rogers ME, Hamilton JG, Bates PA, Maingon RD.",Non-OADS,/arxiv_data1/oa_pdf/dd/1d/abd-89-02-0372.PMC4008083.pdf
Â©2014 by Anais Brasileiros de Dermatologia s376COMMUNICATION DOI: http://dx.doi.org/10.1590/abd1806-4841.20142645 Abstract: Thimerosal is an organic mercury derivative found in ophthalmic solutions and certain vaccines in Brazil.,Non-OADS,/arxiv_data1/oa_pdf/61/b5/abd-89-02-0376.PMC4008084.pdf
"Therefore, submis-sion of outcomes to the national (UK) and Europeanblood and marrow transplant database (http://www.ebmt.org) may be a vital contribution in informing futuremanagement decisions.Understanding mechanisms underlying disease and treatment is important, to achieve the future goal to suc- cessfully treat patients with JIA and other autoimmuneconditions, both through ASCT and other immunomodu-latory methods.",Non-OADS,/arxiv_data1/oa_pdf/73/7d/imm0142-0227.PMC4008230.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/31/ijn-9-2069.PMC4008283.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2069â2072International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2069Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJN.S6430 1Passing through the renal clearance barrier:  toward ultrasmall sizes with s table ligands   for potential clinical applications Xiao-Dong Zhang1 Jiang Yang2 Sha-Sha Song1 Wei Long1 Jie Chen1 Xiu Shen1 Hao Wang1 Yuan-Ming Sun1 Pei-Xun Liu1 Saijun Fan1 1tianjin Key Laboratory of Molecular  Nuclear Medicine, Institute of  radiation Medicine, Chinese Academy  of Medical Sciences and Peking Union  Medical College, tianjin, Peopleâs  republic of China;  2Department  of Biological Systems engineering,   University of Wisconsin-Madison,   Madison, WI, USA Correspondence: Xiao-Dong Zhang   N 238, Nankai district, tianjin,   300192, Peopleâs republic of China   tel +86 22 8568 3046  Fax +86 22 8568 3046  email xiaodongzhang@irm-cams.ac.c nAbstract:  The use of nanoparticles holds promise for medical applications, such as X-ray  imaging, photothermal therapy and radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/b1/31/ijn-9-2069.PMC4008283.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b1/31/ijn-9-2069.PMC4008283.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/31/ijn-9-2069.PMC4008283.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7d/6e/vhrm-10-237.PMC4008284.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 237â246Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  237ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S5488 6limitations of real-world treatment with  atorvastatin monotherapy for lowering lDl-c   in high-risk cardiovascular patients in the Us elizabeth Marrett1 changgeng Zhao1 ning Jackie Zhang2 Qiaoyi Zhang1 Dena R Ramey1 Joanne e T omassini1 andrew M T ershakovec1 David R neff1 1Merck & co, inc., Whitehouse  station, nJ, Usa; 2college of Health  and Public affairs, U niversity of   central Florida, Orlando, Fl, Usa correspondence: David R neff   Merck sharp & Dohme corp.,   1 Merck Drive, PO Box 100,   Whitehouse station,   nJ 08889-0100, Usa   Tel +1 267 305 5961   email david.neff@merck.co mBackground:  Guidelines endorse statin therapy for lowering low-density lipoprotein cholesterol   (LDL-C)  to recommended levels, in patients with cardiovascular disease (CVD) risk, if needed,  after lifestyle changes.",Non-OADS,/arxiv_data1/oa_pdf/7d/6e/vhrm-10-237.PMC4008284.pdf
Available from: http://www.athero.org/IASPositionPaper.asp .,Non-OADS,/arxiv_data1/oa_pdf/7d/6e/vhrm-10-237.PMC4008284.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/7d/6e/vhrm-10-237.PMC4008284.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/6e/vhrm-10-237.PMC4008284.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/2e/cia-9-711.PMC4008285.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 711â718Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  711OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5980 2Impact of type 2 diabetes mellitus   on hospitalization costs in older patients   with acute myocardial infarction Kai-li Fu1 guan-qi Fan1 lu han1 Xiao-zhen Wang2 Jia Wang1 Yu-shu Wang1 Ming Zhong1 Yun Zhang1 Wei Zhang1 Zhi-hao Wang3 1Key laboratory of Cardiovascular  remodeling and Function research,   Chinese Ministry of education and  Chinese Ministry of Public health,   and Department of Cardiology, Qilu  hospital of shandong University,   2shandong University of Traditional  Chinese Medicine, 3Department of  geriatric Medicine, Qilu hospital of  shandong University, Jiânan, Peopleâs  republic of China Correspondence: Wei Zhang   Department of Cardiology,   Qilu hospital of shandong University,   107 Wen hua Xi road, Jiânan 250012,   Peopleâs republic of China   Tel +86 531 8216 9339   Fax +86 531 8616 9356   email weizhangsdu@sina.c n    Zhi-hao Wang   Department of geriatric Medicine,   Qilu hospital of shandong University,   107 Wen hua Xi road, Jiânan 250012,   Peopleâs republic of China   Tel +86 531 8216 9339   Fax +86 531 8616 9356   email wangzhihaosdu@gmail.co mBackground:  The purpose of this study was to evaluate the impact of type 2 diabetes mellitus  on hospitalization costs in older patients with acute myocardial infarction (MI).",Non-OADS,/arxiv_data1/oa_pdf/79/2e/cia-9-711.PMC4008285.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/79/2e/cia-9-711.PMC4008285.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/2e/cia-9-711.PMC4008285.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/96/58/ceor-6-217.PMC4008286.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2014:6 217â225ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  217REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S6071 0Respiratory syncytial virus: current   and emerging treatment options Tiffany L T urner1 Benjamin T Kopp1 Grace Paul1 Lindsay C Landgrave2 Don Hayes Jr1 Rohan Thompson1 1Department of Pediatrics,    Ohio State University College   of Medicine, 2Clinical Pharmacy,    Nationwide Childrenâs Hospital,    Columbus, OH, USA Correspondence: Tiffany L Turner   Department of Pediatrics, Ohio State   University College of Medicine, Nationwide   Childrenâs Hospital, 700 Childrenâs Drive,   Columbus 43205, OH, USA   Tel +1 614 722 4766   Fax +1 614 722 4755   Email t iffany.",Non-OADS,/arxiv_data1/oa_pdf/96/58/ceor-6-217.PMC4008286.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/96/58/ceor-6-217.PMC4008286.pdf
Available from: http://www.cdc.gov/features/rsv /.,OADS,/arxiv_data1/oa_pdf/96/58/ceor-6-217.PMC4008286.pdf
"Available from: http://www.cdc.gov/rsv/research/ us-surveillance.htm l. Accessed March 28, 2014.",OADS,/arxiv_data1/oa_pdf/96/58/ceor-6-217.PMC4008286.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/96/58/ceor-6-217.PMC4008286.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/58/ceor-6-217.PMC4008286.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/e0/copd-9-381.PMC4008287.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 381â395International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  381ExPErt O PInIO nopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S5845 4Expert consensus on acute exacerbation   of chronic obstructive pulmonary disease   in the Peopleâs republic of China Bai-qiang Cai1 Shao-xi Cai2 rong-chang Chen3 Li-ying Cui4 Yu-lin Feng5 Yu-tong Gu6 Shao-guang Huang7 rong-yu Liu8 Guang-nan Liu9 Huan-zhong Shi10 Yi Shi11 Yuan-lin Song6 tie-ying Sun12 Chang-zheng Wang13 Jing-lan Wang1 Fu-qiang Wen5 Wei xiao14 Y ong-jian xu15 xi-xin Yan16 Wan-zhen Yao17 Qin Yu18 Jing Zhang6 Jin-ping Zheng3 Jie Liu6 Chun-xue Bai6 1Department of Pulmonary Medicine, Peking Union  Medical College Hospital, Chinese Academy of Medical  Sciences and Peking Union Medical College, Beijing,  2Southern Medical University South Hospital, Guangzhou,  3The First Affiliated Hospital of Guangzhou Medical  College and Guangzhou Institute of respiratory Diseases,  Guangzhou, 4Affiliate Hospital of Inner Mongolia Medical  University, Huhehaote, 5Huaxi Hospital of Sichuan  University, Chendu, 6Zhongshan Hospital, Shanghai Medical  College, Fudan University and Shanghai respiratory  research Institute, Shanghai, 7ruijing Hospital of Shanghai  Jiaotong University, Shanghai, 8The First Affiliated  University of Anhui Medical University, Hefei, 9the First  Affiliated University of Guangxi Medical University,  nanning, 10Beijing Chao-Yang Hospital, Capital Medical  University, Beijing, 11General Hospital of nanjing Military  region, nanjing, 12Beijing Hospital of the Ministry of  Health, Beijing, 13xinqiao Hospital, third Military Medical  University, Chongqing, 14Qilu Hospital of Shandong  University, Jinan, 15tongji Hospital, tongji Medical College,  Huazhong University of Science and technology, Wuhan,  16The Second Affiliated Hospital of Hebei Medical  University and Hebei research Institute of respiratory  Medicine, Shijiazhuang, 17The Third Affiliated Hospital of  Beijing University, Beijing, 18The First Affiliated University  of Lanzhou University, Lanzhou, Peopleâs republic of China Correspondence: Chun-xue Bai   180 Fenglin road, Department of Pulmonary  Medicine, Zhongshan   Hospital, Shanghai, 200032,   Peopleâs republic of China   Email bai.chunxue@zs-hospital.sh.c nAbstract:  Chronic obstructive pulmonary disease (COPD) is a common disease that severely  threatens human health.",Non-OADS,/arxiv_data1/oa_pdf/1c/e0/copd-9-381.PMC4008287.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1c/e0/copd-9-381.PMC4008287.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/e0/copd-9-381.PMC4008287.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/fd/ndt-10-675.PMC4008288.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 675â679Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  675Shor T repor Topen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5019 7Dissociative symptoms reflect levels   of tumor necrosis factor alpha in patients   with unipolar depression Gustav Bizik1 petr Bob1 Jiri raboch1 Josef pavlat1 Jana Uhrova2 hana Benakova2 T omas Zima2 1Center for Neuropsychiatric  research of Traumatic Stress,   Department of psychiatry and UhSL,   2Department of Clinical Biochemistry  and Laboratory Diagnostics,   1st Faculty of Medicine, Charles  University, prague, Czech republic Correspondence: Gustav Bizik   Department of psychiatry, Charles  University, 1st Faculty of Medicine,   Ke Karlovu 11, 128 00 prague,   Czech republic   Tel +420 224 965 122   Fax +420 224 923 077   email gustav.bizik@lf1.cuni.c zAbstract:  Recent evidence indicates that the nature of interactions between the nervous system  and immune system is important in the pathogenesis of depression.",Non-OADS,/arxiv_data1/oa_pdf/98/fd/ndt-10-675.PMC4008288.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/98/fd/ndt-10-675.PMC4008288.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/fd/ndt-10-675.PMC4008288.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/fe/ijn-9-2051.PMC4008289.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2051â2067International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2051RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S4182 2Nanomedicines in the treatment of hepatitis C   virus infection in Asian patients: optimizing   use of peginterferon alfa Chen-Hua Liu1â3 Jia-Horng Kao1â3 1Department of Internal Medicine,   National Taiwan University Hospital,   Taipei, Taiwan; 2Hepatitis Research  Center, National Taiwan University  Hospital, Taipei, Taiwan; 3Graduate  Institute of Clinical Medicine,    National Taiwan University College   of Medicine, Taipei, Taiwan Correspondence: Jia-Horng Kao   Graduate Institute of Clinical Medicine,   National Taiwan University College of   Medicine and Hospital, 7 Chung-Shan   South Road, Taipei, Taiwan   Tel +886 2 2312 3456 ext 67307   Fax +886 2 2382 5962   email kaojh@ntu.edu.t wAbstract:  Asia is endemic for hepatitis C virus (HCV) infection, which is the leading cause  of cirrhosis, hepatic decompensation, hepatocellular carcinoma , and liver transplantation  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/4a/fe/ijn-9-2051.PMC4008289.pdf
Accessed at http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/4a/fe/ijn-9-2051.PMC4008289.pdf
"Pegintron [package insert] Kenilworth NJ:  Schering Corporation 2011, Accessed at http://www.fda.gov/downloads/ Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedand - Approved/ApprovalApplications/TherapeuticBiologicApplications/ ucm094490.pd f on 10 April 2014.",Non-OADS,/arxiv_data1/oa_pdf/4a/fe/ijn-9-2051.PMC4008289.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4a/fe/ijn-9-2051.PMC4008289.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/fe/ijn-9-2051.PMC4008289.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/35/cmar-6-205.PMC4008290.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2014:6 205â216Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  205Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S3815 6Role of microRNA in epithelial to mesenchymal   transition and metastasis and clinical perspectives Antonio DÃ­az-LÃ³pez1 Gema Moreno-Bueno1,2 Amparo Cano1 1Departamento de BioquÃ­mica,   Facultad de Medicina, Universidad  AutÃ³noma de Madrid, instituto de  investigaciones BiomÃ©dicas âAlberto  Solsâ (CSiC-UAM), idiPAZ, Madrid,   Spain; 2FundaciÃ³n MDAnderson  internacional, Madrid, Spain Correspondence: Amparo Cano   Departamento de BioquÃ­mica,   Universidad AutÃ³noma de Madrid,   instituto de investigaciones Biomedicas,   âAlberto Solsâ CSiC-UAM, Arturo   Duperier 4, Madrid, 28029 Spain   Tel +34 91 497 5400   Fax +34 91 497 5353   email acano@iib.uam.e sAbstract:  The microRNAs (miRNAs) are a class of small, 20â22 nucleotides in length,  endogenously expressed noncoding RNAs that regulate multiple targets posttranscriptionally.",Non-OADS,/arxiv_data1/oa_pdf/7f/35/cmar-6-205.PMC4008290.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/7f/35/cmar-6-205.PMC4008290.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/35/cmar-6-205.PMC4008290.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/be/cia-9-737.PMC4008291.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 737â740Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  737CAse serIesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5839 4Journal name: Clinical Interventions in Aging Journal Designation: Case Series Y ear: 2014 Volume: 9 Running head verso: Liabeuf et al Running head recto: Ferrous sulfate and oral mucosa ulceration in the elderly DOI: http://dx.doi.org/10.2147/CIA.S58394 sophie Liabeuf1â3 ValÃ©rie Gras1 Julien Moragny1 Marie-Laure Laroche4 Michel Andrejak1,3 On behalf of the French National  Network of Pharmacovigilance  Centers 1regional Pharmacovigilance Center,   Division of Clinical Pharmacology,   Amiens University Medical Center  and Jules Verne University of Picardy,   Amiens, France; 2Clinical research  Centre, Clinical Pharmacology  Division, Amiens University  Medical Center and the Jules Verne  University of Picardy, Amiens, France;  3INserM U1088, Amiens, France;   4regional Pharmacovigilance Center,   Department of Pharmacology,   T oxicology and Pharmacovigilance,   Limoges University Medical Center,   Limoges, France Correspondence: sophie Liabeuf Clinical Pharmacology Division, Amiens  University Medical Center, Avenue renÃ©  Laennec â salouel, Amiens, France T el +33 322 456085 Fax +33 322 455660 email liabeuf.sophie@chu-amiens.f rObjective:  To report a series of cases of ulceration of the oral mucosa linked to direct contact  with ferrous sulfate in elderly patients.",Non-OADS,/arxiv_data1/oa_pdf/d0/be/cia-9-737.PMC4008291.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d0/be/cia-9-737.PMC4008291.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d0/be/cia-9-737.PMC4008291.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/c4/jpr-7-219.PMC4008292.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 219â226Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  219ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S6232 9From Catastrophizing to Recovery:   a pilot study of a single-session treatment   for pain catastrophizing Beth D Darnall John A Sturgeon Ming-Chih Kao Jennifer M Hah Sean C Mackey Division of Pain Medicine,    Stanford Systems Neuroscience   and Pain Laboratory, Stanford   University School of Medicine,    Palo Alto, CA, USA Correspondence: Beth D Darnall   Division of Pain Medicine, Stanford   Systems Neuroscience and Pain   Laboratory, Stanford University   School of Medicine,  1070 Arastradero,   Suite 200, MC  5596 Palo Alto,   CA 94304-1336, USA   Email bdarnall@stanford.ed uBackground:  Pain catastrophizing (PC) â a pattern of negative cognitive-emotional responses  to real or anticipated pain â maintains chronic pain and undermines medical treatments.",Non-OADS,/arxiv_data1/oa_pdf/eb/c4/jpr-7-219.PMC4008292.pdf
Available  from: http://www.iasp-pain.org/files/Content/ContentFolders/Globa lY earAgainstPain2/20042005RighttoPainRelief/factsheet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/eb/c4/jpr-7-219.PMC4008292.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/eb/c4/jpr-7-219.PMC4008292.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/c4/jpr-7-219.PMC4008292.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/1a/jaa-7-067.PMC4008293.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Asthma and Allergy 2014:7 67â75Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  67OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S5392 0Differential serum protein markers   and the clinical severity of asthma norbert Meyer1,2 sarah Janine nuss1 Thomas rothe1 Alexander siebenhÃ¼ner1 cezmi A Akdis2 gÃ¼nter Menz1 1hochgebirgsklinik Davos, Davos- Wolfgang, switzerland; 2swiss institute  of Allergy and Asthma research  (siAF), Davos Platz, switzerland correspondence: norbert Meyer;  gÃ¼nter Menz   hochgebirgsklinik Davos,   herman-Burchard-str 1, 7265   Davos-Wolfgang, switzerland   Tel +41 081 417 4444   Fax +41 081 417 3030   email norbert.meyer@insel.c h;   guenter.menz@hgk.c hBackground:  Asthma is a heterogeneous disease characterized by different clinical phenotypes  and the involvement of multiple inflammatory pathways.",Non-OADS,/arxiv_data1/oa_pdf/16/1a/jaa-7-067.PMC4008293.pdf
The frequency of asthma patients fulfilling  American Thoracic Society criteria (for detailed information  see http://www.thoracic.or g) for severe asthma was signifi - cantly higher in cluster 1 than in cluster 2.,Non-OADS,/arxiv_data1/oa_pdf/16/1a/jaa-7-067.PMC4008293.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/16/1a/jaa-7-067.PMC4008293.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/1a/jaa-7-067.PMC4008293.pdf
http://dx.doi.org/10.1016/j.mcn.2014.01.002 1044-7431Â©2014TheAuthors.PublishedbyElsevierInc.,OADS,/arxiv_data1/oa_pdf/76/38/main.PMC4008386.pdf
OncoImmunology 2014; 3:e27845; http://dx.doi.org/10.4161/onci.27845Monocytic myeloid-derived suppressor cells   in advanced melanoma patients Indirect impact on prognosis through inhibition   of tumor-specific T-cell responses?,Non-OADS,/arxiv_data1/oa_pdf/4c/de/onci-3-e27845.PMC4008451.pdf
J Clin Oncol 2012; 30:1835-41; PMID:22529253 ;  http://dx.doi.org/10.1200/JCO.2011.40.22712.,Non-OADS,/arxiv_data1/oa_pdf/4c/de/onci-3-e27845.PMC4008451.pdf
Clin  Cancer Res 2013; Forthcoming; PMID:24323899 ;  http://dx.doi.org/10.1158/1078-0432.CCR-13-25083.,Non-OADS,/arxiv_data1/oa_pdf/4c/de/onci-3-e27845.PMC4008451.pdf
Nat Rev Immunol 2012; 12:253-68; PMID:22437938 ; http://dx.doi.org/10.1038/ nri3175 4.,Non-OADS,/arxiv_data1/oa_pdf/4c/de/onci-3-e27845.PMC4008451.pdf
Cancer Res 2013; 73:3877-87; PMID:23633486 ;  http://dx.doi.org/10.1158/0008-5472.CAN-12-4115,Non-OADS,/arxiv_data1/oa_pdf/4c/de/onci-3-e27845.PMC4008451.pdf
Cancer Immunol Immunother 2009; 58:49-59; PMID:18446337 ; http://dx.doi.org/10.1007/ s00262-008-0523-47.,Non-OADS,/arxiv_data1/oa_pdf/4c/de/onci-3-e27845.PMC4008451.pdf
Blood  2011; 118:2254-65;  PMID:21734236 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4c/de/onci-3-e27845.PMC4008451.pdf
Nat Med 2012; 18:1254-61; PMID:22842478 ;  http://dx.doi.org/10.1038/nm.28839.,OADS,/arxiv_data1/oa_pdf/4c/de/onci-3-e27845.PMC4008451.pdf
Clin  Cancer Res 2012; 18:6485-96; PMID:23032742 ;  http://dx.doi.org/10.1158/1078-0432.CCR-12-1516,Non-OADS,/arxiv_data1/oa_pdf/4c/de/onci-3-e27845.PMC4008451.pdf
OncoImmunology 2014; 3:e28133;  http://dx.doi.org/10.4161/onci.28133Is tumor (R)ejection by the immune system   the â5th Râ of radiobiology?,Non-OADS,/arxiv_data1/oa_pdf/3c/1c/onci-3-e28133.PMC4008452.pdf
Semin Immunol 2010; 22:113-24; PMID:20403709 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/3c/1c/onci-3-e28133.PMC4008452.pdf
OncoImmunology 2014; 3:  (Forthcoming) http://dx.doi.org/10.4161/onci.28518 3.,Non-OADS,/arxiv_data1/oa_pdf/3c/1c/onci-3-e28133.PMC4008452.pdf
J Natl  Cancer Inst 2013; 105:256-65; PMID:23291374 ;  http://dx.doi.org/10.1093/jnci/djs629 4.,Non-OADS,/arxiv_data1/oa_pdf/3c/1c/onci-3-e28133.PMC4008452.pdf
Cancer Cell 2013; 24:589-602; PMID:24209604 ;  http://dx.doi.org/10.1016/j.ccr.2013.09.0145.,Non-OADS,/arxiv_data1/oa_pdf/3c/1c/onci-3-e28133.PMC4008452.pdf
N Engl J Med  2012; 366:925-31;  PMID:22397654 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/1c/onci-3-e28133.PMC4008452.pdf
Cancer Immunol Res  2013; 1:365-72;  PMID:24563870 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/1c/onci-3-e28133.PMC4008452.pdf
J Clin Invest 2012; 122:3718- 30; PMID:22945631 ; http://dx.doi.org/10.1172/ JCI61931 11.,Non-OADS,/arxiv_data1/oa_pdf/3c/1c/onci-3-e28133.PMC4008452.pdf
"OncoImmunology 2014; 3:e27663; http://dx.doi.org/10.4161/onci.27663Chemokines and chemokine receptors required  for optimal responses to anticancer chemotherapy yuting Ma1,2,3, sandy a djemian3,4, Lorenzo Galluzzi1,2,3, Laurence Zitvogel5,6,7, and Guido Kroemer1,2,4,8,9,* 1universitÃ© Paris Descartes/Paris v ; sorbonne Paris CitÃ©; Paris, France; 2equipe 11 labellisÃ©e par la Ligue Nationale contre le Cancer ; Centre de r echerche des Cordeliers;   Paris, France; 3Gustave r oussy Cancer Campus; v illejuif, France 4INserM, u 848; v illejuif, France; 5INserM, u 1015; v illejuif, France; 6FacultÃ© de MÃ©decine; u niversitÃ© Paris- saclay;  Le Kremlin BicÃªtre, France; 7Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507; v illejuif, France; 8Metabolomics and Cell Biology Platforms;   Gustave r oussy Cancer Campus; v illejuif, France; 9PÃ´le de Biologie; h Ã´pital e uropÃ©en Georges Pompidou; a P-hP; Paris, France Keywords:  ATP; autophagy; cancer stem cells; Î³ Î´ T lymphocytes; immunogenic cell death; immunosurveillance.",Non-OADS,/arxiv_data1/oa_pdf/e0/b3/onci-3-e27663.PMC4008453.pdf
Immunity 2013; 39:782- 95; PMID:24138885 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/b3/onci-3-e27663.PMC4008453.pdf
J Clin Invest 2012; 122:3127-44; PMID:22922255 ; http://dx.doi.org/10.1172/ JCI61067 3.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/onci-3-e27663.PMC4008453.pdf
Cell  2008; 133:1006-18;  PMID:18555777 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/b3/onci-3-e27663.PMC4008453.pdf
Cell Death Differ 2014; 21:59- 68; PMID:23787997 ; http://dx.doi.org/10.1038/ cdd.2013.73 5.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/onci-3-e27663.PMC4008453.pdf
Nature 2011; 475:222- 5; PMID:21654748 ; http://dx.doi.org/10.1038/ nature10138 6.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/onci-3-e27663.PMC4008453.pdf
Immunity 2013; 38:729- 41; PMID:23562161 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/b3/onci-3-e27663.PMC4008453.pdf
Cancer Res 2013; Forthcoming;  PMID:24302580 ; http://dx.doi.org/10.1158/0008- 5472.CAN-13-1265 9.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/onci-3-e27663.PMC4008453.pdf
J Exp Med 2011; 208:491-503; PMID:21383056 ; http://dx.doi.org/10.1084/ jem.20100269 10.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/onci-3-e27663.PMC4008453.pdf
Cancer Res 2010; 70:490-500;  PMID:20068181 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-1890,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/onci-3-e27663.PMC4008453.pdf
"OncoImmunology 2014; 3:e27927; http://dx.doi.org/10.4161/onci.27927Application of iPS cell-derived macrophages   to cancer therapy satoruÂ  senju1,2,*, ChihiroÂ Koba1,2, MiwaÂ h aruta1,2, yusukeÂ Matsunaga1,2, KeikoÂ Matsumura1,2, erikoÂ h aga1,2, yukoÂ s asaki1,2,  TokunoriÂ Ikeda1,2, KoutaroÂ Takamatsu1,2, andÂ y asuharuÂ Nishimura1 1Department of Immunogenetics; Graduate s chool of Medical s ciences; Kumamoto u niversity; Kumamoto, Japan;   2CresT; Japan s cience and Technology a gency; Kawaguchi, Japan Keywords:  gastric cancer, interferon Î² , iPS cells, macrophages, pancreatic cancer, peritoneal dissemination we established a method to produce a large quantity of myeloid cells from human inducible pluripotent stem cells  (iPsCs).",OADS,/arxiv_data1/oa_pdf/a3/5b/onci-3-e27927.PMC4008454.pdf
Cancer Res  2006; 66:605-12;  PMID:16423985 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/5b/onci-3-e27927.PMC4008454.pdf
Cancer Metastasis Rev  2006; 25:315-22;  PMID:16967326 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/5b/onci-3-e27927.PMC4008454.pdf
J Clin Invest 2009; 119:2818-29; PMID:19726877 ;  http://dx.doi.org/10.1172/JCI385915.,Non-OADS,/arxiv_data1/oa_pdf/a3/5b/onci-3-e27927.PMC4008454.pdf
Gene Ther 2011; 18:874- 83; PMID:21430784 ; http://dx.doi.org/10.1038/ gt.2011.22 6.,OADS,/arxiv_data1/oa_pdf/a3/5b/onci-3-e27927.PMC4008454.pdf
Gene Ther 2013; 20:504- 13; PMID:22875043 ; http://dx.doi.org/10.1038/ gt.2012.59 7.,OADS,/arxiv_data1/oa_pdf/a3/5b/onci-3-e27927.PMC4008454.pdf
"OncoImmunology 2014; 3:e27872;  http://dx.doi.org/10.4161/onci.27872Altering the intratumoral localization   of macrophages to inhibit cancer progression AndreaÂ Casazza andÂ MassimilianoÂ Mazzone* Laboratory of Molecular o ncology and Angiogenesis; Vesalius r esearch Center; V iB; Leuven, Belgium;   Laboratory of Molecular o ncology and Angiogenesis; Vesalius r esearch Center; Department of o ncology; K. u. Leuven; Leuven, Belgium Keywords:  angiogenesis, hypoxia, immunity, neuropilin, semaphorin, tumor-associated macrophages hypoxia confers to macrophages angiogenic and immunosuppressive properties which promote tumor growth and  progression.",Non-OADS,/arxiv_data1/oa_pdf/56/9d/onci-3-e27872.PMC4008455.pdf
Cancer Res 2014; 74:24-30;  PMID:24220244 ; http://dx.doi.org/10.1158/0008- 5472.CAN-13-1196 2.,Non-OADS,/arxiv_data1/oa_pdf/56/9d/onci-3-e27872.PMC4008455.pdf
Blood   2009 ; 114:844-59; PMID:19454749 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/9d/onci-3-e27872.PMC4008455.pdf
Cancer Cell  2013 ; 24:695- 709; PMID:24332039 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/56/9d/onci-3-e27872.PMC4008455.pdf
Nature   2010 ; 467:1123 -7; PMID:20881961 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/9d/onci-3-e27872.PMC4008455.pdf
Blood  2006 ; 107:3321 - 9; PMID:16380453 ; http://dx.doi.org/10.1182/ blood-2005-06-2445 7.,Non-OADS,/arxiv_data1/oa_pdf/56/9d/onci-3-e27872.PMC4008455.pdf
J Clin Invest 2012 ; 122:1832 - 48; PMID:22484816 ; http://dx.doi.org/10.1172/ JCI589768.,Non-OADS,/arxiv_data1/oa_pdf/56/9d/onci-3-e27872.PMC4008455.pdf
Arterioscler Thromb Vasc Biol 2011 ; 31:741- 9; PMID:21205984 ; http://dx.doi.org/10.1161/ ATVBAHA.110.211920 9 .,Non-OADS,/arxiv_data1/oa_pdf/56/9d/onci-3-e27872.PMC4008455.pdf
Nat Rev Clin Oncol 2011 ; 8:393-404;  PMID:21629216 ; http://dx.doi.org/10.1038/ nrclinonc.2011.83 10.,Non-OADS,/arxiv_data1/oa_pdf/56/9d/onci-3-e27872.PMC4008455.pdf
Cancer Cell   2013 ; 23:277-86; PMID:23518347 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/9d/onci-3-e27872.PMC4008455.pdf
"OncoImmunology 2014; 3:e28185;   http://dx.doi.org/10.4161/onci.28185Trial Watch DNA vaccines for cancer therapy Jonathan Pol1,2,3,4,â , Norma Bloy1,2,3,4,â , Florine Obrist1,2,3,4, Alexander e ggermont1, JÃ©rÃ´me Galon5,6,7, 8, wolf HervÃ© Fridman6,7,9,  isabelle Cremer6,7,9, Laurence Zitvogel1,10, Guido Kroemer2,3,5,11,12,â¡,*, and Lorenzo Galluzzi1,3,5,â¡,* 1Gustave Roussy; v illejuif, France; 2iNSeRM, U848; v illejuif, France; 3equipe 11 labellisÃ©e par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers; Paris,  France; 4UniversitÃ© Paris-Sud/Paris X i; Paris, France; 5UniversitÃ© Paris Descartes/Paris v ; Sorbonne Paris CitÃ©; Paris, France; 6UniversitÃ© Pierre et Marie Curie/Paris vi ; Paris, France;  7iNSeRM, UMRS1138; Paris, France; 8Laboratory of i ntegrative Cancer i mmunology; Centre de Recherche des Cordeliers; Paris, France; 9equipe 13, Centre de Recherche   des Cordeliers; Paris, France; 10iNSeRM, U1015; C iCBT507; v illejuif, France; 11PÃ´le de Biologie, HÃ´pital e uropÃ©en Georges Pompidou, AP-HP; Paris, France;   12Metabolomics and Cell Biology Platforms, Gustave Roussy; v illejuif, France â These authors contributed equally to this work â¡These authors share senior co-authorship Keywords:  cross-presentation, dendritic cells, electroporation, Listeria monocytogenes , mucosal immunity, Saccharomyces cerevisiae Abbreviations:  ADT, androgen deprivation therapy; CEA, carcinoembryonic antigen; DC, dendritic cell; EBV, Epstein-Barr virus;  FDA, Food and Drug Administration; HPV, human papillomavirus; ICOS, inducible T-cell co-stimulator;   LTB, E. coli  heat labile toxin, B subunit; MAMA, mammaglobin A; PSA, prostate specific antigen;   PSMA, prostate-specific membrane antigen; TAA, tumor-associated antigen; TERT, telomerase reverse transcriptase;   VRP, virus-like replicon particle During the past 2 decades, the possibility that preparations  capable of eliciting tumor-specific immune responses would  mediate robust therapeutic effects in cancer patients has  received renovated interest.",Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
"56 In spite of a significant amount of encouraging clinical  results,56 no DNA-based vaccines are currently licensed by the US  Food and Drug Administration (FDA) for use in cancer patients, neither as a prophylactic nor as a therapeutic intervention (source http://www.fda.gov).",Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
"In same period, 6 clinical trials have been launched to test the safety and therapeutic potential of DNA-based anticancer vaccines in cancer patients (source http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
"As for the clinical trials listed in our previous Trial  Watch dealing with this topic, 56 the following studies have  changed status: NCT00669136, now listed as âTerminatedâ; NCT00629057, NCT01147965, NCT01152398, and NCT01191684, now listed as âCompletedâ; NCT00669734 and NCT01304524, now listed as âActive, not recruitingâ; and NCT01116245 and NCT01064375, whose status is âUnknownâ (source http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Nat Med 2003; 9:269-77; PMID:12612576 ;  http://dx.doi.org/10.1038/nm0303-269 2.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Curr Opin Immunol 2004 ; 16:127- 9; PMID:15023402 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Annu Rev Immunol 1994 ; 12:991-1045 ;  PMID:8011301 ; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Science   1991 ; 254:1643 -7; PMID:1840703 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2013; 2:e25771; PMID:24286020; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2012 ; 1:1111-34;  PMID:23170259 ; http://dx.doi.org/10.4161/ onci.21494 7.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Nat Rev Cancer 2012 ; 12:265- 77; PMID:22437871 ; http://dx.doi.org/10.1038/ nrc3258 8.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Nat Rev Cancer 2008 ; 8:351- 60; PMID:18418403 ; http://dx.doi.org/10.1038/ nrc2373 9.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2013 ; 2:e26621 ;  PMID:24498550 ; http://dx.doi.org/10.4161/ onci.26621 10.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2012 ; 1:1557- 76; PMID:23264902 ; http://dx.doi.org/10.4161/ onci.22428 11.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Nat Rev Cancer 2008 ;  8:108-20; PMID:18219306 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
J Biomed Biotechnol  2010 ;  2010 :174378 ; PMID:20368780 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Immunol Rev  2011 ;  239:62-84; PMID:21198665 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Curr Opin  Immunol  2010 ; 22:264-70; PMID:20172703 ;  http://dx.doi.org/10.1016/j.coi.2010.01.019 15.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Nat Med  1996 ; 2:985-91; PMID:8782455 ;  http://dx.doi.org/10.1038/nm0996-98516.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Curr  Opin Cell Biol 2010 ; 22:181-5; PMID:20044243 ;  http://dx.doi.org/10.1016/j.ceb.2009.12.001 17.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Cell Cycle  2008 ; 7:1949 -55; PMID:18642442 ;  http://dx.doi.org/10.4161/cc.7.13.6222 18.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Mol Ther  2009 ; 17:1651- 7; PMID:19532136 ; http://dx.doi.org/10.1038/ mt.2009.126 20.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Clin Cancer Res 2004 ; 10:2986 -96;  PMID :15131034 ; http://dx.doi.org/10.1158/1078- 0432.CCR-03-0291 21.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Gene Ther  1997 ; 4:238-43; PMID:9135737 ;  http://dx.doi.org/10.1038/sj.gt.3300376 23.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Mol Ther  2000 ; 1:195- 203; PMID:10933931 ; http://dx.doi.org/10.1006/ mthe.2000.0030 27.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Mol Ther  2001 ; 4:157- 60; PMID:11482988 ; http://dx.doi.org/10.1006/ mthe.2001.043028.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
J Neurooncol  2003 ;  65:279-89; PMID:14682378 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Ann Neurol  2003 ; 54:479-87; PMID:14520660 ;  http://dx.doi.org/10.1002/ana.10688 30.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Hum  Gene Ther  2003 ; 14:227-41; PMID:12639303 ;  http://dx.doi.org/10.1089/10430340360535788 31.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Cancer  Gene Ther  2003 ; 10:737-44; PMID:14502226 ;  http://dx.doi.org/10.1038/sj.cgt.7700634 32.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Cancer Gene Ther  2003 ; 10:755- 63; PMID:14502228 ; http://dx.doi.org/10.1038/ sj.cgt.7700626 33.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Hum Gene Ther  2001 ; 12:883-92; PMID:11387054 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Methods Mol Biol  2008 ;  423:361-72; PMID:18370214 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Hum Gene Ther  2005 ; 16:35-48; PMID :15703487 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Cancer  Gene Ther  2007 ; 14:717-23; PMID:17557109 ;  http://dx.doi.org/10.1038/sj.cgt.7701064 38.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Gene Ther  2010 ; 17:360- 9; PMID:20033066 ; http://dx.doi.org/10.1038/ gt.2009.159,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2012 ; 1:97- 9; PMID:22720223 ; http://dx.doi.org/10.4161/ onci.1.1.17930 41.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Cancer Gene Ther   2003 ; 10:251-9; PMID:12679797 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Blood  2004 ;  104:1631 -8; PMID:15161670 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Cancer Gene Ther  1999 ; 6:322-30; PMID:10419050 ;  http://dx.doi.org/10.1038/sj.cgt.7700019 44.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Clin  Cancer Res 2010 ; 16:3279 -87; PMID:20448220 ;  http://dx.doi.org/10.1158/1078-0432.CCR-10-0385 46.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Cancer Res  2012 ; 72:2937 -48; PMID:22505652 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Proc Natl Acad Sci U S A  1993 ; 90:11307 -11; PMID:8248244 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Proc Natl Acad Sci U S A 1996 ; 93:15388 -93;  PMID:8986821 ; http://dx.doi.org/10.1073/ pnas.93.26.15388 49.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Gene Ther   1997 ; 4:419-25; PMID:9274718 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Arch Otolaryngol Head  Neck Surg 1998 ; 124:1097 -104; PMID:9776187 ;  http://dx.doi.org/10.1001/archotol.124.10.1097 52.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Melanoma Res  2006 ; 16:521-6; PMID:17119453 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2013 ; 2:e23803 ;  PMID:23734328 ; http://dx.doi.org/10.4161/ onci.23803 57.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology   2013 ; 2:e23140 ; PMID:23802067 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Cancer J 2011 ; 17:359-71;  PMID:21952287 ; http://dx.doi.org/10.1097/ PPO.0b013e3182325e63 59.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Trends Mol Med  2012 ; 18:564- 74; PMID:22917663 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology   2013 ; 2:e26013 ; PMID:24083086 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2013 ; 2:e22566 ;  PMID:23483777 ; http://dx.doi.org/10.4161/ onci.22566 62.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Science   2003 ; 302:415-9; PMID:14564000 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2013 ; 2:e25238 ;  PMID:24083080 ; http://dx.doi.org/10.4161/ onci.25238 64.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2012 ; 1:894-907;  PMID:23162757 ; http://dx.doi.org/10.4161/ onci.2093165.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology   2012 ; 1:699-716; PMID:22934262 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology   2012 ; 1:242-3; PMID:22720257 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Vaccine  2009 ; 27:5450 -9; PMID:19622402 ;  http://dx.doi.org/10.1016/j.vaccine.2009.07.005 70.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Methods  2006 ; 40:86-97;  PMID:16997717 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology   2012 ; 1:1537-45; PMID:23264900 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Hum Gene Ther 2009 ; 20:181- 9; PMID:19301471 ; http://dx.doi.org/10.1089/ hum.2008.073 74.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
BMC Cancer  2012 ; 12:361; PMID:22906006 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Clin Vaccine  Immunol  2010 ; 17:889-94; PMID:20375244 ;  http://dx.doi.org/10.1128/CVI.00044-10,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
J Virol  2008 ; 82:5643 -9; PMID:18353952 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Nat Biotechnol  1998 ; 16:867- 70; PMID:9743122 ; http://dx.doi.org/10.1038/ nbt0998-867 81.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Gene Ther   1999 ; 6:508-14; PMID:10476210 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Curr Gene Ther 2011 ; 11:447-56; PMID:22023474 ;  http://dx.doi.org/10.2174/156652311798192860 84.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology   2013 ; 2:e26536 ; PMID:24404424 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Annu Rev Immunol 2013 ; 31:51-72;  PMID :23157435 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-100008 86.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Nat Rev Cancer  2005 ; 5:615-25;  PMID:16034368 ; http://dx.doi.org/10.1038/ nrc1669 88.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2012 ; 1:1194 -6; PMID:23170277 ;  http://dx.doi.org/10.4161/onci.20686 89.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
J Virol  2001 ; 75:4040 -7; PMID:11287553 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
J Transl  Med 2013 ; 11:62; PMID :23497415 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Vaccine   2013 ; 31:3843 -8; PMID:23831327 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
"Breast Cancer  Res Treat  2013 ; 138:109-18; PMID:22678162 ;  http://dx.doi.org/10.1007/s10549-012-2110-9 96.Bilusic M, Heery  CR, Arlen  PM, Rauckhorst  M,  Apelian  D, Tsang  KY, Tucker  JA, Jochems  C, Schlom   J, Gulley  JL, et al.",Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Cancer Immunol  Immunother  2014 ; 63:225-34; PMID:24327292 ;  http://dx.doi.org/10.1007/s00262-013-1505-8 97.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Cancer Res  2013 ; 73:1676 -88; PMID:23348421 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
N Engl J Med  1991 ; 324:1156 -61; PMID:1707140 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
N Engl J Med 2013 ; 368:1314 -25; PMID:23550669 ;  http://dx.doi.org/10.1056/NEJMoa1212299 102.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
N Engl J Med 2012 ;  367:945-6; PMID:22931264 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2012 ; 1:1220 -1; PMID:23170287 ;  http://dx.doi.org/10.4161/onci.20448104.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology   2013 ; 2:e24962 ; PMID:23894725 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Clin Biochem   2004 ; 37:249-57; PMID:15003725 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology   2013 ; 2:e23185 ; PMID:23802069 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
"Annu Rev Immunol 2012 ; 30:531-64;  PMID:22224781 ; http://dx.doi.org/10.1146/ annurev.immunol.25.022106.141623 109. von Boehmer  H, Daniel  C. Therapeutic opportunities  for manipulating T(Reg) cells in autoimmunity and cancer.",Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Nat Rev Drug Discov 2013 ; 12:51- 63; PMID:23274471 ; http://dx.doi.org/10.1038/ nrd3683 110.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology   2013 ; 2:e23852 ; PMID:23762787 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Expert Rev Vaccines  2008 ; 7:987-93; PMID:18767948 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Curr Cancer Drug Targets  2004 ; 4:443-54; PMID:15320719 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Cancer Treat Rev  2013 ; 39:219-29; PMID:22658319 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Nat Rev Clin Oncol 2011 ; 9:16-32; PMID:22124364 ;  http://dx.doi.org/10.1038/nrclinonc.2011.177 117.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Infect Immun  2000 ; 68:2775 - 82; PMID:10768972 ; http://dx.doi.org/10.1128/ IAI.68.5.2775-2782.2000 119.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Biomark Med   2013 ; 7:159-67; PMID:23387497 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Immunol Lett  2004 ; 92:259-68; PMID :15081621 ;  http://dx.doi.org/10.1016/j.imlet.2004.01.006 123.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Vaccine  2013 ;  31:4241 -6; PMID:23523410 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology   2013 ; 2:e23035 ; PMID:23526738 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2012 ; 1:1440 -2;  PMID:23243622 ; http://dx.doi.org/10.4161/ onci.21286 127.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Nat Rev  Urol 2010 ; 7:300; PMID:20545033 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Lancet   2010 ; 375:1437- 46; PMID:20398925 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
N Engl J Med 2012 ; 367:1187 -97; PMID:22894553 ;  http://dx.doi.org/10.1056/NEJMoa1207506 131.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
J Transl  Med 2006 ; 4:1; PMID:16390546 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology   2013 ; 2:e24523 ; PMID:23762812 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Ann Oncol  2012 ; 23(Suppl  8):viii22- 7; PMID:22918924 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Semin Oncol 2012 ; 39:296-304;  PMID:22595052 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
EMBO Rep 2006 ; 7:599-604; PMID:16741504 ;  http://dx.doi.org/10.1038/sj.embor.7400705 137.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Bioessays   1992 ; 14:619-25; PMID:1365918 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology   2013 ; 2:e23429 ; PMID:23802084 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
PLoS One  2010 ; 5:e12670 ;  PMID:20844763 ; http://dx.doi.org/10.1371/ journal.pone.0012670 140.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
J Clin Invest 2010 ;  120:3234 -41; PMID:20679728 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Expert  Rev Mol Med  2008 ; 10:e33; PMID:19000329 ;  http://dx.doi.org/10.1017/S1462399408000859 142.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Curr Drug Targets  2009 ; 10:118-25; PMID:19199907 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
OncoImmunology  2013 ; 2:e26084 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Vaccine   2009 ; 27:987-94; PMID:19110021 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Clin Cancer Res  2008 ; 14:4316 -25; PMID:18594015 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Lancet  1976 ;  2:1016 -7; PMID:62227 ; http://dx.doi.org/10.1016/ S0140-6736(76)90847-3 148.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Br J Cancer 1976 ; 34:111-5; PMID:962990 ;  http://dx.doi.org/10.1038/bjc.1976.133 149.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
N Engl J Med 1968 ; 278:523- 9; PMID:5637238 ; http://dx.doi.org/10.1056/ NEJM196803072781002 150.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Proc Natl Acad Sci U S A  1968 ; 59:1216 - 22; PMID:5240025 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
N Engl J Med 1968 ;  279:279-83; PMID:5660301 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2013 ; 2:e25752 ;  PMID:24083082 ; http://dx.doi.org/10.4161/ onci.25752 153.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Expert Rev Vaccines 2013 ;  12:493-504; PMID:23659298 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2012 ; 1:822- 8; PMID:23162749 ; http://dx.doi.org/10.4161/ onci.20491 155.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Viral Immunol  2009 ; 22:195-204; PMID:19435416 ;  http://dx.doi.org/10.1089/vim.2008.0071 156.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Am J Gastroenterol  2006 ; 101:524-32; PMID:16542289 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Cancer Immunol Immunother  2013 ; 62:1293 - 301; PMID:23624851 ; http://dx.doi.org/10.1007/ s00262-013-1400-3 158.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Hum Gene Ther  2013 ; 24:728-38; PMID:23902422 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2012 ; 1:179- 88; PMID:22720239 ; http://dx.doi.org/10.4161/ onci.1.2.19026 160.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2013 ; 2:e23510 ;  PMID:23687621 ; http://dx.doi.org/10.4161/ onci.23510 161.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Nat Rev Drug Discov 2012 ; 11:215-33;  PMID:22301798 ; http://dx.doi.org/10.1038/ nrd3626163.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Nat Rev Mol Cell Biol 2011 ; 12:385- 92; PMID :21527953 ; http://dx.doi.org/10.1038/ nrm3115 164.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2012 ; 1:372-4; PMID:22737619 ;  http://dx.doi.org/10.4161/onci.18963 165.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Vet J  2008 ; 175:155- 63; PMID:17398127 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Vaccine   2010 ; 28:1201 -8; PMID:19944791 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
N Engl J Med 2010 ; 363:411- 22; PMID:20818862 ; http://dx.doi.org/10.1056/ NEJMoa1001294 169.,OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Vaccine  2007 ; 25:3731 - 41; PMID:17350735 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
Oncoimmunology  2013 ; 2:e25396 ;  PMID:23894726 ; http://dx.doi.org/10.4161/ onci.25396,Non-OADS,/arxiv_data1/oa_pdf/ff/12/onci-3-e28185.PMC4008456.pdf
"OncoImmunology 2014; 3:e27988; http://dx.doi.org/10.4161/onci.27988NKp44L A new tool for fighting cancer vincentÂ v ieillard*, FlorenceÂ Baychelier, andÂ PatriceÂ DebrÃ© sorbonne u niversitÃ©; u PMC, u niv Paris 06; C r7; CIMI-Paris; Paris, France;   INserM, u 1135; CIMI-Paris; Paris, France;   CNrs, erL8255; CIMI-Paris; Paris, France Keywords:  natural killer cells, MLL5, natural cytotoxicity receptors, immunotherapy, tumor cells, NKp44, NKp44L we have recently identified that the ligand of natural cytotoxicity triggering receptor 2 (NC r2, best known as NKp44)  is expressed on a large panel of malignant cells.",Non-OADS,/arxiv_data1/oa_pdf/d4/ff/onci-3-e27988.PMC4008457.pdf
Lancet  2000; 356:1795-9;  PMID:11117911 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/ff/onci-3-e27988.PMC4008457.pdf
Nat Rev Immunol 2012; 12:239-52;  PMID:22437937 ; http://dx.doi.org/10.1038/nri3174 3.,Non-OADS,/arxiv_data1/oa_pdf/d4/ff/onci-3-e27988.PMC4008457.pdf
J Exp Med 1998; 187:2065-72;  PMID:9625766 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/ff/onci-3-e27988.PMC4008457.pdf
Annu Rev Immunol 2013; 31:413-41; PMID:23298206 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-095951 5.,Non-OADS,/arxiv_data1/oa_pdf/d4/ff/onci-3-e27988.PMC4008457.pdf
Immunol Cell Biol 2013; In press; PMID:24366519 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/ff/onci-3-e27988.PMC4008457.pdf
Oncogene 2002; 21:4849-54; PMID:12101424 ; http://dx.doi.org/10.1038/ sj.onc.12056158.,OADS,/arxiv_data1/oa_pdf/d4/ff/onci-3-e27988.PMC4008457.pdf
J Clin Oncol 2011; 29:682- 9; PMID:21205756 ; http://dx.doi.org/10.1200/ JCO.2010.31.1118 9.,Non-OADS,/arxiv_data1/oa_pdf/d4/ff/onci-3-e27988.PMC4008457.pdf
Cancer Res  2011; 71:6696-707;  PMID:21908553 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/ff/onci-3-e27988.PMC4008457.pdf
Front Immunol 2013; 4:325; PMID:24109484 ;  http://dx.doi.org/10.3389/fimmu.2013.00325,Non-OADS,/arxiv_data1/oa_pdf/d4/ff/onci-3-e27988.PMC4008457.pdf
"Mabs 2013 ;  5:621- 3; PM id:23 924791 ; http://dx.doi.org/10.4161/ mabs.25864.Biosimilars enter Europe Broad spectrum biosensors Four scientists from ibis Biosciences, an  abbo t company, have contributed a special  focus review on broad spectrum biosensors in Virulence.",Non-OADS,/arxiv_data1/oa_pdf/01/92/bbug-5-1.PMC4008458.pdf
Virulence  2013 ;  4:752-8; PM id:24 128433 ; http://dx.doi.org/10.4161/ viru.26652,Non-OADS,/arxiv_data1/oa_pdf/01/92/bbug-5-1.PMC4008458.pdf
Mob genet  elemen ts  2012 ; 2: 211-23; PM id:23 550063 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/01/92/bbug-5-1.PMC4008458.pdf
This avoids bio-safety concerns of genetically engineered transgenic plants and lengthy plant transformation  *Correspondence to: Karl Josef Kunert; Email: karl.kunert@up.ac.za Submitted: 04/17/2013; Revised: 05/22/2013; Accepted: 05/23/2013; Published Online: 05/29/2013http://dx.doi.org/10.4161/bioe.25158Plants are increasingly used as alternative expression hosts for the  production of recombinant proteins offering many advantages including higher biomass and the ability to perform post-translational modifications on complex proteins.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
"13,14 Based on their active site residues for catalysis, most  proteases can be distinguished as serine, cysteine, aspartic, and metallo-types 14 with serine proteases consisting of about 200 mem - bers, and the cysteine, aspartic, and metallo-type proteases about 100 members in each class (http://merops.sanger.ac.uk).",Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
J Biotechnol 2007; 127:335-47; PMID:16959350; http://dx.doi.org/10.1016/j.jbiotec.2006.07.012 2.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
EMBO Rep 2005; 6:593-9; PMID:15995674; http://dx.doi.org/10.1038/sj.embor.7400470 3.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Trends Plant Sci 2009; 14:669-79; PMID:19836291; http://dx.doi.org/10.1016/j.tplants.2009.09.009 4.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol J 2010; 8:529-63; PMID:20132515; http://dx.doi.org/10.1111/j.1467-7652.2009.00494.x 5.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol J 2010; 8:620-37; PMID:20233333; http://dx.doi.org/10.1111/j.1467-7652.2010.00507.x6.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Biotechnol Adv 2009; 27:879-94; PMID:19647060; http://dx.doi.org/10.1016/j.biotechadv.2009.07.002 7.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Biotechnol Bioeng 2009; 102:965-70; PMID:18819157; http://dx.doi.org/10.1002/bit.22118 8.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol J 2006; 4:359-68; PMID:17147641; http://dx.doi.org/10.1111/j.1467-7652.2006.00187.x 10.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol J 2008; 6:633-48; PMID:18452504; http://dx.doi.org/10.1111/j.1467-7652.2008.00344.x11.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Planta 2004; 220:183-97; PMID:15517349; http://dx.doi.org/10.1007/s00425-004-1407-2 12.  van de r Hoorn RAL.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Annu Rev Plant Biol 2008; 59:191-223; PMID:18257708; http://dx.doi.org/10.1146/annurev.arplant.59.032607.092835 13.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Mol Biol 1996; 32:275-302; PMID:8980483; http://dx.doi.org/10.1007/BF00039386 14.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Chem Rev 2002; 102:4639-750; PMID:12475205; http://dx.doi.org/10.1021/cr010182v 15.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Nucleic Acids Res 2012; 40(Database issue):D343-50; PMID:22086950; http://dx.doi.org/10.1093/nar/gkr987 16.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
J  Exp Bot 2006; 57:1431-43; PMID:16551685; http://dx.doi.org/10.1093/jxb/erj123,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
BMC Biol 2009; 7:48; PMID:19664215; http://dx.doi.org/10.1186/1741-7007-7-48 46.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol J 2009; 7:899-913; PMID:19843249; http://dx.doi.org/10.1111/j.1467-7652.2009.00452.x 47.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
J Exp Bot 2010; 61:4169-83; PMID:20581122; http://dx.doi.org/10.1093/jxb/erq166 48.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol J 2003; 1:101-12; PMID:17147747; http://dx.doi.org/10.1046/j.1467-7652.2003.00010.x 49.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Physiol 2006; 141:1185-93; PMID:16896231; http://dx.doi.org/10.1104/pp.105.074419 50.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Protein Expr Purif 2008; 61:117-21; PMID:18634882; http://dx.doi.org/10.1016/j.pep.2008.06.005 51.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol J 2012; 10:806-14; PMID:22564275; http://dx.doi.org/10.1111/j.1467-7652.2012.00698.x 52.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Appl Biochem Biotechnol 2012; 168:1608-20; PMID:22965305; http://dx.doi.org/10.1007/s12010-012-9882-6 53.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol  J 2011; 9:250-63; PMID:20618764; http://dx.doi.org/10.1111/j.1467-7652.2010.00546.x 54.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
FASEB J 2009; 23:3581-9; PMID:19470800; http://dx.doi.org/10.1096/fj.09-131771 55.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Physiol Plant 2012; 145:130-9; PMID:22242903; http://dx.doi.org/10.1111/j.1399-3054.2012.01574.x 57.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Cell Tissue Organ Cult 2013; http://dx.doi.org/10.1007/s11240-013-0309-z31.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Planta 1995; 196:586-96; PMID:7647686; http://dx.doi.org/10.1007/BF00203660 32.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Trends Biotechnol 2006; 24:426-32; PMID:16843560; http://dx.doi.org/10.1016/j.tibtech.2006.06.012 33.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Curr Opin Biotechnol 2006; 17:341-6; PMID:16828275; http://dx.doi.org/10.1016/j.copbio.2006.06.010 34.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol J 2010; 8:564-87; PMID:20233335; http://dx.doi.org/10.1111/j.1467-7652.2009.00497.x 35.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Biotechnol Bioeng 2005; 89:848-58; PMID:15685597; http://dx.doi.org/10.1002/bit.20410 36.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol J 2009; 7:146-60; PMID:19055607; http://dx.doi.org/10.1111/j.1467-7652.2008.00382.x 37.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Transgenic Res 2009; 18:467-82; PMID:19140023; http://dx.doi.org/10.1007/s11248-008-9240-1 38.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Proteomics 2009; 9:746-56; PMID:19137543; http://dx.doi.org/10.1002/pmic.200700234 39.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
PLoS One 2012; 7:e48938;  PMID:23152824; http://dx.doi.org/10.1371/journal.pone.0048938 40.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Biotechnol J 2006; 1:1071-9; PMID:17004305; http://dx.doi.org/10.1002/biot.200600145 41.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol J 2007; 5:495-510; PMID:17490448; http://dx.doi.org/10.1111/j.1467-7652.2007.00259.x 42.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Planta 2010; 231:387-95; PMID:20041332; http://dx.doi.org/10.1007/s00425-009-1058-4 43.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
J Biotechnol  2010; 145:273-80; PMID:19995584; http://dx.doi.org/10.1016/j.jbiotec.2009.12.006 44.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol J 2004; 2:261-70; PMID:17147617; http://dx.doi.org/10.1111/j.1467-7652.2004.00072.x17.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Proteomics  2008; 8:2285-98; PMID:18446799; http://dx.doi.org/10.1002/pmic.200700507 18.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Proteomics 2010; 10:2536- 44; PMID:20422621; http://dx.doi.org/10.1002/pmic.200900382 19.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol J 2012; 10:83-94; PMID:21895943; http://dx.doi.org/10.1111/j.1467-7652.2011.00643.x 20.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Physiol 2001; 125:1912-8; PMID:11299370; http://dx.doi.org/10.1104/pp.125.4.1912 22.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Biochim Biophys Acta 2012; 1817:239-46; PMID:21645493; http://dx.doi.org/10.1016/j.bbabio.2011.05.014 23.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Vaccine 2005; 23:1770-8; PMID:15734039; http://dx.doi.org/10.1016/j.vaccine.2004.11.003 24.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Annu Rev Plant Biol 2004; 55:555-90; PMID:15377232; http://dx.doi.org/10.1146/annurev.arplant.55.031903.141801 25.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Mol Biol 1998; 38:101-9; PMID:9738962; http://dx.doi.org/10.1023/A:1006029617949 26.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Curr Opin Biotechnol 2005; 16:167-73; PMID:15831382; http://dx.doi.org/10.1016/j.copbio.2005.01.005 27.,OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Mol Breed 2001; 7:329-40; http://dx.doi.org/10.1023/A:1011653220724 28.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Physiol 2008; 148:1212-8; PMID:18775971; http://dx.doi.org/10.1104/pp.108.126284 29.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Vet Immunol Immunopathol 2008; 121:83-90; PMID:18006078; http://dx.doi.org/10.1016/j.vetimm.2007.08.010 30.,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Plant Biotechnol J 2009; 7:537-49; PMID:19486322; http://dx.doi.org/10.1111/j.1467-7652.2009.00422.x,Non-OADS,/arxiv_data1/oa_pdf/ba/1d/bbug-5-15.PMC4008460.pdf
Available from: http://www.the-scientist.com//?articles.view/articleNo/38223/title/ open- Access-Genomes/ 3. sampl e i. Cri tics urge caution as UK genome project  hunts for volunteers [ inte rnet].,Non-OADS,/arxiv_data1/oa_pdf/96/c1/bbug-5-3.PMC4008462.pdf
"Available  from: http://www.theguardian.com/science/2013/ nov/07/personal-genome-project-uk-launchOpen access Genome Project in UK First vaccination against malaria every year, around 660  000 p eople die from  malaria, most of them small children under  the age of five.",Non-OADS,/arxiv_data1/oa_pdf/96/c1/bbug-5-3.PMC4008462.pdf
Available  from: http://www.theguardian.com/society/2013/ oct/08/malaria-vaccine-trial-children-babies 2013 Nobel Prizes awarded this yearâs Nobel Prizes have been awarded  by th e Royal swedi sh Academy of scie nces.,Non-OADS,/arxiv_data1/oa_pdf/96/c1/bbug-5-3.PMC4008462.pdf
Available from:  http://www.elsevier.com/about/press-releases/ research-and-journals/elsevier-announces-article-retraction-from-journal-food-and-chemical-toxicology 8.,Non-OADS,/arxiv_data1/oa_pdf/96/c1/bbug-5-3.PMC4008462.pdf
"*Correspondence to: Mingtao Zeng; E-mail: mt.zeng@ttuhsc.edu Submitted: 10/20/2013; Revised: 11/25/2013; Accepted: 11/26/2013; Published Online: 12http://dx.doi.org/10.4161/bioe.27339Addition of poly (propylene glycol)   to multiblock copolymer   to optimize siRNA delivery Zhi Dai, Maria T arÃ©va lo, Junwei Li, and Mingtao Zeng* center of excel lence for Infectious Diseases; Department of Biomedical scien ces; Paul L Foster schoo l of Medicine;   Texas Tech University healt h scien ces cente r; el Paso , TX U sa Keywords:  RNAi, siRNA delivery, copolymer, poly(ethylene glycol), poly(propylene glycol), poly(L-lysine) Previous studies have examined different strategies for siRN a de livery with varying degrees of success.",Non-OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Trends  Mol Med 2009; 15:491-500; PMID:19846342 ;  http://dx.doi.org/10.1016/j.molmed.2009.09.001 2.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Nucleic Acid Ther 2011; 21:133-47;  PMID:21749290 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Methods Mol Biol 2011; 721:339-53;  PMID:21431696 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Proc Natl Acad Sci U S A 2004; 101:8682-6;  PMID:15173583 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Nat Med 2005; 11:50-5; PMID :15619632 ; http://dx.doi.org/10.1038/ nm1164 6.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Nucleic Acids Res 2004; 32:e149; PMID:15520458 ;  http://dx.doi.org/10.1093/nar/gnh140 8.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Mol Cancer Ther 2009; 8:2674-83;  PMID:19723880 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Pathology 2012; 44:453-9;  PMID:22810054 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
J Control Release 2012; 161:875-83; PMID:22762887 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Mol Pharm 2012; (Forthcoming); PMID:22686936 ;  http://dx.doi.org/10.1021/mp300152v12.,Non-OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Nature 2009; 457:426-33;  PMID :19158789 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
J Gene Med 2005; 7:992-1009;  PMID :15920783 ; http://dx.doi.org/10.1002/ jgm.773 15.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Top Curr Chem 2010; 296:227-49; PMID:21504104 ;  http://dx.doi.org/10.1007/128_2010_69 17.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
J Am Chem Soc 2005; 127:2810-1;  PMID:15740090 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
J Control Release 2012; 159:251-60; PMID:22285552 ;  http://dx.doi.org/10.1016/j.jconrel.2012.01.015 19.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Biomacromolecules 2008; 9:2048-55;   PMID:18572920 ; http://dx.doi.org/10.1021/ bm800287z 20.,Non-OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Biomaterials 2007; 28:4132-42; PMID:17582489 ;  http://dx.doi.org/10.1016/j.biomaterials.2007.05.03523.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Biomaterials 2012; 33:3942-51; PMID:22365809 ;  http://dx.doi.org/10.1016/j.biomaterials.2011.11.088 24.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Biomaterials 2005; 26:4209-17;  PMID:15683643 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Biomaterials 2011; 32:3124-33;  PMID:21277018 ;  http://dx.doi.org/10.1016/j.biomaterials.2011.01.006 26.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Biomacromolecules 2008; 9:3294-307;  PMID:18942877 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
J Mater Chem 2011; 21:3100-6; http://dx.doi.org/10.1039/c0jm03385e 28.,Non-OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Biomacromolecules 2011; 12:2243-50; PMID :21557603 ; http://dx.doi.org/10.1021/ bm2003303 29.,Non-OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Pharm Res 2011; 28:1013-22; PMID :21181546 ;  http://dx.doi.org/10.1007/s11095-010-0344-y 30.,Non-OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
Biomacromolecules 2010; 11:60-7;  PMID:19957992 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/4f/bbug-5-30.PMC4008463.pdf
"In this study, we found that this bacterium secretes  *Correspondence to: Shigeyuki Kawai; Email: kawais@kais.kyoto-u.ac.jp Submitted: 09/17/2013; Revised: 11/29/2013; Accepted: 12/02/2013; Published Online: 01/09/2014http://dx.doi.org/10.4161/bioe.27397Regulation of pH attenuates toxicity   of a byproduct produced by   an ethanologenic strain of Sphingomonas  sp.",Non-OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
J Appl Phycol 2009; 21:569-74; http://dx.doi.org/10.1007/ s10811-008-9384-7 3.,Non-OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
Adv Mat Res 2010; 93-94:463-6; http://dx.doi.org/10.4028/www.scien - tific.net/AMR.93-94.4634.,Non-OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
Bioresour Technol 2011; 102:186-93; PMID:20663661 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
Bioengineered 2013; 4:224-35; PMID:23314751 ; http://dx.doi.org/10.4161/ bioe.23396 6.,OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
Carbohydr Polym 1988; 8:161-82;  http://dx.doi.org/10.1016/0144-8617(88)90001-X 7.,OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
J Appl Phycol 2008; 20:1033-43; http://dx.doi.org/10.1007/s10811-007-9303-38.,Non-OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
Nippon Suisan Gakkai Shi 1993; 59:295-9;  http://dx.doi.org/10.2331/suisan.59.295 9.,Non-OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
J Ind  Microbiol Biotechnol 2000; 24:51-7; http://dx.doi.org/10.1038/sj.jim.2900771 10.,OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
J Ind Microbiol Biotechnol 2000; 25:249-54; http://dx.doi.org/10.1038/ sj.jim.7000065 11.,OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
Energy Environ Sci 2011; 4:2575-81; http://dx.doi.org/10.1039/c1ee01236c,OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
Science 2012; 335:308-13; PMID:22267807 ; http://dx.doi.org/10.1126/ science.1214547 13.,Non-OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
J Ferment Bioeng 1995; 79:538-44; http://dx.doi.org/10.1016/0922-338X(95)94744-C 14.,OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
Bioresour Technol 2011;  102:7466-9;  PMID:21640583 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
J Biomed Biotechnol 2012; 2012:989572;  PMID:23251086 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
Proc Natl Acad Sci U S A 1980; 77:7347- 51; PMID:7012838 ; http://dx.doi.org/10.1073/ pnas.77.12.7347 21.,OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
Anal Biochem 1967; 19:119-32;  PMID:4227774 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/ee/bbug-5-38.PMC4008464.pdf
"OncoImmunology 2014; 3:e27878;   http://dx.doi.org/10.4161/onci.27878Trial Watch Chemotherapy with immunogenic cell death inducers erikaÂ v acchelli1,2,3,4,â , FernandoÂ Aranda1,2,3,4,â , AlexanderÂ  eggermont1, JÃ©rÃ´meÂ Galon5,6,7, 8, CatherineÂ SautÃ¨s-Fridman6,7,9,  isabelleÂ Cremer6,7,9, LaurenceÂ Zitvogel1,10, GuidoÂ Kroemer2,4,5,11,12,â¡,*, andÂ LorenzoÂ Galluzzi1,4,5,â¡,* 1Gustave Roussy; v illejuif, France; 2iNSeRM, U848; v illejuif, France; 3UniversitÃ© Paris-Sud/Paris X i; Paris, France; 4equipe 11 labellisÃ©e par la Ligue Nationale contre le Cancer,  Centre de Recherche des Cordeliers; Paris, France; 5UniversitÃ© Paris Descartes/Paris v ; Sorbonne Paris CitÃ©; Paris, France; 6UniversitÃ© Pierre et Marie Curie/Paris vi ; Paris, France;  7iNSeRM, UMRS1138; Paris, France; 8Laboratory of i ntegrative Cancer i mmunology; Centre de Recherche des Cordeliers; Paris, France; 9equipe 13, Centre de Recherche des  Cordeliers; Paris, France; 10iNSeRM, U1015; C iCBT507; v illejuif, France; 11PÃ´le de Biologie, HÃ´pital e uropÃ©en Georges Pompidou; AP-HP; Paris, France;   12Metabolomics and Cell Biology Platforms, Gustave Roussy; v illejuif, France â These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
"During the last 13 mo, the results of no less than 44 studies assessing the efficacy of ICD inducers in (partially or completely) off-label clinical settings have been published in peer-reviewed scientific journals (source http://www.ncbi.nlm.nih.gov/pubmed) ( Table  1).",Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
e27878-6 Oncoi mmunology volume 3 http://www.clinicaltrials.gov).,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
"Both these patients also suffered from less severe toxicities, including grade I-II mucositis (source http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Nat Rev Cancer  2007 ; 7:139-47; PMID:17218951 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Nat Rev Cancer  2013 ; 13:365-76; PMID:23535846 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Science  2011 ;  331:1565 -70; PMID:21436444 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Annu Rev Immunol  2004 ; 22:329-60; PMID :15032581 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Nat Immunol  2002 ; 3:991-8;  PMID:12407406 ; http://dx.doi.org/10.1038/ ni1102-991 7.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Trends Immunol  2013 ; 34:471-81;  PMID:23891238 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Science   2012 ; 337:1678 -84; PMID:23019653 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Oncoimmunology   2013 ; 2:e22409 ; PMID:23482968 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Nat Rev Drug Discov 2012 ; 11:215-33;  PMID:22301798 ; http://dx.doi.org/10.1038/ nrd3626 12.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Clin Chem  2013 ; 59:85-93; PMID:23193058 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Oncoimmunology  2012 ; 1:1445 -7; PMID:23243624 ;  http://dx.doi.org/10.4161/onci.21318 17.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Oncoimmunology  2013 ; 2:e22789 ;  PMID:23482847 ; http://dx.doi.org/10.4161/ onci.22789 18.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
N Engl J Med 2010 ; 363:711-23;  PMID:20525992 ; http://dx.doi.org/10.1056/ NEJMoa1003466 20.,OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
N Engl J Med  2011 ; 364:2517-26; PMID:21639810 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Lancet Oncol  2010 ; 11:155- 64; PMID:20004617 ; http://dx.doi.org/10.1016/ S1470-2045(09)70334-1 22.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Oncoimmunology  2013 ; 2:e26535 ;  PMID:24244910 ; http://dx.doi.org/10.4161/ onci.26535 23.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Oncoimmunology  2013 ; 2:e24238 ;  PMID:23762803 ; http://dx.doi.org/10.4161/ onci.24238 25.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Oncoimmunology   2012 ; 1:493-506; PMID:22754768 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Cancer Epidemiol Biomarkers Prev  2007 ; 16:1931 -4;  PMID:17932340 ; http://dx.doi.org/10.1158/1055- 9965.EPI-07-0396,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Oncoimmunology  2012 ; 1:1323 - 43; PMID:23243596 ; http://dx.doi.org/10.4161/ onci.22009 28.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
Clin Cancer Res  2012 ; 18:4522 -5; PMID:22761465 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/onci-3-e27878.PMC4008470.pdf
